2017 American Transplant Congress » 2017 ATC Sessions

Date & Time:
None. Available on demand

Location: None listed

Session Type:

Meeting: 2017 American Transplant Congress

Apolipoprotein L1 & Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.

J. Locke,¹ D. Sawinski,² R. Reed,¹ B. Shelton,¹ P. MacLennan,¹ V. Kumar,¹ S. Mehta,¹ R. Mannon,¹ R. Gaston,¹ B. Julian,¹ J. Carr,³ J. Terry,³ M. Kilgore,¹ A. Massie,⁴ D. Segev,⁴ C. Lewis.¹
De Novo Donor-Specific Antibodies After Allograft Nephrectomy.

G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹
A Proof of Concept for Liver Graft Modification Using Warm Ex Vivo Perfusion – “It Is Not Just About Rescuing Marginal Grafts”.

N. Goldaracena, J. Echeverri, N. Selzner, D. Grant, J. Feld, M. Selzner.
Aquaporin 4 Blockade Alters T Cell Anatomical Distribution and Prolongs Cardiac Allograft Survival in Sensitized Recipients.

M. Nicosia,¹ R. Fan,¹ G. Farr,² M. Pelletier,² P. McGuirk,² K. Ayasoufi,¹ A. Valujskikh.¹
Assessment of Islet Damage During Isolation Utilizing miRNAs and Its Significance with Post-Transplant Outcome in TPIAT.

P. Saravanan,¹ M. Kanak,² G. Yoshimatsu,¹ M. Lawrence,¹ B. Naziruddin.³
Autologous Expanded Tregs and Porcine Hematopoietic Cells to Prolong Xenogeneic Pig Skin Graft Acceptance in Baboons.

J. Stern,¹ S. Kofman,¹ P. Alonso-Guallart,¹ E. Berglund,¹ M. Danton,¹ J. Weiner,¹ D. Ayares,² R. Hawley,¹ K. Yamada,¹ D. Sachs,¹ M. Sykes,¹ A. Griesemer.¹
BK Polyomavirus-Specific 9mer T-Cell Responses Predict Control of Viremia in Kidney Transplant Recipients: First Report from the Swiss Transplant Cohort Study.

H. Hirsch,¹ C. Leboeuf,¹ S. Wilk,¹ R. Achermann,² I. Binet,³ D. Golshayan,² K. Hadaya,² C. Hirzel,² M. Hoffmann,² U. Huynh-Do,² M. Koller,² O. Manuel,² N. Mueller,² T. Mueller,² S. Schaub,² C. Van Delden,² F. Weissbach.¹
BK Virus Infection and Risk of Urinary Tract Cancers Among Kidney Transplant Patients in the Transplant Cancer Match Study.

G. Gupta,¹ S. Kuppachi,² R. Kalil,² C. Buck,³ C. Lynch,² E. Engels.³
Benefits of Induction in Recipients of Acute Renal Failure Donor Kidneys.

M. Barrett, A. Smith, K. Woodside, R. Sung.
CTLA4-Ig Inhibits Effector CD8⁺ T Cell Function In Vivo and Rescues Ongoing Acute Allograft Rejection.

J. Young,¹ S. Khiew,¹ J. Yang,¹ M.-L. Alegre,² A. Chong.¹
Characterization of a B Lymphocyte Signature Predictive of Chronic Lung Allograft Dysfunction.

C. Brosseau,^1,2 M. Durand,^1,2 E. Durand,^1,2 J. Loy,² A. Foureau,² P. Lacoste,² P.-J. Royer,² A. Magnan,² S. Brouard.¹
Circulating Donor-Specific Anti-HLA Antibodies Accelerate the Progression of Interstitial Fibrosis in Kidney Allografts.

C. Gosset, D. Viglietti, M. Rabant, E. Pillebout, A. Bouquegneau, J. Taupin, D. Glotz, C. Legendre, J. Duong Van-Huyen, A. Loupy, C. Lefaucheur.
Clinical Significance of Alloantibodies in Hand Transplantation: Impact on Rejection and Functional Outcome.

E. Berglund,¹ M. Andersen Ljungdahl,¹ D. Bogdanovic,¹ D. Berglund,³ J. Wadström,¹ A. Weissenbacher,² P. Petruzzo,⁴ S. Schneeberger.²
Contribution of New Generation Sequencing to CMV Resistance Analysis in Renal Transplant Recipients (on Behalf of the CMV Resist Group).

C. Danthu,¹ M. Gomes-Mayeras,¹ D. Andouard,² E. Munteanu,¹ R. Moulinas,^1,4 G. Ligat,² S. Hantz,^1,2 J. Rerolle,³ F. Garnier,¹ M. Essig,³ S. Alain.^1,2,4
Current Practice and Center-Level Variation in Simultaneous Liver-Kidney Listing.

X. Luo, A. Massie, J. Garonzik-Wang, R. Choudhury, A. Shaffer, S. Zhou, D. Segev.
Disease Progression on Neoadjuvant Chemotherapy Is a Strong Predictor of Recurrence for Pediatric Hepatoblastoma.

M. Kueht,¹ S. Commander,¹ T.-A. Ha,¹ A. Rana,^1,2 Y. Shi,¹ S. Vasudevan,^1,2 J. Goss.^1,2
Donor Derived Transmission Events in 2015-2016: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).

C. Wolfe,¹ M. Clark,² S. Tlusty,² D. Kaul,¹ M. Michaels.¹
Donor Recipient Matching Based on HLA Epitopes Improves Outcome in Kidney Transplant Recipients.

O. Staeck,¹ M. Niemann,³ F. Halleck,¹ D. Khadzhynov,¹ C. Schönemann,² P. Reinke,¹ E. Spierings,⁴ K. Budde,¹ N. Lachmann.²
Donor-Derived Cell-Free DNA Correlates with Antibody-Mediated Rejection in Kidney Allografts.

R. Bloom,¹ J. Bromberg,² E. Poggio,³ D. Hiller,⁴ R. Woodward,⁴ J. Sninsky,⁴ J. Yee,⁴ D. Brennan.⁵
Emergency Department Utilization Among Kidney Transplant Recipients in the United States.

B. Lovasik, R. Zhang, J. Schrager, S. Pastan, A. Adams, R. Patzer.
Factors Associated with Death or Transplant in Low-MELD Patients.

A. Harper,¹ E. Edwards,¹ J. Heimbach.²
Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.

A. Loupy,¹ J. Duong Van-Huyen,¹ L. Hidalgo,² J. Reeve,² M. Racapé,¹ O. Aubert,¹ J. Venner,² D. Viglietti,¹ P. Bruneval,¹ C. Lefaucheur,¹ P. Halloran.²
High Regulatory T Cells Rate Early After Lung Transplantation Is Associated with Bronchiolitis Obliterans Syndrome Development.

M. Durand,^1,2 P. Lacoste,^2,3 C. Brosseau,^1,3 E. Durand,³ J. Loy,³ K. Henrio,^2,3 R. Danger,¹ P. Royer,³ A. Fourreau,³ A. Magnan,^3,4 S. Brouard.¹
Increasing Liver Transplant Waitlist Dropout for Hepatocellular Carcinoma with Widening Geographical Disparities: Implications for Organ Allocation.

N. Mehta, M. Sarkar, J. Dodge, R. Hirose, J. Roberts, F. Yao.
Induction of Sensitization and Resistance to Transplant Tolerance by Allogeneic Pregnancy.

A. Suah,¹ J. Young,¹ S. Hsu-Wei Khiew,¹ Q. Wang,¹ D. Yin,¹ M.-L. Alegre,² A. Chong.¹
Inferior Graft and Patient Survival After Living Donor Renal Transplantation of Negatively Selected Right Kidneys.

S. Yamanaga,^1,2,3 A. Posselt,¹ C. Freise,¹ C. Niemann,¹ A. Rosario,¹ D. Fernandez,¹ T. Kobayashi,³ A. Ahearn,⁴ M. Tavakol,¹ S.-M. Kang.¹
Inflammatory Cytokines Are Associated with Angiotensin II Type 1 Receptor Antibodies and Vascular Inflammation in Pediatric Renal Transplantation.

M. Pearl,¹ J. Grotts,¹ M. Rossetti,¹ Q. Zhang,¹ M. Palma Diaz,¹ D. Gjertson,¹ P. Weng,¹ E. Reed,¹ E. Tsai.²
Infusion of Polyclonal Tregs Modulates Subclinical Kidney Transplant Inflammation: Final Report of TASK Pilot Trial.

S. Chandran, Q. Tang, M. Sarwal, Z. Laszik, A. Putnam, T. Sigdel, E. Tavares, J. Bluestone, F. Vincenti.
Innate Lymphoid Cells Play a Critical Role in Regulating Allograft Homeostasis in Human Intestinal Transplantation.

P. Cha, B. Houlihan, J. Kaiser, C. Cosentino, B. Monahan, A. Shukla, J. Hawksworth, C. Matsumoto, T. Fishbein, A. Kroemer.
Ischemia-Reperfusion Injury-Induced Innate Immune Signaling in Human Orthotopic Liver Transplantation.

R. Sosa,¹ A. Zarrinpar,² M. Rossetti,¹ C. Lassman,¹ B. Naini,¹ N. Datta,² R. Busuttil,² D. Gjertson,¹ J. Kupiec-Weglinski,^1,2 E. Reed.¹
Liver Retransplantation: The Largest Post MELD Single Center Experience.

F. Kaldas, I. Korayem, V. Agopian, T. Russell, S. Ebaid, A. Zarrinpar, H. Yersiz, D. Farmer, R. Busuttil.
Lower Mean Tacrolimus Troughs Increase Risk of De Novo Donor-Specific Antibodies in the First Year of Kidney Transplant.

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.
Mesenchymal Stem Cells Suppress T Cell Proliferation and Improve Allograft Survival in a Nonhuman Primate Transplant Model.

S. Kim, D. Mathews, L. Higginbotham, C. Breeden, C. Larsen, A. Adams.
Myeloid-Derived Suppressor Cells (MDSC) Accumulate in Intestinal Transplant (IT) Recipients (rc) and Suppress Recipient T-Cell (T) Response Against Donor Antigen.

S. Okano,¹ D. Kish,² K. Keslar,² W. Baldwin,² R. Fairchild,¹ C. Miller,¹ K. Abu-Elmagd,¹ A. Khanna,¹ M. Fujiki,¹ J. Fung,¹ G. Costa,¹ K. Hashimoto.¹
Retrospective Analysis of Multiple Hemodialysis Access Modalities.

V. Bowers,¹ H. Pearson,¹ J. Huang,¹ J. Leone,¹ A. Tanious,¹ K. Dawley,¹ E. Rogers,¹ V. Camba,² C. Albertson,² D. Lahiff,² T. Rashid,² J. Buggs.¹
Saftey & Long Term Outcomes of Tocilizumab (Anti-IL6R, TCZ) Therapy in Treatment of Chronic Antibody Mediated Rejection (CABMR) & Transplant Glomerulopathy (TG) in Highly-HLA Sensitized (HS) Patients (PTs).

J. Choi,¹ O. Aubert,² A. Vo,¹ A. Loupy,² M. Haas,³ S. Louie,¹ A. Kang,¹ A. Peng,¹ R. Najjar,¹ E. Huang,¹ M. Toyota,⁵ X. Zhang,⁴ S. Jordan.¹
Shared Epitopes Contribute to Accumulation of Highly Sensitized Patients in Kidney Paired Donation Program.

S. Stepkowski, B. Mierzejewska, C. Baum, D. Bekbolsynov, R. Brunner, J. Kopke, S. Rees, M. Rees.
The Impact of Social Support on Kidney Transplant Listing Decisions: Results from a Discrete Choice Experiment.

K. Ladin,^1,2 J. Emerson,² Z. Butt, E. Gordon, D. Hanto, T. Lavelle.²
To Accept or Not Accept, That Is the Question: Donor Heart Selection Process and Outcome of Discarded Organs Transplanted in Another Center.

A. Aliabadi-Zuckermann,¹ J. Goekler,¹ A. Kaider,² J. Riebandt,¹ R. Moayedifar,¹ E. Osorio,¹ T. Haberl,¹ G. Laufer,¹ J. Smits,³ A. Zuckermann.¹
Transplant Economics Post Implementation of the Affordable Care Act and the Budget Control Act Sequestration Adjustment on Medicare Reimbursement.

E. Zavala,¹ J. Rogers,² R. Howey,³ S. Karp.¹
10 Years or More of Follow Up After Total Pancreatectomy and Intra Portal Islet Auto Transplantation (TP/IAT) for Treatment of Chronic Pancreatitis, Is It a Durable Operation?

S. Chinnakotla, T. Dunn, G. Beilman, M. Bellin, T. Pruett, V. Kirchner, J. Wilhelm, M. Freeman, D. Sutherland.
A Molecular Approach to Chronic Rejection: Antibody or T-Cell Mediated?

L. Kamal, P. O Broin, M. Lubetzky, Y. Bao, E. Akalin.
A Possible Unintended Consequence of the Kidney Allocation System: The Effect of Duration of Dialysis on Mental Health Outcomes.

S. Radomski,^1,2 I. Feurer,² R. Forbes,² B. Concepcion,² H. Schaefer.²
Addition of hEPCR.hCD55.hTFPI.hCD47 Modulates Multi-Lineage Cell Sequestration and Coagulation Activation by GalTKO.hCD46 Transgenic Pig Livers Perfused Ex Vivo with Human Blood.

A. Cimeno,¹ L. Burdorf,¹ D. Parsell,¹ C. Phelps,² D. Ayares,² A. Azimzadeh,¹ R. Pierson III,¹ R. Barth,¹ J. LaMattina.¹
Assessment of the Risk Index for Living Donor Kidney Transplantation (LKDPI) in a European Cohort.

O. Staeck, G. Rehse, D. Khadzhynov, A. Kleinsteuber, L. Lehner, M. Duerr, K. Budde, F. Halleck.
Autophagy Regulates LG3 Maturation and Export in Apoptotic Exosome-Like Vesicles.

D. Beillevaire,^1,2,4 M. Francis,^1,2,4 G. Diane,² B. Éric,^3,4 D. Mélanie,^1,2,4 H. Marie-Josée.^1,2,4
B Cell-Derived Cytokines Rather Than T/B Cognate Interactions Mediate CD8 T Cell Reconstitution Following Lymphoablation.

D. Zwick, K. Ayasoufi, R. Fan, V. Gorbacheva, K. Keslar, R. Fairchild, A. Valujskikh.
CD4 T Cell Migration Across Lymphatic Endothelium Is Enhanced by Sphingosine 1-Phosphate (S1P) and Differentially Regulated by S1P Receptors (S1PR).

Y. Xiong,¹ C. Brinkman,¹ K. Hippen,² B. Blazar,² J. Bromberg.¹
Clinical and Histopathologic Features of Antibody Mediated Rejection (ABMR) in Highly Sensitized (HS) vs Non-Sensitized (NS) Pediatric Renal Transplant Recipients.

J. Steggerda, I. Kim, M. Haas, X. Zhang, A. Wang, H. Pizzo, E. Kamil, S. Jordan, D. Puliyanda.
Compartmental Infiltration of Kidney Allograft with Monocyte-Macrophage Subtypes Defines the Type of Rejection.

T. van den Bosch,¹ M. Clahsen-van Groningen,² F. Rezaee,³ D. Hesselink,¹ D. Nieboer,⁴ E. Steyerberg,⁴ C. Baan,¹ A. Rowshani.¹
Composite Prognostic Score Improves Clinical Benefit in Kidney Recipients Receiving Standard of Care Therapy for Antibody-Mediated Rejection.

D. Viglietti, A. Loupy, O. Aubert, E. Pillebout, C. Legendre, D. Glotz, C. Lefaucheur.
Contemporary Outcomes and Risk Factors of Acute Graft-versus-Host Disease After Liver Transplant.

J. Markus, A. Bukannan, B. Kashat, R. Salgia.
Current Treatments for Small Hepatocellular Carcinoma: A Network Meta-Analysis of Randomized Controlled Trials.

Z. Guo, Z. Zheng, X. He, G. Chen.
De Novo, Non-Donor Specific HLA Antibodies Are Associated with Inferior Allograft Outcomes After Kidney and Simultaneous Kidney-Pancreas Transplantation.

S. Hassan,¹ G. Lucisano,¹ E. Santos,² D. McKeown,³ D. Goodall,¹ A. Gueret-Wardle,¹ A. McLean,¹ P. Brooks,² M. Willicombe,¹ D. Taube.¹
Delayed Renal Implantation Improves Survival Following Simultaneous Liver-Kidney Transplantation in High Acuity Recipients.

K. Lunsford,¹ V. Agopian,² A. Saharia,¹ J. Balough,¹ C. Mobley,¹ S. Gordon-Boroughs,¹ H. Gritsch,² H. Podder,¹ R. Knight,¹ G. Danovitch,² X. Li,¹ A. Gaber,¹ R. Busuttil,² R. Ghobrial.¹
Dementia and Alzheimer's Disease Among Older Kidney Transplant Recipients.

M. McAdams DeMarco, S. Bae, N. Chu, A. Gross, C. Brown IV, E. Oh, P. Rosenberg, K. Neufeld, R. Varadhan, M. Albert, J. Walston, D. Segev.
First Report of Human Liver Transplantation After Normothermic Machine Perfusion (NMP) in the United States.

Q. Liu, B. Soliman, G. Iuppa, A. Nassar, A. Hassan, T. Diago Uso, K. Hashimoto, F. Aucejo, M. Fujiki, B. Eghtesad, J. Cywinski, S. Irefin, J. Fung, K. Abu-Elmagd, C. Miller, C. Quintini.
Five Year Experience with Laparoscopic Sleeve Gastrectomy in Obese Renal Transplant Candidates.

A. Jung, Y. Kim, V. Dhar, D. Hanseman, J. Tadros, S. Dehart-Kilgore, R. Alloway, D. Schauer, S. Shah, A. Govil, E. Woodle, T. Diwan.
Impact of Cold Ischemia Time on Outcomes in Kidney Paired Donation (KPD).

R. Redfield,¹ D. Vock,² R. Hayes,¹ A. Matas.²
Improved Outcome of Kidney Transplants by Donor Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes.

O. Staeck,¹ M. Niemann,⁴ F. Halleck,¹ D. Khadzhynov,¹ C. Schönemann,² P. Reinke,¹ E. Spierings,³ K. Budde,¹ N. Lachmann.²
Induction of Delayed Renal Allograft Tolerance Using Only Clinically Available Reagents in Non-Human Primates.

K. Hotta, T. Oura, A. Dehnadi, S. Boskovic, M. Matsunami, I. Rosales, N. Smith, R. Colvin, A. Cosimi, T. Kawai.
Influenza Viral Dynamics in a Large Cohort of Transplant Patients with Natural Influenza Infection.

V. Ferreira,¹ A. Humar,¹ E. Cordero,² E. Blumberg,³ A. Limaye,⁸ F. Silveira,⁵ L. Danziger-Isakov,⁶ M. Levi,⁷ J. Kalpoe,⁴ J. Englund,⁹ M. Multicenter Influenza Group, D. Kumar.¹
Kidney Transplant Rejection Associated with DQ Eplet Mismatches.

S. Chakola,¹ P. Warner,² N. Andeen,³ B. Najafian,³ N. Leca,¹ C. Blosser.¹
Life Threatening Disparities in Calculated MELD Due to Variation in Laboratory Methods within a UNOS Region.

E. Verna,¹ C. Connelly,¹ L. Dove,¹ J. Emond,¹ P. Adem,² N. Babic,³ J. Corsetti,⁴ J. Faix,⁵ J. Hayden,⁶ M. Lifshitz,⁷ M. Chiles,¹ S. Mohan,¹ H. Eldad,¹ A. Kratz.¹
Lymphotoxin (LT) β Receptor-Mediated Non-Classical NFκB Signaling in Lymphatic Endothelial Eells (LEC) is Required for Homeostatic T Cell Migration.

W. Piao, C. Brinkman, J. Bromberg.
Maintenance of the Phenotype and Abundance of Islet-Resident Macrophages Promotes Islet Graft Survival and Appears to Prevent Type 1 Diabetes.

P. Kyriazis, T. Thornley, K. Agarwal, L. Ma, T. Strom, M. Koulmanda.
Minimal Effect of Broader Heart Sharing on Regional Outcomes.

A. Bitar,¹ M. Skeans,² R. Davies,³ M. Farr,⁴ A. Kao,⁵ L. Robbins-Callahan,⁶ J. Rogers,⁷ S. Silvestry,⁸ M. Colvin.^1,2
Modifiable Deceased Organ Donor Critical Care Parameters Impact Donor Lung Utilization.

A. Spaugy,¹ M. Sally,¹ K. Ellis,¹ T. Groat,¹ M. Patel,² D. Malinoski.¹
Molecular Profiles of Renal Allograft Biopsies at 12 Months Post Renal Transplant in Patients Exposed to Low Dose CNI and Everolimus vs. Patients Exposed to Full Dose CNI and MMF.

L. Gallon,¹ J. Leventhal,¹ D. Maluf,² V. Sai Bontha,² A. Shetty,¹ O. Traitanon,¹ M. Ansari,¹ J. Mathew,¹ S. Wongpraphairot,¹ V. Mas.²
Noninvasive Prognostication of Renal Allograft Failure Following BK Virus Associated Nephropathy – A Validation Study.

E. Abuhelaiqa, C. Snopkowski, C. Li, J. Lee, T. Muthukumar, H. Yang, M. Suthanthiran, D. Dadhania.
Outcomes of Hand Assisted Laparoscopic Right Donor Nephrectomy, Single Center Experience.

A. El-Hinnawi, A. Rajab, R. Pelletier.
Outcomes with Steroid Avoidance Regimen After Kidney Transplantation without Induction Immunosuppression.

A. Sakhuja,¹ A. Naik,² D. Cibrik,² H. Amer.³
Penis Transplantation: First U.S. Experience.

D. Ko, K. Li, H. Salinas, I. Schol, M. Treiser, F. McGovern, A. Feldman, B. Bojovic, J. Winograd, M. Grant, R. Ehrlichmann, C. Tanrikut, J. Lee, G. Choy, R. Liu, I. Rosales, R. Colvin, K. Eberlin, C. Cetrulo, Jr.
Personalizing Immunosuppression with Molecular Phenotyping in Pediatric Liver Transplantation.

M. Ningappa, C. Ashokkumar, Q. Sun, B. Higgs, K. Soltys, G. Bond, G. Mazariegos, R. Sindhi.
Prospective Randomized Trial for Predicting CMV Infection According to Baseline CMV-Specific T-Cell Immunity in Kidney Transplant Patients.

M. Jarque,² E. Melilli,¹ A. Gutierez,³ F. Moreso,⁴ L. Guirado,⁵ A. Manonelles,¹ J. Cruzado,^1,2 S. Luque,² E. Crespo,² N. Montero,¹ F. Diekman,⁶ J. Grinyó,^1,2 O. Bestard.¹
Renal Outcomes Following Intestinal Transplantation.

C. Puttarajappa,¹ A. Humar,¹ S. Hariharan,¹ R. Cruz Jr,¹ A. Ganoza,¹ D. Landsittel,^1,3 X. Gao,³ M. Bhattarai,¹ H. Sogawa.^1,2
The Impact of the New Kidney Allocation System on Length of Dialysis Prior to Transplantation.

T. Melanson,¹ M. Basu,¹ L. Plantinga,¹ S. Pastan,¹ S. Mohan,² R. Patzer.¹
The Use of Very High KDPI Kidneys in Elderly Kidney Transplant Recipients – Discarded in the U.S. but Successfully Transplanted in Europe.

F. Halleck, D. Khadzhynov, G. Rehse, L. Lehner, E. Schrezenmeier, M. Dürr, K. Budde, O. Staeck.
Treating Ischemically Damaged Porcine Kidneys with Mesenchymal Stromal Cells During Normothermic Machine Perfusion.

M. Pool,¹ J. Sierra Parraga,² M. Roemeling-van Rhijn,³ M. Reinders,⁴ M. Hoogduijn,² R. Ploeg,^1,5 H. Leuvenink,¹ C. Moers.
Young African American Heart Transplant Recipients Have an Elevated Risk of Post-Transplant Mortality.

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.
36 Hours of Ex-Vivo Warm Cellular Perfusion of Swine Liver Using the Organ Care System (OCS™) Liver with Excellent Functional, Metabolic and Histological Outcomes.

J. Magliocca,¹ J. Markmann,² M. Abouljoud,³ M. Ghobrial,⁴ A. Demetris.⁵
Ex Vivo Normothermic Perfusion of Isolated Segmental Porcine Bowel: A Novel Functional Model of the Small Intestine.

M. Hamed,¹ A. Barlow,¹ S. Khosla,¹ A. Sagar,¹ F. Gribble,² M. Murphy,³ G. Pettigrew,¹ E. Bolton,¹ J. Bradley,¹ M. Nicholson,¹ S. Hosgood,¹ K. Saeb-Parsy.¹
Reassessing Thymoglobulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry.

I. Ashoor,¹ K. Martz,² R. Beyl,³ V. Dharnidharka.⁴
A New Methodology for Measuring and Monitoring Equity in Access to Deceased Donor Kidney Transplants.

D. Stewart, A. Wilk, W. Cherikh, A. Harper, R. Urban, D. Klassen, E. Edwards.
A Non-Invasive Urinary Common Rejection Module (uCRM) Gene Expression Score Quantifies and Differentiates Kidney Transplant Injury.

T. Sigdel,¹ J. Yang,¹ O. Bestard,² S.-C. Hsieh,¹ S. Roedder,² I. Damm,¹ J. Liberto,¹ S. Nandoe,¹ M. Sarwal.¹
APOL1 Genotype Does Not Affect Donor Renal Function Post Live Kidney Donation.

K. Koutroutsos,¹ R. Sergeant,² F. Powell,² C. Freeman,² R. Charif,¹ J. Galliford,¹ P. Brookes,² D. Taube,¹ M. Loucaidou.¹
Anti-CD40 mAb Promotes Kidney Immunoregulatory Capacity in NHP Transplants by Altering Kidney Tubular Cell (TEC) Expression of CD40 and IL-6.

J. Arp,¹ Y. Ma,¹ H. Yang,² A. El Warrak,¹ A. Haig,¹ W. Liu,¹ K. Reimann,³ P. Luke,¹ Z. Zhang,¹ D. Rothstein,⁴ A. Jevnikar.¹
Antidepressant Medication Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

K. Lentine,¹ A. Naik,² R. Ouseph,¹ Z. Zhang,¹ D. Axelrod,³ D. Segev,⁴ V. Dharnidharka,⁵ D. Brennan,⁵ H. Randall,¹ R. Gadi,¹ N. Lam,⁶ G. Hess,⁷ M. Schnitzler,^1,8 B. Kasiske.⁸
Association with Tacrolimus Intraindividual Variability, Acute Microinflammation Based on 1 Year-Transplanted Kidney Biopsy After Transplantation, and Biopsy-Proven Acute Rejection.

S.-Y. Kim, S.-I. Min, W. Cho, S. Cho, M.-J. Cho, S. Ahn, S.-K. Min, J. Ha.
Bariatric Surgery Prior to Living Kidney Donation: A Solution to Expand the Donor Pool.

M.-T. Nguyen, D. Carpenter, A. Mathur, J. Van Bever, R. Sandoval, L. Ratner.
Binding of Antigens by Its Specific Antibodies Results in Exosome Formation Leading to Rejection of Syngeneic Murine Cardiac Grafts.

M. Sharma, W. Liu, M. Gunasekaran, S. Bansal, T. Mohanakumar.
Blood Transfusion Induced Donor Specific Antibodies Are Associated with Rejection and Graft Failure.

S. Hassan,¹ F. Regan,^2,3 C. Brown,⁴ A. Harmer,³ N. Anderson,³ P. Brookes,⁵ D. Taube,¹ M. Willicombe.¹
Clinical Correlation of Endomyocardial Biopsies Molecular Profiling: Taking Rejection Diagnosis Beyond Histology.

L. Potena,¹ L. Borgese,¹ A. Gaudenzi,¹ V. Agostini,¹ J. Reeve,² M. Masetti,¹ F. Grigioni,¹ O. Leone,¹ P. Halloran.
Complement Activating Anti-HLA Antibodies: Identification of Specific Histo-Mmolecular Phenotype of Rejection for Complement-Targeting Therapy.

C. Lefaucheur,¹ B. Sis,² D. Viglietti,¹ L. Hidalgo,² O. Aubert,¹ D. Glotz,¹ C. Legendre,¹ A. Zeevi,³ P. Halloran,² A. Loupy.¹
Current Status of HIV-to-HIV Transplants in the United States.

C. Durand,¹ A. Tobian,^1,3 N. Desai,¹ A. Cameron,¹ N. Dagher,⁴ D. Brown,¹ S. Halpern,¹ S. Bagnasco,¹ D. Ostrander,¹ A. Redd,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² D. Segev.¹
Dual Targeting with Carfilzomib and Tocilizumab Abrogates Antibody-Mediated Rejection and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation.

B. Ezekian, J. Kwun, M. Manook, K. Freischlag, V. Curfman, E. Branum, J. Park, J. Yi, S. Jordan, S. Knechtle.
Effects of Liver Transplantation on Cardiac Function in Patients Transplanted for NASH Cirrhosis.

H. Maddur, L. VanWagner, D. Gregory, B. Wodzinski, K. Maganti, M. Rinella.
Employment Patterns After Kidney Transplantation: Rates, Contributing Factors, and Outcomes.

J. Kim, J. Rana, M. Ashwin, Y. Li, O. Famure.
Expression of Injury and Repair Genes in Ex Vivo Perfused Swing Lung Transplants.

P. Dromparis,¹ S. Wagner,¹ N. Aboelnaz,² J. Luc,² D. Freed,² J. Nagendran,² M. Mengel,¹ B. Adam.¹
Gut Microbial Metabolite Improves Function and Prolongs Kidney Allograft Survival in Mice.

H. Wu,^1,2 T. Kwan,¹ Y. Loh,¹ X. Chen,¹ L. Macia,^2,3 S. Alexander,^2,4 S. Chadban.^1,2
Impact of Antihypertensive (AHT) Choice and Advagraf^® Dose on Interstitial Fibrosis/Tubular Atrophy (IF/TA) and IF/TA Progression in Renal Allografts 24 Months Post-Transplantation (Tx).

S. Cockfield,¹ D. Rush,² S. Wilson,³ J. Howell,⁴ FKC-014 Study Group.
Impact of Donor BK-Virus Replication on Posttransplant BKV Replication After Living-Donor Transplantation.

J. Grellier, A. Del Bello, L. Esposito, A. Hebral, C. Mengelle, N. Kamar.
Induction of Mixed Chimerism to Prolong Liver Allograft Survival in Cynomolgus Monkeys.

E. Berglund, J. Stern, P. Alonso Guallart, S. Chaudhry, S. Kofman, M. Danton, J. Weiner, J. Lefkowitch, S. Baker, M. Martinez, Y. Kato, T. Kato, M. Sykes, A. Griesemer.
Living and Deceased Donor Uterus Transplantation – The 2-Arm Czech Uterus Transplant Trial: The First Year Report with Four Cases Done so Far.

J. Fronek,¹ R. Chmel,² L. Janousek,¹ M. Novackova,² J. Matecha,² M. Olausson.³
Longitudinal Study of Donor Specific Antibodies in a Pediatric Kidney Transplant Population; Response to Optimization of Anti-Proliferative Therapy.

A. Rounds, M. Moss, M. Bock, J. Goebel.
MELD Exception Score: LSAM Modeling of a Fixed Floor.

J. Heimbach,¹ R. Hirose,² D. Schladt,³ J. Pyke,³ J. Zeglin,³ S. Leppke,³ J. Lake,⁴ W. Kim.^5,3
Multicenter Validation of a Clinicopathologic Risk Score to Predict Hepatocellular Carcinoma Recurrence Following Liver Transplantation: Analysis of 4984 Patients from the US Multicenter HCC Transplant Consortium.

V. Agopian, On Behalf of the US Multicenter HCC Transplant Consortium.
Mutations in Influenza A Virus and Clinical Implications in Transplant Recipients.

V. Ferreira,¹ A. Humar,¹ E. Cordero,² E. Blumberg,³ S. Husain,¹ J. Kalpoe,⁴ M. Multicenter Influenza Group, D. Kumar.¹
Outcomes Following Cholecystectomy in Kidney Transplant Recipients.

S. DiBrito, C. Holscher, I. Olorundare, C. Haugen, Y. Alimi, D. Segev, J. Garonzik-Wang.
Post-Liver Transplant (LT) Early Allograft Dysfunction (EAD) Modulates the Effect of Pre-LT Kidney Function on Post-LT Survival.

H. Wadei, M. Mai, B. Taner, K. Croome, A. Keaveny, L. Mai, D. Lee.
Pre-Transplant CMV-Specific T-Cell Immunity Is an Additional Independent Variable Predicting CMV Infection After Kidney Transplantation.

E. Crespo,¹ M. Jarque,¹ S. Luque,¹ E. Melilli,² A. Manonelles,² S. Gil-Vernet,² J. Cruzado,² J. Grinyó,² O. Bestard.²
Pre-Transplant Circulating TNFR2+ Regulatory T Cells Predict Acute Rejection within the First 6 Months After Kidney Transplantation.

M.-T. Nguyen,¹ S. Sahakian,² S. Liu,² Y. Wang,² J. Tchervenkov,² S. Paraskevas.²
Predicting Immunologic Risk for Acute Rejection in Pediatric Liver Transplantation.

S. Antala, L. Bow, R. Morotti, G. Gan, D. Yanhong, U. Ekong, S. Emre.
Procurement Kidney Biopsy versus KDRI for Predicting Graft Survival.

I. Hall,¹ C. Parikh,² B. Schröppel,³ F. Weng,⁴ Y. Jia,² H. Thiessen-Philbrook,² P. Reese,⁵ M. Doshi.⁶
Prolonged Survival with Co-Stimulatory Blockade Based Immunosuppression in Pig-to-Primate Liver Xenotransplantation.

J. Shah, M. Patel, N. Elias, I. Rosales, N. Navarro-Alvarez, M. Hertl, A. Cosimi, R. Colvin, J. Markmann, D. Sachs, P. Vagefi.
Similar Elevation of Gene Expression Associated with Antibody-Mediated Rejection (ABMR) of Renal Allografts Can Be Detected in Both Plasma Exosomes (pExo) and Biopsies (Bx) by Assessing mRNA Transcript Profiles.

H. Zhang,¹ C. Nast,² J. Doldron,² M. Cheung,² J. Mirocha,³ J. Kahwaji,¹ A. Vo,¹ S. Jordan,¹ M. Toyoda.¹
Simplified Classification of Pancreas Transplant Insufficiency.

A. Kahl, C. Hinrichs.
Trends in the Number and Medical Urgency of Adult Heart Transplant Candidates Listed as Status 1A from 2006-2015.

W. Parker,¹ M. Churpek,¹ S. Fedson,² E. Garrity.¹
Zero HLA Mismatch Matters in ABO Incompatible Kidney Transplant.

T. Alhamad,¹ K. Lentine,² K. Venkatachalam,¹ A. Malone,¹ D. Brennan.¹
mTOR Inhibition Diminishes Peripheral Blood CD8⁺CD28^–CD38^hi Effector/Memory T Cells and Facilitates Resolution of Belatacept-Refractory Kidney Rejection.

C. Castro-Rojas,¹ A. Godarova,¹ A. Leino,² R. Alloway,² M. Jordan,³ E. Woodle,² D. Hildeman.¹
A Novel 3-Dimensional Culture System Enables In Vitro Study of Human Bone Marrow Plasma Cells.

J. Driscoll,¹ S. Tremblay,² S. Knechtle,³ E. Woodle.²
A Pretransplant Model Incorporating Serum Biomarkers Is Superior to the Milan Criteria in Stratifying Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation: Analysis of 4407 Patients from the US Multicenter HCC Transplant Consortium.

V. Agopian, On Behalf of the US Multicenter HCC Transplant Consortium.
Absence of Independent and Additional Predictive Ability of Preimplantation Kidney Allograft Biopsies for Long-Term Outcome: Population Based Study.

O. Aubert, D. Viglietti, C. Loheac, M. Rabant, C. Gosset, J. Duong Van Huyen, D. Glotz, C. Legendre, C. Lefaucheur, A. Loupy.
Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Non-Human Primates: The Immunomodulatory Effect of Donor Bone Marrow Transplantation Does Not Prevent the Development of Chronic Rejection in the Absence of Durable Mixed Chimerism.

Z. Ng, A. Lellouch, A.-R. Gama, I. Schol, I. Rosales, R. Colvin, L. Geoghegan, J. Kurtz, C. Cetrulo.
Differential Effects of the Novel ATP-Competitive mTOR Inhibitor (TORKinib) AZD2014 and Rapamycin on Alloimmunity and Transplant Survival.

D. Fantus, Y. Ono, H. Dai, S. Yokota, O. Yoshida, A. Thomson.
Effective Targeting Plasma Cells with Daratumumab (Anti-CD38) and Mozobil (Anti-CXCR4) in a Sensitized Non-Human Primate Model.

J. Kwun,¹ B. Ezekian,¹ M. Manook,¹ E. Branum,¹ V. Curfman,¹ J. Park,^1,2 K. Freishlag,¹ J. Yoon,¹ S. Knechtle.¹
Efficacy and Safety of ASP0113 versus Placebo in CMV-Seronegative Kidney Transplant Patients Receiving an Organ from a CMV-Seropositive Donor.

F. Vincenti,¹ K. Budde,² P. Merville,³ F. Shihab,⁴ V. Peddi,⁵ M. Shah,⁶ E. Cassuto-Viguier,⁷ A. Weidemann,^8,9 M. Lee,¹⁰ T. Flegel,¹⁰ J. Erdman,¹⁰ X. Wang,¹⁰ C. Lademacher.¹⁰
Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study.

A. Weymann,¹ R. Ganschow,¹ B. Ericzon,¹ A. Dhawan,¹ K. Sharif,¹ E.-D. Martzloff,² B. Rauer,² J. Ng,² P. Lopez.²
Epigenetic Modifications in the Progression to Chronic Renal Allograft Injury.

V. Bontha,¹ D. Maluf,¹ M. Dozmorov,² K. Archer,³ L. Gallon,⁴ V. Mas.¹
Extracellular Mitochondria Cause B7 Costimulation Blockade Resistant Allograft Rejection in Mice.

T. Brennan,¹ L. Lin,¹ M. Song,¹ F. Feng,¹ Q.-J. Li,² A. Kirk,^1,2 H. Xu.¹
Genome-Wide Genotyping in 1022 Heart Transplantation Recipients & 758 Donors Reveal Association with Acute Allograft Rejection.

J. van Setten,¹ B. Cole,² B. Chang,² N. de Jonge,¹ M. Holmes,² C. Baan,⁴ O. Manintveld,⁴ A. Peeters,⁴ F. Dominguez,⁵ K. Khush,³ P. Garcia-Pavia,⁵ M. Huibers,¹ R. de Weger,¹ J. Moore,² F. Asselbergs,¹ B. Keating.²
Graft-versus-Host Disease in Intestine Transplantation.

J. Clouse, C. Kubal, B. Ekser, J. Fridell, R. Mangus.
Hepatic Ischemia Reperfusion Injury After Liver Transplantation Is Associated with Acute Kidney Injury.

S. Kubal,¹ M. Anderson,² J. Fridell,¹ B. Ekser,¹ T. Taber,² P. Li,¹ M. Ghabril,³ M. Lacerda,³ R. Mangus.¹
Hepatitis B Virus Infection Is Associated with Recurrent Nephropathy After Kidney Transplantation.

G. Chen, C. Wang, Z. Wu, C. Wang, J. Qiu, L. Chen.
Impact of Antihypertensive (AHT) Choice and Advagraf^® Dose on Immunologic Events in Renal Allografts 24 Months Post-Transplantation (Tx).

D. Rush,¹ S. Cockfield,² S. Wilson,³ J. Howell,⁴ FKC-014 Study Group.
Impact of Cognitive Impairment on Kidney Transplantation Listing Between Sexes.

C. Haugen,¹ H. Ying,² J. Garonzik Wang,¹ M. McAdams-DeMarco,² D. Segev.^1,2
Improved Outcomes After Liver Transplantation from Controlled DCD Donors with Normothermic Regional Perfusion.

G. Oniscu, F. Hunt, W. Herries, I. Currie, A. Sutherland, C. Beattie, E. Thomson.
Increasing Organ Supply in the US: A Systematic Review of Presumed Consent vs. Informed Consent (2006-2016).

M. Ahmad,¹ A. Hanna,¹ A. Mohamed,^1,2 R. Mhaskar,¹ T. Jarmi,^1,3 A. Schlindwein,⁴ C. Pley,⁴ I. Bahner.¹
Induction Therapy in Low Risk Elderly Kidney Transplant Recipients: Donor Factors.

F. Al Ammary, M. DeMarco, Q. Huang, E. King, S. Bay, A. Muzaale, A. Wiseman, D. Segev.
Is Peri-Transplant Plasmapheresis Effective in the Prevention of Recurrence of FSGS?

P. Verghese, M. Rheault, S. Chinnakotla, S. Jackson, A. Matas, B. Chavers.
Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.

T. Schachtner,^1,2 P. Reinke.^1,2
Long-Term Liver and Kidney Survival Following Combined Liver-Kidney Transplantation, with or without Preformed Donor-Specific Antibodies.

A. Del Bello,¹ O. Bestard,² J. Visentin,³ N. Congy-Jolivet,¹ L. Couzi,³ M. Neau-Cransac,³ F. Jambon,³ N. Kamar.¹
Mouse FCs May Contain Lymphoid Progenitor Cells That Have the Capacity to Generate B and T Cells In Vivo.

A. Chhabra, Y. Wen, Y. Huang, H. Xu, A. Merchak, S. Ildstad.
Normothermic Donor Lung Preservation with Portable EVLP Significantly Reduces Ischemia/Reperfusion Injury in Lung Recipients by Promoting Cytokine Antagonists.

C. Falk,¹ B. Wiegmann,² C. Neudörfl,¹ C. Kühn,² I. Tudorache,² M. Wvsar,² A. Haverich,² G. Warnecke.²
Orthotopic Liver Transplantation of Xenogeneic Livers Repopulated with Autologous Hepatocytes: Proof of Normal Function and Consistent Survival.

G. Oldani, S. Lacotte, L. Orci, V. Delaune, C. Toso.
Outcomes of Protocol Allograft Kidney Biopsy in DeNovo Donor Specific Antibodies.

S. Parajuli, P. Reville, T. Ellis, A. Djamali, D. Mandelbrot.
Post-Donation GFR Changes in Living Kidney Donors.

E. Poggio,¹ S. Arrigain,² J. Augustine,¹ S. Flechner,³ J. Schold.²
Post-Donation Remaining Donor Kidney Function as Measured by CKD-EPI Formula at 2 Years Correlates and Is Predicted by Remaining Donor Kidney Volume.

S. Hussain, A. Diez, A. Khalil, M. Yaqub, D. Mishear, T. Taber, O. Adebiyi, C. Sundaram, W. Goggins, J. Powelson, A. Sharfuddin.
Precise Antibody Characterization Using Multiple Solid Phase Assay Platforms Is Critical for Accurate Virtual Crossmatching.

D. Li,¹ O. Timofeeva,¹ M. Awwad,¹ C. Cody,² S. Najjar,² S. Rosen-Bronson.¹
Pregnancy After Kidney-Pancreas Transplantation: Maternal and Offspring Outcomes.

S. Rao,¹ L. Coscia,² D. Armenti,² S. Constantinescu,^1,2 M. Moritz.^2,3,4
Prominence of Graft-Infiltrating PD-L1^hi Cross-Dressed Dendritic Cells in Mouse Liver Transplant Tolerance.

Y. Ono, A. Perez Gutierrez, S. Yokota, O. Yoshida, T. Nakao, G. Camirand, D. Geller, A. Thomson.
Proteomic Profiles of Deceased Donor Kidney Biopsies Obtained Prior to Transplantation Correlate with Allograft Function at One Year.

M. Kaisar,^1,2 L. van Dullemen,¹ Z. Akhtar,¹ H. Huang,¹ B. Kessler,² R. Ploeg.¹
Resumption of Standard Dose Immunosuppression Following Resolution of BK Viremia Does Not Lead to Viremia Recurrence.

K. Alquadan, A. Santos, M. Casey, T. Ozrazgat-Baslanti, S. Bozorgmehri, J. Gregg, K. Womer.
Risk of Ischemic Biliary Injury Is Not Associated with Prolonged Hepatic Artery Ischemic Times During Liver Transplantation.

E. Armenia,¹ N. Schomaker,¹ A. Kalra,¹ J. Gralla,¹ A. Truesdale,¹ S. Biggins,² T. Nydam,¹ J. Burton.¹
Safety and Activity of Anti-C1s Humanized Monoclonal Antibody TNT009 in Late Antibody-Mediated Kidney Allograft Rejection – Results of a First-in-Human Phase 1 Trial.

F. Eskandary,¹ B. Jilma,² J. Muehlbacher,³ M. Wahrmann,¹ H. Regele,⁴ N. Kozakowski,⁴ S. Panicker,⁵ J. Reeve,⁶ P. Halloran,⁶ J. Gilbert,⁵ G. Bohmig.¹
Specific Gene Expression Signature of Complement-Activating Donor Specific Anti-HLA Antibody-Mediated Rejection in Kidney Allografts.

C. Lefaucheur,¹ D. Viglietti,¹ L. Hidalgo,² O. Aubert,¹ A. Zeevi,³ P. Halloran,² A. Loupy.¹
Tacrolimus Intra-Patient Variability Determined from Daily Trough Levels in Adherent Kidney and Liver Transplant Recipients.

A. Leino,¹ T. Kaiser,¹ Y. Zou,² E. King,² A. Vinks,² W. Jiang,⁴ U. Christians,³ E. Woodle,¹ R. Alloway.¹
The Effect of the Procurement Surgeon on Transplanted Abdominal Organ Outcomes: An OPTN/SRTR Analysis to Evaluate Regional Organ Procurement Collaboration.

O. Serrano,¹ D. Vock,² R. Kandaswamy,¹ T. Pruett,¹ A. Matas,¹ E. Finger.¹
Validation of a Prediction Model for Cardiac Allograft Vasculopathy.

E. Kransdorf, T. Aintablian, M. Kittleson, J. Patel, J. Kobashigawa.
Women Are Delisted for Being Too Sick for Liver Transplant More Frequently Than Men.

G. Cullaro, J. Lai.
20 and 25-Year Outcomes Following Pediatric Liver Transplantation.

W. Andrews,¹ N. Gupta,² U. Ekong.³
Advanced Donation within a Paired Exchange Program.

M. Charlton,¹ F. Desrosiers,¹ G. Bretzlaff,¹ D. Serur.²
Belatacept in Chronic Kidney Disease Stabilizes and Improves Renal Function in Pancreas Transplant Recipients: Intermediate Results.

J. Chen, M. Mujtaba, T. Taber, M. Yaqub, J. Powelson, O. Adebiyi, J. Fridell, A. Sharfuddin.
Biological Interplay Between Circulating HLA-sp Alloreactive Memory B-Cells and Long-Lived Plasma Cells in Kidney Transplant Patients Undergoing Chronic ABMR.

S. Luque,² M. Lúcia,⁴ M. Jarque,² E. Crespo,² E. Melilli,¹ J. Martorell,³ J. Cruzado,^1,2 J. Torras,^1,2 J. Grinyó,^1,2 O. Bestard.^1,2
C5b-9 Deposition in Glomerular Capillaries Is Responsible for Poor Allograft Survival in Antibody-Mediated Rejection.

V. Goutaudier,¹ H. Perrochia,¹ M. Marron-Wojewodzki,¹ F. Garo,¹ C. René,¹ N. Pirot,² G. Mourad,¹ M. Le Quintrec.¹
CMV-Infected Kidney Grafts Drive the Expansion of Blood-Born CMV-Specific T-Cells Restricted by Shared HLA Molecules Through Presentation on Donor's Cells.

P. Gatault,^1,2 S. Al-Hajj,¹ J. Noble,^1,2 E. Chevallier,^1,2 M. Piollet,¹ C. Forconi,¹ R. Lemoine,¹ J.-M. Halimi,^1,2 M. Büchler,^1,2 C. Baron.^1,2
Calibration of BK Virus Nucleic Acid Amplification Testing to the 1^st WHO International Standard for BK Virus.

S. Tan,¹ S. Milligan,² M. Sahoo,³ N. Taylor,² B. Pinsky.^1,2,3
Candidate Sex and Size Disparity in Liver Offer Acceptance.

M. Bowring,¹ A. Massie,¹ C. Haugen,¹ J. Ruck,¹ D. Segev,¹ S. Gentry.^1,2
Cardiovascular Events Are a Substantial and Increasing Cause of Graft Loss in Liver Transplant Recipients.

M. Sell, A. Mardis, I. Lee, B. O'Brien, C. Perez, A. Rogers, C. Mardis, N. Patel, J. Fleming, H. Meadows, N. Pilch, K. Chavin, D. Taber.
Combination αCD28+αCD40 Costimulation Blockade Attenuates Acute and Chronic Rejection in Non-Human Primates.

N. O'Neill, T. Zhang, W. Sun, G. Braileanu, X. Cheng, I. Tatarov, W. Hassanein, A. Azimzadeh, R. Pierson.
De Novo Low-Dose Sirolimus versus Mycophenolate Mofetil in Combination with Extended-Release Tacrolimus in Kidney Transplant Recipients.

J. Lee,¹ K. Huh,¹ J. Ha,² C.-K. Oh,³ M. Ju,⁴ C.-D. Kim,⁵ H. Cho,⁶ C. Jung,⁷ B. Lim,⁸ Y. Kim.¹
Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection.

G. Gu, H. Hang, T. Lu, Q. Xia.
Donor Batf3-Dependent Dendritic Cells Initiate Acute Rejection in a Skin Transplantation Model.

T. Borges, N. Murakami, L. Riella.
Dual Targeting of Costimulation and Proteasome to Desensitize and Prolong Graft Survival of Sensitized Nonhuman Primates.

J. Kwun,¹ C. Burghuber,¹ M. Manook,¹ B. Ezekian,¹ J. Park,^1,2 K. Freishlag,¹ J. Yoon,¹ N. Iwakoshi,³ A. Farris,⁴ S. Knechtle.¹
Early Detection of Xenograft Rejection or Injury by Donor Derived Cell Free DNA in Pig to Baboon Cardiac Xenotransplantation.

A. Singh,¹ S. Agbor-Enoh,² J. Chan,¹ S. Groham,² P. Corcoran,¹ B. Lewis,³ M. Thomas,³ D. Ayares,⁴ K. Horvath,¹ H. Valantine,² M. Mohiuddin.¹
Educational Strategies for Increased Wait-Listing Rates: Opportunities for Dialysis Center Intervention.

A. Waterman,¹ J. Peipert,¹ H. Xiao,² C. Goalby,¹ K. Lentine.²
Effect of Preformed Donor-Specific Antibodies in Intestine/Multivisceral Transplantation.

M. Safwan,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ S. Skorupski,² O. Fagoaga,² M. Abouljoud,¹ S. Nagai.¹
Elevated Donor HbA1C Confers Impaired Overall Survival Following Renal Allotransplantation in Recipients of Allografts from Donors with Diabetes Mellitus: A National Analysis.

M. Mulvihill, B. Yerokun, R. Davis, A. Barbas, M. Hartwig.
Experience with Obinutuzumab (Type II Anti-CD20) in Kidney Transplant Patients with Donor Specific Antibody (DSA+) Antibody Mediated Rejection.

J. Choi, A. Vo, E. Huang, S. Louie, A. Kang, A. Peng, R. Najjar, S. Jordan.
Expression of T-Cell Mediated Rejection (TCMR) Associated Genes in Native and Renal Allograft Renal Biopsies with Inflamed Scars (i-IFTA).

Z. Lyu,¹ L. Pang,¹ G. Zeng,² Y. Huang,² P. Randhawa.²
HLA Eplet Mismatches Predict DSA Formation, Graft Survival, and Re-Transplantation Rate in Pediatric Renal Transplantation.

M. Sypek,^1,2 S. Hiho,³ L. Cantwell,³ P. Hughes,² A. Le Page,⁴ J. Kausman.¹
Hepatitis E Virus-Associated Cryoglobulinemia in Solid-Organ-Transplant Recipients: A Prospective Study.

O. Marion,¹ F. Abravanel,² L. Esposito,¹ S. Lhomme,² A. Del Bello,¹ J. Izopet,² N. Kamar.¹
High Titer De Novo Donor-Specific HLA Alloantibodies and Cardiac Allograft Vasculopathy After Pediatric Heart Transplantation.

B. Das,¹ S. Zhang,² A. Gao,² C. Lacelle.³
IVIg+Rituximab Desensitization (DES) Combined with Alemtuzumab (ATZ) Induction Does Not Increase Risk for Viral Infections (VIs) and Associated Complications in HLA-Sensitized (HS) Kidney Transplant Patients (KTx Pts).

S. Ge, B.-H. Shin, J. Mirocha, D. Thomas, M. Chu, E. Rodriguez, C. Chao, A. Petrosyan, O. Galera, A. Vo, J. Choi, A. Peng, J. Kahwaji, S. Jordan, M. Toyoda.
Impact of T-Cell Depletion on CMV-Specific Memory T and B Cell Homeostatic Proliferation After Kidney Transplantation.

M. Jarque,² S. Luque,² E. Crespo,² E. Melilli,¹ J. Torras,^1,2 J. Grinyó,^1,2 O. Bestard.^1,2
Increased Long-Term Mortality 20 years After Living Kidney Donation.

G. Mjoen,¹ S. Hallan,² H. Holdaas.¹
Kidney Injury Molecule-1 Mitigates Tissue Damage from Transplant Renal Ischemia Reperfusion Injury.

J. Lee,^1,2 X. Zhang,² A. Haig,³ D. Lian,² P. Anderson,² R. Navaratnam,² L. Gunaratnam.^1,2
Long Wait Time Regions for Liver Transplantation for HCC Have a Higher Cumulative Incidence of Death.

R. Hogen, J. Dinorcia, M. Lo, B. Nguyen, Y. Genyk, L. Sher, K. Dhanireddy.
Molecular Analysis of Acute Rejection in Formalin-Fixed Paraffin-Embedded Clinical Face Transplant Biopsies.

T. Win,¹ B. Dyring-Andersen,¹ V. Barrera,² S. Ho Sui,² R. Lopdrup,¹ H. Kiwanuka,¹ N. Murakami,¹ J. Teague,¹ E. Lowry,¹ E. Bueno,¹ A. Chandraker,¹ L. Riella,¹ B. Pomahac,¹ R. Clark.¹
Novel Personalized Immune-Monitoring Assay for Predicting Operational Tolerance by Using Humanized Mouse Model.

Y. Fukasaku,¹ R. Goto,¹ Y. Ganchiku,¹ M. Zaitsu,¹ M. Watanabe,¹ N. Kawamura,¹ Y. Koshizuka,¹ K. Yamashita,² T. Shimamura,³ A. Taketomi.¹
Outcome of Living Donor Transplantation in Pediatric Recipients Over the Last Three Decades by Era: An Analysis of UNOS Database.

V. Whittaker, M. Laftavi, Z. Acun, R. Gruessner, A. Gruessner.
Prescription Opioid Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

K. Lentine,¹ N. Lam,² D. Segev,³ D. Axelrod,⁴ Z. Zhang,¹ H. Xiao,¹ G. Hess,⁵ B. Kasiske,⁶ R. Gadi,¹ R. Devraj,⁷ D. Brennan,⁸ H. Randall,¹ M. Schnitzler.^1,6
Redefining Pediatric Heart Status 1A and 1B Criteria: Results of Early Policy Evaluation.

W. Cherikh,¹ R. Davies,² Y. Cheng,¹ W. Mahle.³
Renal Function After Liver Transplantation Alone in Patients Meeting the Proposed UNOS Simultaneous Liver-Kidney (SLK) Criteria.

K. Roayaie,¹ E. Langewisch,² J. Burg,¹ C. Enestvedt,¹ E. Maynard,¹ D. Scott.¹
Results of Biliary Reconstruction with PTFE Graft in Liver Transplantation.

E. Ayvazoglu Soy,¹ G. Moray,¹ A. Torgay,² H. Ozdemir,³ M. Haberal.¹
Results of the Initial Phase of the Portable Organ Care System (OCS™) Liver PROTECT Pivotal Trial.

J. Markmann,¹ M. Ghobrial,³ J. Magliocca,⁴ A. Demetris,⁵ M. Abouljoud.²
Significant Allosensitisation Despite Early, within 24 Hour, Graft Nephrectomy.

G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹
Successful Induction of Tolerance of Fully Allogeneic Lung Graft with Adenosine A_2A Receptor (A2AR) Agonist in MHC-Defined CLAWN Miniature Swine.

H. Sahara, M. Sekijima, T. Murokawa, Y. Ariyoshi, T. Iwanaga, Y. Ichinari, A. Shimizu, K. Yamada.
The Unfunded OPTN/UNOS Mandate of Living Kidney Donor Follow-Up: Fewer Than 50% of Centers in Compliance.

M. Henderson, A. Thomas, A. Massie, X. Luo, A. Shaffer, C. Holscher, D. Segev.
Using Donors with False Positive HIV Tests – An Unexpected Benefit of the HOPE Act.

C. Durand,¹ S. Halpern,¹ G. Bismut,¹ B. Doby,¹ N. Desai,¹ A. Cameron,¹ S. Florman,² S. Lerner,² S. Huprikar,² J. Locke,³ S. Mehta,³ P. Stock,⁴ N. Neidlinger,⁵ D. Brown,¹ B. Haydel,² A. Redd,^1,6 A. Massie,¹ A. Tobian,¹ D. Segev.¹
De Novo Use of Everolimus Reduces Late-Onset Cytomegalovirus Primary Disease Occurring After Antiviral Prophylaxis Discontinuation in Kidney Transplant Recipients.

A. Devresse,¹ V. Avettand-Fenoel,² A. Scemla,³ L. Morin,³ X. Lebreton,³ C. Tinel,³ L. Amrouche,³ L. Lamhaut,⁴ M.-O. Timsit,⁵ J. Zuber,³ C. Legendre,³ D. Anglicheau.³
A Mutation of the Erythropoietin Receptor Correlates with Improved Function of Deceased-Donor Renal Transplants.

M. Fischereder,¹ S. Friedrich,¹ U. Klingmüller,² T. Kauke,³ T. Breidenbach,⁴ D. Boesebeck,⁵ E. Angelika,⁵ C. Cohen,¹ B. Banas,⁶ M. Guba,⁷ M. Stangl,⁸ B. Krämer,⁹ C. Hugo,¹⁰ K. Lopau,¹¹ M. Stadtler,¹² T. Mone.¹²
Abrogating MyD88 Signaling in Donor Lung Resident Hematopoietic Cells Promotes Cell Based Tolerance Induction in Lung Allografts in Mice.

Z. Zheng,¹ J. Wang,¹ X. Yeap,¹ L. Li,³ L. Zhang,² M. He,¹ X. Luo,² Z. Zhang.¹
Acute Mouse CMV Infection Abrogates Transplant Tolerance by Modulating Myeloid Cell Differentiation and Function: A Possible Role for Transcription Factor RORγt.

A. Dangi,¹ L. Zhang,¹ X. Zhang,^2,3 Z. Zhang,^2,3 X. Luo.^1,2,3
Alcohol-Induced Hepatic Cirrhosis Is Rising Among Young Adults.

C. Kling,¹ J. Perkins,¹ D. Donovan,² R. Carithers,³ L. Sibulesky.¹
Assessment of Simple Indices Based on a Single Fasting Blood Sample in Search for an Optimal Tool to Estimate Beta Cell Function After Islet Transplantation.

J. Golebiewska,¹ J. Solomina,² E. Konsur,² K. Cieply,² L. Basto,² A. Kotukhov,² K. Golab,² C. Thomas,³ A. Debska-Slizien,¹ P. Witkowski.²
Belatacept for Chronic Antibody-Mediated Rejection in Kidney Transplantation.

D. Kumar,¹ G. Gupta,¹ J. Reeve,² P. Sanghi,¹ S. Bobba,¹ M. Levy,¹ C. Bhati,¹ P. Kimball,¹ H. Fattah,¹ A. King,¹ H. Massey,¹ P. Halloran.²
CD16a-Activated NK Cells in ABMR Are Highly Similar to CD3-Activated Effector T Cells in TCMR.

M. Parkes, P. Halloran, L. Hidalgo.
CD4 Depletion Is Necessary and Sufficient for Long-Term Nonhuman Primate Xenotransplant Survival.

S. Kim, L. Higginbotham, D. Mathews, C. Breeden, A. Stephenson, C. Larsen, M. Ford, J. Tector, A. Adams.
Can Viral Load Be Used as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Metaanalysis.

Y. Natori,¹ A. Alghamdi,¹ D. Kumar,¹ V. Miller,² P. Ljungman,³ S. Husain,¹ A. Humar.¹
Clinical Evaluation of the Safety and Preliminary Efficacy of Continuous Infusion of Treprostinil to Prevent Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplant Recipients.

O. Almazroo,¹ M. Miah,¹ V. Pillai,¹ A. Humar,² A. Tevar,² C. Hughes,² A. AlKhafaji,³ A. Demetris,⁴ S. Dermont,² S. Fedorek,² H. Johnson,¹ R. Lopez,² R. Planinsic,² B. Sengupta,² I. Sethu,² M. Sturdevant,² S. Ziobert,¹ R. Venkataramanan.^1,2,4
Clinical Risk Factors for Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant Recipients (LTRs): Results of an International Cohort Study.

N. Law,¹ B. Hamandi,¹ C. Fegbeutel,² F. Silveira,³ E. Verschuuren,⁴ P. Ussetti,⁵ P. Chin-Hong,⁶ A. Solé,⁷ C.-L. Holmes-Liew,⁸ E. Billaud,⁹ P. Grossi,¹⁰ O. Manuel,¹¹ D. Levine,¹² R. Barbers,¹³ D. Hadjiliadis,¹⁴ L. Singer,¹ S. Husain.¹
Current Practice and Ethical Dimensions of Implementing APOL1 Testing into Living Donor Evaluation: A National Survey.

E. Gordon,¹ C. Wicklund,¹ R. Sharp,² J. Lee,¹ C. Johnson,¹ J. Friedewald.¹
Early Results of the UK REVIVE Trial for Ex-Vivo Liver Warm Blood Perfusion of DCD and DBD Livers Using the Portable Organ Care System (OCS™) Liver Technology.

D. Vijayanand, F. Zahreldeen, J. Kingston, S. Farid, T. Mdlongwa, A. Ramsden, S. Willis, C. Moriarty, M. Attia.
Early and Late Antibody Mediated Rejection and Mixed Acute Rejection Are Clinically Distinct and Demonstrate Biologic Differences in Immunodominant Donor Specific Antibody Characteristics.

A. Lichvar,¹ E. Portwood,¹ P. Brailey,¹ S. Tremblay,¹ A. Shields,² A. Govil,¹ M. Cardi,² M. Cuffy,¹ R. Alloway,¹ A. Girnita,¹ E. Woodle.¹
Effect of Hypothermic Pulsatile Machine Perfusion on Kidney Delayed Graft Function in Simultaneous Liver-Kidney Transplantation: A Single Center Study.

I. Korayem,¹ H. Gritsch,² J. Veale,² G. Lipshutz,² V. Agopian,¹ F. Kaldas,¹ D. Farmer,¹ R. Busuttil,¹ A. Zarrinpar.¹
Extra-Renal Cardiac Injury Is Associated with Upregulation of NOD2 and Nlrp3 in the Heart After Renal IRI.

A. Scheinok, S. Kasimsetty, E. Soo, C. Nelson, A. Shigeoka, D. McKay.
FcγRIIB-Mediated Coinhibition Attenuates Donor-Reactive CD8+ T Cell Responses.

A. Morris, D. Pinelli, D. Liu, M. Ford.
Five Year Outcomes with Alemtuzumab Induction Therapy in Elderly Renal Transplant Recipients.

M. Casagrande, K. Cunningham, C. Tseng, C. D'Agostino, L. Wong, C. Richardson.
Graft Survival in De Novo Donor-Specific Antibodies and Positive Flow Crossmatch Kidney Transplants Is influenced by Class I and Class II.

S. Montag,^1,2 B. Ho,¹ H. Bhagat,³ E. Lee,^3,4 K. Atiemo,¹ A. Daud,¹ R. Kang,¹ L. Zhao,^1,2 J. Schwartz,³ D. Ladner.¹
HLA-C Mismatching and Humoral Alloimmune Responses in Pediatric Kidney Recipients with Subclinical Vascular Injury.

M. Seifert, M. Yanik, V. Hauptfeld-Dolejsek, R. Mannon.
Hispanic Paradox in Patients with Liver Cirrhosis.

K. Atiemo, J. Caicedo, D. Ganger, E. Gordon, L. Zhao, S. Montag, H. Maddur, L. VanWagner, L. Kulik, S. Flamm, S. Goel, A. Kho, R. Kang, M. Abecassis, D. Ladner.
Impact of Peri-Transplant Viral Upper Respiratory Infection on Pediatric Liver Transplant Outcomes.

J. Kohler,¹ T. Miloh,¹ K. Hosek,¹ J. Goss,² F. Munoz.¹
Intraabdominal Infections (IAI) and Bloodstream Infections in Small Intestinal and Multivisceral Transplants (IMVTX).

A. Spence,¹ S. Fogleman,¹ G. Raffaele,² C. Matsumoto,² P. Kumar,¹ R. Biswas,¹ T. Fishbein,² J. Timpone.¹
Long-Term Consequences of Post-Donation Preeclampsia.

H. Ibrahim,¹ D. Berglund,¹ S. Jackson,² A. Matas.¹
Post-Donation Experiences of Non-Directed (Altruistic) Living Kidney Donors in the United States.

A. Maghen,¹ G. Vargas,¹ S. Connor,¹ S. Nassiri,¹ E. Hicks,² L. Kwan,¹ S. Maliski,³ J. Veale.
Potential Mechanism Involving Regulatory T Cells in Induction of Tolerance in Mouse Vascularized Composite Allotransplantation Under Combined Costimulation Blockade.

M. Anggelia,^1,2 Y.-Y. Huang,³ W.-Y. Chuang,⁴ H.-Y. Cheng,¹ G. Brandacher,⁵ F.-C. Wei,^1,2 C.-H. Lin.^1,2
Pre-Transplant Evaluation of KSORT^SM to Assess Risk for Rejection in Highly Sensitized Patients.

S. Nandoe,¹ S. Roedder,³ S. Hsieh,¹ T. Sigdel,¹ P. Lindner,⁴ J. Ekberg,⁴ J. Alberu,⁵ F. Vincenti,¹ M. Sarwal.¹
Predictors of Web-Based Patient Portal Usage Among Kidney and Liver Transplant Recipients.

A. Ruiz, K. Smith, J. Wedd, K. Little, S. Pastan, R. Patzer.
Primary Graft Dysfunction After Pediatric Heart Transplant.

K. Mowers, K. Simpson, P. Eghtesady, O. Petrucci, C. Canter, C. Castleberry.
Release of HMGB1 in Serum and Urine of Brain-Death Donors Is Associated with Delayed Graft Function (DGF) of the Kidney.

A. Zmijewska,¹ J. Chen,¹ J. Locke,² J. Zmijewski,¹ R. Mannon.¹
Repeat Biopsies After the Diagnosis of BK Virus Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings.

C. Drachenberg,¹ J. Papadimitriou,¹ R. Ugarte,² M. Mavanur,² B. Thomas,² C. Cangro,² N. Costa,² M. Weir,² A. Haririan.²
Robotic Kidney Transplantation: Bakirkoy Experience.

S. Sahin,¹ V. Tugcu,¹ A. Yavuzsan,¹ F. Akbay,² S. Apaydin.²
Survival Outcomes from DCD Transplant Are Comparable to DBD Transplant from Kidneys Procured from Donors > 50 Years of Age. A UNOS/OPTN Propensity Score Matched Pair Analysis.

H. Sharma, D. Mikhail, J. Chen, B. Al-Harbi, P. Luke, A. Sener.
TIE'ing Statins to Microvascular Stability and Endothelial Cell Immunogenicity.

C. Ghosh,¹ A. Mak,¹ M. McGourty,¹ S. Parikh,² X. Chen,² S. Goldberg,¹ J. Wedel,¹ D. Briscoe.¹
Tacrolimus Appears to Be a Protective Factor for De Novo DSA Formation in Non-Sensitized Kidney Transplant Patients.

M. Marron-Wojewodzki,¹ I. Szwarc,¹ C. Rene,² G. Mourad,¹ M. Le Quintrec.^1,3
Temporal Trends and Variation in BMI Thresholds for Living Donation Across the US.

A. Naik,¹ D. Cibrik,¹ A. Sakhuja,² K. Lentine.³
The Ultimate Calculated Panel Reactive Antibody Value Predicts Mortality After Heart Transplantation.

E. Kransdorf,¹ M. Kittleson,¹ J. Patel,¹ M. Pando,² L. Czer,¹ J. Kobashigawa.¹
Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.

M. Manook,^1,2 J. Kwun,¹ J. Yoon,¹ K. Samy,¹ A. MacDonlad,¹ H. Xu,¹ R. Smith,³ S. Sacks,³ A. Dorling,³ N. Mamode,² S. Knechtle.¹
Vendor to Center in 0-60: A Safe and Effective Blueprint for Creating an In-House On-Call System for Organ Offers.

K. Driggers, J. Davenport, D. Cassidy, L. Curry, A. Milling, A. Hauser, H. Crego, P. Baliga, N. Pilch, D. Dubay, J. Anderson.
A Universal Strategy to Characterize Allograft Infiltrating Cells by Bioinformatics Deconvolution of Next Generation Sequencing Data.

G. Thareja,¹ H. Yang,² S. Hayat,¹ C. Li,² F. Mueller,² C. Snopkowski,² L. Perry,² M. Magruder,² J. Lee,² D. Dadhania,² K. Suhre,¹ M. Suthanthiran,² T. Muthukumar.²
Acute Cellar Rejection and Long-Term Graft Survival in Pediatric Kidney Transplant Recipients.

A. Massie, J. Garonzik-Wang, N. Desai, D. Segev.
Analysis of Differences in Living Donor and Recipient Pairs Estimated GFR at Six Months Over Time.

D. Keith.
Antibodies to Angiotensin Type II Receptor I Are Associated with Primary Graft Dysfunction After Orthotopic Heart Transplant in Patients with Ventricular Assist Device as Bridge to Transplant.

M. Hickey,¹ E. DePasquale,² S. Shah,³ D. Vucicevic,² J. Zhang,¹ N. Valenzuela,¹ M. Deng,² E. Reed.¹
Assessing Self-Efficacy During the Transition from Pediatric to Adult Liver Transplant Care.

J. Bilhartz, M. Lopez, S. Eder, E. Fredericks.
BK Virus, Cytomegalovirus and Epstein-Barr Virus Reactivation in Renal Transplant Patients: Results from a Large Multicenter Study.

A. Blázquez-Navarro,¹ C. Dang-Heine,¹ M. Or-Guil,² C. Bauer,³ T. Westoff,⁴ C. Hugo,⁵ P. Reinke,¹ B. Sawitzki,¹ N. Babel.^1,4
CD28 Directed Immunotherapy Is More Potent Than Belatacept in a Nonhuman Primate Xenotransplant Model.

S. Kim,¹ L. Higginbotham,¹ D. Mathews,¹ C. Breeden,¹ A. Stephenson,¹ C. Larsen,¹ M. Ford,¹ J. Tector,² A. Adams.¹
Center Volume Does Not Influence the Risk Associated with Using High DRI Donor Livers.

S. Black,¹ E. Beal,¹ K. Mumtaz,² D. Hayes Jr.,³ A. El-Hinnawi,¹ K. Washburn,¹ D. Tumin.⁴
Chagas Disease and Outcome in Kidney Transplant.

M. Taylor, A. Martinoia, S. Di PIetrantonio, M. Torres, H. Petrone.
Dendritic Cell Expression of Rictor (mTORC2), but Not Raptor (mTORC1), Protects Against Renal Ischemia-Reperfusion Injury.

H. Dai,^1,3 N. Rogers,^1,2 A. Watson,¹ D. Fantus,¹ A. Thomson.¹
Designing a Novel Selective Immunoproteasome Inhibitor Reveals a Critical Role of the IP and STAT5 Pathway in Regulating T Cell Exhaustion and Promoting Long Term Heart Allograft Acceptance.

S. Routray, E. Karreci, M. Uehara, J. Assaker, A. Mihali, S. Eskandari, L. Riella, R. Abdi, Y. Kawano, C. Nathan, G. Lin, J. Azzi.
Dual Costimulatory Blockades Failed to Achieve Transplant Tolerance Despite Induction of Mixed Chimerism in NHPs.

T. Oura,¹ K. Hotta,¹ I. Rosales,² A. Dehnadi,¹ J. Lei,¹ J. James Markmann,¹ M. Matsunami,¹ J. Paster,¹ I. Hanekamp,¹ K. Pruner,¹ K. Kawai,¹ D. Ndishabandi,² R.-N. Smith,² B. Cosimi,¹ T. Kawai.¹
Early Acute Cellular Rejection(eACR) as a Marker of Immunologic Competency Following Liver Transplantation(LT).

V. Kirchner, A. Bandgdiwala, D. Vock, M. Hassan, R. Kandaswamy, J. Lake, N. Lim, A. Mahgoub, E. Minja, A. Pugalenthi, B. Sengupta, O. Serrano, J. Thompson, W. Payne, T. Pruett, S. Chinnakotla.
Evaluation of Cytomegalovirus Prophylaxis Regimens in Intestinal Transplant Recipients: A Single Center Experience.

M. Eley,¹ M. Keck,¹ D. Collier,² M. Vacha.¹
Evolution of Health Related Quality of Life (HRQOL) in Kidney Donors.

H. Ibrahim,¹ D. Berglund,¹ S. Jackson,² A. Matas.¹
Ex-Situ Extended Limb Preservation: A Protocol for Porcine Limb Perfusion.

E. Dalla Pozza,¹ E. Duraes,¹ M. Madajka,¹ R. Frautschi,¹ K. Cho,¹ N. Dawlagala,¹ V. Fahradyan,¹ H. Shah,¹ C. Cakmakoglu,¹ C. Quintini,² F. Papay,¹ A. Rampazzo,¹ B. Bassiri Gharb.¹
Factors Predicting 30-Day Hospital Readmission After Kidney Transplant.

J. Ostrem, M. Brokhof, N. Kenyon, E. Hollinger, S. Jensik, O. Olaitan, M. Hertl, N. Alvey.
Glycolytic and Glutaminolytic Metabolism Supports IL-15 Induced Inflammatory Response of Temra CD8 from Kidney Transplant Recipients.

T.-M. Doan-Ngoc,¹ G. Tilly,¹ M. Yap,¹ A. Caristan,¹ L. Jacquemont,¹ R. Danger,¹ M. Cadoux,¹ S. Bruneau,¹ M. Giral,¹ P. Guerif,¹ B. Nicol,¹ A. Garcia,¹ D. Laplaud,¹ S. Brouard,¹ C. Pecqueur,² N. Degauque.¹
Impact of Alemtuzumab Induction on Hepatitis C Treatment Outcomes Post-Renal Transplantation.

S. Jonchhe, J. Husson, J. Casale, R. Adekunle, P. Mathur, J. Gripshover, B. Ravichandran.
Incidence of De Novo Donor-Specific Antibodies Following Kidney Transplantation.

B. Ho,¹ H. Bhagat,² E. Lee,^2,3 K. Atiemo,¹ A. Daud,¹ R. Kang,¹ S. Montag,^1,4 L. Zhao,^1,4 J. Schwartz,² D. Ladner.¹
Increased Ischemic Inflammation Induces Recipient Endogenous Memory CD4 Cell-Graft Dendritic Cell Interactions to Provide Help for Activation of Endogenous Memory CD8 T Cells.

H. Tsuda, T. Tanaka, C. Su, A. Valujskikh, R. Fairchild.
Is “Death with a Functioning Graft (DWF)” Really Death with Function? Data from the Long-Term Deterioration of Kidney Allograft Function (DeKAF) Study.

R. Gaston,¹ A. Fieberg,² L. Hunsicker,³ D. Rush,⁴ R. Leduc,² J. Connett,² A. Matas,² DeKaf Investigators.
Long-Term Outcome of Antibody-Mediated Rejection Due to Pre-Existing vs. De Novo DSA in Kidney Allograft Recipients.

O. Aubert,¹ C. Lefaucheur,¹ S. Higgins,¹ L. Hidalgo,² J. Duong Van Huyen,¹ D. Viglietti,¹ X. Jouven,¹ D. Glotz,¹ P. Halloran,² A. Loupy.¹
Lymph Node Stromal Laminins Differentially Regulate T Cell Activation.

T. Simon, J. Bromberg.
More Rapid Decline in Male VS Female Living Kidney Donations (LKD) Varies by Income.

J. Lesage, J. Gill, C. Rose, Y. Joffres, J. Gill.
Non-Renal Factors Predicting Combined Liver-Kidney Transplantation for Non-Dialysis-Requiring Wait-Listed End Stage Liver Disease Patients: 14 Years of US Experience.

A. Santos, M. Casey, K. Alquadan, J. Gregg, K. Womer.
Pre-Transplant HLA-Specific B Cell Breadth of Reactivity in a Novel Multiplex Bead-Based Assay Predicts Rejection in Kidney Transplant Recipients.

Z. Ilyas,¹ A. Aki,¹ A. Tambur,¹ P. Heeger,² M. Ansari.¹
Preventing of Rejection of Vascularized Composite Allografts by Targeting T Cell Metabolism.

B. Oh,¹ C. Cheng,² G. Furtmüller,¹ W. Lee,¹ J. Powell,² G. Brandacher.¹
Rapid Depletion of Circulating DSA and Treatment of Acute Antibody-Mediated Rejection with the Combination of CTLA-4Ig/Belatacept and Bortezomib in Mouse and Man.

J. Young,¹ A. Vannier,¹ G. Bumgardner,² A. Chong,¹ R. Pelletier.²
Simultaneous or Sequential Heart-Liver Transplantation Confer Superior Survival in Patients with Listed for Heart-Liver Transplantation: A National Analysis.

K. Anderson,¹ M. Mulvihill,² B. Yerokun,² A. Barbas,² M. Hartwig.²
Sirolimus Prolonged Survival After Living Donor Liver Transplantation for HCC Beynd Milan Criteria; Outcome of a Multicenter Prospective Randomized Phase II Trial (ClinicalTrials.gov Identifier: NCT01374750).

K.-W. Lee,¹ S.-H. Kim,² N.-J. Yi,¹ S.-K. Hong,¹ G. Yoon,¹ H. Kim,¹ D. Oh,¹ S.-S. Han,² S.-J. Park,² K.-S. Suh.¹
Substance Abuse in Acute Liver Failure: Time to Talk About Opiates.

M. Jesse, N. Rebhan, A. Yoshida, D. Moonka, A. Eshelman, M. Abouljoud, M. Rizzari.
TACI Polymorphisms Associated with De Novo Alloantibodies in Humans and Allograft Rejection in Mice.

J. Platt,¹ E. Farkash,² A. Lefferts,¹ M. Samaniego,³ M. Cascalho.¹
Tacrolimus Time in Therapeutic Range Predicts Adverse Clinical Outcomes in the First Year of Kidney Transplant.

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.
The Objective Liver Frailty Index Significantly Improves the Clinician “Eyeball Test” to Predict Mortality in Liver Transplant Candidates.

J. Lai, K. Covinsky, C. McCulloch, S. Feng.
Transplant Readiness Assessment Clinic: A New Approach to Kidney Waitlist Management in the KAS Era.

X. Cheng,¹ J. Lee,² Z. Tulu,² J. Tan.²
Type 1 Diabetic Patients Have Better Endothelial Function After Simultaneous Pancreas-Kidney Transplantation Than After Kidney Transplantation with Continued Insulin Therapy.

A. Kolonko,² A. Kowalik,¹ J. Ziaja,¹ D. Kaminska,³ A. Owczarek,⁴ A. Kujawa-Szewieczek,² M. Kusztal,³ J. Badura,¹ D. Bozek-Pajak,¹ A. Zakrzewska,⁵ P. Choreza,⁴ R. Krol,¹ S. Chlopicki,⁵ M. Klinger,³ A. Wiecek,² J. Chudek,⁶ L. Cierpka.¹
Urinary Retention Associated with Polyomavirus (BK) Viruria and Higher Peak Blood BK Following Kidney Transplant (KTx).

W. Cheungpasitporn,¹ H. Amer,² F. Cosio,² C. Schinstock.²
We Wish This Would Never Happen Again! Implementation of an Adverse Event Review System to Improve the Safety of Pediatric Solid Organ Transplant (SOT) Patients.

J. Gossett,¹ M. Lake,¹ J. Bucuvalas,² A. Basu,¹ L. Burkhart,¹ L. Danziger-Isakov,¹ A. Lorts.¹
When Does the Learning Curve End? A High-Volume Single Center Experience with Laparoscopic Donor Nephrectomy Over 16 Years.

S. Yamanaga,^1,2,3 A. Posselt,¹ C. Freise,¹ C. Niemann,¹ A. Rosario,¹ D. Fernandez,¹ T. Kobayashi,³ A. Ahearn,⁴ M. Tavakol,¹ S.-M. Kang.¹
A Humanized Anti-CD47 Monoclonal Antibody Therapy Alleviates Ischemia-Reperfusion Injury of Porcine Renal Allografts Donated After Cardiac Death.

M. Xu,¹ B. Banan,¹ X. Wang,¹ D. Chirumbole,¹ B. Rabe,¹ S. Garcia-Aroz,¹ D. Nayak,¹ Z. Zhang,¹ J. Jia,¹ G. Upadhya,¹ J. Gaut,² P. Manning,³ Y. Lin,¹ W. Chapman.¹
Acute Cellular Rejection Is Associated with Increased Risk of Early and Late Graft Failure.

A. Massie, J. Garonzik-Wang, D. Segev.
Adoptive Immunotherapy with Liver Allograft-Derived Lymphocytes Compensate for the Susceptibility to Post-Liver Transplant Blood Stream Infection Associated with FCGR3A SNP.

H. Ohdan, M. Ohira, S. Shimizu, Y. Tanaka, H. Tahara, K. Ide, K. Ishiyama, T. Kobayashi.
Antibody Mapping by Protein Microarray Revealed a Unique Repertoire in Lung Transplant Recipients That Developed Chronic Lung Allograft Dysfunction.

D. Nayak,¹ K. Garcia,² P. Pirrotte,² R. Hachem,³ R. Bremner,¹ M. Smith,¹ T. Mohanakumar.¹
Bioengineering Human Islets to Form Peri-Islet Vessels from Intraislet Endothelial Cells for Improving Human Islet Function.

G. Loganathan, S. Narayanan, M. Dhanasekaran, A. Patel, W. Tucker, M. Hughes, S. Williams, A. Balamurugan.
CCR7⁺CD8⁺T Cell Suppresses Effector T Cell Related Allo-Immune Responses in Kidney Transplant Recipients.

B. Chung, K. Kim, B.-M. Kim, K. Doh, C. Yang.
Co-Stimulation Blockade to Minimize and Withdraw Long Term Calcineurin Inhibitors (CNI) in Simultaneous Pancreas and Kidney Transplant (SPK).

P. Stock,¹ R. Mannon,² B. Armstrong,³ D. Ikle,³ M. Robian,⁴ Y. Morrison,⁴ J. Odorico,⁵ J. Fridell,⁶ A. Mehta,⁷ K. Newell.⁷
Comprehensive Functional Assessment of the Pathogenic Potential of Immunodominant Donor Specific Antibody Following Treatment of Late Antibody Mediated Rejection or Mixed Acute Rejection.

A. Lichvar,¹ E. Portwood,¹ P. Brailey,¹ S. Tremblay,¹ A. Shields,² B. Abu Jawdeh,¹ J. Kremer,² F. Paterno,¹ R. Alloway,¹ A. Girnita,¹ E. Woodle.¹
Delayed Graft Function[mdash]Less Ominous for ARF or DCD Recipients?

M. Barrett, A. Smith, K. Woodside, R. Sung.
Desensitization versus Deceased Donor Kidney Transplantation: What to Choose When Both Become Available?

B. Orandi,¹ X. Luo,² J. Garonzik-Wang,² R. Montgomery,³ D. Segev.²
Early Results of Immune Profile Emerging Before Detection of De Novo Humoral Alloimmunity in Kidney Transplant Recipients.

J. Zimmerer, B. Ringwald, R. Pelletier, A. El-Hinnawi, A. Rajab, G. Bumgardner.
Ectopic Lymphoid Structures Are Present in Type I T-Cell Mediated Kidney Transplant Rejection.

K. de Leur,^1,2 M. Clahsen-van Groningen,³ G. de Graav,¹ D. Hesselink,¹ J. Samsom,⁴ C. Baan,¹ K. Boer.¹
Effect of Everolimus-Based Immunosuppressive Regimen on New Onset of Diabetes After Kidney Transplantation – A 24 Month Subanalysis from the ELEVATE Study.

H. Holdaas,¹ S. Chadban,¹ J. de Fijter,¹ L. Rostaing,¹ U. Mancilla,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ M. van der Giet.¹
Endoscopic Ultrasound Guided Biopsy Sampling of the Pancreas Transplant- The Future of Graft Surveillance?

E. Nordheim,¹ V. Paulsen,² A. Lars,² R. Horneland,³ K. Brabrand,⁴ A. Hartmann,¹ T. Jenssen.^1,5
Experience with Belatacept (CTLA4-Ig) Conversion in Highly HLA Sensitized (HS) and ABO-Incompatible (ABOi) Patients Who Received Incompatible Kidney Transplants Post Desensitization (DES).

J. Choi,¹ A. Peng,¹ A. Vo,¹ E. Huang,¹ R. Najjar,¹ S. Louie,¹ A. Kang,¹ S. Ge,¹ M. Toyoda,¹ X. Zhang,² S. Jordan.¹
Experience with the Bacterial Enzyme IdeS (IgG Endopeptidase) for Desensitization of Highly-HLA Sensitized (HS) Kidney Allograft Recipients.

S. Jordan,¹ J. Choi,¹ C. Kjellman,² L. Winstedt,² X. Zhang,⁴ S. Louie,¹ A. Kang,¹ M. Haas,³ A. Vo.¹
Impact of Type of Recipient Diabetes on 1 and 3-Year Kidney Allograft and Patient Outcomes.

S. Kim, F. Wu, D. Cibrik, Y. Li, A. Naik.
Increase in Post-Transplant Mortality Under KAS.

A. Massie, J. Garonzik-Wang, D. Segev.
Inhibition of Multiple Nodes in the PI3K/Akt/mTOR Pathway Synergistically Suppresses Epstein-Barr Virus B Cell Lymphomas.

A. Sang, G. Ivison, X. Qu, C. Esquivel, S. Krams, O. Martinez.
Just Keeps Getting Worse: Racial and Ethnic Disparities in Access to Live Donor Kidney Transplantation in the US Over the Last Twenty Years.

T. Purnell,¹ X. Luo,¹ L. Kucirka,¹ M. Henderson,¹ E. Gordon,² L. Boulware,³ D. Segev.¹
Lower Incidence of DSA-Induced Chronic Antibody-Mediated Rejection in Abo-Incompatible Renal Transplantation.

M. Okada,¹ Y. Watarai,¹ K. Iwasaki,² K. Futamura,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
Macrophage Specific Deletion of RhoA Inhibits Fractalkine Signaling and Abrogates Chronic Rejection of Cardiac Allograft.

M. Kloc, Y. Liu, W. Chen, X. Li, R. Ghobrial.
Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection.

C. Jadlowiec, P. Morgan, A. Nehra, M. Hathcock, W. Kremers, R. Wiesner, T. Taner.
Nucleic Acid Scavenging Microfiber Mesh Inhibits Trauma Induced Inflammation and Thrombosis After Organ Transplantation.

J. Kwun,¹ J. Lee,¹ J. Jackman,² M. Manook,¹ E. Elster,³ A. Kirk,¹ B. Sullenger.¹
One-Year Graft and Patient Survival of Deceased Donor Kidney Transplants Under KAS.

A. Wilk,¹ D. Stewart,¹ M. Aeder,² A. Kucheryavaya,¹ D. Klassen.¹
Performance-Based vs. Self-Reported Functional Assessment on Outcomes After Kidney Transplant.

K. Tibaldi, N. Dhillon, R. Goldberg, H. Paniagua, A. Patel.
Preceeding the Rejection: Clinical Results of a Saliva Test After Renal Transplantation.

D. Abendroth,¹ M. Marzinzig,¹ M. Stangl.²
Protease Inhibitor-Based Regimens Are Associated with Inferior Outcomes in HIV-Infected Kidney Transplant Recipients.

B. Shelton,¹ D. Sawinski,² R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ J. Locke.¹
Share35: Increasing Biliary Complications and Healthcare Resources?

J. Fleming,¹ C. Perez,¹ M. Sobhanian,¹ D. Taber,² G. Chedister,² D. Axelrod,³ K. Chavin.²
State Population Health and Center-Level Variation in Rate of Living Kidney Donation.

R. Reed, B. Shelton, P. MacLennan, M. Hanaway, V. Kumar, R. Gaston, J. Locke.
TRPV4 Channels Mediate Pulmonary Edema and Inflammation During Ischemia-Reperfusion Injury.

E. Charles, Y. Zhao, K. Hong, C. Marziano, J. Mehaffey, I. Kron, S. Sonkusare, V. Laubach, A. Sharma.
Technical Refinement to Prevent Hepatic Outflow Disturbance in Right Lobe Living Donor Liver Transplantation: Simplified One-Orifice Venoplasty.

J. Kim, D. Choi.
The Cumulative United States Experience with Transplants (Txs) from Living Donors (LDs): 140,156 LD Txs in 28 Years.

R. Gruessner,¹ M. Laftavi,¹ V. Whittaker,¹ O. Pankwycz,² Z. Acun,¹ A. Gruessner.¹
The Gut Microbiota Regulates Murine Cardiac Transplant Outcome.

Y. Xiong, C. Brinkman, L. Hittle, W. Fricke, E. Mongodin, J. Bromberg.
The Impact of Delayed Graft Function on Long Term Graft Survival Adjusted for Donor Kidney Quality Assessed by the KDPI.

L. Lehner, F. Halleck, D. Khadzhynov, E. Schrezenmeier, M. Dürr, K. Budde, O. Staeck.
The TAKE-IT Intervention Improves Medication Adherence in Adolescent Kidney Transplant Recipients.

B. Foster,¹ A. Pai,² S. Furth,³ TAKE-IT Investigators.
Tolerant Pediatric Liver Transplant (LT) Recipients (TOL) from WISP-R (NCT00320606) Split into Two Phenotypically Distinct Groups by PD1 Expression on CD4+ T Cells at Baseline, Prior to Immunosuppression Withdrawal (ISW).

B. Burrell,¹ S. Feng,² N. Bridges,³ U. Ekong,⁴ S. Kanaparthi,¹ A. Kirk,⁵ A. Long,¹ K. Spain,⁶ L. Stempora,⁵ L. Turka,¹ N. Tchao.¹
Use of Ledipasvir/Sofosbuvir with or without Ribavirin in Patients Post-Liver Transplant: Evaluation of Real-World Datasets.

S. Flamm,¹ M. Charlton,² M. Manns,³ M. Prieto,⁴ I. Fernandez,⁵ M. Londono,⁶ R. Kwok,⁷ C. Smith,⁸ S. Lee,⁹ H. Ngo,⁹ A. Osinusi,⁹ A. Copans,⁹ L. Rossaro,⁹ M. Shoreibah,¹⁰ O. Massoud,¹⁰ M. Curry,¹¹ M. Bourliere.¹²
Utility of Weighted Composite Endpoints in Kidney Transplantation.

J. Schold, D. Goldfarb, S. Flechner, L. Buccini, J. Augustine, E. Poggio.
A Regulatory T Cell (Treg)-Intrinsic Role for p27kip1 in Acquired Transplant Tolerance.

P. Morawski, L. Wang, X. Yang, Y. Chen, W. Hancock, A. Wells.
A Search for a Biomarker Which Predicts Belatacept-Resistant Rejection.

G. de Graav,¹ C. Baan,¹ M. Clahsen-van Groningen,² R. Kraaijeveld,¹ M. Dieterich,¹ W. Verschoor,¹ D. Roelen,³ M. Cadogan,¹ J. van de Wetering,¹ J. van Rosmalen,⁴ W. Weimar,¹ D. Hesselink.¹
A Single Skin Commensal Strain Is Sufficient to Accelerate Skin Transplant Rejection.

Y. Lei,¹ L. Chen,¹ Y. Wang,¹ A. Chong,¹ Y. Belkaid,² M.-L. Alegre.¹
Belatacept Conversion for Calcineurin Inhibitor (CNI) Toxicity: Our First 100 Patients.

R. Crew, S. Patel, A. Pai, I. Batal, H. Fernandez.
Belatacept Conversion in Kidney Recipients with Low GFR Does Not Improve Renal Function.

D. Abdelwahab,¹ S. Byron,² B. Kaplan,¹ R. Heilman.¹
Beyond the Bones – The Association Between Vitamin D, Graft Outcomes, Malignancy and Vascular Disease.

A. Seitz,¹ A. Cherukuri,² R. Baker.¹
CD47 Blockade Reduces Ischemia/Reperfusion Injury in Donation After Cardiac Death Rat Kidney Transplantation.

X. Wang,¹ M. Xu,¹ J. Jia,¹ Z. Zhang,¹ J. Gaut,² G. Upadhya,¹ P. Manning,³ Y. Lin,¹ W. Chapman.¹
Circulating Exosomes Isolated from Human Lung Transplant Recipients with Rejection Are Immunogenic and Induce Antibodies to Lung Associated Self-Antigens, Kα1 Tubulin and Collagen-V.

M. Gunasekaran, M. Sharma, S. Bansal, S. Biswas Roy, R. Walia, R. Bremner, M. Smith, T. Mohanakumar.
De Novo DSA with T Cell Mediated Rejection (TCMR) Leads to Early Allograft Scarring and Dysfunction.

A. Cherukuri, A. Sharma, M. Mangiola, P. Sood, P. Randhawa, A. Zeevi, R. Mehta, S. Hariharan.
Deceased Donors with a History of IV Drug Use and Donor Derived Hepatitis C Virus.

D. Kaul,¹ M. Clark,² M. Michaels,¹ S. Tlusty,² C. Wolfe.¹
Donation After Circulatory Death (DCD) Kidneys Are More Likely to Be Discarded than Kidneys from Neurologically Brain Dead Donors (NBD).

J. Gill,¹ C. Rose,¹ J. Lesage,¹ Y. Joffres,¹ J. Gill,¹ K. O'Connor.²
EBV-Specific CD8⁺ T Cells from Pediatric Thoracic vs Abdominal Transplant Recipients Are Shaped Differently by the Chronic EBV Loads with Potential Impact on the Risk of PTLD.

M. Yamada,^1,2 M. Camila,² P. Fadakar,^1,2 K. Hornor,¹ M. Michaels,^1,2 M. Green,^1,2 C. Nguyen,^1,2 B. Feingold,^1,2 G. Mazariegos,^1,2 D. Metes.²
EPTS Is a Poor Predictor of Post-KT Mortality for Older Recipients.

M. McAdams DeMarco, X. Luo, A. Massie, D. Segev.
Eight Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients.

J. Leventhal,¹ J. Galvin,¹ J. Mathew,¹ L. Gallon,¹ D. Stare,¹ A. Sweeney,¹ J. Miller,¹ M. Abecassis,¹ S. Ildstad.²
Even with National Sharing, the Prospects of a 100% Sensitized Patient Receiving a Transplant Vary Dramatically Depending on the Precise CPRA Value.

D. Stewart,¹ A. Kucheryavaya,¹ D. Tyan,² H. Gebel,³ R. Bray,³ N. Turgeon.³
Gut Microbiota-Urinary Tract Infection Axis in Kidney Transplant Recipients.

J. Lee,¹ M. Mcgruder,¹ L. Zhang,¹ D. Dadhania,¹ M. Thangamani,¹ L. Ling,² Y. Taur,² E. Pamer,² M. Suthanthiran.¹
Host-Derived, Intragraft Dendritic Cells Are Extensively Cross-Dressed by Donor MHC.

A. Hughes, H. Dai, A. Williams, M. Oberbarnscheidt, A. Morelli, F. Lakkis.
How to Improve Pre-Kidney Transplant Education for Hispanics: Preferences and Perceptions of Northwestern Memorial Hospital's Hispanic Transplant Program.

H. Gomez, E. Malagon-Blackwell, J. Caicedo.
IL-21R Antagonist Inhibits Differentiation of B Cells Towards Plasmablasts upon Alloantigen Stimulation.

K. de Leur,^1,2 F. Dor,⁴ M. Dieterich,¹ L. van der Laan,² R. Hendriks,³ C. Baan.¹
Immune Sensitization During Pregnancy Reduces Long-Term Benefit for Kidney Recipients of Offspring Living Donors.

J. Cohen,¹ L. Owei,² D. Sawinski,¹ P. Porrett.²
In Clinic Systems to Address Adherence Barriers Decrease Late Allograft Rejection for Kidney Transplant Patients.

D. Hooper, C. Varnell, Jr., K. Rich, D. Dahale, J. Huber, A. Pai, A. Modi.
Intensive Care Unit Enhanced Recovery Pathway for Liver Transplant Recipients: A Prospective, Observational Study.

C. Kensinger, A. King, S. Karp, P. Pandharipande, K. Wright, L. Weavind.
Is Reluctance to Accept Younger Kidney Donors Justified?

H. Ibrahim,¹ D. Berglund,¹ S. Jackson,² A. Matas.¹
Islet Rejection in Autoimmune NOD Mouse Recipients: Implications for Stem Cell Therapies.

R. Gill,¹ M. Coulombe,¹ T. Kupfer,¹ K. Beard,¹ A. Burrack.²
Lessons Learned from Simultaneous Biopsies of Both Kidney and Pancreas Grafts in Recipients of Simultaneous Kidney-Pancreas Transplants.

S. Parajuli, B. Astor, A. Djamali, R. Redfield, E. Arpali, D. Kaufman, J. Odorico, D. Mandelbrot.
Live Donor Liver Transplantation Using Grafts with More Than Two Bile Ducts – Does It Affect Patient Outcome?

D. Kollmann, G. Sapisochin, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, A. Ganekar, D. Grant, M. Selzner, N. Goldaracena.
Long-Term Outcomes After Liver Transplantation (tx) with Everolimus (EVR) and Mycophenolic Acid (MPA) in a Calcineurin Inhibitor-Free Regimen: The CERTITUDE Trial.

F. Saliba,¹ C. Duvoux,² S. Dharancy,³ J. Dumortier,⁴ Y. Calmus,⁵ F. Di Giambattista,⁶ F. Conti.⁵
Meta-Analysis of Clinical Significance of Complement Activating Anti-HLA DSA in Kidney Transplantation.

A. Bouquegneau,^1,2 C. Ulloa,¹ O. Aubert,¹ C. Loheac,¹ D. Viglietti,¹ J. Empana,¹ P. Jabre,¹ X. Jouven,¹ C. Lefaucheur,¹ A. Loupy.¹
Myeloid HO-1 Orchestrates Liver Graft Function via SIRT1/p53 Signaling: From Mouse-to-Human.

K. Nakamura,¹ M. Zhang,² B. Ke,¹ S. Kageyama,¹ N. Datta,¹ A. Zarrinpar,¹ R. Busuttil,¹ J. Araujo,² J. Kupiec-Weglinski.¹
Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.

M. Lim,¹ D. Sawinski,¹ J. Cohen,^1,2 B. Weiss,^3,4 J. Hogan,^1,3 L. Dember.^1,3
Preliminary Results of Clinical Normothermic Ex Vivo Liver Perfusion in a North American Setting.

M. Bral,¹ B. Gala-Lopez,¹ D. Bigam,¹ N. Kneteman,¹ A. Malcolm,¹ S. Livingstone,¹ A. Andres,¹ J. Emamaullee,¹ L. West,¹ P. Friend,² A. Shapiro.¹
Reduced Conversion from IgM Anti-HLA-DSA to IgG Anti-HLA-DSA in Belatacept-Treated vs. Cyclosporine-Treated Patients in BENEFIT and BENEFIT-EXT Trials.

M. Everly,¹ R. Townsend,² H. Gebel,³ R. Bray.³
Strategy for Analysis of Donor-Specific Antibody Repertoire: Paired Immunoglobulin Heavy and Light Chain Analysis of Individual Memory B Cells.

M. Lucia,¹ A. Gomez,² S. Luque,³ O. Bestard,³ W. Robinson,² O. Martinez.¹
Sulfatide-Selective NKT Cells Mediate M2 to M1 Polarization Resulting in Amelioration of Kidney Fibrosis.

S. Lee,¹ M.-Y. Yu,² Y. Kim,² S. Yang,¹ S. Han,¹ H. Lee,² J. Lee,³ D. Kim,² Y. Kim.²
The Safety and Efficacy of Directly-Acting Antivirals with or without Ribavirin for HCV Genotype 1 Infection: A Systematic Review and Meta-Analysis.

Z. Guo, J. Gu, X. He, G. Chen.
U.S. Outcomes in Early Liver Transplantation for Alcoholic Hepatitis: Results from the American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH).

B. Lee,¹ N. Mehta,¹ L. Platt,² G. Im,³ G. Therapondos,⁴ H. Han,⁵ D. Victor,⁶ D. Dronamraju,⁷ I. Hanouneh,⁸ M. Voigt,⁹ M. Rinella,¹⁰ S. Eswaran,¹¹ J. Hause,¹¹ C. Hsu,¹² J. Dodge,¹ Z. Li,² N. Terrault.¹
Unexplained Cost Variation for Liver Transplantation: A National Study of US Transplant Centers.

C. Santos, B. Hota, M. Hertl.
Unintended Consequence of the New Kidney Allocation System – Disproportionate Allocation of High Quality Kidneys to Highly Sensitized Recipients.

B. Murthy, N. Galvan, J. Moffett, C. O'Mahony, J. Goss, A. Rana.
Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.

N. Lam,¹ A. Garg,² G. Knoll,³ J. Kim,⁴ K. Lentine,⁵ E. McArthur,⁶ K. Naylor,⁶ S. Bota,⁶ M. Sood.³
“Donor Age or Quality” a Qualitative Analysis of Livers Declined for 830.

M. Dokus, E. DeAngelis, G. Ramaraju, K. Tomiyama, J. Huang, M. Levstik, R. Hernandez-Alejandro, M. Orloff, R. Kashyap.
A Comparison of Desensitization Protocols: Rituximab with/without Plasmapheresis in ABO-Incompatible Living Donor Liver Transplantation.

E. Lee, S. Kim, S. Lee, S.-J. Park.
A Dedicated Young Adult Service with a Youth Worker Increases Engagement of Teenagers and Young Adults with Kidney Transplantation and Impacts Favourably on Clinical Outcomes.

D. Cross, P. Harden.
A Prospective Iterative Trial of Carfizomib-Based Desensitization Trial: Initial Comparative Observations.

S. Tremblay,¹ A. Shields,^1,2 R. Alloway,¹ P. Brailey,¹ A. Leino,¹ A. Lichvar,¹ B. Abu Jawdeh,¹ J. Driscoll,¹ A. Girnita,¹ E. Woodle.¹
Addition of FEV1 Drop to LAS May Improve Access of CF Patients to Transplant: Analysis of the SRTR and US CF Foundation Patient Registries.

E. Dasenbrook,¹ M. Skeans,² A. Fink,³ B. Marshall,³ M. Valapour.^1,2
Baseline Immune Assessment to Individualize Immunosuppression in SPK Recipients with Type 1 Diabetes.

Y. Kudva, V. Dadlani, A. Miller, M. Abdallah, W. Kremers, M. Stegall, R. Abraham.
Causes and Long-Term Consequences of Diarrhea After Kidney Transplantation.

A. Devresse,¹ F. Aulagnon,² A. Scemla,² L. Morin,² F. Lanternier,³ D. Anglicheau,² O. Lortholary,³ C. Legendre,² V. Avettand-Fenoel,⁴ J. Zuber.²
Circulating Inflammatory Factors in Deceased Organ Donors Result in Innate Immune Activation.

T. Brennan, L. Lin, J. Pollara.
Comparing the Role of Post-Transplant Readmissions and Bed Days on Total One Year Cost of Care.

W. Bannister,¹ M. Schnitzler,² J. Tao,¹ A. Bonagura,¹ B. Laihinen,¹ F. Irwin,¹ C. Horstman.¹
Determinants of Severe Interstitial Fibrosis in Kidney Allografts: Major Impact of Circulating Donor-Specific Anti-HLA Antibodies.

C. Gosset, D. Viglietti, M. Rabant, E. Pillebout, J. Taupin, D. Glotz, C. Legendre, J. Duong Van-Huyen, A. Loupy, C. Lefaucheur.
Direct Acting Antiviral Drugs Are Highly Effective in Hepatitis C (HCV) Patients with End Stage Renal Disease (ESKD) and Advanced Liver Disease (ALD).

J. Korula, T. Shah, E. Ranger, E. Barba, D. Vu, R. Naraghi.
Donor Age Is the Most Important Predictor of Longterm Graft Function in Simultaneous Pancreas-Kidney Transplantation from Donors After Cardiac Death.

J. Chen,¹ D. Mikhail,^1,2 H. Sharma,³ A. Hijazi,¹ D. Nap,¹ L. Stitt,⁴ J. Jevnikar,⁵ M. Cooper,⁶ P. Luke,^1,2 A. Sener.^1,2
Donor Warm Ischemic Time >80min Is an Important Predictor of Kidney Graft Survival from Donors After Cardiac Death.

J. Chen,¹ D. Mikhail,² H. Sharma,³ A. Hijazi,¹ D. Nap,¹ L. Stitt,⁴ J. Jevnikar,⁵ M. Cooper,⁶ P. Luke,² A. Sener.²
Donor-Derived Cell-Free DNA Predicts Biopsy-Proven Acute Cellular Rejection in Pediatric Kidney Transplant Recipients.

D. Stoltz,¹ A. Brubaker,¹ M. Grskovic,² R. Woodward,² A. Gallo.¹
Fosfomycin Tromeltamol (FOS) Is an Effective Alternative in Post Renal Transplant Urinary Tract Infection Prophylaxis Caused by Escherichia coli and Enterococcus faecalis without Increasing Resistance Rate.

J. Arreola-Guerra,¹ J. Alberu,² L. Morales-Buenrostro,² E. Maravilla,³ R. Rosado,³ J. Sifuentes.³
Generation of Natural Antibodies Post Transplant and Association with Kidney Allograft Loss.

S. See,¹ A. Loupy,² O. Aubert,² Y. Veras,¹ X. Lebreton,² B. Gao,³ C. Legendre,² D. Anglicheau,² E. Zorn.¹
Glomerular CD45 Immunostaining in Post Perfusion Graft Biopsies Predicting Rejection.

A. Yuvaraj, A. Prasad, K. Gopalakrishnan, N. Krishnan.
HLA-DR Based Murine Transplant Model for Studying Collagen Type V Autoimmunity in Chronic Allograft Rejection.

V. Agashe, Y. Zhou, E. Jankowska-Gan, W. Burlingham.
IL-7 Receptor Heterogeneity as a Mechanism for Repertoire Change During Post-Depletional Homeostatic Proliferation and Its Relation to Costimulation Blockade Resistant Rejection.

H. Xu, T. Brennan, A. Kirk.
Identifying the Specific Causes and the Determinants of Outcome in Kidney Recipients with Transplant Glomerulopathy: A Multicenter Study.

O. Aubert,¹ S. Higgins,¹ P. Campbell,² C. Loheac,¹ D. Viglietti,¹ D. Glotz,¹ C. Legendre,¹ C. Lefaucheur,¹ B. Sis,² J. Duong Van Huyen,¹ A. Loupy.¹
IgM Immunotherapy Restores Immune Homeostasis in Type 1 Diabetes.

P. Chhabra,¹ C. Wilson,² D. Moore,² K. Brayman.¹
Impact of Bariatric Surgery on Risk of Organ Rejection Among Solid Organ Transplant Recipients.

M. Soghikian, D. Gregory, J. Wilcox, A. Shetty, D. Ladner, L. VanWagner.
Is Deceased Donor Kidney Transplantation (DDTX) Justified in Patients with More Than 10 Years of Pre-TX Dialysis Exposure?

C. Rose, J. Gill, J. Lesage, Y. Joffres, J. Gill.
Kidney Transplant Recipient Intermediate and Long Term Outcomes for Living Donor Gifted Lithiasis.

S. Doshi, M. Yaqub, T. Taber, M. Mujtaba, D. Mishler, O. Adebiyi, C. Sundaram, J. Powelson, A. Sharfuddin.
Largest US Series of Minimally Invasive Full and Laparoscopy-Assisted Living Donor Hepatectomy.

K. Collins, J. Emond, A. Fox, B. Samstein.
Multiple Dosing of Anti-C1s Antibody TNT009 – Effect on HLA Antibody-Triggered Complement Activation in Healthy Volunteers and Kidney Transplant Recipients with Antibody-Mediated Rejection.

J. Muhlbacher,¹ B. Jilma,² M. Wahrmann,³ F. Eskandary,³ J. Gilbert,⁴ S. Panicker,⁴ G. Böhmig.³
Neutropenia in Kidney Transplantation: A Hidden Threat to Graft Survival.

A. Vergottini, A. Karabala, P. Abrams, J. Verbesey, S. Ghasemian, J. Moore, M. Grafals, B. Javaid, M. Cooper, A. Gilbert.
Non-Invasive Detection of Rejection with ImmunoPET Imaging.

D. Mathews,¹ K. Lindsay,² P. Santangelo,² Y. Dong,¹ J. Tso,³ A. Adams.¹
Normothermic Regional Perfusion of Donors Following Circulatory Death Improves Outcomes in Liver Transplantation.

E. Mowlem,¹ L. Randle,² C. Fear,¹ K. Crick,¹ S. Messer,⁴ S. Large,⁴ A. Butler,³ C. Watson.³
Novel Cell Intrinsic Role of the Adaptor Protein TSAd in Maintaining Alloimmune T Regulatory Cell Function.

J. Wedel,^1,2 M. Stack,^1,2 T. Seto,^1,2 M. Sheehan,^1,2 K. Liu,^1,2 E. Flynn,^1,2 D. Briscoe.^1,2
Organs with Extended Cold Ischemia Time May Offer Aged Kidney Transplant Recipients New Options in an Expanded Donor Pool.

M. Postalcioglu,¹ B. Byun,¹ A. Kaze,² A. Siedlecki,¹ E. Milford,² R. Abdi.¹
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes (T1D) Post Renal Transplantation.

J. Markmann, R. Alejandro, M. Bellin, N. Bridges, W. Clarke, T. Eggerman, E. Foster, B. Hering, D. Kaufman, O. Korsgren, X. Luo, A. Naji, J. Oberholzer, A. Posselt, M. Rickels, C. Ricordi, M. Robien, P. Senior, A. Shapiro, N. Turgeon.
Relationship Between Mixed Chimerism and Tolerance in HLA-Matched and -Mismatched Recipients of Kidney and Hematopoietic Cell Transplants.

S. Busque, J. Scandling, J. Shizuru, R. Lowsky, A. Shori, J. Kent, E. Engleman, S. Strober.
Signal Inhibitory Regulatory Protein-α Regulates Pathologic Reactive Oxygen Species in Acute Kidney Injury.

N. Rogers,^1,2,3 D. Meijles,³ P. Pagano,³ J. Isenberg.³
Socioeconomic Status and Perceived Donation-Related Financial Burden Among Living Kidney Donors.

J. Ruck, A. Massie, M. Henderson, D. Segev.
The miRNome of EBV+ PTLD is Distinct from EBV+ Infectious Mononucleosis.

Y. Balachandran,¹ V. Kaul,¹ E. Maloney,¹ A. Harris-Arnold,¹ K. Weinberg,² S. Boyd,² D. Bernstein,² C. Esquivel,¹ O. Martinez,¹ S. Krams.¹
Tracking the In Vitro Phenotype and Proliferative Capacity of CD57+ CD4 T Cells.

J. Espinosa,¹ J. Lockley,¹ F. Shaw,¹ R. Osborne,¹ M. Joshi,¹ T. Woody,¹ M. Ellis,¹ B. Hollister,¹ J. Cheeseman,¹ R. Townsend,² A. Kirk.¹
Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients.

D. Taber, M. Gebregziabher, L. Egede, P. Baliga.
Transplantation of Organs from Donors with Hepatitis C: The Potential to Substantially Increase Transplant Activity.

P. Trotter,^1,2 M. Robb,² I. Ushiro-Lumb,² J. Powell,³ C. Watson,¹ J. Bradley,¹ J. Neuberger.^2,4
A Molecular Signature Characterized by Dominance of Negative Regulation over Cytotoxic Effectors in Tolerant Kidney Allograft Recipients.

J. Lee,¹ J. Leventhal,² C. Li,¹ A. Katapodis,³ S. Ildstad,⁴ M. Suthanthiran.¹
A Novel Belatacept Regimen to Optimize Efficacy and Safety.

D. Wojciechowski,¹ S. Chandran,² M. Sarwal,² J. Yang,² F. Vincenti.²
Accelerated Rejection of Secondary Third Party Allografts in Older Recipients Is Facilitated by an Augmented Innate Immune Response.

T. Heinbokel, K. Minami, A. Elkhal, S. Tullius.
Anti-Angiotensin Type 1 Receptor Antibodies Associate with Rejection in Simultaneous Pancreas and Kidney Transplant and Pancreas Transplant Alone Recipients.

A. Peng, D. Dafoe, J. Choi, A. Vo, X. Zhang, R. Najjar, E. Huang, S. Jordan.
Assessment of Attitudes Toward Use of Hepatitis C Positive Liver Allografts in US Transplant Centers.

S. Kilaru,¹ E. Tapper,² M. Curry.³
At-Home Transplant Education Increases Black and Low-Income Dialysis Patients' Transplant Knowledge, Attitudes, Informed Decision-Making, and Pursuit: An Explore Transplant @ Home Randomized Controlled Trial.

A. Waterman,¹ J. Peipert,¹ A.-M. McSorley,¹ C. Goalby,¹ L. Peace.²
B Cell Deficiency Inhibits Both Antibody Mediated Rejection and T Cell Mediated Acute Rejection in a Rat Kidney Transplant Model.

S. Panzer, S. Reese, N. Wilson Schlei, B. Verhoven, D. Xiang, W. Zhong, A. Djamali.
CTLA4Ig Suppresses Memory Responses to HLA-A2⁺ Skin Grafts in a Mouse Model of Allosensitization by Reducing CD138⁺ Plasma Cells.

G. Wu, I. Kim, N.-N. Chai, S. Jordan, A. Klein.
Clinical Outcomes of ABO and HLA Incompatible Kidney Transplantation – Nationwide Cohort Study.

E. Ko,^1,2 J. Yu,^1,2 C. Yang,^1,2 B. Chung,^1,2 Korean Organ Transplantation Registry (KOTRY).
Cultural Competency of a Mobile, Customized Patient Education Tool for Improving Potential Kidney Transplant Recipients' Knowledge and Decision-Making.

D. Axelrod,¹ C. Kynard-Amerson,² D. Wojciechowski,³ K. Lentine,⁴ M. Schnitzler,⁴ J. Peipert,² A. Waterman.²
Effects of New KPD Histocompatibility Policy on Refusal Rate and Transplants.

R. Leishman,¹ M. Aeder,² M. Leffell,³ C. Murphey,⁴ N. Reinsmoen,⁵ S. Saidman,⁶ T. Sandholm,⁷ A. Toll,¹ A. Harper,¹ N. Turgeon.⁸
Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study.

R. Ettenger,¹ B. Tönshoff,¹ H. Tedesco,¹ L. Dello Strologo,¹ S. Marks,¹ L. Pape,¹ E. Martzloff,² B. Rauer,² J. Ng,³ P. Lopez.²
Evolution of Lipid Profile and Major Adverse Cardiac Events in Kidney Transplant Recipients Converted from Calcineurin Inhibitor to Everolimus: 24-Month Subanalysis from Elevate Study.

M. van der Giet,¹ J. de Fijter,¹ F. Oppenheimer,¹ G. Russ,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ H. Holdaas.¹
Five-Year Outcomes After Transplantation of Kidneys from Deceased Donors with Acute Kidney Injury.

J. Latona,¹ A. Shah,^1,2 A. Frank,^1,2 W. Maley,^1,2 C. Doria,^1,2 C. Ramirez.^1,2
Forty-Six Consecutive Cases of Pure Live Donor Right or Extended Right Hepatectomy: Single Surgeon Initial 1-Year Experience.

S. Hong, K.-S. Suh, H.-S. Kim, S.-W. Ahn, K. Yoon, D. Oh, H. Kim, N.-J. Yi, K.-W. Lee.
Genomic Diversity of Epstein-Barr Virus in Post-Transplant Lymphoproliferative Disorder.

E. Maloney, O. Martinez.
Geographic Disparity in Kidney Transplantation After KAS.

S. Zhou,¹ A. Massie,¹ X. Luo,¹ E. Chow,¹ S. Bae,¹ S. Gentry,² S. Gustafson,³ A. Wey,³ B. Thompson,³ N. Salkowski,³ J. Snyder,³ D. Segev.¹
HCV+ Waitlist Candidates More Likely to Die Waiting for Kidney Transplant from HCV- Donor.

B. Shelton,¹ D. Sawinski,² S. Mehta,¹ R. Reed,¹ P. MacLennan,¹ J. Locke.¹
High CTLA-4 Expression and Diminished FOXO3 Expression Underlie Differential CD28 Signaling on Human Memory Th17 Cells.

S. Krummey,¹ S. Suchard,¹ S. Nadler,² C. Larsen,² M. Ford.¹
Higher Mortality Among Candidates Who Refuse to Accept DCD Kidney Offers.

M. Bowring, A. Massie, D. Segev.
Importance of Acquisition of Carbapenemase (KPC)-Producing Enterobacteriaceae in Solid Organ Transplant Recipients: A Single-Center Experience.

S. Han,¹ K. Lee,¹ K.-A. Lee,¹ H. Paik,² J. Lee,² M. Kim,³ D. Joo,³ J. Choi,³ S. Kim,³ Y. Kim.³
Improving Liver Allocation Using Optimized Neighborhoods.

S. Mehrotra, V. Kilambi.
Induction of Proliferative Responses in B Cell and Plasma Cell Populations Following Proteasome Inhibitor Desensitization Treatment in Rhesus Macacques and Humans.

J. Driscoll,¹ S. Knechtle,² J. Kwun,² S. Tremblay,¹ N. Salomonis,³ S. Potter,³ B. Aronow,³ M. Manook,² R. Alloway,¹ H. Singh,³ E. Woodle.¹
Long-Term Drug-Free Survival of Tiny Cynomolgus Islet Allografts.

M. Koulmanda, V. Chipashivili, M. Duggan, T. Strom.
Maximizing the Potential of Treg-Based Therapies for Transplant Rejection via Computational Immune-Modeling: Effect of Dose, Timing, and Distribution.

G. Raimondi,¹ A. Arun,¹ O. Dorabiala,² J. Arciero.³
No Gains in Long-Term Survival Following Liver Transplantation Over the Past Three Decades.

A. Rana,¹ M. Kueht,¹ J. Moffett,¹ N. Galvan,¹ R. Cotton,¹ J. Vierling,^1,2 A. Mindikoglu,^1,2 C. O'Mahony,¹ J. Goss.¹
Outcomes Following Hysterectomy in Kidney Transplant Recipients.

S. DiBrito, I. Olorundare, C. Haugen, C. Holscher, L. Kucirka, D. Segev, J. Garonzik-Wang.
Outcomes of Kidney Transplantation After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: 10 Years UNOS Database Analysis.

J. Ramirez,¹ H. Aghil,¹ M. Baz,³ B. Sawaya,¹ N. Rajagopalan,² X. Mei,³ R. Gedaly,³ A. El-Husseini.¹
Podocyte-Specific Knockdown of SHROOM3 Causes Albuminuria and Foot-Process Effacement by Interaction with FYN.

M. Menon, N. Philippe, C. Wei, W. Zhang, J. He, B. Murphy.
Post-Transplant Reduction in Pre-Existing Donor-Specific Antibody Levels After Belatacept- vs Cyclosporine-Based Immunosuppression.

R. Bray,¹ H. Gebel,¹ R. Townsend,² M. Polinsky,² L. Yang,² U. Meier-Kriesche,² C. Larsen.¹
Quantitative Analysis of 10-Year Surveillance Renal Allograft Biopsies.

A. Denic, B. Smith, W. Park, A. Rule, L. Cornell, M. Stegall.
Regulation of T Cell Migration by Specifically Targeting Lymphotoxin β Receptor (LTβR)-Mediated Non-Canonical NFkB Signaling.

W. Piao, Y. Xiong, C. Brinkman, J. Bromberg.
Short-Term Adverse Effects of Early Borderline Changes in Renal Allograft Biopsies.

S. Bhusal, P. Sood, A. Cherukuri, C. Wu, C. Puttarajappa, W. Hoffman, P. Randhawa, A. Tevar, N. Shah, S. Hariharan, R. Mehta.
Stable Deceased Donor Transplantation Rates Among Pediatric Candidates Post-KAS Implementation.

B. Shelton,¹ C. Ray,¹ D. Sawinski,² R. Reed,¹ P. MacLennan,¹ J. Locke.¹
The Molecular Phenotypes of Rejection in Kidney Transplant Biopsies.

P. Halloran, J. Reeve, INTERCOMEX Study Group.
The mTOR Signal Regulates Myeloid Derived Suppressor Cells Differentiation and Immunosuppressive Function in Acute Kidney Injury.

C. Yang, C. Zhang, R. Rong, T. Zhu.
Time to Kidney Transplantation Following Live Donor Candidate Referral.

K. Kumar, J. Tonascia, A. Muzaale, A. Poon, T. Purnell, J. Garonzik-Wang, E. King, M. Bowring, A. Massie, D. Segev.
Training for Transplant: Frailty Assessment and Optimization in Kidney Transplant Candidates.

M. Mrdutt, D. Doherty, S. Tanner, J. Lappin.
Truth in Pathology: Autopsy Findings in Lungs Declined for Transplantation.

A. Friedman, J. Lewis, H. Irving, K. Delli Carpini.
2B4-Mediated Inhibition of Proliferation and Glycolytic Function Attenuates T Cell Alloreactivity.

S. Laurie, D. Liu, M. Cortes, M. Wagener, M. Ford.
A Combination of Anti-CD40L-Ab, Rapamycin, and Donor Apoptotic Cells Prolongs Allogeneic Pancreatic Islet Survival in Sensitized Mice by Regulating Memory Responses.

A. Dangi,¹ H.-K. Kang,¹ X. Zhang,^2,3 X. Luo.^1,2,3
A Kidney Paired Donation Standard Acquisition Charge.

M. Rees,^1,2 L. Reece,² S. Rees,² B. Crandall,³ A. Leichtman.⁴
A Multi-Center Experience of Direct Acting Anti-Viral Agents in HCV Positive Patients Receiving HCV Positive Livers.

N. Kapila,¹ B. Zervos,² B. Ismail,¹ C. Lindenmeyer,³ V. Sanghi,³ K. Menon,³ G. Schnickel,² J. Rivas,² D. Reino,² A. Tzakis.²
ABO-Incompatibility Using Ritiuximab Does Not Increase Hepatocellular Carcinoma Recurrence After Liver Transplantation.

J. Kim, S. Kim, J. Lee, K.-S. Kim, J. Lee, G.-S. Choi, J. Park, C. Kwon, J.-W. Joh, S.-K. Lee.
Analysis of Outcomes in High Risk Kidney Transplants.

E. Liu, M. Aull, J. Lee, S. Kapur.
Assessment of the Association Between Measures of Metabolic Function and Pancreas Graft Survival.

S. Mittal,¹ R. Franklin,² J. Levy,² S. Gough,² E. Sharples,¹ P. Friend.¹
CD8+ TAb-supp Cells Suppress the Production of Multiple Alloantibody Isotypes in Response to MHC-Mismatched Cellular and Vascularized Allografts.

J. Zimmerer, C. Avila, S. Elzein, B. Ringwald, G. Bumgardner.
Center-Level Differences in Outcomes Following High-KDPI Kidney Transplants.

L. Wu, A. Massie, X. Luo, M. Bowring, D. Segev.
Cumulative Deficits Frailty Index for Transplant Candidates Predicts Candidacy for Solid Organ Transplantation.

R. Varughese,^1,2 O. Theou,³ X. Huang,¹ O. Famure,¹ Y. Li,¹ N. Chowdhury,¹ E. Renner,^1,2 J. Kim,^1,2 J. MacIver,^1,5 S. Mathur,⁴ K. Rockwood,³ L. Singer.^1,2
Dialysis Facility Providers' Awareness of Racial Disparities in Kidney Transplantation.

J. Kim, M. Basu, L. Plantinga, C. Escoffery, S. Pastan, R. Patzer.
Dominant Role of Clonal Deletion in Achieving Immune Tolerance After Unrelated Cord Blood Transplantation.

P. Szabolcs,^1,2 X. Chen,¹ M. Hill.¹
Donor-Derived Nonclassical Monocytes Produce MIP-2 to Recruit Recipient Neutrophils and Cause Ischemia Reperfusion Injury After Lung Transplant.

S. Chiu,¹ Z. Zheng,¹ M. Akbarpour,¹ R. Fernandez,¹ A. McQuattie-Pimentel,¹ P. Reyfman,¹ K. Anekalla,¹ D. Kreisel,² H. Perlman,¹ G. Budinger,¹ A. Misharin,¹ A. Bharat.¹
Donor-Specific B Cell Responses: Predicting the Future of Kidney Transplants.

M. Cascalho,¹ E. Farkash,² L. Adam,¹ M. Samaniego,³ J. Platt.
Emerging Safety and Tolerability of Obinutuzumab, a Type 2 Anti-CD20 Monoclonal Antibody for the Desensitization of Renal Transplant Candidates.

R. Redfield,¹ S. Jordan,² T. Schindler,³ H. Tran,⁴ C. Looney,⁴ C. Green,⁴ A. Morimoto,⁴ R. Rajwanshi,⁴ M. Cascino,⁴ P. Brunetta,⁴ D. Borie.⁴
FOXP3 rs3761548 A/C+A/A Genotype Is a Risk Factor for Steroid Resistant Rejection After Liver Transplantation.

Y. Tanaka, V. Sapana, H. Ohdan.
High Mortality in Transplant Recipients Associated with Coccidioidomycosis Derived from Organ Donors.

N. Jeyakumar,² N. Neidlinger,³ M. Salvatore,³ C. Brown,⁴ T. Carpenter,³ M. Fung,¹ P. Chin-Hong.¹
Higher Mortality Among Candidates Who Refused Increased-Infectious Risk Kidney Offers.

M. Bowring, L. Kucirka, A. Massie, C. Holscher, D. Segev.
Higher Tacrolimus Blood Levels Predict Better Graft Survival in Kidney Recipients with De Novo DSA.

M.-A. Béland,¹ R. Noël,¹ I. Côté,¹ I. Lapointe,¹ E. Wagner,² J. Riopel,³ E. Latulippe,³ O. Désy,¹ S. Béland,¹ I. Houde,¹ S. De Serres.¹
Immunosuppression and Graft Rejection in Living-Related HLA-Identical Renal Transplantation.

R. Ossman,¹ M. Jamme,¹ P. Galichon,¹ A. Hertig,¹ B. Moulin,² C. Legendre,³ E. Morelon,⁴ J.-L. Taupin,⁵ L. Rostaing,⁶ E. Rondeau.¹
In Vivo Administration of Plerixafor in Humans Mobilizes Bone Marrow Resident Plasma Cells That Demonstrate Apoptosis in Both Bone Marrow and Peripheral Blood.

E. Woodle, S. Tremblay,¹ C. Castro-Rojas,² J. Driscoll,¹ S. Knechtle,³ A. Shields,¹ R. Alloway,¹ D. Hildeman.²
Living Kidney Donor Pharmaceutical Care Needs Identified Through Linked Transplant Registry and Pharmacy Claims Data.

K. Lentine,¹ S. Gustafson,² M. Schnitzler,¹ G. Hess,³ D. Segev,⁴ A. Garg,⁵ N. Lam,⁶ D. Axelrod,⁷ D. Brennan,⁸ H. Randall,¹ B. Kasiske.⁹
MELD-Based Allocation Leads to Inferior Survival After Liver Transplantation.

P. Ritschl, L. Wiering, M. Hippler-Benscheidt, F. Aigner, M. Biebl, M. Schmelzle, K. Kotsch, J. Pratschke, R. Öllinger.
Outcomes Following Colectomy in Kidney Transplant Recipients.

S. DiBrito, Y. Alimi, C. Holscher, I. Olorundare, D. Segev, J. Garonzik-Wang.
Outcomes with Kidney Transplant from Deceased Donors with Acute Kidney Injury and Prolonged Cold Ischemia Time: UNOS Analysis.

G. Dube, S. Mohan, M. Chiles.
P-LKDPI: A Donor Risk Index for Pediatric Recipients of Living Donor Kidney Transplantation.

A. Massie, N. Desai, A. Neu, D. Segev.
Podocyte Participates in the ST2 Related Renal Fibrosis.

Y. Kim,¹ S. Yang,^2,3 R. Cha,⁴ M.-Y. Yu,¹ S. Lee,³ H. Lee,¹ J. Lee,⁵ D. Kim,^1,3 S. Kim,³ Y. Kim.^1,2,3
Presence of Anellovirus Nucleic Acid Sequences in Involved Tissue Is Associated with Worse Patient Survival in Post-Transplant Lymphoproliferative Disorder.

V. Dharnidharka, R. Chen, M. Ruzinova, P. Parameswaran, H. O'Gorman, K. Wylie, G. Storch.
Reduction of Recipient Cell Cross-Dressing with Donor MHC Molecules Prolongs Allograft Survival in Mice.

J. Marino, H. Tector, B. Gonzalez-Nolasco, A. Lellouch, A. Harney, C. Cetrulo, Jr, J. Markmann, G. Benichou.
Respiratory Viral Infections Following Human Lung Transplant Can Induce Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V.

M. Gunasekaran,¹ A. Limaye,² M. Sharma,¹ S. Biswas Roy,¹ S. Bansal,¹ R. Walia,¹ R. Bremner,¹ M. Smith,¹ T. Mohanakumar.¹
Role of Donor-Derived Tissue Resident Memory T cells in Modulating Alloimmunity.

R. Crepeau, D. Liu, M. Ford.
Stability of Immune Phenotype, Alloreactive, and Antiviral Immunity After Switch to Belatacept-Based Regimen After Kidney Transplantation.

J. Schaenman, M. Rosetti, T. Sidwell, V. Groysberg, G. Sunga, E. Liang, J. Gadzhyan, B. Abdalla, E. Lum, T. Pham, G. Dannovitch, J. Veale, H. Gritsch, E. Reed, S. Bunnapradist.
The Associations Between Body Mass Index and Kidney Transplant Outcomes Are Mediated by Weight-Adjusted Immunosuppression Dosing.

K. Flabouris,^1,2 S. Chadban,^1,3,4 M. Ladhani,^1,3,5 M. Cervelli,⁶ P. Clayton.^1,2,6
The Natural History of Kidney Rejection: How Do Molecular Disease States Change Over Time in Patients with Repeat Indication Biopsies?

J. Reeve, P. Halloran.
Treating Hepatitis C+ Patients Before or After Kidney Transplantation: A Medical Decision Analysis.

B. Kiberd,¹ K. Tennankore,¹ K. Doucette.²
Twenty Year Trends in Outcomes and Costs Following Kidney Transplantation.

A. Ojo,¹ N. Agashivala,² L. Gache,³ W. Irish.³
Utility of IL-2 Complexes in Promoting Vascularized Composite Allograft Survival.

H. Xu,¹ S. Dahiya,² L. Wang,² T. Akimova,² W. Hancock,^2,4 S. Levin.³
VO_2peak: A Significant Marker of All-Cause Mortality Among Patients with End-Stage Renal Disease Being Evaluated for Kidney Transplant.

H. Chakkera,¹ M. Temkit,¹ B. Kaplan,¹ G. Gaesser,² R. Heilman,¹ H. Khamash,¹ K. Reddy,¹ E. Steidley,¹ A. Mathur,¹ S. Nair,¹ G. Mour,¹ J. Huskey,¹ A. Moss,¹ A. Singer,¹ W. Hewitt,¹ I. Qaqish,¹ S. Behmen,¹ S. Angadi.²
Waitlist Desensitization and the Rate of Deceased Donor Kidney Transplantation After Implementation of the Kidney Allocation System.

E. Huang, S. Jordan, R. Najjar, J. Choi, A. Peng, A. Vo.
A Cost Comparison for Telehealth Utilization in the Kidney Transplant Waitlist Evaluation Process at a VA Center.

R. Forbes, D. Rybacki, T. Johnson, D. Shaffer, D. Hale.
A Novel Equation, GRAIL (GfR Assessment in Liver Disease) Correctly Classifies Patients with Reduced GFR and Predicts Development of ESRD.

S. Asrani,¹ L. Jennings,¹ M. Nadim,² J. Levitsky,³ J. Trotter,¹ G. Klintmalm.¹
Access to Simultaneous Pancreas and Kidney Transplant (SPK) Should Not Be Restricted to BMI > 28.

M. Laftavi, A. Gruessner, V. Whittaker, Z. Acun, O. Pankowycz, R. Gruessner.
Accumulating Mitochondrial DNA in Aging Augments Inflammatory Responses Subsequent to IRI.

M. Seyda,^1,2 M. Quante,¹ T. Heinbokel,¹ G. Liu,¹ H. Uehara,¹ J. Schuitenmaker,¹ R. Abdi,³ C. Falk,² A. Elkhal,¹ S. Tullius.¹
Ambulatory Antibiotic Utilization and Outcomes in an Adult Kidney Transplant Population: A Pharmacovigilance Analysis.

L. Avery, C. Fominaya, R. Crawford, D. Taber.
Antibodies Specific for HLA Class I and Lung Associated Self-Antigens, Kα1Tubulin and Collagen V, Induces Exosomes Following In Vitro Binding to Human Airway Epithelial Cells.

M. Gunasekaran, M. Sharma, S. Bansal, S. Biswas Roy, R. Walia, M. Smith, R. Bremner, T. Mohanakumar.
B Cells in Liver Transplant Tolerance.

M. Morita,¹ G. Asonye,¹ N. Gupta,¹ J. Fung,² C. Miller,³ S. Qian,^1,3 L. Lu.^1,3
Changes in Peripheral Blood Gene Expression Profile After Calcineurin Inhibitor (CNI) Withdrawal in Kidney Transplant Recipients.

P. Cravedi,¹ W. Zhang,¹ D. Salomon,² M. Fribourg,¹ G. Remuzzi,³ E. Gotti,³ F. Casiraghi,³ Z. Yi,¹ P. Heeger,¹ CTOT09, ATHENA Consortia.
DNA Methylation Dynamics from Ischemia/Reperfusion Injury to Long-Term Allograft Function.

V. Bontha,¹ D. Maluf,¹ M. Dozmorov,² D. Bagchi,¹ K. Archer,³ V. Mas.¹
Does Cirrhosis Regress in HCV Liver Transplant Recipients Achieving Sustained Virologic Response in the Era of Direct-Acting Antiviral Agents?

J. Putra,¹ T. Schiano,² M. Fiel.¹
Endocapillary NK Cells Are Increased in Indication Renal Transplant Biopsies with Antibody and T Cell Mediated Rejection.

A. Shammout, J. Barnes, E. Farkash.
Evaluation of the Enhanced Recovery After Surgery Protocol in Living Liver Donors.

A. Khalil, S. Ganesh, C. Hughes, A. Tevar, J. Hatche, S. Esper, A. Humar.
Extended Experience with Tocilizumab (Anti-IL6R) for Difficult to Desensitize (Des) Patients Awaiting HLA Incompatible Kidney Transplant.

A. Vo, J. Choi, I. Kim, E. Huang, S. Louie, A. Kang, S. Williamson, K. Myers, A. Peng, R. Najjar, S. Jordan.
Gene Expression During Development of Chronic Antibody-Mediated Rejection in Renal Allografts from Non-Human Primates: Validation of Markers Used in Humans and Sequential Changes in Protocol Biopsies.

B. Adam,¹ R. Smith,² M. Matsunami,² I. Rosales,² B. Afzali,¹ T. Oura,² A. Cosimi,² T. Kawai,² R. Colvin,² M. Mengel.¹
Geographic Disparities in Access to Deceased Donor Kidney Transplant.

S. Gustafson,¹ A. Wey,¹ B. Thompson,¹ A. Massie,² S. Zhou,² N. Salkowski,¹ D. Segev,^1,2 S. Gentry,^1,3 J. Snyder.¹
How Much Is a Kidney Worth? Comparing Kidney Transplant Strategies in Liver Transplant Candidates.

X. Cheng,¹ W. Kim,² J. Tan,¹ J. Goldhaber-Fiebert.³
Impact of Belatacept Conversion on Kidney Transplant Function, Histology and Gene Expression.

P. Sanghi,¹ G. Gupta,¹ D. Kumar,¹ J. Reeve,² M. Levy,¹ A. Sharma,¹ H. Fattah,¹ P. Kimball,¹ H. Massey,¹ A. King,¹ P. Halloran.²
Impact of mTOR-Inhibition on Tolerance-Induction Following Heart Transplantation.

M.-T. Dieterlen, K. Klaeske, J. Fischer, J. Hahn, K. Jawad, J. Garbade, F. Mohr, S. Lehmann.
Is There an Association Between Number of Outpatient Primary Care Visits (OPV) and Outcomes in Kidney Transplantation (KTP)?

A. O'Shea, R. Kalil.
KDPI and Small (<20 kg) Pediatric Kidney Donors.

J. Smith,^1,2 S. Gustafson,² A. Wey,² J. Snyder,² A. Israni.²
Kidney Quality Dramatically Influences Patient and Death Censored Graft Survival in SLK Recipients.

T. Zens, J. Danobeitia, P. Stahler, G. Leverson, R. Redfield, A. D'Alessandro, L. Fernandez.
Knowledge and Attitudes Associated with Willingness to Accept HIV+ Organs Among Persons Living with HIV.

S. Anjum, S. Halpern, K. Kumar, A. Nyugen, S. Rasmussen, A. Massie, A. Tobian, D. Segev, J. Sugarman, C. Durand.
Living Kidney Donors: Battling High Attrition Rates During Evaluation Process.

J. Verbesey, A. Bacigalupo, A. Gilbert, A. Li, C. Zuttermeister, M. Grafals, J. Moore, B. Javaid, P. Abrams, S. Ghasemian, M. Cooper.
Optimization of Pancreatic Islet-Like Clusters from hiPSCs for Cell Therapy in Type 1 Diabetes.

G. Pettinato, P. Kyriazis, M. Thompson, M. Koulmanda, R. Fisher.
Outcomes of Organs Transplants When the Donor Is a Prior Recipient.

G. Lee,¹ D. Goldberg,² M. Levine,¹ P. Abt.¹
Poor Outcomes on the Waiting List for Pediatric Lung Retransplant Patients Listed in Low Volume Centers.

B. Scully,¹ J. Heinle,¹ M. Kueht,¹ E. McKenzie,¹ G. Mallory,² E. Melicoff,² A. Rana.¹
Prolonged Dialysis Prior to Renal Transplantation.

D. Aufhauser Jr,¹ A. Peng,¹ D. Murken,¹ S. Concors,¹ M. Levine.^1,2
Rapamycin Directly Alters Human Endothelial Cell Alloimmunogenicity.

V. Bendersky,¹ H. Xu,² A. Kirk.²
Reduction in Kidney Offer Acceptance at Centers Undergoing Systems Improvement Agreements.

M. Bowring, L. Nicholas, A. Massie, D. Segev.
Rituximab Desensitization (DES) and Alemtuzumab Induction Significantly Reduced EBV Viremia and Post-Transplant Lymphoproliferative Disorder (PTLD) in HLA-Sensitized (HS) Kidney Transplant Patients.

B.-H. Shin,¹ S. Ge,¹ J. Mirocha,² D. Thomas,¹ E. Rodriguez,¹ C. Chao,¹ O. Galera,¹ A. Vo,¹ J. Choi,¹ A. Peng,¹ J. Kahwaji,¹ S. Jordan,¹ M. Toyoda.¹
Single Kidney Transplantation from DCD Maastricht Category 3 Donors ≥ 60 Years: Is It Safe?

E. Favi,¹ C. Puliatti,² M. Ferraresso,¹ S. Iesari,³ R. Cacciola.²
T_FR:T_FH Cell Ratio Correlates with Anti-Donor Germinal Center Reactivity and Donor-Specific Antibody Formation Following Transplantation.

G. La Muraglia II, M. Ford, I. Badell.
The Clinical and Economic Burden of Pneumonia in Canadian Solid Organ Transplant Recipients.

N. Law,¹ B. Hamandi,² A. Alghamdi,¹ E. Papadimitropoulos,² S. Husain.¹
The Combined Effects of Induction Regimens and Antiviral Prophylaxis on the Risk of CMV Infection in Different Serostatus Subgroups After Liver Transplantation.

C. Low,² S. Hosseini-Moghaddam,^1,2 C. Rotstein,² E. Renner,² A. Humar,² D. Kumar,² S. Husain.²
The Innate Immune-System May Play an Enhanced Role in Acute Cellular Rejection in Patients on Belatacept-Based Immunosuppression.

D. Dobi,¹ Q. Tang,² S. Chandran,³ F. Vincenti,³ Z. Laszik.¹
The Phenotypic and Functional Characteristics of a Novel CD11b⁺CD11c⁺F4/80⁺ Monocytic Myeloid-Derived Suppressor Cell Subset.

B. Jiang,^1,2 I. Aljabban,¹ C. Yang,¹ D. Ndishabandi,¹ R. White,¹ P. Russell,¹ J. Madsen,¹ R. Colvin,¹ A. Alessandrini.¹
The Relationship Between Frailty and Decreased Physical Performance with Death on the Kidney Transplant Waiting List.

E. Lorenz, F. Cosio, S. Bernard, S. Bogard, B. Bjerke, E. Geissler, S. Hanna, W. Kremers, M. Stegall, A. Cheville, N. LeBrasseur.
The Role of Natural Killer Cells in Recognition and Killing of Stem Cells and Stem Cell-Derived Hepatoblasts.

T. Cisneros, D. Dillard, M. Castro, J. Arredondo-Guerrero, S. Krams, C. Esquivel, O. Martinez.
Use of Hepatitis C Infected Organs for Kidney Transplantation: A Medical Decision Analysis.

B. Kiberd,¹ K. Doucette,² K. Tennankore.¹
α-Lipoc Acid Improve the Short Term Outcomes in Human Liver Transplantation.

P. Casciato,¹ N. Ambrosi,² C. Fiorella,² M. Vasquez,¹ A. Gadano,¹ M. de Santibañes,¹ E. de Santibañes,¹ M. Zandomeni,¹ M. Chahdi,¹ J. Laquinandi,¹ P. Santofimia Castaño,³ J. Iovanna,³ E. Chuluyan,² C. Incardona.⁴
A Multistate Modeling Analysis of Time-Varying CPRA States and Its Impact on Kidney Transplant: A Focus on KAS Implementation.

S. Kulkarni,¹ I. Hall,² R. Formica,¹ D. Stewart,³ E. Greene,⁴ Y. Deng.⁴
A New Strategy for Loco-Regional Therapy of Hepatocellular Carcinoma: Stereotactic Body Radiotherapy as a Bridge to Liver Transplantation.

T. Uemura,¹ A. Kirichenko,² M. Bunker,³ M. Vincent,¹ L. Machado,¹ A. Singhal,¹ N. Thai.¹
A Novel Computational HLA Matching Algorithm for Improving Donor-Recipient Histocompatibility and Graft Outcomes After Kidney Transplantation.

V. Kosmoliaptsis,¹ D. Mallon,¹ S. Fuggle,² R. Johnson,² C. Watson,¹ J. Bradley,¹ C. Taylor.¹
A Promising MyD88 Inhibitor TJ-M2010-2 Protects Heart from Myocardial Ischemia Reperfusion Injury.

Y. Miao, L. Xie, X. Zhang, Z.-C. Ding, M. Yang, Y. Yang, P. Zhou.
A Study on Gene Expression of the Protective Effect of Nitric Oxide Releasing Nanofiber in Rat Renal Ischemia-Reperfusion Injury.

H. Ahn,¹ S. Joo,¹ H. Ko,¹ K. Jung,¹ J. Shin.²
ASP0113 Elicits an Immune Response in CMV-Seronegative Dialysis Patients: Comparison to Healthy Subjects.

P. Bonate,¹ C. Van Sant,² K. Cho,¹ E. Zook,¹ L. Smith,³ S. Boutsaboualoy, X. Wang,¹ R. Wu,¹ A. Koester,⁴ D. Rammelsberg,⁶ R. Goldwater,⁴ T. Marbury.⁵
Accepting a High-KDPI Kidney versus Waiting for Another Offer Can Improve Chances of a Functioning Graft.

A. Wey,¹ N. Salkowski,¹ W. Kremers,² A. Israni,¹ B. Kasiske,¹ J. Snyder.¹
Achieving Ideal Outcome After Intestinal Transplantation: How Close Are We?

A. Ganoza,¹ N. Celik,¹ G. Bond,¹ K. Soltys,¹ J. Rudolph,² R. Sindhi,¹ G. Mazariegos.¹
Activated Th1 and Th17 cT_FH Phenotype Correlates with DSA Production in Kidney Transplant Recipients.

C. Macedo, P. Fadakar, K. Hadi, B. Ellinof, A. Zeevi, S. Hariharan, D. Metes.
Alemtuzumab Induction Is Associated with a Lower Incidence of BK Virus Nephropathy Compared with IL2RA Induction.

A. Gueret-Wardle, S. Hassan, G. Lucisano, C. Roufosse, M. Willicombe, D. Taube.
Ambiguous Nucleic Acid Tests (NAT) Results – Case of a Donor with Intermittent HCV NAT(+) but No HCV Transmission.

M. Nowicki,^1,2 H. Prince,² C. Chinchilla,² C. De Los Santos,² J. Trageser,³ L. Stocks.³
An OPO Offer Acceptance Report for Hard-to-Place Kidneys.

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
Antibiotic Prophylaxis Against Urinary Tract Infections After Renal Transplant.

P. Klem,¹ J. Gralla,² D. Chang,¹ A. Wiseman,² S. Davis,² J. Cooper.²
Antibody-Mediated Vascular Rejection of Kidney Allografts: What Does It Happen After 15 Years?

B. Rodriguez Cubillo,¹ I. Perez Flores,¹ M. Moreno De La Higuera,¹ M. Calvo,¹ N. Calvo Romero,¹ A. Pascual,² J. Cortes,² J. Blanco,² A. Sanchez-Fructuoso.¹
Antioxidant Thermoresponsive Hydrogel as a Versatile Islets Scaffolds for Treating Type I Diabetes.

Y. Zhu,¹ X. Zhang,² G. Ameer,¹ X. Luo.²
Antiretroviral Therapy Modification of HIV+ Patients Listed for Kidney Transplantation.

D. Lee,¹ G. Malat,³ T. Bias,¹ S. Epstein,¹ L. Levin Mizrahi,² M. Harhay,² S. Talluri,² K. Ranganna.²
Assessing the Impact of the New KAS on Transplant Rates in Highly-HLA Sensitized (HS) Patients After Desensitization (Des) 2 Years Post Implementation.

A. Vo,¹ S. Williamson,¹ K. Myers,¹ E. Huang,¹ J. Choi,¹ X. Zhang,² A. Peng,¹ R. Najjar,¹ S. Jordan.¹
Assessment of Donor-Reactive T-Cell Immunity by the Novel Urine Cell-Derived Alloantigen Assay Allows Prediction of Acute Rejection in Renal Transplant Patients.

C. Thieme,¹ B. Weist,¹ A. Müskes,¹ P. Reinke,¹ T. Westhoff,² N. Babel.^1,2
Assessment of a Medication Education Program Among New Transplant Recipients at a Large Academic Health Center.

G. Meadows,¹ J. Kyle,¹ A. Dodson,¹ K. Gutierrez,¹ P. MacLennan,² F. Iqbal,² L. Weldon,¹ D. Jones,¹ A. James.¹
Associations Between Provision of Transplant Pharmacy Services and Center-Level Patient and Graft Outcomes in U.S. Adult Kidney Transplant Programs.

J. Park,¹ J. Trofe-Clark,² T. Kaiser,³ N. Pilch,⁴ D. Taber.⁴
Avoidance or Reduction of Rituximab Might Improve Clinical Outcomes in ABO-Incompatible Renal Transplantation: Advantages and Disadvantages of Rituximab.

M. Okada,¹ Y. Watarai,¹ K. Iwasaki,² K. Murotani,³ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
BK Polyoma Virus and Malignancy: Cause or Co-Incidence?

R. Prashar, A. Shah, D. Stewart, S. Williamson, A. Patel.
BK Viruria Levels within 3 Months Post Renal Transplantation Can Predict the Development of BK Viraemia.

N. Lioufas,¹ R. Masterson,^1,2 P. Hughes.
Bacteremia in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes.

S. Brar, Y. Wang, A. Cannitelli, Y. Li, O. Famure, S. Husain, J. Kim.
Banff 2013 Classification of Renal Allograft Pathology Is Superior to Banff 2007 in Detecting and Managing Milder and Earlier Cases of Antibody-Mediated Rejection.

J. Hassler,¹ V. Ariyamuthu,² A. Hendricks,¹ B. Tanriover,² J. Torrealba.¹
Benefits of Expanding Options for Patients Registered in the Kidney Paired Donation Program.

S. Stepkowski, B. Mierzejewska, D. Belbolsynov, C. Baum, J. Kopke, R. Brunner, S. Rees, M. Rees.
Blockade of Tim-3 and PD-1 Reverses Dysfunctions of Tumor Infiltrating Lymphocytes in HBV Related Hepatocellular Carcinoma.

A. Hu, F. Liu, X. Zhu, X. He.
Blood Transfusion Before Organ Transplant: Patient Sensitization and Outcomes.

I. Cich, K. Rudser, R. Brown, H. Ibrahim, R. Thorson, J. Patil, G. Loor, M. Hertz, C. Cohn.
C3d Assay Result in Potential Transplant Recipients with HLA-DSA, AHG-CDC CxM Negative and FxM Positive or Negative with Their Potential Donors.

A. Contreras, A. Casillas, N. Castelan, N. Gonzalez-Tableros, M. Lopez, A. Arvizu, A. De Santiago, J. Alberu, J. Arreola-Guerra.
C3d-Binding Anti-DQ DSA Is Associated with a High Risk for Late ABMR and Graft Failure in Stable Kidney Transplant Recipients.

D. Lee,¹ B. Kim,² J. Kim,³ I. Kim,⁴ M. Chun.⁵
CD4 T Cell Depletion Mitigates Ischemic Hepatocellular Damage and Promotes Immune Regulation in Mouse Liver Allografts.

S. Kageyama, K. Nakamura, R. Busuttil, J. Kupiec-Weglinski, Y. Zhai.
CMV Infection in Renal Transplant Recipients: Incidence and Efficacy of Prophylaxis According to Cytokine Single Nucleotide Polymorphisms.

I. Perez-Flores, M. Moreno De La Higuera, N. Calvo Romero, B. Rodriguez Cubillo, A. Shabaka, M. Calvo Arevalo, V. Lopez De La Manzanara, A. Sanchez-Fructuoso.
CXCL12 Modulation of Localized Immune Responses to Subcutaneous Islet Macrocapsulation.

M. Penson, M. Sremac, R. Sirbulescu, T. Brauns, F. Harrington, M. Poznansky.
Can Pre-Treatment CDC Titres Predict Graft Outcomes in HLA Incompatible Transplants?

A. Prasad,¹ A. Yuvaraj,¹ D. Briggs,² N. Krishnan.¹
Charlson Comorbidity Index (CCI) as Prognostic Indicator of Outcomes in Older Patients Undergoing Renal Transplantation.

A. Asderakis, U. Contractor, U. Khalid, P. Donato, L. Szabo.
Chronic Antibody Mediated Rejection (cABMR) in ABO-Incompatible and ABO-Compatible Kidney Transplants: A Single US Center Experience.

S. Sethi, A. Vo, E. Huang, L. Varanasi, J. Choi, A. Peng, R. Najjar, S. Jordan.
Chronic Hepatitis E-Genotype 3 Infection in Transplant Recipients: A Single Kidney and Pancreas Transplant Centre Experience.

A. Kousios,¹ R. Charif,¹ E. Sanchez,² S. Khan,³ F. Regan,⁴ S. Ijaz,⁵ D. Muir,² B. Smith,³ R. Tedder,⁵ D. Taube,¹ J. Galliford.¹
Cibinetide (ARA 290), the Innate Repair Receptor Ligand, Improves Engraftment in Pancreatic Islet Transplantation by Protecting Islets and Reducing Inflammatory Reactions.

M. Watanabe,¹ M. Han Yao,¹ H. Zemack,¹ B.-G. Ericzon,¹ A. Cerami,² M. Brines,² T. Lundgren,¹ M. Kumagai-Braesch.¹
Ciprofloxacin for Urinary Tract Infection Prophylaxis in Post-Renal Transplant Patients with Ureteral Stent Placement.

P. Kakadiya, M. Levy, G. Gupta, A. King, S. LeCorchick.
Circulating Donor-Specific Memory B Cells (mBc) Discriminates Kidney Transplant Patients with Histological Lesions of ABMR in Absence of Circulating DSA.

S. Luque,² M. Lúcia,⁴ M. Jarque,² E. Crespo,² E. Melilli,¹ J. Martorell,³ J. Cruzado,^1,2 J. Torras,^1,2 J. Grinyó,^1,2 O. Bestard.^1,2
Clearance of Transaminases During Normothermic Ex Vivo Liver Perfusion.

M. Bral,¹ N. Aboelnazar,² B. Gala-Lopez,² S. Hatami,² D. Freed,¹ A. Shapiro.¹
Clinical Utility of Viral miRNA in Urinary Exosomes to Diagnose BK Virus Nephropathy After Kidney Transplantation.

J.-W. Seo,¹ Y. Lee,¹ H. Moon,¹ Y. Kim,¹ K.-H. Jeong,¹ J.-Y. Moon,¹ C.-D. Kim,² J. Park,³ B. Chung,⁴ Y.-H. Kim,⁵ S.-H. Lee.¹
Clinically Relevant Immunosuppression Promotes MCMV Reactivation and Dissemination Following Transplantation of Latently Infected Kidneys.

Z. Zhang,¹ S. Yan,¹ L. Zhao,¹ S. Kurian,² M. Hummel,¹ D. Salomon,² M. Abecassis.¹
Clusterin Levels at 3-Months Associate with DGF and 12-Month Fibrosis – Reinforcing the Early Injury to Fibrosis Continuum.

M. Menon,¹ L. Liriano-Ward,² N. Philippe,¹ C. Wei,¹ W. Zhang,¹ Z. Yi,¹ K. Keung,² P. O'Connell,² B. Murphy.¹
Combining Neural Stem Cell Transplantation with Mixed Hematopoietic Chimerism Promotes Restoration of Self-Tolerance in Established Experimental Autoimmune Encephalomyelitis.

W. Orent, J. Marino, B. Gonzalez Nolasco, J. Paster, A. Harney, D. Sachs, G. Benichou.
Comparing Outcomes of ABO Incompatible to DSA Positive/CDC-AHG Negative Kidney Transplantation.

T. Kitrungphaiboon,¹ N. Townamchai,¹ D. Saengpanit,¹ K. Iampenkhae,² K. Jutivorakool,¹ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
Comparison Between IgG, C1q and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.

M. Moreno Gonzales,¹ D. Mitema,² B. Smith,³ C. Schinstock,³ M. Stegall,³ M. Gandhi.³
Comparison of Local Recurrence Rates Between Endhole vs Anti-Reflux Catheters in Patients Undergoing DEB-TACE for Solitary LR-5 HCC Tumors.

A. Arepally, L. Stein, R. Shrestha, M. Tully, S. Citron, A. Cherian, H. Pollinger, M. Bosley, R. Raymond.
Comparison of Locoregional Therapies for Hepatocellular Carcinoma in Liver Transplant Recipients.

M. Chen, B. Philosophe.
Comparison of Long-Term Survival Outcome Between Primary Liver Transplantation and Hepatic Resection with Consequent Salvage Transplantation for Hepatocellular Carcinoma within Milan Criteria – A Single-Center Experience.

K. Ng,¹ K. Chok,¹ A. Chan,¹ T. Wong,¹ J. Fung,² C.-M. Lo.¹
Complement Binding Activity (C3d, C1q) of De Novo Donor-Specific HLA Antibody Is Associated with Increased Risk of Antibody-Mediated Rejection in Non-Sensitized Kidney Transplant Recipients.

H. Lee,¹ E. Han,¹ A.-R. Choi,¹ K. Park,² J. Ryu,² B. Chung,³ C. Yang,³ E.-J. Oh.¹
Complement Markers in Immunoadsorption Combined with Membrane Filtration.

P. Malvezzi,¹ F. Defendi,² F. Eskandary,³ T. Jouve,¹ L. Rostaing,¹ C. Dumestre-Perard,² G. Böhmig.³
Contribution of γδ T-Cell Subsets and IL-17A Release to Ischemia Reperfusion Injury (IRI) and Kidney Allograft Rejection in Mice.

A. Thorenz,¹ S. Rong,¹ N. Völker,¹ R. Chen,¹ J. Bräsen,² H. Haller,¹ C. Klemann,³ F. Gueler.¹
Correlation of Donor Clinical and Histopathological Characteristics with Graft Function in Kidney Transplant Recipients.

M. Zachariah,¹ C. Yip,¹ M. Zachariah, I. Mallawaarachchi,² A. Dweivedi,² S. Patel,⁴ A. Gundroo,¹ J. Tomaszewski,¹ L. Lin,¹ C. Shirley.¹
Cost Effectiveness of Post-Prophylaxis Screening Strategies for Cytomegalovirus Viremia in CMV D+R- Kidney Transplant Recipients.

C. Puttarajappa,¹ S. Hariharan,¹ K. Smith.²
Course and Outcome of Renal Transplant Recipients Admitted to the Intensive Care Unit (ICU): Long Term Follow-Up.

A. El-Agroudy,¹ A. Alqahtani,¹ B. Dandi,² E. Farid,² A. Alaradhi.²
Cross-sectional and Serial Evolution of Quality of Life in Elderly Kidney Donors.

S. Ake,¹ D. Berglund,² S. Jackson,³ A. Matas,² C. Gross,² H. Ibrahim.²
Cytomegalovirus Renal Infection: Rare Manifestation of a Common Post-Transplant Viral Infection — A Case Series.

M. Posadas Salas, J. Thompson, T. Ngo, S. Self.
Cytomegalovirus Viral Load: Characterization of Results from Clinical Specimens.

S. Kleiboeker.
D-Dimer Level, in Association with Humoral Responses, Negatively Correlates with Survival of Porcine Islet Grafts in Nonhuman Primates with Immunosuppression.

H. Kang,¹ H. Lee,¹ E. Park,¹ J. Kim,² B. Min,² C.-G. Park.²
DSA Presence Does Not Affect Renal Histology and Clinical Outcome in Chronic Active Antibody Mediated Rejection.

K. Sablik,¹ M. Clahsen–van Groningen,¹ C. Looman,¹ J. Damman,¹ D. Roelen,² M. van Agteren,¹ M. Betjes.¹
De Novo DSA Positivity Is Associated with a Higher Rate of Post-Transplant Bacterial and Viral Infections.

A. Brooks,¹ L. Rebellato,² K. Briley,² P. Bolin,² S. Kendrick,³ A. Maldonado,⁴ C. Haisch,² M. Everly.¹
Defining a BKV Cutt-Off and Profile for Early Detection of BKV Associated Nephropathy.

C. Nihei,¹ F. Agena,¹ F. Paula,¹ D. David,¹ M. Fink,³ L. Pierrotti,² E. David-Neto.¹
Depressive Symptoms, Physical Frailty, and Kidney Transplant Adverse Outcomes.

J. Konel, F. Warsame, H. Ying, C. Haugen, M. McAdams DeMarco, D. Segev.
Development of De Novo Donor Specific Antibodies (dnDSAs) Not the Presence of Pre-Transplant Donor Specific Antibodies (Pre-DSAs) Increase Rejection Risk in Crossmatch Negative Kidney Transplant Recipients.

H. Khamash, L. Archambault, M. Buras, H. Kosiorek, M. Pando, K. Reddy, B. Kaplan, R. Heilman.
Development of an Automatic Regulated Normothermic Kidney Preservation Device for Long-Term Organ Perfusion.

A. Weissenbacher,¹ O. Boubriak,² L. Lo Faro,¹ R. Ploeg,¹ J. Hunter,¹ D. Voyce,³ N. Mikov,³ A. Cook,³ C. Coussios,² P. Friend.¹
Dexamethasone Prolongs Cardiac Allograft Survival in a Murine Model Through Myeloid-Derived Suppressor Cells.

T. Nakao,¹ T. Nakamura,¹ K. Masuda,¹ T. Matsuyama,¹ H. Ushigome,¹ E. Ashihara,² N. Yoshimura.¹
Diagnostic Bronchoscopy in Kidney Transplant Recipients with Acute Respiratory Failure: Risk or Value?

D. Khadzhynov, J. Deissler, F. Halleck, L. Lehner, K. Budde, O. Staeck.
Different Prognostic Factors for Early and Late Recurrence After Adult Living Donor Liver Transplantation for Hepatocellular Carcinoma.

S. Hong, K.-W. Lee, H.-S. Kim, S.-W. Ahn, K. Yoon, H. Kim, N.-J. Yi, K.-S. Suh.
Differential Effects of Immunosuppressive Drugs on DNA Methylation in T Cells.

F. Peters,¹ A. Peeters,¹ L. Hofland,² M. Betjes,¹ K. Boer,¹ C. Baan.¹
Direct Intrahepatic Delivery of Pegylated-Catalase Is Protective in a Rat Ischemia-Reperfusion Injury Model.

E. Beal,¹ S. Black,¹ J. Kim,¹ V. Velazquez,² K. Washburn,¹ D. Hayes Jr.,³ B. Whitson.¹
Does EBV Viremia at Time of Transplant Have a Negative Impact on Transplant Outcomes?

P. Verghese, H. Balfour, D. Schmeling, J. Grimm, S. Chinnakotla, A. Matas.
Does Histologic Grade in BK Polyoma Nephropathy Associate with Viral Load, Allograft Dysfunction or Allograft Loss? A Single Center Experience.

M. Swee,¹ S. Kuppachi,¹ M. Fraer,¹ P. Rastogi,² P. Ten Eyck,¹ M. Sanders.¹
Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation.

V. Hellström,¹ G. Tufveson,¹ A. Wallgren,² A. Loskog,² E. Larsson,² T. Töttermann,² M. Bengtsson,² A. Laurell,² C. Lundberg,¹ B. Holmström,¹ G. Enblad,² T. Lorant.¹
Donor Factors Show Low Impact on Patient and Kidney Allograft Outcomes: A Paired Analysis of Left/Right Deceased Donor Kidney Pairs.

T. Schachtner,^1,2,3 M. Stein,² P. Reinke.^1,2
Donor Kidney Volume Predicts One and Three Month eGFR in Live Donor Kidney Transplant Recipients.

D. Al-Adra,¹ M. Lambadaris,² A. Barbas,¹ Y. Li,² N. Goldaracena,¹ O. Famure,² S. Kim,² A. Ghanekar.¹
Donor Lymphoid Chimerism in Early Recognition and Prediction of Clinical Outcome Caused by Acute Graft versus Host Disease After Solid Organ Transplant.

A. Zhang,¹ Y. Sun,² K. Hashimoto,⁴ M. Fujiki,⁴ M. Askar,³ J. Fung,⁵ C. Miller,⁴ K. Abu-Elmagd,⁴ B. Eghtesad.⁴
Donor and Recipient Outcomes with Trans-Umbilical Laparoendoscopic Single-Site Donor Nephrectomy.

H. El Hennawy, A. Fahmy.
Donor/Recipient Matching Using the Creatinine Clearance Match Ratio (CCMR) Is Superior to the Kidney Donor Profile Index (KDPI) Predicting Early but Not Late Outcomes for Deceased Donor Kidney Transplantation.

J. Halldorson, N. Karimi.
Down but Not Out: Leucopenia Can Be Safely Treated with Reduction in Immunosuppression without Increasing Risk to the Kidney Allograft.

A. Gilbert,¹ A. Vergottini,¹ A. Karabala,¹ M. Grafals,¹ B. Javaid,¹ J. Moore,¹ J. Verbesey,² P. Abrams,² S. Ghasemian,² M. Cooper.²
Down-Regulation of Nuclear HMGB1 by Small Interfering RNA Protects Against Liver Ischemia-Reperfusion Injury.

G. Zhao, C. Fu, L. Wang, L. Zhu, S. Chen, G. Chen.
Dual Treatment of Suboptimal Doses of CsA and MSC Infusion Fully Prevents Acute Rejection in an Allogenic Model of Renal Transplantation.

L. de Ramon,¹ A. Merino,¹ E. Ripoll,¹ N. Bolaños,¹ M. Gomà,³ J. Cruzado,^1,2 J. Grinyó,^1,2 J. Torras.^1,2
Early Antibody-Mediated Rejection C4d Status Remains a Marker of Prognosis in HLA-Incompatible Kidney Transplantation.

J. Malheiro,¹ S. Santos,¹ S. Tafulo,² L. Dias,¹ L. Martins,¹ J. Ramon,¹ A. Castro-Henriques.¹
Effect of Bone Marrow Derived Mesenchymal Stem Cells on Renal Ischemia-Reperfusion Injury in Rabbit.

J. Jang, H. Ri, I. Hong.
Effect of Embolization History and Tumor Treatment Response on Plasma TGFβ in HCC Patients Listed for Liver Transplantation.

P. Thevenot,¹ K. Núñez,¹ J. Gonzalez-Rosario,¹ T. Sandow,¹ A. Alharbi,¹ A. Bokhari,¹ D. Wyczechowska,² A. Ochoa,² A. Cohen.¹
Effect of Epigenetic Modifications in Ischemia-Reperfusion-Injury Post Liver Transplantation: An Integrative Approach.

D. Bagchi, S. Bontha, M. Dozmorov, A. Fernandez, V. Mas, D. Maluf.
Effect of Induction Therapy in ABO Incompatible Living-Donor Kidney Transplantation: A Single Center Experience.

L. Lanfranco, L. Esposito, A. Del Bello, O. Cointault, A. Allal, L. Rostaing, N. Kamar.
Effect of Influenza Vaccination in the Severity of Illness in Hospitalized Transplant Recipients with Laboratory-Confirmed Influenza.

A. Bagenski,¹ F. Silveira.²
Eight Years of Low-Dose Valganciclovir; Evaluating the Incidence and Risk Factors of CMV in Kidney Transplant Recipients.

S. El Hajj, M. Kim, J. Azzi, S. Gabardi.
Elevated Circulating AT1R Levels Indicate Heightened Risk for Antibody Mediated Rejection and Graft Failure.

P. Kimball, G. Gupta, F. McDougan.
Emerging Variables Which May Enhance Care of HIV Positive Renal Transplant Recipients.

D. Leonard, M. Prendergast.
Enhanced Liver Regeneration After Partial Hepatectomy in Mice Treated with a Prolyl Hydroxylase Inhibitor.

J. Latona,¹ A. Shah,¹ J. Cheng,² P. Messersmith,² E. Heber-Katz.³
Estimating Donor Organ Quality with Baseline Histology and Kidney Donor Risk Index for Predicting Graft Outcomes in Deceased Donor Kidney Transplantation.

K. Park,¹ S. Park,² H. Park,² J. Park,¹ H. Chung,¹ M. Kim,³ H. Cho,² J. Lee.¹
Evaluation of Immunological States of Patients with Cytomegalovirus Infection After Kidney Transplantation.

A. Tanaka, K. Ide, Y. Tanaka, K. Ishiyama, M. Ohira, H. Tahara, S. Shimizu, D. Kumar, H. Ohdan.
Expanded Criteria for HCC in Liver Transplantation.

M. Haberal,¹ A. Akdur,¹ G. Moray,¹ G. Arslan,² F. Ozcay,³ H. Selcuk,⁴ H. Ozdemir.⁵
Facing Unintended Challenges of Increased Risk Donor Kidneys in a New Kidney Allocation Era.

A. Rahnemai-Azar,¹ J. Perkins,¹ A. Limaye,² N. Leca,³ C. Blosser,³ C. Johnson,³ S. Morrison,¹ R. Bakthavatsalam,¹ L. Sibulesky.¹
Factors Affecting Desensitization Outcome.

A. Zachary,¹ R. Montgomery,² M. Leffell.¹
Favorable Long-Term Prognosis of Hepatitis B Surface Antigen Positive Intrahepatic Cholangiocarcinoma for Both Hepatic Resection and Incidental Liver Transplantation via Inhibiting Cancer-Associated Lymphangiogenesis.

J. Gu, S. Jeong, M. Sha, J. Zhang, Q. Xia.
Fibromuscular Dysplasia in Living Kidney Donors: Characteristics and Recipient Outcomes.

M. Gonzalez Suarez, H. Amer, I. Jaffer, T. Vrtiska, A. Rule, M. Prieto, S. Textor.
Full Dose Cyclosporine Permanently Reverses Uncontrolled BK Viremia That Is Refractory to Tacrolimus Minimization.

A. Caero, M. Shah, D. McKay, J. Kerr, J. Joliat, E. Chatfield, R. Steiner.
Functional Gain in eGFR Among Living Kidney Donors and Its Association with Remaining Kidney Volume.

S. Hussain, A. Khalil, M. Yaqub, T. Taber, O. Adebiyi, C. Sundaram, J. Powelson, W. Goggins, A. Diez, A. Sharfuddin.
GSK3β and VDAC in Endoplasmic Reticulum Stress and Apoptosis Modulation During Orthotropic Liver Transplantation.

M. Zaouali,^1,5 A. Panisello Roselló,¹ E. Folch Puy,¹ A. Lopez,² A. Rolo,³ C. Castro,² C. Palmeira,³ A. Garcia-Gil,⁴ R. Adam,² J. Roselló-Catafau.¹
Ganciclovir Resistant Cytomegalovirus Infection in Abdominal Tansplant Recipients.

J. Fose, M. Jorgenson, K. Rolling, E. McCreary, D. Mandelbrot, J. Smith.
Gene Expression Signature of Subclinical Allograft Kidney ABMR Compared to Clinical ABMR.

O. Aubert,¹ C. Lefaucheur,¹ S. Higgins,¹ L. Hidalgo,² J. Duong Van Huyen,¹ D. Viglietti,¹ X. Jouven,¹ D. Glotz,¹ C. Legendre,¹ P. Halloran,² A. Loupy.¹
Genome-Wide Genotyping in > 1500 Liver Allograft Recipient and Donor Pairs Reveals Several Associations with Acute Cellular Rejection.

B. Keating,¹ B.-L. Chang,¹ J. van Setten,² B. Cole,¹ L. Jennings,¹ G. Klintmalm,³ A. Shaked.¹
Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor Specific Antibodies and HLA Antigen Complexes in the Renal Allograft.

T. Nakamura,¹ H. Ushigome,¹ K. Watabe,² Y. Imanishi,² S. Harada,¹ S. Nobori,¹ K. Masuda,¹ N. Yoshimura.¹
HCC and Cardiac Cirrhosis After the Fontan Procedure in a Patient with Congenital Heart Disease and Situs Inversus.

P. Nguyen, N. Galvan, M. Kueht, C. O'Mahony, R. Cotton, A. Rana, J. Goss.
HIV and Cognitive Impairment in Kidney Transplant Candidates.

A. Shaffer, H. Ying, C. Haugen, M. McAdams DeMarco, D. Segev.
HLA Donor-Specific Antibody (DSA) Negative Antibody-Mediated Rejection (AMR): Incidence, Treatment and Outcomes.

R. Redfield, S. Parajuli, W. Zhong, B. Astor, A. Djamali, D. Mandelbrot.
Hepatic Artery and Biliary Complications in Liver Transplant Recipients with Radioembolization Bridging Treatment for Hepatocellular Carcinoma.

S. Radunz,¹ J. Treckmann,¹ F. Saner,¹ S. Müller,² J. Theysohn,³ A. Paul,¹ T. Benkö.¹
High-Dose Acyclovir for Cytomegalovirus Prevention in Seropositive Solid Organ Transplant Recipients.

J. Fose,¹ E. McCreary,¹ M. Jorgenson,¹ M. Lucey,² J. Smith.²
High-Risk Human Papillomavirus Associated with Genital Squamous Cell Carcinoma in Nonwhite Organ Transplant Recipients.

K. Nadhan,¹ M. Larijani,¹ L. Ogrich,¹ C. Shaver,¹ A. Doyle,² C. Chung.¹
Highly Sensitized Patients and the Association of Early Cardiovascular Disease: Analysis of Korean Organ Transplantation Registry(KOTRY) Data.

J. Jeong,¹ J. Yang,² M. Kim,³ S. Shin,⁴ B. Chung,⁵ S. Han,⁶ C. Ahn.⁷
How to Promote Regeneration After Ischemic Reperfusion Injury: Dual Role of CD 137 Agonistic Antibody.

J. Lee,^1,3 H. Kim,³ H. Chung,¹ K. Park,¹ B. Kwon,^3,4 H. Cho.^2,3
Human Islet-Derived Extracellular Vesicles Stimulate CD14+ Monocytes Resulting in Proinflammatory Cytokine Production.

A. Rutman, S. Negi, C. Hasilo, M. Gasparrini, J. Tchervenkov, S. Paraskevas.
Human Organs Allocated for Research – Maximising Use of a Precious Resource Using a New Ex Vivo Model of Reperfusion Injury.

B. Sandhu, H. Bishop, D. Loja, N. Galloway-Phillips, J. Crawley, C. Pusey, V. Papalois.
Human Transitional B Cell Cytokine Profile Predicts Renal Allograft Rejection and Clinical Course.

A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.
Hypoxia Induces Tissue Factor Upregulation in Isolated Human Islets.

B. Sandhu,¹ M. Prendecki,¹ G. Rutter,¹ A. Martinez-Sanchez,¹ N. Kanda,¹ N. Galloway-Phillips,¹ R. Smith,² C. Pusey,¹ V. Papalois.¹
IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-CMV IgG, Resulting in Inhibition of Antibody (Ab)-Mediated NK Cell Activation in Kidney Transplant Patients (KTX Pts).

B.-H. Shin,¹ S. Ge,¹ M. Chu,¹ J. Choi,¹ L. Winstedt,² C. Kjellman,² S. Louie,¹ A. Vo,¹ A. Peng,¹ S. Jordan,¹ M. Toyoda.¹
Identification of Antibody-Mediated Rejection After Kidney Transplantation by Specific MicroRNAs.

M. Matz,¹ F. Heinrich,² P. Durek,² C. Lorkowski,¹ K. Wu,³ N. Lachmann,⁴ K. Budde,¹ M.-F. Mashreghi.²
Identification of Kidney Transplant Patients at Risk for Skin Cancer by Differentially Methylated Regions in T Cells.

F. Peters,¹ A. Peeters,¹ P. Mandaviya,² J. van de Wetering,¹ M. Betjes,¹ C. Baan,¹ K. Boer.¹
Identification of NKG2D as Senescence Marker in Zero-Hour Kidney Biopsies Is Indicative for Clinical Outcome.

T. Resch,¹ J. Günther,¹ H. Hackl,² A. Sattler,³ S. Ebner,¹ P. Ritschl,³ M. Biebl,³ R. Öllinger,³ S. Schneeberger,¹ G. Brandacher,⁴ H. Schwelberger,¹ B. Zelger,⁵ D. Stauch,³ A. Pascher,³ J. Pratschke,³ K. Kotsch.³
Identification of Novel Diagnostic Biomarkers in Liver Transplantation Tolerance.

G.-Q. Shen,¹ M. Morita,¹ C. Miller,¹ K. Hashimoto,¹ L. Lu,¹ S. Qian,¹ J. Fung.²
IgG Antibody Subclasses in Potential Renal Transplant Recipients with DSA, AHG-CDC CxM Negative and FxM Positive or Negative with Their Potential Donors.

A. Contreras, A. Casillas, L. Llorente, G. Lima, A. Arvizu, A. De Santiago, M. Vilatoba, J. Alberu, J. Arreola-Guerra.
Immediate vs Delayed Initiation of CMV Prophylaxis…Safe and Cost Beneficial?

L. Cotiguala, A. Carlson, C. Truax, B. Sirandas, I. Hall, L. Smith.
Immunosuppressive Ability of NFkB Inhibitor: Withaferin A.

M. Kanak,¹ Y. Shindo,¹ M. Levy,^1,2 B. Naziruddin.³
Immunosuppressive Regimen Modification Approaches in BK Nephropathy – A Comparative Study.

H. Ahmed, A. Roche-Recinos, C. Drachenberg, R. Ugarte, N. Costa, M. Mavanur, B. Thomas, A. Haririan.
Immunosuppressive Treatment Alters Gut Microbiota and Modified Gut Microbiota Affects Immune Status.

Z. Zhang, Y. Xu, Q. Zhang, X. Hu.
Impact of Cytokine Gene Polymorphism on Clinical Outcome of Renal Transplantation.

I. Pérez-Flores,¹ J. Santiago,² A. Moreno Dela Higuera,¹ N. Calvo,¹ B. Rodriguez-Cubillo,¹ E. Urcelay,² A. Shabaka,¹ M. Calvo,¹ A. Sanchez-Fructuoso.¹
Impact of Donor Asystole in Intestine Transplant.

J. Schroering, C. Kubal, R. Mangus.
Impact of Early Allograft Dysfunction on Graft and Patient Outcomes After Liver Transplantation.

Z. Guo, D. Zheng, X. He, G. Chen.
Impact of Everolimus Added to a De Novo Belatacept Regimen on the Risk of BK Viremia After Kidney Transplant.

C. Larsen,¹ M. Alseiari,² S. Chandran,² F. Vincenti,² D. Wojciechowski.¹
Impact of Filgrastim Use on Maintenance Doses of Immunosuppressants and Clinical Outcomes in Renal Transplant Patients.

C. Kane,¹ K. Lang,² T. Rendulic,¹ M. Goetz,¹ R. Evans,¹ K. Trobaugh,¹ J. Berger.¹
Impact of Post Kidney Donation Gout on eGFR and Kidney Stones.

B. Sengupta, J. Menk, A. Matas.
Impact of Pre-Donation eGFR on Long-Term Post-Donation eGFR in Younger Living Kidney Donors.

D. Vock, H. Ibrahim, A. Matas.
Impact of Race on Selection of the Living Donor Candidate.

D. Bohorquez, A. Thomasson, P. Porrett.
Impact of Timeliness of Assessment of Positive Cytomegalovirus Polymerase Chain Reaction Results in Abdominal Organ Transplant Recipients.

K. Roach, H. Triemer, M. Hurtik, A. Mehta.
Impact of a Novel Prehabilitation Program in Kidney Transplant Candidates.

M. McAdams DeMarco, H. Ying, A. Nastasi, D. Segev.
Improvement in Inflammatory Response Follows Clearance of BKVN.

E. Abuhelaiqa,¹ S. Salvatore,² J. Lee,¹ J. Lee,¹ T. Muthukumar,¹ S. Seshan,² D. Dadhania.¹
Improving Donor Screening for Cytomegalovirus (CMV): Is CMV IgG Avidity Better Than CMV IgM?

H. Prince,¹ M. Nowicki.^1,2
Improving Value by Standardizing the Use of IVIG Amongst Pediatric Solid Organ Transplant (SOT) Patients.

J. Sawyer,¹ J. Bucuvalas,² L. Danziger-Isakov,³ J. Gossett,³ L. Burkhart,³ A. Lorts.³
Incidence and Risk Factors for Cervical Dysplasia Associated to Human Papillomavirus Infection in Women with Kidney Transplant.

I. Parra-Avila, J. Alberu, L. Marino-Vazquez, L. Morales-Buenrostro, R. Rosado-Canto.
Incidence of Cytomegalovirus Infection Among Liver Transplant Recipients Maintained on a Cyclosporine vs. Tacrolimus-Based Immunosuppression Regimen.

C. Burrelli, M. Bradley, S. Pouch, E. Elkhammas, H. Winters.
Incidental Hepatocellular Carcinoma in Explanted Livers: An Assessment After LIRADS Introduction.

S. Garcia Aroz,¹ D. Ludwig,² K. Fowler,² N. Vachharajani,¹ M. Xu,¹ Y. Lin,¹ M. Doyle,¹ W. Chapman.¹
Increased Gene Expression of TGF-β in Peripheral Blood Mononuclear Cells from Renal Transplant Patients with Polyomavirus BK Viremi.

W. Yin.^1,2
Inflammatory Conditions Dictate the Effect of MSC on B Cell Function.

F. Luk,¹ L. Carreras-Planella,² S. Korevaar,¹ S. de Witte,¹ F. Borràs,² M. Betjes,¹ C. Baan,¹ M. Hoogduijn,¹ M. Franquesa.^1,2
Influence of an Enhanced Recovery Protocol in Laparoscopic Living Donor Nephrectomy.

A. Rege, D. Vikraman, K. Ravindra, T. Brennan, H. Leraas, D. Sudan.
Integration of Kidney-Exchange, (Un)Specified Living Donor Transplantation, ABO Incompatible and Desensitisation Programs in a Computerized Allocation Program: A Simulation.

M. de Klerk,¹ J. Kal,¹ S. Middel,¹ J. van de Wetering,¹ M. Kho,¹ M. Betjes,¹ W. Zuidema,¹ D. Roelen,³ K. Glorie,² J. Roodnat.¹
Intended and Unexpected Impact of the New Kidney Allocation System on a Large Volume Transplant Program.

A. de Mattos, M. Alnimri, L.-X. Chen, J. Sageshima, C. Santhanakrishnan, R. Perez.
Intravoxel Incoherent Motion MRI Is an Effective Way to Monitor Acute Allograft Rejection in Rat Models.

S. Zeng, X. Hu.
Is There Any Difference Between ABO-Incompatible and ABO-Compatible Liver Transplantation? Oncologic Aspect.

J. Lee,¹ J. Lee,¹ S. Song,¹ S.-K. Kwon,¹ D. Kim,¹ J. Lee,² M. Kim,¹ G. Choi,¹ J. Choi,¹ D. Han,¹ S. Kim,¹ D. Joo.¹
Ischemia Reperfusion Injury (IRI) Causes Local Release of Free Heme Which Aggravates Inflammation and Contributes to Delayed Graft Function.

F. Gueler,¹ R. Chen,¹ A. Thorenz,¹ K. Madyaningrana,² J. Bräsen,³ H. Haller,¹ S. Immenschuh,³ V. Vijayan.³
KDPI Obscures Trends in Absolute Donor Risk.

N. Salkowski, S. Gustafson, A. Wey, J. Snyder.
KDPI Usefulness in Spain: A Comparison with Classical ECD/SCD.

C. Arias-Cabrales,¹ M. Pérez-Sáez,¹ D. Redondo,¹ A. Buxeda,¹ C. Burballa,¹ S. Bermejo,¹ A. Sierra,¹ M. Mir,¹ A. Burón,² A. Zapatero,³ M. Crespo,¹ J. Pascual.¹
Kidney Allocation Using CMV Matching Optimizes Low and High Risk Profiles for Prevention of CMV Infection in Kidney Transplant Recipients.

J. Lockridge,¹ E. Langewisch,² D. Basuli,¹ A. Olyaei,³ C. Shaut,⁴ D. Norman.¹
Kidney Allograft Offers: Predictors of Turndown and the Relationship of Organ Acceptance Sequence to Kidney Allograft Survival.

J. Cohen,^1,2 J. Shults,² D. Goldberg,^2,3 D. Sawinski,¹ P. Abt,⁴ P. Reese.^1,2
Kidney Transplant Allocation with CMV Matching Reduces CMV Infection and Related Costs.

J. Lockridge,¹ E. Langewisch,² D. Basuli,¹ A. Olyaei,³ C. Shaut,⁴ D. Norman.¹
Kidney Transplantation in HCV+ Recipients in a New Era of Diagnostics and Therapeutics.

C. Traynor, S. Bumb, C. Berg, M. Ellis, J. Roberts, A. Muir, L. King, C. Brady, S. Sanoff.
Kidney-Specific Immunosuppression without Adverse Systemic Effects.

D. Kentrup,¹ K. Schuette-Nuetgen,¹ H. Pawelski,¹ H. Pavenstädt,¹ S. Hermann,² M. Schaefers,² G. Larbig,³ A. Kuebelbeck,³ S. Reuter.¹
Kinetic Estimation of Glomerular Filtration Rate and Urine Creatinine as Predictors of Delayed Graft Function in Kidney Transplantation from Non-Heart Beating Donors.

M. Calvo, M. Moreno De La Higuera, V. Lopez De La Manzanara, A. Shabaka, M. Poma, I. Perez-Flores, N. Calvo Romero, B. Rodríguez-Cubillo, A. Sanchez-Fructuoso.
Kinetics of Cytomegalovirus (CMV) DNAemia in CMV Mismatch Solid Organ Transplant Patients with Primary CMV Infection.

C. Hernandez, D. Chiang, S. Fuentes, C. Cervera.
Lack of Specificity of LC-MS/MS Based Urinary Biomarkers for Polyomavirus BK Nephropathy (BKPyVN).

G. Zeng,¹ L. Pan,² Z. Lyu,² Y. Huang,¹ P. Randhawa.¹
Lack of Utility of KDPI in Dual Kidneys from Donors at the Extremes of Age.

D. Felts, M. Khan, B. Alradawna, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, A. Palanisamy, W. Doares, S. Kaczmorski, R. Stratta.
Liver Mesenchymal Stem Cells Inhibit T Cell Alloresponses.

T. Taner, M. Gustafson, M. Hansen, A. Dietz, M. Stegall.
Liver Regeneration in Porcine Hepatectomy Model.

H. Chen, D. Joo, M. Shaheen, J. Yang, S. Nyberg.
Living Kidney Transplant: The Influence of Intraoperative Hemodynamics on Delayed Graft Function.

R. Schutt,¹ J. Case,¹ B. Barrick,¹ A. Toll,² C. Marsh.¹
Long-Term Outcomes of Renal Function in Pediatric Living Related Intestinal Transplantation.

S. Garcia Aroz,¹ K. Czech,² L. Briar,² G. Testa,³ E. Benedetti,¹ E. John.²
Longer Pre-Transplant Dialysis Exposure Is More Frequent in Living Donor Kidney Transplantation (LDTX) Involving Lower Income Donor and Recipients and Is Associated with an Increased Risk of LDTX Failure.

J. Gill, C. Rose, J. Lesage, Y. Joffres, J. Gill.
Low Dose Valganciclovir for CMV Prophylaxis in the First Year of Kidney Transplantation.

P. Klem,¹ L. Al-Omar,² J. Cooper,² S. Davis,² J. Gralla,² D. Choe,¹ A. Wiseman.²
Low Incidence of Acute Rejection within the Six Months After Transplantation in HIV Recipients Treated with Raltegravir, the ANRS 153 Treve Trial.

M. Matignon,¹ A. Lahiani,⁹ J. Lelievre,² D. Desvaux,⁶ K. Abassi,⁹ A. Diallo,⁹ M. Peraldi,⁷ A. Taburet,⁴ J. Saillard,⁵ C. Delaugerre,³ L. Assoumou,⁹ P. Grimbert,¹ TREVE ANRS Study Group.⁵
Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate Risk Renal Transplants: A Single Center Experience.

A. Baghban,¹ K. Belfield,² M. Azar,¹ E. Cohen,² M. Malinis.¹
Measles Screening and Vaccination in Solid Organ Transplant Recipients: Adherence to Infectious Disease Community of Practice (IDCOP) Recommendations.

F. Irani,¹ R. Butler,² C. Kovacs.
Medicinal Herb Cordyceps Sinensis Promotes Long-Term Allograft Survival by Tipping the Balance Between CD4+FoxP3+ Tregs and CD8+ Tcm Cells.

Z. Dai,¹ H. Dai.²
MicroRNAs Differentiate Between Antibody and T-Cell Mediated Renal Allograft Rejection.

T. van den Bosch,¹ M. Clahsen-van Groningen,² F. Rezaee,³ D. Nieboer,⁴ E. Steyerberg,⁴ C. Baan,¹ A. Rowshani.¹
Microarray Analysis of Rejection in Formalin-Fixed Paraffin-Embedded Biopsies: Similarities and Disparities with Conventionally Stabilized Biopsies.

K. Famulski, J. Revee, P. Halloran.
Microcirculation Inflammation in Kidney Allograft Biopsies.

M. Giordani,¹ M. Bedini Rocca,¹ S. Groppa,¹ C. Mombelli,¹ S. Christiansen,² M. Ocampo,¹ G. Rosa Diez,¹ N. Imperiali.¹
Minor Degree of Persistent Microscopic Hematuria in Potential Living Kidney Donors Is Associated with Pathology.

V. Kumar,¹ M. Saha,¹ J. Locke,² R. Gaston,¹ M. Hanaway.²
Modulating Ischemia-Reperfusion Injuries with Pharmacological Agents: A Bench-to-Bedside Approach.

M. Thomas, G. Tardif, A. Melanger, P. Berna.
Mycophenolate Dose Reductions Are Not Associated with De Novo Donor-Specific Antibodies.

S. Davis, J. Gralla, P. Klem, A. Wiseman, J. Cooper.
Mycophenolic Acid Needs Ca²⁺ to Exert Its Anti-inflammatory Action via Shedding of Toll-Like Receptor4 and Tumor Necrosis Factor Receptor 1.

J. Kim,¹ W. Yang,¹ C. Baek,¹ N. Han,² S.-K. Park.¹
NKG2C+ NK Cell Adaptive Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.

D. Redondo,¹ M. Crespo,¹ J. Yélamos,² A. Muntasell,² M. Pérez-Sáez,¹ C. Vilchez,³ J. Pascual,¹ M. Lóez-Botet.²
Naïve and Interferon-gamma Activated Mesenchymal Stem Cells Differentially Affect Immune Responses In Vitro and In Vivo.

R. Patil,¹ K. Premanand,¹ L. Halliday,¹ E. Szilagyi,¹ M. Willman,² J. Yu,¹ R. Hickey,¹ D. Berman,² A. Antony,¹ F. Pan,¹ X. Wang,¹ K. McHenry,⁴ D. Salomon,³ N. Kenyon,² A. Bartholomew.¹
Nafamostat Mesilate Ameliorates Ischemia-Reperfusion Renal Injury via Anti-Apoptotic Mechanism.

D. Choi,¹ J. Jeong,² H. Bae,¹ Y. Ham,¹ K. Lee,¹ K. Na.¹
Neutering Worsens Liver Ischemia/Reperfusion Injury in Both Male and Female Mice.

D. Murken,¹ D. Aufhauser Jr,¹ S. Concors,¹ Z. Wang,¹ G. Ge,¹ W. Hancock,² M. Levine.¹
Neutropenia in Kidney and Liver Transplant Recipients: Risk Factors and Consequences.

T. Mavrakanas,¹ M. Fournier,² S. Clairou,² J. Amiel,² D. Vinh,³ C. Coursol,² D. Thirion,² M. Cantarovich.⁴
New Approach for Targeted Immunotherapy in Vascularized Composite Allotransplantation.

F. Feturi,¹ H. Wang,² Y. Brudno,² V. Erbas,³ Z. Zhang,³ H. Sahin,³ D. Mooney,² V. Gorantla,³ R. Venkataramanan.¹
Non-Directed Donors (NDD) Less Than 25 Years.

D. Larson, J. Wiseman, A. Roman, D. Berglund, H. Ibrahim, A. Matas.
Nonmelanoma Skin Cancer Rates Are Not Affected by Chronic HIV(+) or HCV(+) Infection in Organ Transplant Recipients.

K. Nadhan, E. Usedom, S. Shipman, A. Doyle, G. Malat, E. Buchanan, C. Chung.
Novel Therapies for Diabetic Kidney Disease.

M. Nguyen, K. Kodama, M. Sarwal.
Nox4 and Oxidative Stress Mediate TGF-β1 Induced Human Kidney Proximal Cell Apoptosis in Ischemic Reperfusion Injury.

S.-H. Yoon,¹ S. Cho,¹ D.-I. Kim,¹ S.-R. Yoon,¹ W.-M. Hwang,¹ S.-L. Yu,² J. Kang.²
OPO Performance Metrics: Relationship with Kidney Transplant Program Performance Metrics and Kidney Utilization.

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
OPO-Wide Waitlist Size and Deceased Donor Kidney Transplant Rate.

S. Zhou,¹ A. Massie,¹ S. Gentry,² D. Segev.¹
Obesity Predicts New-Onset Diabetes After Live Kidney Donation.

K. Lentine,¹ A. Naik,² N. Lam,³ M. Schnitzler,^1,6 H. Xiao,¹ D. Axelrod,⁴ G. Hess,⁵ B. Kasiske,⁶ A. Garg,⁷ S. Gustafson,⁶ D. Brennan,⁸ D. Segev.^9,6
Occult Hepatitis C Virus in Recipients of Kidney Transplantation: Prevalence and Clinical Implications.

C. Jimenez,¹ T. Olea,¹ M. Lopez,¹ I. Castillo,² J. Bartolomé,² J. Quiroga,² E. Gonzalez,¹ V. Carreño,² R. Selgas.¹
On the Pathogenesis of Post-Transplant Diarrhea in Kidney Transplant Recipients.

J. Lee,¹ M. Mcgruder,¹ L. Zhang,¹ M. Thangamani,¹ D. Dadhania,¹ L. Westblade,¹ M. Satlin,¹ A. Robertson,² L. Ling,² Y. Taur,² E. Pamer,² M. Suthanthiran.¹
Outcome After Living Donor Liver Transplantation for Hepatocellular Carcinoma in Elderly Patients > 65 Years: Assessing the Long Term Survival.

A. Thorat, S.-C. Hsu, L.-B. Jeng, H.-R. Yang, P.-C. Li, C.-C. Yeh, T.-H. Chen, K.-S. Poon.
Outcome of ABO-Incompatible Kidney Transplantation After Stratified Desensitization.

K. Nanmoku, A. Kurosawa, T. Kubo, T. Shinzato, T. Shimizu, T. Kimura, T. Yagisawa.
Outcome of Adult Living Donor Renal Transplants in Different Era: Analysis of UNOS Database.

V. Whittaker, R. Gruessner, M. Laftavi, Z. Acun, A. Gruessner.
Outcome of Kidney Transplantation from Deceased Octogenarian Donors.

P. Donato, L. Furian, C. Silvestre, F. Neri, C. Di Bella, M. Di Bello, P. Rigotti.
Outcome of Living-Donor Kidney Transplantation in Cross-Match-Positive Recipients at a Single Center.

D. Okada,¹ M. Okumi,¹ K. Unagami,² T. Shimizu,¹ H. Ishida,¹ K. Tanabe.¹
Outcomes Following Transplantation for Hepatocellular Carcinoma.

P. Tabrizian, K. Nakazawa, J. Prigoff, M. Schwartz, S. Florman.
Outcomes of 100 ABO Incompatible Kidney Transplants: A Single US Center Experience.

S. Sethi, A. Vo, E. Huang, L. Varanasi, J. Choi, A. Peng, R. Najjar, S. Jordan.
Outcomes of Deceased Donor Kidney Transplantation in Elderly Recipients Aged 70 Years and Older.

A. Adamusiak,¹ T. Salter,² P. Andrews,² C. Callaghan.¹
Outcomes of Kidney Transplantation Using Deceased Diabetic Donors.

F. Khan,¹ W. Suki,¹ D. Nguyen,² E. Graviss.²
PTEN Inhibition in MSC Upregulates PD-L1 and Enhances Their Immunomodulatory Capacity Prolonging Skin Allograft Survival.

M. Climov, M. Uehara, Z. Solhjou, H. Matsumine, N. Bouyani, E. Kefaloyianni, B. Basmani, V. Kasinath, G. Giatsidis, D. Orgill, R. Abdi.
Percentage of CD19⁺ B Cells as a Predictor of Acute Antibody-Mediated Rejection After Administration of Rituximab in ABO-Incompatible Kidney Transplantation.

T. Hirose, D. Iwami, K. Hotta, H. Sasaki, H. Higuchi, N. Shinohara.
Pharmakokinetics of Daclatasvir, Sofosbuvir and GS-331007 in a Prospective Cohort of HCV Positive Kidney Transplant Recipients.

E. Schrezenmeier,¹ P. Galander,¹ F. Hoffmann,² C. Jaeger,² J. Lisec,² J. Schrezenmeier,² O. Staeck,¹ L. Lehner,¹ D. Khadzhynov,¹ F. Halleck,¹ M. Duerr,¹ K. Budde.¹
Plasma Extracellular Vesicles MicroRNA Signatures Associate with Graft Function Recovery Post-Acute Renal Allograft Injury.

V. Bontha, A. Fernandez-Pineros, D. Bagchi, D. Maluf, E. Rhone, V. Mas.
Poor Outcome of Polyomavirus -Associated Nephropathy with Glomerular Parietal Epithelial Cells Infected by Polyomavirus.

G. Huang,¹ W. Chen,² J. Qiu,¹ X. Chen,¹ L. Chen,¹ C. Wang.¹
Poor Predictability of Quantiferon-TB Assay in Recipients and Donors for Tuberculosis Development After Kidney Transplantation in an Intermediate-TB-Burden Country.

J. Yang,¹ J. Ryu,¹ J. Jang,² J.-G. Lee,² C. Ahn.¹
Poor Prediction of Rejection and Kidney Survival by Donor-Specific-Antibodies Characterization.

L. Couzi,^1,2,3 M. Courant,¹ J. Visentin,^1,2,3 V. Dubois,⁴ S. Lepreux,^1,2 G. Guidicelli,¹ O. Thaunat,^5,6 P. Merville,^1,2,3 J.-L. Taupin.⁷
Post Transplant Outcomes in Hepatitis C Positive Patients.

M. Lubetzky, N. Hayde, L. Kamal, M. Ajaimy, P. Bedi, G. Deboccardo, J. Rocca, S. Greenstein, J. Graham, A. Chokechanachaisakul, A. Courson, M. Kinkhabwala, E. Akalin.
Post-Transplant Urinary Transglutaminase 2 Is a Potent Biomarker to Predict Kidney Allograft Inflammation or Fibrosis.

S. Shin,¹ Y.-M. Wee,¹ M. Choi,¹ Y. Cho,² H. Go,² Y. Kim,¹ D. Han.¹
Postoperative Serum Lactate Dehydrogenase Is a "Troponin-Like" Marker of Renal Transplant Distress.

R. Steiner, J. Halldorson.
Pre-TACE Immune Status Correlates with Treatment Response and Tumor Biology in HCC as a Bridge to Transplant.

T. Sandow,¹ H. Bohorquez,² D. Kirsch,¹ A. Albar,¹ P. Thevenot,³ K. Nunez,³ D. DeVun,¹ J. Gimenez,¹ G. Galliano,⁴ A. Cohen,² G. Loss,² D. Kay,¹ P. Gulotta.¹
Predicting Recurrence Prior to Transplant: The Response of HCC to Chemoembolization.

T. Sandow,¹ H. Bohorquez,² D. Kirsch,¹ P. Thevenot,³ K. Nunez,³ A. Albar,¹ D. DeVun,¹ J. Gimenez,¹ G. Galliano,⁴ A. Cohen,² G. Loss,² D. Kay,¹ P. Gulotta.¹
Predicting Residual Renal Compensation in Living Kidney Donors Post-Donation.

A. Diez, G. Diltz, J. Von Visger, U. Nori, T. Pesavento, R. Pelletier.
Prediction of Delayed Graft Function in Chinese Kidney Allograft Recipients.

H. Zhang, S. Qin, L. Zheng, L. Liu, C. Wang.
Predictive Value of Pre-Transplant Cross-Match Techniques on Living Donor Kidney Transplant Outcomes.

M. Meneghini,¹ E. Melilli,¹ I. Revuelta,³ R. Rajalingam,² E. Rigol,⁴ S. Chandran,² F. Diekmann,³ F. Vincenti,² J. Cruzado,¹ J. Martorell,⁴ O. Bestard.¹
Presence of Complement Activating Donor Specific Antibodies Is Associated with Poor Renal Allograft Survival: Two Centre Retrospective Study.

A. Babu,^1,4,5 O. Shaw,² L. Howe,² N. Kessaris,³ A. Dorling,³ N. Mamode,³ R. Vaughan,² N. Krishnan,⁵ R. Higgins,⁵ D. MItchell,¹ D. Briggs,⁴ S. Daga.^1,5,6
Prevalence and Clinical Outcomes in Kidney Transplant Patients with Viral and Fungal Opportunistic Infections and Malignancy.

M. Lubetzky, N. Hayde, L. Kamal, M. Ajaimy, P. Bedi, G. Deboccardo, E. Akalin.
Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratio in Patients Undergoing Liver Transplantation with Hepatocellular Carcinoma within Milan Criteria.

S.-K. Kwon,¹ J. Lee,¹ S. Song,¹ J. Lee,¹ D. Kim,¹ J. Lee,² M. Kim,¹ G. Choi,¹ J. Choi,¹ D. Han,¹ S. Kim,¹ D. Joo.¹
Prognostic Tools to Choose Candidates for Successful Desensitization.

D. Pinelli,¹ A. Zachary,² J. Friedewald,¹ M. Leffell,² D. Lucas,² R. Montgomery,² A. Tambur.¹
Program-Specific Offer Acceptance Behavior for Kidney Programs Across the Spectrum of KDPI.

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
Protective Effect of Crepidiastrum denticulatum Extract Pretreatment Against Hepatic Ischemia-Reperfusion Injury in Mice.

H. Jang, H. Lee, C. Park, D. Eom, J. Lee, M. Oh, J. Yoo, C. Rho.
Protective Effects of Bryostatin-1 on Neutrophil Migration in an In Vitro Model of Ischemia Reperfusion Injury: Impact for Therapy.

F. Becker,¹ L. Kebschull,¹ T. Castor,³ D. Palmes,² S. Alexander,² F. Gavins.²
Quantitative Gene Expression Analysis of CRM-Panel Genes Using FFPE Kidney Tissues for Transplant Injuries.

T. Sigdel, M. Nguyen, D. Dobi, S.-C. Hsieh, J. Liberto, F. Vincenti, M. Sarwal, Z. Laszik.
Rates of CMV Infection in Kidney Transplant Recipients Who Received Subtherapeutic Valganciclovir Prophylaxis.

K. Belfield, E. Cohen, M. Malinis, A. Baghban.
Re-Evaluation of Imaging Studies in Patients with Hepatocellular Carcinoma at a Transplant Center Impacts Patient Care.

A. Kardashian, B. Madani, C. Frenette.
Reasons for Ineligibility for Kidney Donation by Race: Gap for Blacks Represented by Modifiable Factors, However Are Big Hurdles to Overcome.

D. Simpson,¹ M. Levine,¹ S. Amaral.²
Recurrent HCC After Radiofrequency Ablation or Liver Resection Can Be Effectively Treated with Salvage Transplantation.

H. Muaddi,¹ D. Al-Adra,¹ J. Shaw,¹ D. Grant,¹ P. Greig,¹ I. McGilvray,¹ M. Cattral,¹ A. Wei,¹ C.-A. Moulton,¹ J. Kachura,² R. Beecroft,² M. Selzner,¹ A. Ghanekar,¹ S. Gallinger,¹ S. Cleary,¹ G. Sapisochin.¹
Regulatory T Cells Inhibit Plasmablast Formation and IgG Production by Tempering T Follicular Helper Cell Function.

P. Fadakar, C. Macedo, M. Yamada, K. Hadi, D. Metes.
Reliability of Donor Kidney Biopsies from Time of Organ Recovery Compared to Immediate Post-Reperfusion Biopsies.

M. Barrett, A. Prater, E. Farkash, D. Christopher, D. Fritze, N. Matusko, R. Sung, K. Woodside.
Renal Function Outcomes of Hypertensive Living Kidney Donors (HLD) and Recipients of HLD Kidneys: Results of a Case-Control Study.

T. Pesavento,¹ A. Diez,¹ R. Pelletier,² U. Nori,¹ J. VonVisger.¹
Reproducibility of the Cobas CMV Test (cobas CMV) and Clinical Concordance with the Cobas Ampliprep / Cobas TaqMan CMV Test (CAP/CTM CMV).

P. Baum,¹ J. Yao,² A. Butcher,¹ P. Hemyari,¹ A. Valsamakis,³ S. Young.⁴
Results of Stem Cell and Renal Transplantation in Patients with End Stage Renal Disease After Plasma Cell Dyscrasias.

C. Moliz,¹ B. Redondo,¹ M. Molina,¹ E. Morales,¹ E. Gonzalez,¹ J. Cabrera,² A. Andres.¹
Retroactive Application of a New Risk Index for Living Donor Kidney Transplantation (LKDPI) to Renal Transplants in Veracruz, Mexico.

G. Martinez-Mier,^1,2 E. Soto-Miranda,¹ S. Avila-Pardo,² L. Budar-Fernandez,¹ M. Mendez-Lopez,¹ P. Moreno-Ley,¹ E. Aguilar-Sandoval,¹ G. Coello-Torres,³ F. Diaz-Trueba.³
Risk Factor for Hepatitis E Virus Infection Among Solid-Organ-Transplant Patients.

N. Kamar,¹ S. Lhomme,² F. Abravanel,² L. Esposito,¹ A. Hebral,¹ O. Marion,¹ A. Del Bello,¹ J. Izopet.²
Risk Factors and 2 Year Outcomes of Low Estimated Glomerular Filtration Rate in the Immediate Post-Operative Period for Living Kidney Donors.

H. Pahari,¹ S. Nagai,¹ K. Takahashi,¹ F. Tinney,² J. Denny,¹ L. Malinzak,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ M. Abouljoud,¹ D. Kim.¹
Risk Factors and Consequences of De Novo Anti-HLA Donor Specific Antibodies in Kidney Transplant Recipients: The Force Awakens.

B. Javaid, S. Rosen-Bronson, D. Li, M. Awwad, A. Gilbert, S. Ghasemian, J. Verbesey, P. Abrams, M. Grafals, J. Fenton, C. Cannon, J. Rapisura, J. Moore, M. Cooper.
Risk Factors for Hospital Readmission with Urinary Tract Infections (UTIs) Following Kidney Transplantation (KT).

E. Minja, S. Jackson, A. Matas.
Risk Factors for Polyomavirus Infection After Renal Transplantation: Introduction of the Protective Effect of Peritoneal Dialysis.

S. Hosseini-Moghaddam, Q. Xu, J. Kum, H. Alharbi, A. Jevnikar, M. John, G. Singh, S. Parsons, M. Edgar, P. Luke.
Risk Factors of Treatment Failure in Antibody Mediated Rejection.

V. Pernin,¹ I. Szwarc,¹ T. Kanouni,² V. Garrigue,¹ J. Serre,¹ S. Delmas,¹ G. Mourad,¹ M. Le Quintrec.¹
Risk Prediction Model for Delayed Graft Function in a Cohort of Brazilian Kidney Transplantation from Deceased Donors: What You See Is Not What You Get.

S. Costa,^1,2 T. Sandes-Freitas,^1,2 E. Daher,² R. Esmeraldo.¹
Role of Chemokines in Resolution of BK Virus-Associated Nephropathy and Chronicity of Pathology Changes in Kidney Transplant Recipients.

J. Zuckerman, F. Palma Diaz, C. Magyar, B. Abdalla, E. Lum, S. Bunnapradist, T. Pham, G. Dannovitch, J. Veale, H. Gritsch, E. Reed, J. Schaenman.
Role of Protease Activated Receptor 1 and Sphingosine-1-Phospate Receptor 1 in Mice Hepatic Ischemia-Reperfusion Injury for Targeting Cell Signal Pathways of Activated Protein C.

T. Ito, N. Kuriyama, H. Kato, Y. Iizawa, A. Tanemura, Y. Murata, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Sequential Monitoring of Natural Killer Cell Reconstitution Against CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation.

P. Ki Hyun,¹ L. Hyeyoung,² R. Ji Hyeong,¹ K. Yonggoo,² H. Kyungja,² C. Byung Sik,² K. Hee-Je,³ M. Woosung,³ O. Eun-Jee.²
Serum AFP Greater Than 200 ng/ml as a Predictor for Low Survival in Patients with Hepatocelullar Carcinoma Recurrence in a Brazilian Multicentric Study.

I. Boin,¹ M. Possatto,¹ E. Ataide,¹ R. Silva,² R. Silva,² H. Felicio,² L. Amado,³ A. Lima,³ T. Seva-Pereira.¹
Sexual Acquisition of HIV-Infection After Kidney Transplantation: Late Presentation and Potentially Fatal Complications.

M. Cristelli, M. Ribeiro, D. Santos, M. Mazolin, H. Tedesco-Silva, J. Medina-Pestana.
Short- and Long-Term Graft Survival After Kidney Transplantation in Western Europe.

M. Coemans,¹ G. Verbeke, D. Anglicheau, O. Bestard, M. Giral, M. Naesens.^1,2
Short-Term Combination Treatment of FK506 and Anti-CD40 Ligand Remarkably Prolong Allograft Survival Time in Mouse Skin Transplantation.

X. Zhang, Z. Ding, M. Yang, Y. Miao, Y. Yang, P. Zhou.
Single Nuclear Polymorphisms of Complement Component 4 and Component 5 in Renal Transplant Recipients with Antibody-Mediated Rejection.

Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.
Single-Center Initial Experience in Treating Chronic Hepatitis C in Kidney Transplant Recipients.

G. Meinerz, C. da Silva, R. Bruno, E. Keitel, V. Garcia.
Solid Organ Cancer After Kidney Transplantation: Risk Factors and Long Term Impact.

A. Buxeda, D. Redondo, M. Pérez-Sáez, A. Bartolomé, M. Mir, A. Pascual, A. Sans, M. Crespo, J. Pascual.
Steatotic Human Livers Show Inferior Function Compared to Non-Steatotic Livers During Ex-Situ Viability Assessment by Oxygenated Machine Perfusion.

N. Karimian,¹ V. Huang,¹ F. Fontan,¹ M. Aburawi,¹ S. Geerts,¹ S. Mert,¹ I. Beijert,² R. Porte,² M. Yarmush,¹ K. Uygun,¹ J. Markmann,¹ H. Yeh.¹
Steroid Withdrawal and De Novo Donor-Specific HLA Antibodies in Renal Transplant Patients: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results.

J. Alonso-Titos,¹ P. Ruiz-Esteban,¹ E. Palma,¹ V. Lopez,¹ A. Caballero,² M. Leon,³ M. Cobos,⁴ J. Cruzado,⁵ J. Sellares,⁶ A. Torres,⁴ D. Hernandez.¹
Subclinical Rejections in Kidney Transplant Recipients Treated with Direct Acting Antiviral Agents for Hepatitis C Treatment within 1 Year of Transplant.

T. Rege,¹ K. Hatahet,¹ A. Gillespie,¹ M. Ghanta,¹ I. Lee,¹ K. Qureshi,¹ K. Lau,² S. Karhadkar,² A. DiCarlo,² S. Constantinescu,¹ S. Rao.¹
Successful Launch of an ABO-Incompatible Kidney Transplantation Program to Overcome the Shortage of Compatible Living Donors: Experience at a Single Center.

S. Song,¹ J. Lee,¹ J. Lee,¹ S.-K. Kwon,¹ B. Kim,^2,3 J. Lee,¹ Y. Kim,^1,3 M. Kim,^1,3 S. Kim,^1,3 K. Huh.^1,3
Successful Utilization of Deceased Donor Kidney Allografts with KDPI>85: A Single Center Experience.

A. Agarwal, W. Ally, K. Brayman.
Succinate Accumulation During Warm and Cold Ischemia in Mouse, Pig and Man: Mechanistic and Therapeutic Implications for Transplant Ischemia-Reperfusion Injury.

J. Martin,^1,3 A. Costa,² A. Gruszczyk,^1,3 M. Hamed,¹ N. Georgakopoulos,¹ G. Pettigrew,¹ A. James,³ C. Frezza,² M. Murphy,³ K. Saeb-Parsy.¹
Suppression of Inflammation by Withaferin A in Cerulein-Induced Pancreatitis Model Results in Improved Syngeneic Islet Engraftment.

G. Yoshimatsu,¹ M. Kanak,² C. Chang,¹ C. Darden,¹ M. Lawrence,¹ B. Naziruddin.³
T Cell Responses to Viral Peptide Stimulation Predict Influenza Vaccine-Induced Seroconversion in Pediatric Solid Organ Transplant Recipients.

E. Mayer,¹ M. Altrich,² C. Cordes,² S. Fausett,² J. Tepp,³ R. Albrecht,³ A. Fernandez-Sesma,³ B. Herold,¹ I. Ramos,³ R. Madan.¹
Tacrolimus Suppresses Calcineurin Activity and Ca2+ Influx Age-Specifically.

F. Krenzien,^1,2 M. Quante,¹ H. Uehara,¹ R. Abdi,¹ H. Cetina Biefer,¹ M. Schmelzle,² J. Pratschke,² A. Elkhal,¹ S. Tullius.¹
Tacrolimus and Mycophenolic Acid Have a Limited Inhibitory Effect on Monocyte Signaling Pathway Phosphorylation, Function and Differentiation.

N. Kannegieter,¹ D. Hesselink,¹ M. Dieterich,¹ R. Kraaijeveld,¹ A. Rowshani,¹ P. Leenen,² C. Baan.¹
Targeting JAK-STAT Pathways with Tofacitinib Provides a Novel Approach for Conditioning in Allogeneic BMT Recipients.

H. Xu, A. Merchak, M. Xu, C. Mort, T. Dowling, L. Kahn, M. Binion, A. Chhabra, Y. Wen, Y. Huang, S. Ildstad.
Testing the Efficacy of Contrast Enhanced Ultrasound in Detecting Transplant Rejection Using a Murine Model of Heart Transplantation.

K. Fisher,¹ M. Uehara,² S. Ohori,² C. Meral,¹ S. Giannini,³ T. Ichimura,² N. Smith,⁴ F. Jolesz,¹ I. Guleria,² Y. Zhang,¹ P. White,¹ N. McDannold,¹ K. Hoffmeister,³ M. Givertz,⁵ R. Abdi.²
The American Transplant Congress Effect on Kidney Discard Rates in the United States.

D. Abdelwahab,¹ G. Wei,² I. Hall.²
The Beneficial Effect of Janus Kinase 3 Inhibitor on Transplanted Islet via Protection from Oxidative Stress-Induced β Cell Death.

S.-J. Kang,^1,2,3,4 H. Chung,^1,2,3,4 S. Lee,^1,2,3,4 J.-S. Shin,^1,3,5 H.-J. Kim,^1,2,3,4 J.-M. Kim,^1,3,5 B.-H. Min,^1,3,5 S. Choi,^1,2,3,4 C.-G. Park.^1,2,3,4,5
The Delivery of Stem Cell Therapy to Extended Criteria Donor Human Livers Using Normothermic Machine Perfusion.

R. Laing,¹ S. Stubblefield,³ B. Ricky,¹ S. Barnaby,² M. Alfaifi,¹ A. Ting,³ D. Mirza,² P. Newsome,¹ H. Mergental,² S. Afford.¹
The Evolution of Hepatitis B Surface Antibody (Anti-HBs) Titer of the Kidney Transplant Recipients: A 5-Year Experience Guideline for the Optimal Maintaining Immunization.

W. Chancharoenthana, A. Leelahavanichkul, S. Wattanatorn, Y. Avihingsanon, K. Praditpornsilpa, N. Townamchai.
The Feared Five Fungal Infections in Kidney Transplant Recipients: 20-Year Experience at a Midwestern Center.

S. Parajuli, A. Wick, S. Pandeya, B. Astor, J. Smith, A. Djamali, D. Mandelbrot.
The Glasgow Prognostic Score and Its Variants Predict Mortality in Living Donor but Not in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma: A Double-Center Validation Study.

A. Kaltenborn,¹ J. Gwiasda,¹ N. Heits,² F. Braun,² H. Schrem.¹
The Impact of Belatacept on Anti-HLA Antibodies of Highly Sensitized Kidney Transplant Recipients.

R. Parsons, H. Decker, T. Pearson, C. Larsen, R. Bray, H. Gebel.
The Impact of Elevated Doppler Resistive Indices in Renal Transplant Recipients with Delayed Graft Function.

D. Mikhail,¹ E. Chan,² G. Aboalsamh,³ S. Cruise,⁴ S. Aquil,³ M. Mohamed,³ A. Sener,^1,3 P. Luke.^1,3
The Impact of Hepatitis C Treatment on GFR and Immunosuppression in Renal Transplant Recipients.

J. Husson, R. Adekunle, B. Ravichandran, P. Mathur, S. Jonchhe, K. Stafford.
The Impact of Marginal Factors on the Postoperative Kidney Function of Complex Living Donors for Kidney Transplantation.

T. Hiramitsu, K. Futamura, M. Okada, M. Tsujita, N. Goto, S. Narumi, Y. Watarai.
The Impact of the Donor Risk Index on Tumor Free Survival in Patients Undergoing Liver Transplantation with Hepatocellular Carcinoma.

D. Moonka,¹ S. Nagai,² A. Harper, R. Salgia.¹
The Impact of the Kidney Allocation System on Outcomes for Kidneys with KDPI > 85%.

A. Perry,¹ J. Sageshima,¹ C. Santhanakrishnan,¹ J. McVicar,¹ C. Troppmann,¹ A. De Mattos,² J. Woloszyn,¹ R. Perez.¹
The Incidence, Mortality and Prediction Model for Fractures After Kidney Transplantation in the United States.

X. Liu, S. Bae, M. McAdams DeMarco, D. Segev.
The Role of Toll-Like Receptor 4 in Islet Transplantation and a Novel Method of Protection Using Chemical Surface Modification.

C. Chang,¹ G. Yoshimatsu,² B. Akinbobuyi,⁴ M. Lawrence,² R. Kane,¹ B. Naziruddin.³
The Role of Urinary Chemokines in Distinguishing Causes of Renal Allograft Dysfunction.

S. Chong,¹ R. Fernando,² M. Harber,¹ C. Magee.¹
The Search for a Polyomavirus BK Nephropathy (BKPyVN)-Specific Transcriptomic Signature.

L. Pan,¹ G. Zeng,² Z. Lyu,³ Y. Huang,² P. Randhawa.²
The Use of Kidneys from Deceased Donors Over 80 Years in Kidney Transplantation.

M. Pérez-Sáez,¹ E. Arcos,² J. Comas,² J. Pascual.¹
The Use of a Furosemide Stress Test (FST) for Assessment of Discarded Deceased Donor Kidneys in an Ex-Vivo Normothermic Perfusion Model.

I. Palma, Y. Smolin, S. Kabagambe, A. Perry, I. Palma, J. Sageshima, R. Perez.
The Use of an Haemoglobin Based Oxygen Carrier in a Human Liver Model of Normothermic Machine Perfusion.

Y. Boteon,¹ R. Laing,¹ R. Bogal,¹ D. Neil,² A. Smith,² B. Stephenson,² A. Schlegel,² S. Hübscher,² D. Mirza,² S. Afford,¹ H. Mergental.²
Three Year Outcomes Following Positive Crossmatch Renal Transplantation Despite Failure to Convert to Negative Flow Crossmatch After Desensitization.

S. Patel,¹ J. Benken,¹ S. Akkina,³ P. West-Thielke,² J. Thielke,¹ M. Campara,¹ J. Oberholzer,² E. Benedetti.²
Timing of Mesenchymal Stem Cell Infusions Affects Rejection Free and Overall Islet Allograft Survival.

N. Kenyon,¹ M. Willman,¹ D. Han,¹ A. Rabassa,¹ W. Diaz,¹ R. Leeman,¹ K. McHenry,² D. Salomon,³ A. Bartholomew,⁴ N. Kenyon,¹ D. Berman.¹
Transcriptomic Analysis Revealed a Fibrotic Role of Epithelial Cells Originated from the Recipient in Kidney Transplant.

W. Zhang,¹ Z. Yi,¹ E. Stahl,² M. Menon,¹ K. Keung,³ K. Hao,² P. O'Connell,³ B. Murphy.¹
Transplantation of Chimeric Cells of Myoblast and Mesenchymal Stem Cell Origin for Restoration of Muscle Function.

M. Siemionow, E. Szilagyi, J. Cwykiel, A. Domaszewska-Szostek, A. Heydemann, J. Garcia-Martinez.
Treatment and Outcomes of Simultaneous Acute Rejection and Polyomavirus Allograft Nephropathy.

T. Sparkes, S. Hammad, C. Drachenberg, A. Haririan.
Twelve Hour Ex Vivo Normothermic Perfusion for the Assessment of High-Risk Discarded Deceased Donor Kidneys.

I. Palma, I. Palma, Y. Smolin, S. Kabagambe, A. Perry, J. Sageshima, R. Perez.
Update of a Placebo-Controlled Trial of C1 Esterase Inhibitor for Prevention of Antibody Mediated Rejection (ABMR) in Highly-HLA Sensitized Patients.

A. Vo, J. Choi, A. Peng, K. Lim, L. Varanasi, R. Najjar, E. Huang, D. Puliyanda, S. Jordan.
Urinary Proteomic Biomarkers Discovery for Prediction of Acute Rejection in Kidney Transplant Recipients.

H.-Y. Jung, R. Kim, S. Park, J. Park, K. Lee, E. Lee, J.-H. Lim, K. Kim, J.-Y. Choi, J.-H. Cho, S.-H. Park, Y.-L. Kim, C.-D. Kim.
Urinary Renal Progenitors Isolation: A Novel Predictor of Kidney Graft Outcome.

A. Manonelles,¹ O. Bestard,¹ M. Goma,¹ P. Romagnani,² J. M. Cruzado.¹
Usefulness of Valacyclovir Prophylaxis for Preventing Cytomegalovirus Infection After Anti-Thymocyte Globulin Treatment as Antirejection Therapy.

E. Ko,^1,2 J. Yu,^1,2 B. Choi,^1,2 C. Park,^1,2 Y. Kim,^1,2 C. Yang,^1,2 B. Chung.^1,2
Using Scheduled Commercial Flights for Transport of Liver for Transplant.

V. Gupta,¹ A. Chandra,¹ M. Singh,¹ V. Gupta,¹ S. Kumar,¹ P. Joshi,¹ P. Sharma,² H. Hasan,³ P. Srivastava,⁴ M. Khan,¹ Z. Arshad,¹ R. Kant.¹
Utility of “High-Dose” Ganciclovir in High Viral Load CMV Infection in Transplant Recipients.

M. Alfares, R. Avery, N. Turki, K. Alfares, S. Mehta, R. Boger, A. Valsamakis.
Validation of CYP4F11 as a Marker of Accommodation in Biopsies from Recipients of an ABO-Incompatible Renal Transplant.

K. Dominy,¹ M. Willicombe,³ T. Al Johani,² J. Galliford,³ A. McLean,³ T. Cook,³ C. Roufosse.³
Validation of a Novel Computational Approach for Predicting HLA Immunogenicity Based on Quantification of Structural and Surface Electrostatic Potential Differences Between Donor and Recipient HLA.

V. Kosmoliaptsis,¹ C. Kling,² M. Robb,³ D. Collett,³ J. Bradley,¹ C. Taylor,¹ D. Kabelitz,² D. Mallon.¹
Variations in Risk-Appetite Between UK Kidney Transplant Centres and Impact on Patient and Graft Outcomes.

P. Trotter,^1,2 M. Robb,² D. Summers,^1,2 J. Bradley,¹ J. Neuberger,^2,4 C. Callaghan.^2,3
Vendor to Center in 0-60: A Cost-Effective Blueprint for Creating an In-House On-Call System for Abdominal Organ Offers.

J. Davenport, D. Cassidy, A. Hauser, A. Milling, K. Driggers, H. Crego, J. Anderson, L. Curry, P. Baliga, N. Pilch, D. Dubay.
Which Is More Nephrotoxic to Kidney Transplants: BK Nephropathy or Rejection?

S. Parajuli, B. Astor, D. Kaufman, B. Muth, M. Mohamed, N. Garg, A. Djamali, D. Mandelbrot.
Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis.

K. Yoon, K.-W. Lee, H. Kim, D. Oh, H.-S. Kim, S. Ahn, S. Hong, N.-J. Yi, K.-S. Suh.
Willingness of End-Stage Renal Disease Patients (ESRD) without Hepatitis C (HCV) to Accept a HCV+ Kidney.

P. Reese,¹ D. Goldberg,¹ A. Mussell,¹ M. McCauley,¹ D. Sawinski,¹ N. Molina,² R. Tomlin,² S. Doshi,¹ P. Abt,¹ E. Blumberg,¹ C. Thiessen,² S. Kulkarni,² G. Esnaola.²
Willingness to Donate Organs Among Persons Living with HIV.

S. Halpern, K. Kumar, A. Nguyen, S. Rasmussen, S. Anjum, A. Massie, A. Tobian, D. Segev, J. Sugarman, C. Durand.
Women in the United States Receive More Resections and Ablations for Hepatocellular Carcinoma Than Men.

L. Sobotka,¹ A. Hinton,² L. Conteh.¹
Zero-Time Biopsy of Potential Donor Kidneys to Aid Decision-Making: A 9-Year Single-Center Experience.

Y. Luque, O. Aubert, F. Martinez, L. Amrouche, C. Tinel, L. Galmiche, L.-H. Noel, J.-P. Duong, F. Audenet, C. Legendre, D. Anglicheau, M. Rabant.
iNKT Cell Activation Plus Veto Cell Transfer Yields Complete Chimerism in a Murine Sub-Lethal Bone Marrow Transplant Model.

R. Ishii,¹ T. Hirai,¹ Y. Ishii,² M. Okumi,¹ K. Tanabe.¹
mRNA Biomarkers in Renal Allograft Protocol Biopsies Detected by the Nanostring Platform Predict Tolerance in Non-Human Primates.

M. Matsunami,¹ T. Oura,¹ I. Rosales,² R.-N. Smith,² B. Adam,³ M. Mengel,³ A. Cosimi,¹ R. Colvin,² T. Kawai.¹
A Donor BMI Greater Than 30 Is Not a Contraindication for Live Liver Donation.

N. Goldaracena, A. Doyle, D. Al-Adra, G. Sapisochin, M. Cattral, P. Greig, L. Lilly, I. McGilvray, A. Ghanekar, D. Grant, N. Selzner, M. Selzner.
A Low-Dose Anti-Hepatitis B Immunoglobulin Regimen for Prophylaxis of Hepatitis B Recurrence.

W.-C. Lee, Y.-C. Wang, C.-H. Cheng, T.-H. Wu, C.-F. Lee, T.-J. Wu, H.-S. Chou, K.-M. Chan.
A Phase-Two, Randomised, Placebo-Controlled Trial: Belimumab in Renal Transplantation Targets Naïve, Activated Memory and Antibody Producing B Cells Whilst Sparing Regulatory B Cells.

G. Banham,^1,2 S. Flint,³ N. Torpey,² P. Lyons,¹ D. Shanahan,³ A. Gibson,³ A.-M. O'Sullivan,² R. Jones,^1,2,3 L. Devey,³ A. Richards,³ L. Erwig,³ C. Savage,³ K. Smith,^1,2 R. Henderson,³ M. Clatworthy.^1,2
Applicability and Safety of a Regulatory T Cell Therapy in Adult Liver Transplantation: The “ThRIL” Phase I First-in-Human Trial.

G. Whitehouse, N. Safinia, S. Thirkell, L. Fry, N. Grageda, M. Martinez-Llordella, R. Lechler, N. Heaton, G. Lombardi, A. Sanchez-Fueyo.
Assessment and Transplantation of Declined Human Kidneys Using Ex-Vivo Normothermic Kidney Perfusion.

S. Hosgood,¹ M. Hamed,¹ A. Sawpaul,² R. Figueiredo,² K. Saeb-Parsy,¹ C. Wilson,² M. Nicholson.¹
Belatacept After Kidney Transplantation in Adolescents.

C. Lerch, N. Kanzeleyer, T. Ahlenstiel-Grunow, K. Froede, M. Kreuzer, J. Drube, L. Pape.
Blood and Biopsy Genomic Signatures of Acute Rejection in Liver Transplant Recipients.

J. Levitsky,¹ T. Whisenant,² S. Kurian,² S. Rao,¹ A. Demetris,³ M. Abecassis.¹
Characterization of Human Plasma Cell Proteasome Adaptations to Proteasome Inhibitor Therapy: A Precision Medicine Approach to Overcome Drug Resistance in Desensitization.

J. Driscoll,¹ S. Tremblay,¹ P. Brailey,¹ A. Girnita,¹ R. Alloway,¹ B. Aronow,² H. Singh,² E. Woodle.²
Delayed Graft Function and Long-Term Graft Survival in DBD and DCD Kidney Recipients.

A. Massie, D. Segev.
Dramatic Shifts in Prognosis, Outcomes and Baseline Risk Among Wait Listed Kidney Transplant Candidates in the United States.

J. Schold, E. Poggio, L. Buccini, S. Flechner, J. Augustine, D. Goldfarb.
Early Evolution and Immunopathologic Phenotype of Treg-Rich Organized Lymphoid Structures (TOLS) Associated with Immunological Tolerance in Accepted Mouse Kidney Allografts.

C. Yang,¹ I. Rosales,² E. Farkash,³ D. Ndishabandi,^1,3 R. White,³ P. Russell,¹ J. Madsen,¹ A. Alessandrini,^1,3 R. Colvin.^1,3
Effect of Academic Detailing with Prescribers as an Antimicrobial Stewardship Intervention in Solid Organ Transplant Patients.

M. So,¹ A. Morris,^1,2 C. Bell,² A. Humar,¹ S. Husain.¹
Financial Burden and Time to Returning to Work Among Living Kidney Donors.

D. Larson, D. Berglund, D. Vock, A. Roman, J. Wiseman, H. Ibrahim, A. Matas.
Genomic Analysis of Gene Expression in Human Kidney Transplants Identifies Moxd1 as a Key Driver for Renal Fibrosis.

C. Wei,¹ M. Menon,¹ W. Zhang,¹ C. Woytovich,¹ N. Philippe,¹ J. He,^1,2 B. Murphy,¹ C. Wei.
Glucocorticoid Receptor – Relaxin Signaling in Liver Transplant Ischemia-Reperfusion Injury (IRI): From Bench-to-Bedside.

S. Kageyama,¹ K. Nakamura,¹ R. Sossa,² E. Reed,² N. Datta,¹ A. Zarrinpar,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
HOPE Act – The First Year.

A. Wilk, S. Taranto, R. Urban, D. Klassen.
Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.

C. Jacquelinet,¹ B. Audry,¹ C. Antoine,¹ C. Suberbielle,² D. Glotz,² A. Tambur.³
Immunodominant Donor Specific Antibody Reduction with Proteasome Inhibitor Based Treatment: Clinical Variability and Implications for Long Term Graft Survival.

A. Lichvar,¹ A. Leino,¹ S. Tremblay,¹ A. Shields,² B. Abu Jawdeh,¹ B. Hardy,¹ M. Anand,¹ M. Cuffy,¹ M. Cardi,¹ R. Alloway,¹ E. Woodle.¹
Impact of Ritonavir on Graft Function in Human Immunodeficiency Virus Infected Kidney Transplant Recipients.

K. Roach, E. Meredith, M. Lyon.
Impact of a B-Cell Targeting Agent on Antibody Mediated Rejection and Graft' Survival in Liver Transplantation with Preformed DSAs.

A. Del Bello,¹ V. Dubois,² J. Dumortier,³ N. Congy-Jolivet,⁴ N. Kamar.¹
Importance of B Cell Antigen Specificity in Breg Dependent Tolerance.

S. Kimura, L. Kojima, M. Aburawi, F. Fontan, J. Kim, K. Deng, H. Tector, K. Lee, H. Yeh, J. Markmann.
Increased Use of Donation After Cardiac Death Donors Increases Access to Transplantation without Adverse Effect on Outcomes.

R. Helmick, J. Eason, S. Satapathy, J. Vanatta.
Influence of Donor-Specific Antibodies on Renal Function in Kidney Transplant Recipients Following Early Switch from Calcineurin Inhibitor to Everolimus: Subanalysis from the ELEVATE Study.

J. Cruzado,¹ H. Holdaas,¹ P. Lopez,² P. Bernhardt,² G. Bader,² F. Claas,¹ W. Arns,¹ M. van der Giet,¹ J. de Fijter.¹
Inhibition of Liver Natural Killer Cells Activation Through Co-Transplantation of Pre-Activated Mesenchymal Stem Cells Contributes to Improvement of Islet Graft Survival.

N. Ishida, K. Ishiyama, Y. Saeki, Y. Tanaka, H. Ohdan.
Laparoscopic Sleeve Gastrectomy Improves Renal Transplant Candidacy and Posttransplant Outcomes in Morbidly Obese Patients.

Y. Kim, A. Jung, V. Dhar, J. Tadros, R. Alloway, A. Shields, S. Woodle, T. Diwan.
Maternal Risks and Pregnancy Outcomes After Kidney Transplantation: A Single Center Experience.

A. Devresse,¹ C. Jassogne,¹ C. Hubinont,² M. de Meyer,³ M. Mourad,³ E. Goffin,¹ N. Kanaan.¹
Necroptotic Cellular Death Modulates TNFα Mediated Inflammation and Cardiac Allograft Rejection in Mice.

R. Ang, P. Heeger, A. Ting.
Nephrectomy of the Failed First Kidney Allograft Predisposes Kidney Transplant Recipients to Presensitization with Alloreactive T-Cells and Inferior Allograft Survival After Retransplantation.

T. Schachtner,^1,2 M. Stein,¹ P. Reinke.^1,2
Outcomes of Infrainguinal Revascularization in Renal Transplant Patients.

R. Craig-Schapiro, B. Nejim, M. Malas.
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient and Allograft Survival in Long-Term Follow-Up After Kidney Transplantation.

T. Schachtner,^1,2,3 P. Reinke.^1,2
Risk Factors for Post-Transplant Lymphoproliferative Disorders in Epstein-Barr Virus Mismatch Lung Transplant Recipients.

A. Courtwright, P. Burkett, P. Camp, M. Divo, S. El-Chemaly, S. Keller, G. Mody, I. Rosas, S. Singh, H. Goldberg, H. Mallidi.
Risk of Primary Central Nervous System Lymphoma in Solid Organ Transplant Recipients.

E. Engels, P. Mahale, M. Shiels.
Simple Kidney Transplant Graft Survival (KTGS) Calculator Predicts 5- and 10-Year Allograft Survival.

P. Sood,¹ W. Cherikh,² R. Mehta,¹ A. Tevar,¹ S. Hariharan.¹
TIM-3 – CEACAM1 Checkpoint Regulation of T-Cell Activation and Hepatocellular Function in Liver Transplantation.

K. Nakamura,¹ S. Kageyama,¹ M. Kujawski,³ R. Sosa,² E. Reed,² A. Zarrinpar,¹ R. Busuttil,¹ J. Kupiec-Weglinski.¹
TIM-4 Identifies Pro-Inflammatory B Effector Cells That Are Potent Drivers of Alloimmunity and Allograft Rejection Through Expression of Both IFN-γ and IL-17.

Q. Ding, K. Mohib, D. Rothstein.
Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.

D. Taber, Z. Su, A. Posadas, M. Gebregziabher, L. Egede, D. Dubay, J. McGillicuddy, C. Bratton, S. Nadig, K. Chavin, P. Baliga.
The Benefits of Pancreas After Kidney (PAK) Transplantation.

M. Curry,¹ J. Odorico,² J. Fridell.³
The Degree of NK Cell Activation Determines the Ability of Donor-Specific Antibodies to Mediate Acute vs. Chronic Rejection of Kidney Allografts.

T. Yagisawa,^1,2 T. Tanaka,¹ N. Dvorina,¹ A. Valujskikh,¹ W. Baldwin 3rd,¹ R. Fairchild.¹
The New Kidney Allocation System in France Meets it's Targets: Improving Age and HLA DR-QD Matching for Young Adults.

C. Jacquelinet, B. Audry, F. Bayer, M. Macher.
10 Years of DTAC Experience with Kaposi's Sarcoma – Not Just Another PTLD!

M. Nalesnik,¹ M. Clark,² S. Tlusty,² M. Michaels,¹ C. Wolfe.¹
18 Month Analysis of the Impact of the New Kidney Allocation System on Deceased Donor Kidney Utilization at the Donor Service Area Level.

W. Ally, K. Brayman, A. Agarwal.
25-Hydroxyvitamin D [25(OH)D], but Not 1,25-Dihydroxyvitamin D [1,25(OH)₂D], Independently Predicts Kidney Graft Failure: The Wisconsin Allograft Recipient Database (WisARD).

B. Astor,¹ M. Melamed,² D. Mandelbrot,¹ A. Djamali.¹
Clostridium difficile Infection in Intestinal Transplant Recipients.

V. Goldenberg,¹ A. Berbel,² J. Camargo,¹ J. Simkins.¹
De Novo Donor-Specific Antibody Formation After Kidney Retransplant Is Associated with Specificity Against Class I.

K. Atiemo,¹ B. Ho,¹ H. Bhagat,² E. Lee,^2,3 A. Daud,¹ R. Kang,¹ S. Montag,^1,4 L. Zhao,^1,4 J. Schwartz,² D. Ladner.¹
De-Novo Portal Vein Thrombosis After Adult-to-Adult Living Donor Liver Transplantation (LDLT) Does Not Impact on Long-Term Outcome.

I. Linares,¹ N. Goldaracena,¹ R. Rosales,¹ L. De La Maza,¹ J. Echeverri,¹ M. Kaths,¹ D. Kollman,¹ N. Selzner,² S. McCluskey,³ G. Sapisochin,¹ L. Lilly,² P. Greig,¹ M. Bhat,² A. Ghanekar,¹ M. Cattral,¹ I. McGilvray,¹ D. Grant,¹ M. Selzner.¹
In Vitro Optimisation of the Immunotherapeutic Effects of Umbilical Cord Derived MSC.

S. de Witte,¹ A. Merino,¹ M. Franquesa,¹ T. Strini,¹ J. van Zoggel,¹ S. Korevaar,¹ F. Luk,¹ M. Gargesha,⁴ D. Roy,⁴ S. Elliman,² P. Newsome,³ C. Baan,¹ M. Hoogduijn.¹
A Brief Frailty Assessment and Outcomes Among Candidates for Liver Transplantation.

M. Serper, K. Dwinnells, T. Bittermann, K. Olthoff.
A Clinically Relevant Protocol for Vascularized Composite Allotransplantation Using a Single Dose of AMD3100 for Stem Cell Mobilization.

B. Swearingen,^1,2 S. Graves,^2,3 R. Storb,^2,3 D. Mathes.^1,2
A Comparative Study of Patient and Graft Qualities Between Abo-Compatible and -Incompatible Recipients More Than Ten Years After Kidney Transplantation.

H. Ishida, T. Shimizu, M. Okumi, K. Unagami, K. Omoto, K. Tanabe.
A Comparison of Medical Costs Among ABO-Compatible, -Incompatible, and -Minor Mismatched Living Kidney Transplantation: A Single-Center Study.

D. Fujimori, M. Okumi, K. Ungami, H. Ishida, K. Tanabe.
A Composite Score Associated with Spontaneous Operational Tolerance in Kidney Transplant Recipients.

R. Danger,¹ M. Chesneau,¹ C. Paul,¹ P. Guérif,¹ M. Durand,¹ K. Newell,² S. Kanaparthi,³ L. Turka,⁴ J.-P. Soulillou,¹ R. Houlgatte,⁵ M. Giral,^1,6 G. Ramstein,⁷ S. Brouard.^1,6
A Critical Analysis of Equations for MPA Exposure in Patients Under EC-MPS and Tacrolimus.

E. David-Neto, A. Triboni, F. Ramos, F. Agena, P. Romano, G. Freitas.
A Decade of Paediatric Kidney Transplantation in Children Weighing <20kg.

P. Chandak,¹ J. Stojanovic,² F. Jamshaid,¹ N. Mamode,¹ F. Calder,¹ J. Olsburgh,¹ C. Callaghan,¹ M. Drage,¹ G. Koffman,¹ S. Marks,³ N. Kessaris.¹
A Lower Mean Exposure to Tacrolimus, Not Intra-Patient Variability Is Associated with Chronic Active Antibody Mediated Rejection.

K. Sablik,¹ M. Clahsen–van Groningen,² T. Van Gelder,¹ M. Betjes.¹
A Markov Model for Transplant & Renal Outcomes After Liver & Simultaneous Liver-Kidney Transplants.

X. Cheng,¹ W. Kim,² J. Tan,¹ J. Goldhaber-Fiebert.³
A Multicenter, Prospective and Randomized Trial Comparing Pancreas versus Islet Transplantation: Should We Do It Now?

D. Cantarovich, P.-Y. Benhamou.
A Nationwide Global Strategy for Kidney Transplantation with Controlled Cardiac Death Donor (cDCD) Has Improved Global Results. Spanish Multicentre SENTRA-GEODAS Group.

J. Portoles,^1,2 M. Perez-Saez,^2,3 D. Janeiro,^1,2 E. Melilli,² N. Maruri Kareaga,² E. de Souza,² F. Llamas,² J. Espi,² P. Martin Moreno,² D. Navarro,² A. Sancho-Calabuig,² M. Rodriguez-Ferrero,² D. Hernandez,² J. Pascual.^2,3
A New and Potent Distal Enhancer of the IL2 Gene.

R. Thomas,¹ P. Mehra,¹ M. Johnson,² S. Grant,² A. Wells.¹
A Novel Endpoint for Evaluating the Effect of Everolimus with Reduced Calcineurin Inhibitor on Long-Term Kidney Graft Outcome: The TRANSFORM Study Protocol.

T. Srinivas,¹ C. Legendre,¹ F. Oppenheimer,¹ H. Tedesco-Silva,¹ W.-L. Luo,² P. Bernhardt,² C. Sommerer,¹ S. Chadban,¹ F. Vincenti,¹ J. Pascual.¹
A Novel KPD Mechanism to Increase Transplants When Some Candidates Have Multiple Willing Donors.

T. Sandholm,¹ G. Farina,¹ J. Dickerson,² R. Leishman,³ D. Stewart,³ R. Formica,⁴ C. Thiessen,⁴ S. Kulkarni.⁴
A Novel Method for Detecting and Monitoring Chimerism in Patients with Graft versus Host Disease After Liver Transplantation.

B. Peng, H. Liu, K. Cheng, Y. Zhao, X. She, Y. Niu, Q. Zhuang, Y. Ming.
A Novel Method for iNKT Cell-Mediated Ex Vivo Treg Expansion Applied to Induce Human Transplant Tolerance.

H. Katsumata,^1,2 M. Ikemiyagi,¹ S. Miyairi,¹ R. Ishii,¹ T. Kanzawa,¹ H. Fukuda,¹ T. Hirai,¹ M. Okumi,¹ Y. Ishii,³ K. Tanabe.¹
A Novel Microsurgical Penis Transplant Model to Study Distinct Immunologic Features of Urogenital Tissues.

G. Furtmüller, S. Fidder, B. Simons, B. Oh, B. Kern, D. Lough, M. Chicco, C. Brayton, W. Lee, D. Cooney, R. Redett, G. Brandacher.
A Novel MyD88 Inhibitor Attenuates Allograft Rejection in Heterotopic Tracheal Transplantation in Mice.

M. Yang, X. Zhang, G. Chen, Z.-C. Ding, Y. Miao, Y. Yang, P. Zhou.
A Novel Role for MyD88 Signaling Downstream from Toll-Like Receptors in B Cells Responding to Blood Group Antigens.

H. Sakai, Y. Tanaka, H. Ohdan.
A Novel Technique to Increase Donor Utilization: Our Experience Using High-Dose Tissue Plasminogen Activator Flush in Donation-After-Cardiac-Death Donors for Liver Transplantation.

J. Graham, K. Lorenzen, S. Bellemare, M. Kinkhabwala, J. Rocca.
A Novel, Dose-Adjusted Tacrolimus Trough Concentration (TTC) Model for Prediction and Variance Estimation.

J. Kim,¹ S. Wilson,¹ N. Undre,² S. Fei,¹ R. Kristy,¹ J. Schwartz.¹
A Phase Ib, Open Label, Single Arm Study to Assess the Safety, Pharmacokinetics, and Impact on Humoral Sensitization of SANGUINATE Infusion in Patients with End-Stage Renal Disease.

B. Abu Jawdeh,¹ E. Woodle,¹ A. Leino,¹ T. Dorst,¹ M. Abdallah,¹ A. Govil,¹ D. Byczkowski,² H. Misra,² A. Abuchowski,² R. Alloway.¹
A Pilot Test of the "Individualized Self-Management Training in Adolescent/Young Adult Recipients of Transplantation (iSTART)" Program.

E. Fredericks, S. Eder, D. Egleston, W. Newhouse, D. O'Reilly, G. Freed, J. Magee, K. Resnicow.
A Pilot Trial of Genotype-Guided Dosing versus Standard Clinical Dosing in Pediatric Solid Organ Transplants.

S. Min, T. Daljevic, M. Lafreniere-Roula, C. Manlhiot, N. Nalli, H. Grasemann, S. Schwartz, B. Kamath, V. Ng, R. Parekh, S. Mital.
A Prospective Observational Study to Evaluate Use of a Panel of Reactive T Cell (PRT) Assay as a Pre-Transplant Marker of Rejection in Kidney Transplant Recipients.

D. Brennan,¹ L. Kayler,² D. Wojciechowski,³ A. Limaye,⁴ A. Gaber,⁵ I. Durrant.⁶
A Retrospective Study on the Impact of Abdominal Surgical Histories on Hand-Assisted Laparoscopic Donor Nephrectomy for Living Donor Adult Kidney Transplant.

T. Hiramitsu, K. Futamura, M. Okada, M. Tsujita, N. Goto, S. Narumi, Y. Watarai.
A Single Center Retrospective Review of Pediatric Kidney Transplant Outcomes According to Banff Grade and Cellular Rejection Treatment.

J. Chen,¹ R. Liverman,² R. Garro,^2,3 S. Jernigan,^2,3 P. Winterberg.^2,3
A Single Center's Experience of Direct Acting Anti-Viral Agents in HCV Positive Patients Receiving an HCV Positive Kidney.

N. Kapila,¹ B. Zervos,² B. Ismail,¹ G. Schnickel,² J. Rivas,² D. Reino,² N. Agrawal,² A. Tzakis.²
A Surge in Liver Donors After Years of Decline, Is This the Tip of the Iceberg?

A. Rana,¹ M. Goss,¹ J. Rees,² M. Kueht,¹ J. Vierling,¹ A. Mindikoglu,¹ K. Halazun,³ N. Sussman,¹ B. Kaplan,⁴ P. Wood,⁵ N. Galvan,¹ R. Cotton,¹ C. O'Mahony,¹ J. Goss.¹
A Swine for Human MHC Class I Swap: Implications for Xenotransplantation.

J. Ladowski,¹ R. Santos,² L. Reyes,¹ G. Martens,¹ J. Butler,² R. Sidner,¹ Z.-Y. Wang,¹ C. Cunningham,² M. Tector,¹ A. Tector.¹
A Thirteen-Year Mayo Clinic Retrospective Study of the Syndrome of Rapid Onset ESRD Among Renal Transplant Recipients, 2001-2013.

M. Onuigbo,^1,2 N. Agbasi.³
A UNOS Database Analysis of Patient Outcomes from Kidney Alone versus Simultaneous Kidney Liver Transplants Utilizing Matched Donor Pairs.

T. Zens, J. Danobeitia, P. Stahler, G. Leverson, R. Redfield III, A. D'Alessandro, L. Fernandez.
A-Antigen (Ag)-Specific Tolerance Following A-Ag Administration to Infant Mice.

B. Motyka,¹ Y. Wang,¹ B. Lamarche,¹ I. Adam,¹ J. Pearcey,¹ K. Tao,¹ C. Cairo,² P. Cowan,³ L. West.¹
A2 Incompatible Kidney Transplantation: A Single Center Experience.

L. Kamal, M. Ajaimy, M. Lubetzky, G. DeBoccardo, P. Bedi, S. Greenstein, J. Rocca, J. Graham, M. Kinkhabwala, A. Chokechanachaisakul, A. Courson, E. Akalin.
AAV8 Delivery of TIMP-1 Prevents Hepatocyte Apoptosis After Liver Ischemia/Reperfusion Injury.

S. Duarte, P. Matian, M. Miller, R. Busuttil, A. Coito.
ABO Incompatible Deceased Donor Renal Transplantation: Exploring the Possibilities.

M. Sypek,^1,2 R. Masterson,^1,2 P. Hughes.^1,2
APRIL/BLyS Inhibition Reduces Donor Specific Antibody in Sensitized Mice.

B. Bolt, N. Wilson Schlei, B. Verhoven, R. Redfield.
Accelerated De-Novo Donor-Specific Antibody-Mediated Rejection in a Non-Human Primate Model of Renal Transplantation.

J. Danobeitia, P. Chlebeck, J. Torrealba, T. Zens, L. Zitur, A. D'Alessandro, L. Fernandez.
Access to Living Donor Kidney Transplantation in Nepal.

P. Shrestha,¹ S. Rasmussen,¹ A. Thomas,¹ S. Ferguson,² A. Massie,¹ D. Segev,¹ P. Shrestha.³
Accuracy of Computed Tomography for Detecting Hepatic Steatosis in Donors for Liver Transplantation.

Z. Guo, D. Zheng, X. He, G. Chen.
Acthar in Recurrent Focal Segmental Glomerular Sclerosis After Kidney Transplantation.

T. Alhamad,¹ J. Dieck,² V. Vujjini,² B. Kanawati,¹ D. Brennan,¹ N. Alachkar.²
Activation of Inflammation Amplifier in Kidney Graft and Urinary Biomarker for Chronic Rejection.

H. Higuchi,^1,2 D. Iwami,¹ K. Hotta,¹ N. Shinohara,¹ M. Murakami.²
Acute Antibody-Mediated Rejection in Pediatric Liver Transplantation.

C. Eriksen,¹ M. Zimmerman,¹ J. Kim,¹ S. Lerret,² G. Telega,² B. Vitola,² J. Schiller,³ J. Hong.¹
Acute Rejection in 6 Antigen HLA Matched Kidney Transplant Recipients: Risk Factors and Outcomes.

A. Condon, B. Astor, K. Holdener, T. Ellis, A. Djamali.
Acute Renal Replacement Therapy in Pediatric Liver Transplantation: A Predictor of Increased Risk.

M. Wong,¹ R. Venick,² V. Agopian,¹ S. Ebaid,¹ S. McDiarmid,² A. Zarrinpar,¹ D. Farmer,¹ R. Busuttil,¹ F. Kaldas.¹
Adjunctive Thymoglobulin with Proteasome Inhibitor Based Treatment of Late Mixed Acute Rejection.

A. Lichvar,¹ A. Leino,¹ S. Tremblay,¹ A. Shields,² F. Paterno,¹ A. Govil,¹ M. Anand,¹ T. Diwan,¹ J. Kremer,² R. Alloway,¹ E. Woodle.¹
Adjuvant Chemotherapy with Gemcitabine Plus Cisplatin for Kidney Transplant Patients with Transitional Cell Carcinoma.

Z. Wang, J. Lin, Y. Zhu, J. Zhang, J. Xiao, Y. Guo, Y. Tian.
African American Living Kidney Donors' Attitudes About APOL1 Genetic Testing: Implications for Evaluation and Informed Consent.

E. Gordon,¹ C. Johnson,¹ C. Wicklund,¹ R. Sharp,² J. Friedewald.¹
Age and Gender Disparities in Post-Lung Transplant Mortality.

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.
Age and Race Disparities Among Pediatric and Adult Cystic Fibrosis Lung Transplant Recipients.

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.
Age-Related Differences in Gene Expression Among Kidney Allografts with Normal Histology and Calcineurin Inhibitor Nephrotoxicity.

E. Rhone,¹ S. Bontha,¹ P. Walker,² C. Dumur,³ D. Maluf,¹ J. Almenara,³ V. Mas.¹
Albuminuria in Kidney Transplant Patients Is Associated with Increased Urine Serine Proteases with the Ability to Activate ENaC.

G. Hinrichs,¹ C. Bistrup,² H. Birn,³ B. Jensen.¹
Alemtuzumab Induction Is Safe, and Permits the Avoidance of Steroids in the Majority of Renal Transplant Recipients.

A. Seitz,¹ M. Robb,² N. Ahmad,¹ A. McLean,³ D. Taube,³ R. Johnson,² R. Baker.¹
Alemtuzumab Induction and Belatacept Maintenance in Marginal Pathology Renal Allografts.

T. Sparkes, B. Ravichandran, O. Opara, R. Ugarte, J. Bromberg, R. Barth.
Alemtuzumab Use in a Single Center Pediatric Heart Transplant Cohort.

J. Case,¹ J. Eshelman,² P. Booker,² S. Miyamoto,³ M. Everitt,³ S. Auerbach.³
Allograft Crescent Predicts Graft Failure in Recurrent IgA Nephropathy Patients.

S. Park, H. Cho, M.-Y. Yu, Y. Kim, K. Moon, Y. Kim, H. Lee.
Allograft Cytokine Activation and Elevated Tissue Indoleamine 2,3-Dioxygenase Gene and Protein Expression in Rejecting Pig Transplants.

T. Merchen,¹ Y. Wang,² R. Lassiter,¹ D. Kleven,³ R. Jajosky,³ M. Winn,² C.-S. Ho,⁵ N. Nahman.⁴
Alloimmune Quiescence in Recipients with Long-Term Surviving Kidney Grafts.

K. Brown,¹ W. Baldwin,¹ E. Poggio,² W. Braun,² R. Fairchild.¹
Alternations in Amplitude of Low Frequency Fluctuation in Renal Allograft Recipients That Received Tacrolimus or Sirolimus: An fMRI Study.

J. Wen,¹ X. Ni,¹ L. Wu,² G. Zheng,² L. Zhang,² J. Chen.¹
Ambulatory Blood Pressure Monitoring Detects High Prevalence of Hypertension in Recipients of Non-Renal Transplants.

A. Melk,¹ N. Memaran Dadgar,¹ B. Borchert-Mörlins,¹ R. Sugianto,¹ R. Blöte,¹ I. Goldschmidt,¹ R. Beier,² C. Müller,³ B. Schmidt.⁴
An Analysis of Tacrolimus XL Dosing in Obese Kidney Transplant Recipients.

N. Jasiak, J. Thielke, K. Progar, J. Chen, C. Adams, E. Benedetti, P. West-Thielke.
An Argument for Expanding the Simultaneous Liver and Kidney Transplant Criteria: Validity of the New UNOS Allocation Policy.

S. Nagai,¹ M. Safwan,¹ K. Collins,¹ M. Rizzari,¹ D. Moonka,² K. Brown,² A. Patel,³ A. Yoshida,¹ M. Abouljuod.¹
An Investigation of Biopsy-Proven De Novo Autoimmune Hepatitis After Hepatitis C Clearance with Direct Acting Antivirals in Liver Transplant Patients.

R. Sigireddi, J. Moffett, M. Kueht, R. Ackah, A. Rana, C. O'Mahony, J. Goss, S. Dhingra, S. Khaderi.
Analysis of ApoL1 and MYH9 Genetic Polymorphisms Among the Hispanic Kidney Allograft Recipients.

Y. Chang,^1,2 T. Shah,^1,3 D. Min.¹
Anastomosis Time During Liver Transplantation Impairs Transplant Survival.

I. Jochmans,¹ S. Fieuws,² I. Tieken,³ U. Samuel,³ J. Pirenne.¹
Angioplasty versus Stent in the Treatment of Transplant Renal Artery Stenosis.

L.-X. Chen,¹ G. Fananapazir,² H. Bang,³ M. Gandhi,¹ M. Alnimri,¹ B. Gallay,¹ A. De Mattos.¹
Anti-CD25mAb Sparing Immunosuppressive Regimen Suppressed Recurrence of Post-Transplant Focal Segmental Glomerular Sclerosis- A Single Center Experience.

H. Harada, Y. Wada, N. Fukuzawa.
Anti-HLA I Antibody Enhances Endothelial Cell-Induced Polarization of Human Monocytes to M2a/c-Like Macrophages.

X. Wei, N. Valenzuela, M. Rossetti, E. Reed.
Antibiotic Conservatorship in Orthotopic Liver Transplantation.

J. Yee,² D. Clark,² R. Hogen,^1,2 K. Dhanireddy,¹ S. Biswas,² J. Cobb,² K. Matsushima,² D. Grabo,² A. Strumwasser.²
Antibody Mediated Rejection and Donor Specific Antibodies in Heart Transplant Patients: Single Center Experience.

P. McMullen II,¹ J. Xin,¹ N. Brown,¹ R. Upchurch,¹ J. Weidner,¹ S. Fedson,² A. Husain,¹ S. Marino.¹
Apoptotic Exosome-Like Vesicles Released During Tissue Injury Trigger IL23/IL-17 Autoimmune Axis and Accelerate Rejection.

M. Dieudé,^1,4 J. Turgeon,^1,4 A. Karakeussian-Rimbault,^1,4 L. Pomerleau,¹ A. Robitaille,¹ N. Grandvaux,¹ É. Boilard,^2,4 M.-J. Hébert.^1,3,4
Are Drains Required After Donor Hepatectomy?

S. Sharma, S. Kumar, K. Yadav, S. Sable, A. Chauhan, S. Kapoor, V. Varma, V. Kumaran.
Are ICD-9 V Codes Representative of the Liver Transplant Wait List?

Y. Bababekov, D. Chang, Y.-C. Hung, J. Adler, S. Stapleton, J. Markmann, H. Yeh.
Aryl Hydrocarbon Receptor Regulates Myeloid Derived Suppressor Cells by Activating the ERK Signaling in a Murine Cardiac Transplantation Model.

T. Nakamura, K. Masuda, N. Yoshimura.
Assessment of C4d Positive Biopsies with No Histological Evidence of Inflammation Using Nanostring nCounter Technology.

K. Dominy,¹ M. Willicombe,³ T. Al Johani,² J. Galliford,³ A. McLean,³ T. Cook,³ C. Roufosse.³
Assessment of Cardiosphere-Derived Cell Exosomes as Possible Modulator of Alloimmunity in a Mouse Model of HLA-A2 Allosensitization.

I. Kim,¹ G. Wu,¹ N.-N. Chai,¹ G. De Couto,² E. Marban,² A. Klein,¹ S. Jordan.¹
Assessments of Literacy, Cognitive Function and Transplant Medication Knowledge in Renal Transplant Recipients.

J. Trofe-Clark,¹ W. Gbemudu,² S. Ryan,² D. Sawinski,¹ M. Lim,¹ S. Goral,¹ M. Bleicher,¹ R. Bloom,¹ P. Reese.¹
Association Between Matrix-gla Protein Levels and Aortic Stiffness in Kidney Transplantation.

M. Dinic,¹ N. Maillard,¹ P. Delanaye,² J.-M. Krzesinski,² A.-M. Saint-Remy,² E. Cavalier,³ C. Mariat.¹
Association Between Transportation Strategies and Kidney Transplant Center Staff Perceived Racial Disparities.

K. Lipford, L. McPherson, R. Hamoda, R. Patzer.
Association of BK and CMV Viremia with Pancreas Allograft Survival Among Adults Receiving Simultaneous Pancreas and Kidney Transplant: The Wisconsin Allograft Recipient Database (WisARD).

F. Aziz, B. Astor, S. Parajuli, N. Garg, B. Muth, D. Mandelbrot, A. Djamali, D. Kaufman, J. Odorico, H. Sollinger, M. Mohamed.
Association of Dialysis Facility Neighborhood Socioeconomic Status with Barriers to Kidney Transplant.

K. Ross,¹ M. Basu,² C. Escoffery,³ J. Gander,² S. Mohan,⁴ S. Pastan,² L. Plantinga,¹ K. Smith,² R. Patzer.^1,2
Association of Non-HLA Antibodies with Histological Changes of Antibody Mediated Injury in Kidney Transplantation.

N. Leca,¹ I. Gimferrer,² P. Warner,² K. Nelson,² R. Bakthavatsalam,¹ L. Sibulesy,¹ B. Najafian,³ C. Robinson-Cohen,¹ B. Kestenbaum.¹
Autotransplantation of the Left Lung for the Treatment of Recurrent Life Threatening Pulmonary Hemorrhage Related to Pulmonary Vascular Malformation: A Unique Chance to Study Ischemia/Reperfusion Injury.

C. Falk,¹ I. Tudorache,² C. Müller,³ W. Sommer,² K. Daemen,¹ J. Keil,¹ G. Hansen,³ A. Haverich,² G. Warnecke,² N. Schwerk.³
Avascular Necrosis in Kidney Transplant Recipients: Recent Data from a Cohort Study.

P. Perrin,¹ R. Felten,² S. Caillard,¹ M. Schaeffer,³ B. Moulin,¹ R.-M. Javier.²
Awareness of Change in the Kidney Allocation System Among Dialysis Providers from Facilities with Low Waitlisting.

M. Basu,¹ K. Smith,¹ S. Pastan,¹ L. Plantinga,^1,2 S. Mohan,³ C. Escoffery,² J. Chung,¹ T. Melanson,² R. Patzer.^1,2
BK Virus in Simultaneous Pancreas Kidney Transplantation.

P. Uva,^1,2 L. Leon,¹ E. Minue,¹ A. Dotta,¹ F. Toniolo,¹ R. Pilotti,¹ E. Chuluyan,² D. Casadei.¹
BKV Clearance Time Correlates with T-Cell Receptor Repertoire Shape and Exhaustion State of BKV-Specific T-Cells in Renal Transplant Patients with Severe BKV Infection.

U. Stervbo,^1,2 M. Nienen,¹ B. Weist,² P. Wehler,² T. Westhoff,¹ H.-D. Volk,² P. Reinke,² N. Babel.^1,2
Bariatric Operations at a Service of the Transplant Surgery.

A. Keidar,¹ R. Yemini,¹ M. Ben David,¹ E. Nesher,² J. Vinkler,³ M. Broun,² E. Mor.²
Barriers and Experiences When Patients Decide on a Kidney Transplant Center.

C. Schaffhausen,^1,4 M. Bruin,³ J. Synder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2,4
Barriers to Becoming Active on the Renal Transplant Waiting List: Have They Changed in the Last Five Years?

E. van Hardeveld,¹ T. Furlong,² A. Robertson,² N. Suh,² S. Thwaites,² R. Millar,² R. Masterson,¹ M. Lian,¹ B. Jones,¹ P. Hughes.¹
Beneficial Effects of Human Mesenchymal Stromal Cells on Porcine Hepatocytes Viability and Albumin Secretion.

E. Montanari,¹ J. Pimenta,¹ H.-J. Schuurman,¹ J. Meier,¹ R. Meyer,¹ A. Balaphas,¹ J. Sidibé,² A. Thomas,² S. Passemard,³ S. Gerber-Lemaire,³ C. Gonelle-Gispert,¹ L. Buhler.¹
Beneficial Effects of Hydrogen Sulfide (H2S) on Renal Ischemia-Reperfusion Injury (IRI) in CLAWN Miniature Swine.

Y. Ariyoshi, M. Sekijima, H. Sahara, T. Murokawa, A. Shimizu, K. Yamada.
Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function.

J. Lee,¹ J. Lee,¹ J. Lee,² S. Song,¹ J. Lee,¹ S.-K. Kwon,¹ M. Kim,¹ G. Choi,¹ S. Kim,¹ D. Joo.¹
Benefits of Multimodal Enhanced Recovery Pathway in Patients Undergoing Kidney Transplantation.

K. Espino,¹ L. Kayler.²
Benefits of Mycophenolate Sodium Over Mycophenolate Mofetil in Renal Transplant Patients Carrying UGT1A9 Polymorphism.

N. Calvo Romero, I. Perez-Flores, A. Shabaka, M. Moreno De La Higuera, B. Rodriguez-Cubillo, J. Delgado, M. Calvo, V. Lopez De La Manzanara, A. Sanchez-Fructuoso.
Beta Cell-Specific Free Circulating DNA May Predict the Outcome After Clinical Islet Transplantation.

B. Gala-Lopez,¹ D. Neiman,² T. Kin,¹ D. O'Gorman,¹ A. Pepper,¹ A. Malcolm,¹ B. Glaser,³ R. Shemer,² Y. Dor,² J. Shapiro.¹
Biliary Complications After Pediatric Liver Transplantation: A High Volume Living Donor Liver Transplantation Center Study of 237 Patients Over 27 Years.

D. Oh,¹ N.-J. Yi,¹ S. Ahn,¹ S. Hong,¹ K. Yoon,¹ H.-S. Kim,¹ H. Kim,¹ K.-W. Lee,¹ K.-S. Suh,¹ J. Han,² M. Kim,² J. Lee.²
Biliary Complications Following Liver Transplantation – Single-Center Experience Over Three Decades and Recent Risk Factors.

A. Kaltenborn, A. Gutcke, H. Schrem, J. Gwiasda.
Biliary Complications in Pediatric Liver Transplantation for Cystic Fibrosis: A Single-Center Experience with Choledochocholedochostomy.

P. Rizk, J. Moffett, M. Vu, R. Ackah, R. Sigireddi, M. Finegold, C. O'Mahony, A. Rana, J. Goss.
Binding of Human Neutrophils to Activated Porcine Endothelium Is Mediated by E-Selectin.

C. Laird,¹ B. French,¹ L. Burdorf,¹ X. Cheng,¹ W. Fogler,² J. Magnani,² C. Phelps,³ D. Ayares,³ A. Azimzadeh,¹ R. Pierson.¹
Biodistribution of Adipose Derived Regenerative Cells Administered via the Renal Artery in Novel Rat Transplant Model.

R. Ghita,^1,2 R. Lathan,² D. Hillyard,² P. Mark,^1,2 M. Clancy.^1,2
Biomarkers of Epithelial-Mesenchymal Transition (EMT) in Chronic Allograft Nephropathy: Potential for Early Detection and Development of Novel Therapeutic Agents.

S. Kanangat, R. Miller, S. Rezaeian, H. Eldib, D. Cimbaluk, C. Fhied, I. Kurbegovic-Skaljic, M. Prod, J. Borgia, M. Flaws, D. Castillo, R. DeCresce.
Biopsies (Bx) of Renal Allografts with Antibody- + Cell-Mediated Rejection (ABMR/CMR) Exhibit Gene Expression Signatures from Both Types of Rejection.

H. Zhang,¹ C. Nast,² J. Doldron,² M. Cheung,² J. Mirocha,³ J. Kahwaji,¹ A. Vo,¹ S. Jordan,¹ M. Toyoda.¹
Blocked of Bat3 Expression Promotes Transplant Tolerance by Inducing IL-10 Expression in Dendritic Cells.

G. Gu, H. Hang, Q. Xia.
Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome Appearance After Lung Transplantation.

R. Danger,¹ P. Royer,² D. Reboulleau,² J. Loy,² A. Tissot,² P. Lacoste,² A. Roux,³ M. Reynaud-Gaubert,⁴ R. Kessler,⁵ S. Mussot,⁶ C. Dromer,⁷ O. Brugière,⁸ J. Mornex,⁹ R. Guillemain,¹⁰ M. Dahan,¹¹ C. Knoop,¹² K. Botturi,² C. Pison,¹³ L. Nicod,¹⁴ S. Brouard,¹ A. Magnan,² COLT and SysCLAD Consortia.
Blood Tfh Cells Exhibit Impaired B Cell Help in Operationally Tolerant Patients.

R. Danger,¹ A. Chenouard,¹ M. Chesneau,¹ S. Castagnet,² P. Guérif,¹ N. Degauque,¹ M. Giral,¹ S. Brouard.¹
Bortezomib for Late Antibody-Mediated Rejection After Renal Transplantation: A Single Center Experience of 22 Cases.

J. Choi, J. Jung, S. Chun, S. Shin, Y. Kim, D. Han.
Brain-Dead Donors Terminal Inflammation Is Associated to Delayed Graft Function in Kidney Transplant Recipients.

D. Cucchiari,¹ D. Fritz,² V. Pedro,² A. Ramon,³ P. David,³ R. Jordi,² O. Frederic,² R. Ignacio.²
Building a Conceptual Framework of Treatment Burden After Kidney Transplant: A Qualitative Study.

E. Lorenz, J. Egginton, M. Stegall, A. Cheville, D. Eton.
Burden of Early Hospitalization Among Liver Transplant Recipients.

P. Sharma,¹ N. Goodrich,³ D. Schaubel,² A. Smith,³ R. Merion.^3,4
C-C Chemokine Receptor 5 Polymorphisms and Risk of Antibody-Mediated Rejection in Renal Transplantation.

J. Lee,¹ D. Kim,¹ J. Lee,¹ S.-K. Kwon,¹ S. Song,¹ J. Lee,¹ B. Kim,² M. Kim,¹ S. Kim,¹ Y. Kim,¹ K. Huh.¹
C1q+ and IgG3+ De Novo Donor Specific Antibody Are Associated with Allograft Failure in a Multicenter Cohort.

C. Schinstock,¹ M. Everly,² M. Samaniego,³ M. Gandhi,¹ R. Parikh,⁴ V. Sharma,⁴ M. Stegall,¹ D. Dadhania.⁴
C4d Immunohistochemistry in Lung Allograft Interstitial Capillaries Lacks Linear Correlation with Donor Specific Antibodies, yet It Is Still Diagnostically Relevant.

Y. Butt,¹ T. Gokaslan,¹ V. Kaza,² F. Torres,² J. Torrealba.¹
CCR5-Mediated Recruitment of NK Cells to the Kidney Is Critical for Resistance to Candida albicans Infections.

J. Lee,^1,4 V. Tran,³ H. Kim,¹ B. Kwon,^1,3 K. Park,^1,4 H. Cho.^1,2
CD16+ Monocytes and Skewed Macrophage Polarization Towards M2 Type Hallmark Heart Transplant Acute Cellular Rejection.

T. van den Bosch,¹ K. Caliskan,² M. Kraaij,¹ A. Constantinescu,² O. Manintveld,² P. Leenen,³ J. von der Thüsen,⁴ M. Clahsen-van Groningen,⁴ C. Baan,¹ A. Rowshani.¹
CD19⁺CD38^hiCD24^hi Immature Transitional B Cells in PBMCs of Tolerant Kidney Recipients of Facilitating Cell-Enriched Hematopoietic Stem Cells and Renal Allografts.

Y. Wen,¹ A. Merchak,¹ Y. Huang,¹ H. Xu,¹ L. Kahn,¹ J. Leventhal,² S. Ildstad.¹
CD4 T Cells and Co-Engagement with Foreign Protein Are Required in Antibody Response to Non-Self Blood Group A-Antigen.

I. Adam, B. Motyka, L. West.
CD4 and CD8 T Cells: Respectively Reprogrammed and Recapitulated in the Neonate to Induce Transplant Tolerance.

R. Bascom, K. Tao, L. West.
CD40/CD40 Ligand Signal Controls Cytotoxic Ability of Natural Killer Cells After Invariant Natural Killer T Cell Stimulation.

H. Fukuda,¹ T. Hiai,¹ R. Ishii,¹ H. Katsumata,¹ T. Kanzawa,¹ S. Miyairi,¹ M. Ikemiyagi,¹ Y. Ishii,² M. Okumi,¹ K. Tanabe.¹
CD4⁺/CD8⁺ T Cell Ratio as a Predictive Marker for Early Graft Failure in Pig to Non-Human Primate Islet Xenotransplantation with Immunosuppression.

S. Choi,^1,3,4 H.-J. Kim,^1,2,3,4 I.-H. Yoon,^1,2 J.-S. Kim,^1,2,6 S.-J. Kang,^1,2,3,4 H.-Y. Nam,^1,2 B.-H. Min,¹ J.-S. Shin,^1,6 J.-M. Kim,^1,6 Y.-H. Kim,^1,5 W.-W. Lee,^1,2,3,4 C.-G. Park.^1,2,3,4,6
CD4⁺CD28^null T Cells Require IL-15 & IL-21 to Become Alloresponsive.

B. Dedeoglu, N. Litjens, R. Kraaijeveld, W. Verschoor, C. Baan, M. Betjes.
CD4⁺IFN-γ⁺IL-10⁺ Regulatory Type 1 Cells Facilitate Prolongation of Graft Survival in Old Recipient Mice Treated with Rapamycin.

T. Heinbokel, M. Quante, K. Minami, A. Elkhal, S. Tullius.
CD8+ TAb-supp Cells Are Key Inhibitors of Humoral Alloimmunity by Inhibiting CD4+TFH Cells and Killing Germinal Center B Cells.

J. Zimmerer, C. Avila, S. Elzein, B. Ringwald, R. Warren, G. Bumgardner.
CMV and BK Virus Infections in Kidney Transplant Recipients Receiving an mTORi-Based Regimen versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis.

B. Tanios,¹ S. Mallat,¹ H. Itani,¹ T. Lotfi,¹ S. Gabardi,² E. Akl,¹ J. Azzi.²
CMV-Specific CD4⁺ T Cells in CMV-IgG-Seronegative Individuals Protect from CMV Viremia Following Transplantation with a CMV-Seropositive Donor Kidney.

N. Litjens, L. Huang, B. Dedeoglu, R. Meijers, M. Betjes.
CTLA4-Ig in Combination with FTY720 Reduces the Frequency of Memory Alloreactive T Cells and Promotes Heart Allograft Survival in Sensitized Recipients.

S. Khiew,¹ J. Yang,¹ J. Young,¹ J. Chen,¹ Q. Wang,¹ D. Ying,¹ V. Vu,¹ M. Miller,² R. Sciammas,³ M.-L. Alegre,² A. Chong.¹
CTLA4-Ig, Vascularized Bone Marrow and Donor Bone Marrow Cells Successfully Negate the Development of Acute Skin Rejection of Vascularized Composite Allografts in MHC Class I Mismatched Recipients.

I. Schol, Z. Ng, A. Lellouch, A.-R. Gama, J. Kurtz, C. Cetrulo.
CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute Kidney Allograft Rejection.

L. Schiffer,¹ F. Wiehler,¹ M. Daemmrich,² K. Hueper,³ M. Mengel,⁴ A. Thorenz,¹ S. von Vietinghoff,¹ R. Song,¹ M. Schiffer,¹ F. Gueler.¹
Can We Improve Donation Through Pre-Kidney Transplantation Education Using Internet-Based Resources? An Analysis of Internet Use Patterns Among Hispanics.

H. Gomez, E. Malagon-Blackwell, J. Caicedo.
Can We Successfully Overcome Obesity as a Barrier for Kidney Transplantation?

K. Zorbas,¹ S. Karhadkar,¹ S. Rao,² K. Lau,¹ I. Lee,² A. Gillespie,² S. Constantinescu,² A. Karachristos,¹ A. Di Carlo.¹
Cardiovascular Disease in Japanese Kidney Transplant Recipients.

M. Okumi, K. Unagami, D. Fujimori, K. Hata, T. Hirai, H. Ishida, K. Tanabe, Japan Academic Consortium of Kidney Transplantation (JACK).
Carotid Intima-Media Thickness and Myocardial Strain in Pediatric Kidney Transplant Recipients.

K. Sgambat, S. Clauss, M. Lasota, A. Moudgil.
Cell-Subset Diversity in Adipose Derived Regenerative Cells Used in Renal Ischemic Reperfusion Injury Treatment.

R. Lathan,¹ R. Ghita,^1,2 D. Hillyard,¹ P. Mark,^1,2 M. Clancy.^1,2
Challenges for the Travelling Donor: Variability Between Donor Work-Up and Donor Surgery in the Canadian Kidney Paired Donation Program.

B. Reikie, T. Kroczak, T. McGregor.
Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race.

K. Soliman, A. Posadas Salas, D. Taber.
Change in QTC Interval After Kidney Transplant.

E. Lai, V. Acharya, D. Nguyen, E. Graviss, W. Suki.
Changes in Urinary Neutrophil Gelatinase Associated Lipocalin Combined with Urine Cytokines and Microalbuminuria as Predictors for Interstitial Fibrosis and Tubular Atrophy in Kidney Transplantation: A Matched-Pair Tissue Cohort Study.

W. Chancharoenthana,¹ A. Leelahavanichkul,¹ S. Wattanatorn,¹ J. Issara-Amphorn,² Y. Avihingsanon,¹ K. Praditpornsilpa,¹ N. Townamchai.¹
Characteristics and Performance of Unilateral Deceased Donor Kidney Transplants.

S. Husain,¹ S. Lee,¹ S. Mohan,¹ S. Pastan,² R. Patzer,² M. Chiles.¹
Characterization of De Novo Donor-Specific HLA Antibodies and Correlations with C4d+ Antibody-Mediated Rejection of Kidney Transplants.

R. Rajalingam,¹ D. Kopchaliiska,¹ O. Buenaventura,¹ M. Singh,² S. Tomlanovich.²
Chimerism-Related Allotolerance Is Induced by Exosome Acquisition and Reprogramming of Host Dendritic Cells.

D. Lema,¹ W. Bracamonte-Baran,² E. Jankowska-Gan,¹ F. Claas,³ J. van Rood,³ A. Mulder,³ W. Burlingham.¹
Classification of Fibromuscular Dysplasia in Kidney Donors Based on Severity and Extent of Lesion.

M. Gonzalez Suarez, H. Amer, I. Jaffer, T. Vrtiska, A. Rule, M. Prieto, S. Textor.
Clinic-Based Medication Education Pilot Program.

N. Sulejmani,¹ H. Albanna,¹ T. Rendulic,² B. Summers,¹ A. Jantz.¹
Clinical Experience with Novel Cephalosporin/Beta-Lactamase Inhibitor Combinations in the Treatment of Multidrug Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplant Recipients.

P. Nambiar,¹ K. Brizendine,¹ V. Athans,² E. Cober.¹
Clinical Impact of Strength and Class of Pre transplant Donor Specific Antibody on Kidney Transplant Recipient Receiving Steroid Free Maintenance Immunosupression Regimen.

O. Adebiyi, O. Simo, S. Hussain, D. Mishler, W. Goggins, T. Taber, A. Sharfuddin, M. Yaqub.
Clinical Outcome of Pancreas Transplantation in Elderly Patients with Diabetes Mellitus.

J. Jung,¹ J. Choi,² S. Shin,² Y. Kim,² D. Han.²
Clinical Outcomes in Older Kidney Transplant Recipients. A Single Center Experience.

L. Kamal, N. Hayde, P. Bedi, M. Lubetzky, M. Ajaimy, G. DeBoccardo, E. Akalin.
Clinical Outcomes of Kidney Transplant Recipients by Steroid Early Withdraw Protocol with Basiliximab Induction.

Y. Takada, K. Hotta, D. Iwami, H. Higuchi, T. Hirose, H. Sasaki, N. Shinohara.
Clinical Outcomes of Simplified Once-Daily Immunosuppressive Regimen for Stable Kidney Recipients.

C.-K. Oh,¹ S.-J. Kim,² K. Huh,³ S. Kim,⁴ J. Jeon,⁵ S. Han,⁶ H. Cho,⁷ Y. Kwon,⁸ S. Lee,¹ Y. Kim.³
Clinical and Molecular Significance of Microvascular Inflammation Negative Transplant Glomerulopathy.

M. Lubetzky,¹ N. Hayde,¹ P. O Broin,² Y. Bao,¹ E. Akalin.¹
Clinical and Pathologic Characteristics of Acute Rejection After Alemtuzumab Induction in Kidney Transplant Recipients.

P. Zhang,¹ H. Amer,² C. Schinstock,² M. Alexander,¹ F. Cosio,² M. Stegall,³ L. Cornell.¹
Coagulation Pathway Perturbations Associated with Pig-to-Baboon Lung Xenotransplantation.

S. Sendil, B. French, O. Siddiqui, D. Parsell, C. Laird, A. Cimeno, S. Dahi, L. Burdorf, A. Azimzadeh, R. Pierson III.
Combination Therapy of iNKT Cell Ligand and CD40-CD154 Signal Blockade Establishes Islet Allograft Tolerance in Non-Myeloablative Bone Marrow Transplant Recipients.

T. Kanzawa,¹ T. Hirai,¹ R. Ishii,¹ M. Okumi,¹ H. Ishida,¹ Y. Ishii,² K. Tanabe.¹
Combined Dual-Kidney Liver Transplantation in the United States: A Review of UNOS/OPTN Data Between 2002 and 2012.

G. Shekhtman, E. Huang, E. Lum, G. Danovitch, P.-T. Pham, B. Abdalla, S. Bunnapradist.
Combined Endoscopic and Percutaneous Cholangiography for Biliary Anastomotic Stricture in Adult Right-Lobe Living-Donor Liver Transplantation.

A. Thorat,¹ W.-H. Huang,² C.-J. Yu,² C.-Y. Peng,² H.-R. Yang,¹ C.-C. Yeh,¹ T.-H. Chen,¹ S.-C. Hsu,¹ L.-B. Jeng.¹
Combined Perfusion of Liver and Kidney Enhances the Protective Effects of Normothermic Perfusion on Donation After Cardiac Death Porcine Livers.

Z. Guo, F. Ji, X. He, G. Chen.
Commonly Expressed Living Donation Fears and Concerns by Non-Directed (Altruistic) Living Kidney Donors in the United States.

A. Maghen,¹ G. Vargas,¹ S. Connor,¹ S. Nassiri,¹ E. Hicks,² L. Kwan,¹ S. Maliski,³ J. Veale.¹
Comparative Analysis of Four Surgical Techniques in More Than 700 Pancreas Transplantes in a Single Center.

M. Perosa, J. Branez, L. Mota, B. Zeballos, H. Noujaim, L. Ianhez, D. Machado, L. Alvim, M. Paredes, T. Genzini.
Comparing Outcomes Between Technical Variant Liver Allografts and Whole Allografts in Pediatric Liver Transplantation: A Single Center's Experience.

A. Gallo,¹ J. Lee,¹ M. Damian,² D. Stoltz,¹ C. Bonham,¹ C. Esquivel,¹ J. Mendoza.³
Comparing Renal Function Recovery and Long Term Outcomes in Recipients of Standard and Expanded Criteria Donor Kidney Transplants.

S. Sandal, M. Cantarovich, S. Paraskevas, N. Almaghrawi, P. Chaudhury, J. Tchervenkov.
Comparison of Long Term Renal Function Outcomes for Everolimus (EVR) vs. Sirolimus (SIR) vs. Mycophenolate Acid (MPA) Immunosuppressive Regimens Post Kidney Transplant (Ktx).

H. Tedesco,¹ W. Irish,² K. Dharmesh,³ D. Patel,³ D. Cibrik.⁴
Comparison of Long Term Survival Outcomes for Everolimus (EVR) vs. Mycophenolic Acid (MPA) Immunosuppressive Regimens Post Kidney Transplant.

D. Cibrik,¹ W. Irish,² K. McCague,³ D. Patel,³ H. Tedesco.⁴
Comparison of the Estimated and Measured Glomerular Filtration Rate in Kidney Donor Candidates.

C. Akhimiona, W. Suki, D. Nguyen, E. Graviss.
Complications Requiring Reoperation After Pediatric Liver Transplantation.

D. Yoeli, J. Moffett, K. Hosek, R. Ackah, R. Sigireddi, M. Kueht, N. Galvan, R. Cotton, A. Rana, C. O'Mahony, J. Goss.
Concurrent Psychosocial Variables Confound Perioperative and Postoperative Care in Liver Transplant Recipients with Alcoholic Liver Disease.

S. Sultan,¹ M. Hodorowicz,² J. Powell,¹ M. Connelly,¹ M. Tuten,² P. Sacco,² W. Hutson,¹ R. Barth,¹ J. LaMattina.¹
Confirmation of the Safety of Cryopreserved Human Cord Blood Derived Di-Chimeric Cells in the NSG Mouse Model.

J. Cwykiel, N. Filipek, E. Szilagyi, E. Tfaily, M. Siemionow.
Conservative Management of Pneumatosis Intestinalis After Pediatric Liver Transplantation.

R. Hendrickson, J. Ryan, L. Dandridge, W. Andrews, J. Daniel, R. Fischer, D. Rivard.
Continuation of Immunosuppression Appears to Protect Against Allosensitization in Patients Listed for a Second Kidney Transplant.

S. Kuppachi,¹ M. Sanders,¹ R. Kalil,¹ Z. Stewart,² C. Thomas.¹
Contrast-Induced Acute Kidney Injury in Kidney Transplant Recipients: A Meta-Analysis.

W. Cheungpasitporn,¹ C. Thongprayoon,¹ M. Mao,¹ S. Mao,² M. D'Costa,¹ W. Kittanamongkolchai,¹ K. Kashani.¹
Contributing Factors and Impact of Microbial Contamination in Human Islet Isolation and Transplantation.

R. Meier, D. Andrey, N. Niclauss, P. Sun, C. van Delden, B. Bedat, S. Demuylder-Mischler, S. Borot, P.-Y. Benhamou, A. Wojtusciszyn, N. Pernin, Y. Muller, D. Bosco, T. Berney.
Contribution of Donor versus Recipient T Cells in Face Transplant Rejection.

T. Win,¹ N. Murakami,² I. Avraham-Davidi,¹ J. Teague,¹ E. Lowry,¹ R. Lopdrup,¹ E. Bueno,¹ A. Chandraker,¹ L. Riella,¹ B. Pomahac,¹ R. Clark.¹
Controlled Donation After Circulatory Death (cDCD) Donors May Become Similar to Brain Death Donors (DBD).

C. Antoine,¹ M. Videcoq,² B. Riou,³ D. Dorez,⁴ G. Cheisson,⁵ L. Martin-Lefèvre,⁶ L. Durand,¹ E. Savoye,¹ G. Karam,² B. Barrou.³
Conversion from Calcineurin Inhibitor to Sirolimus in Kidney Transplantation Recipients with Malignancy.

J. Yoon, S. Kang, S. Kim, C. Baeck, H. Kim, S.-K. Park.
Conversion from Tacrolimus-Based to Everolimus-Based Immunosuppressive Therapy 3 Months After Living-Donor Kidney Transplantation: A Randomized-Controlled Clinical Trial.

D. Hesselink,¹ N. Shuker,¹ J. Osinga,¹ M. Clahsen -van Groningen,² J. Damman,² C. Baan,¹ J. van de Wetering,¹ A. Rowshani,¹ J. Kal -van Gestel,¹ W. Weimar,¹ T. van Gelder,³ R. Bouamar.³
Conversion from Twice Daily to Once Daily Tacrolimus Improves Adherence in Kidney Transplant Recipients.

M. Levine,¹ K. Wen.²
Correlation of Complement Activating Donor Specific Antibodies as Measured by C3d and Cross-Match Status.

A. Babu,^1,2,3 N. Krishnan,² D. Briggs,³ D. Mitchell,¹ S. Daga.^1,2,4
Cost-Effectiveness of Renal Machine Perfusion Use After Long Cold Ischemia Time.

A. Matos,¹ D. Malheiro,³ S. Morgado,¹ L. Requi[acirc]o-Moura,¹ M. Souza-Durão,^1,2 E. Tonato,¹ M. Nogueira,¹ M. Borrelli,¹ A. Pacheco-Silva.^1,2
Costimulatory Blockade in Delayed Graft Function.

J. Von Visger,¹ A. Diez,¹ U. Nori,¹ T. Pesavento,¹ R. Pelletier,² A. Rajab,² A. El Hinnawi,² H. Winters.³
Course of Donor Specific Anti-HLA Antibodies After Induction Therapy with Rituximab in Renal Transplantation.

M. Baas,¹ W. Allebes,² M. van den Hoogen,³ I. Joosten,² L. Hilbrands.¹
Course of Inflammatory Bowel Disease Activity in Primary Sclerosing Cholangitis Patients Undergoing Liver Transplantation.

R. Parekh,¹ M. Segovia,² N. Kaur.¹
Cyclosporine Effects on Blood Pressure Are Exaggerated in Pubertal Girls After Renal Transplantation.

A. Melk,¹ R. Sugianto,¹ B. Schmidt,² K. Krupka,³ B. Höcker,³ B. Tönshoff,³ E. Wühl.³
Cytotopic Thrombin Inhibition Prior to Cold Ischaemia Attenuates Microvascular Endothelial Ischaemia-Reperfusion Injury.

B. Sandhu,¹ M. Prendecki,¹ J. Crawley,¹ N. Galloway-Phillips,¹ N. Vallant,¹ J. Mason,¹ A. Dorling,² R. Smith,² C. Pusey,¹ V. Papalois.¹
DC-SIGN Functionalized Porous Silicon Nanoparticles Targeting to Human and Non-Human Primate Dendritic Cells.

S. Stead,¹ S. Kireta,² S. McInnes,³ P. Rose,¹ S. Jesudason,^1,2 S. Grey,⁴ D. Rojas-Canales,² R. Carroll,^1,2 N. Voelcker,⁴ P. Coates.^1,2
DNA Hypermethylation Caused by Ischemia in Kidney Transplants Predicts Future Chronic Injury to the Allograft.

L. Heylen,^1,2,3,4 B. Thienpont,^3,4 M. Naesens,^1,2 J. Depreeuw,^3,4 P. Busschaert,^3,4 D. Kuypers,^1,2 I. Jochmans,^2,5 D. Monbaliu,^2,5 J. Pirenne,^2,5 D. Lambrechts,^3,4 B. Sprangers.^1,2
Daratumumab for Severe Refractory Proliferative Glomerulonephritis with Monoclonal Immune Deposits (PGNMID).

S. Anand,^1,3 D. Miller,¹ G. Chipman,² D. Morris,^1,3 T. Srinivas.¹
De Novo Malignancy Occurrence After Kidney Transplantation in HLA-Sensitized Patients Treated with B-Cell Targeting Therapy.

L. Couzi,^1,2,3 P. Davis,¹ J. Visentin,^1,2,3 B. Taton,¹ G. Guidicelli,¹ H. Kaminski,^1,2,3 P. Merville,^1,2,3 T. Bachelet.⁴
Death After Kidney Transplantation: Assessment of Pre- and Peri-Transplant Risk Factors and of Time-Varying Risk Factors from the Post-Transplant Course.

I. Scheffner,¹ T. Abeling,¹ A. Karch,¹ M. Mengel,² V. Broeker,³ A. Koch,¹ H. Haller,¹ A. Schwarz,¹ W. Gwinner.¹
Deceased Donor-Initiated Non-Simultaneous Extended Altruistic Donor Chains Through the Military Share Program.

M. Rees,^1,2 O. Ekwenna,¹ E. Elster,³ A. Patel,³ D. Murtagh, Jr,¹ A. Roth,⁴ K. Krawiec,⁵ J. Arrington,⁶ I. Ashlagi,⁴ J. Hawksworth.³
Decellularized Rat Liver Scaffolds Support Survival and Metabolic Function of Multilineage Allogenic Cells.

W. Hassanein, A. Werdesheim, A. Cimeno, B. Buckingham, A. Khalifeh, M. Uluer, J. Harrison, D. Parsell, C. Drachenberg, R. Barth, J. LaMattina.
Deciphering the Mechanism of Remote Ischemic Preconditioning and Its Potential Benefits in Ischemia/Reperfusion Injury by Metabolomics.

S. Cho, S.-I. Min, S.-Y. Kim, M.-J. Cho, W. Cho, S. Ahn, S.-K. Min, J. Ha.
Decision Tree Analysis of Renal Transplantation Recipients Outcomes: A Single Center Data Mining in the Big Data Era.

J. Zhou,¹ Y. Shen,² R. Wang,¹ H. Huang,¹ J. Wu,¹ J. Chen.¹
Delayed Calcineurin Inhibitor Introduction and Long Term Renal Outcomes in Liver Transplant Recipients Receiving Basiliximab Induction.

N. Lange,^1,2 D. Salerno,¹ C. Sammons.²
Deleting LAG-3 Accelerates Cardiac Allograft Rejection and Augments T Cell Memory in Mice.

J. Erfe,^1,2 C. Yang,¹ D. Ndishabandi,¹ I. Rosales,¹ R. White,¹ P. Russell,¹ R. Colvin,¹ J. Madsen,¹ A. Alessandrini.¹
Dendritic Cells That Highly Express SOCS1 Induce T-Cell Hypo-Responsiveness and Prolong Islet Allograft Survival.

R. Deng, X. Lu, M. Chen, Z. Xue, X. Zhang, J. Xu, L. Wu, Y. Ma.
Depletion of T-Cells from G-CSF Mobilized Human PBMC Prevents Acute GVHD in NSG Mice.

Y. Huang, H. Xu, A. Merchak, A. Chhabra, Y. Wen, L. Kahn, S. Ildstad.
Describing the Effects of the Antibiotic Regimen Immediate Post Multi-Visceral Transplant in the Pediatric Population on the Time to First Serious Bacterial Infection.

B. Chatani,¹ J. Garcia,² C. Biaggi,² T. Beduschi,³ A. Tekin,³ R. Vianna,⁴ I. Gonzalez.⁵
Desensitization Regimen for the Patients with High Isoagglutinin Titers to Undergo Adult ABO-Incompatible Living Donor Liver Transplantation.

W.-C. Lee, C.-F. Lee, T.-H. Wu, Y.-C. Wang, C.-H. Cheng, T.-J. Wu, H.-S. Chou, K.-M. Chan.
Detection of Right Ventricular Dilation and Dysfunction by Transthoracic Echocardiography Predicts Renal Transplant Outcomes.

F. Tinney Jr,¹ S. Lazar,² A. Naik,² M. Samaniego-Picota,² N. Bhave.²
Detection of Shared and Distinct Gene Expression Signatures in Tissue and Urine During Acute Rejection of Kidney Grafts.

K. Keslar,¹ A. Zmijewska,² J. Chen,² K. Newell,³ P. Heeger,⁴ R. Mannon,² R. Fairchild.¹
Detection of Specific B Cell Memory to the Perlecan LG3 Antigen in the Normal Immune Repertoire.

L. Padet,^1,2,3 M. Dieude,^1,2 B. Yang,^1,2,3 J. Turgeon,^1,2 H. Cardinal,^1,2 M.-J. Hebert.^1,2,3
Determinants of Successful Use of Sirolimus in Renal Transplantation.

M. Naik,¹ W. Gwinner,² W. Arns,³ E. Basic,¹⁰ K. Budde,¹ F. Diekmann,⁴ M. Fischereder,⁵ J. Goßmann,⁶ K. Heller,⁷ N. Heyne,⁸ J.-S. Jürgensen,¹ C. Morath,⁹ U. Riester.¹⁰
Development and Validation of PART (Pharmacotherapy Assessment in Renal Transplant Patients) Criteria to Assess Drug Related Problems in Outpatient Renal Transplant Population.

L. El Raichani,¹ Q. Du,¹ A. Mathieu,¹ S. Almassy,¹ L. Lalonde,¹ N. Boudreau,¹ E. Gélinas-Lemay,¹ D. Berbiche,³ H. Cardinal.²
Development and Validation of an FLF-Transplant Score to Predict Mortality of Patients with Fulminant Liver Failure.

Z. Guo, B. Chen, X. He, G. Chen.
Development of Transplant Glomerulopathy in Recipients with Antibody Mediated Rejection: Activation of Inflammatory Pathway Through Renal Poly (ADP-Ribose) Polymerase (PARP).

B. Ozdemir,¹ F. Ozdemir,² E. Baskin,² M. Haberal.³
Development of an Anti-HLA Antibody-Producing Humanized Mouse Model.

S. Yanagawa, H. Tahara, H. Ohdan.
Diabetes in Liver Transplantation: Evaluation of Management and Associated Clinical Outcomes.

A. Rogers,² N. Patel,² H. Meadows,² A. Mardis,² J. Fleming,² C. Perez,² I. Lee,² M. Sell,² B. O'Brien,² D. Taber,¹ K. Chavin,¹ D. Dubay,¹ C. Mardis,² N. Pilch.¹
Differences in Kinetics of IFN-y Production Between Endogenous and Allotransplant-Induced Memory T Cells.

B. Gonzalez-Nolasco, J. Marino, W. Orent, G. Benichou.
Differences in Racial and Sex Disparities in Liver Transplantation Outcomes Between Older and Younger Adult Recipients.

Q. Huang, C. Haugen, X. Luo, A. Massie, M. McAdams-DeMarco, D. Segev.
Differential Effect of Antibody Removal on ABO Blood Group Type Chain Specific Antibodies Over Time.

A. Bentall,¹ M. Jeyakanthan,² J. Pearcey,² B. Motyka,² C. Cairo,³ T. Lowary,³ J. Buriak,⁴ L. West,² S. Ball.¹
Differential Suppressive Effects of Costimulatory Blockade (CD28/B7), Anti-IL6R, Bruton's Tyrosine Kinase and Janus Kinase Inhibition on De Novo vs. Recall Alloantibody Responses: Are Combined Drug Therapy Approaches Desirable?

I. Kim, G. Wu, N.-N. Chai, A. Klein, S. Jordan.
Digital Image Analysis of Pediatric Liver Allograft Biopsies Correlates with METAVIR Fibrosis Score.

R. Fischer,¹ S. Foster,² J. Daniel,¹ R. Hendrickson,¹ W. Andrews,¹ A. Kats.¹
Direct Comparison of Hypothermic and Normothermic Organ Preservation in a Porcine Ex-Vivo Kidney Model.

N. Vallant,^1,2 B. Sandhu,¹ N. Wolfhagen,¹ C. Pusey,¹ V. Papalois.¹
Discrepancies in Perceived and Measured Cognitive Abilities in Transplant Recipients.

A. Gupta,¹ J. Mahanken,² J. Klein,¹ D. Johnson,³ J. Burns.⁴
Disparities in Access to the Liver Transplant Wait List: A Statewide Analysis.

Y. Bababekov, D. Chang, Y.-C. Hung, J. Adler, S. Stapleton, J. Markmann, H. Yeh.
Disparity in Transplant Referral Patterns Based on Physician Dependent Variables.

V. Loy, A. Rzepczynski, S. Bello, C. Blackburn, A. Lu.
Distinctive Molecular Features of Antibody-Mediated versus T-Cell Mediated Rejection in Facial Transplantation.

R. Lopdrup, T. Win, N. Murakami, J. Teague, A. Chandraker, G. Murphy, C. Lian, E. Bueno, B. Pomahac, R. Clark, L. Riella.
Do Perioperative Blood Transfusions Influence Kidney Transplant Outcomes in the Modern Era?

J. Lineen, J. Trac, Y. Li, O. Famure, J. Kim.
Does Blockade of ICOS/ICOS-L Pathway Act Synergistically with αCD40 Costimulation Pathway Blockade?

N. O'Neill, T. Zhang, X. Cheng, W. Sun, G. Braileanu, I. Tatarov, W. Hassanein, A. Azimzadeh, R. Pierson.
Does Choice of Induction Agent Affect Outcomes in Kidney Transplants from Deceased Donors with Acute Kidney Injury and Prolonged Cold Ischemia Time?

G. Dube, S. Mohan, M. Chiles.
Does Gender Affect Renal Transplant Outcomes?

A. Patel, R. Prashar.
Does HLA Class of Complement Activating Donor Specific Antibodies Matter: Single Centre Retrospective Analysis of Renal Allograft Outcomes.

A. Babu,^1,2,3 D. Briggs,³ D. Mitchell,¹ N. Krishnan,² R. Higgins,¹ S. Daga.^1,2,4
Does Pancreas Transplantation for the Patients with Diabetes Showed Significant Survival Benefit?

J. Choi, J. Jung, S. Chun, S. Shin, Y. Kim, D. Han.
Does Simultaneous Liver Kidney Transplant in Patients with MELD ≥35 on Renal Replacement Therapy at the Time of Transplant Improve Outcome?

B. Ali, C. Gadiparthi, G. Cholankeril, S. Satapathy, J. Eason, S. Nair.
Does an Indeterminate Result on Pre-Transplantation Tuberculosis Interferon Gamma Release Assay Predict Risk for Post-Transplantation Infection or Rejection?

A. Zimmer,¹ R. Razonable.²
Does the Model for End Stage Liver Disease (MELD) Score Predict Outcome in Total Artificial Heart Patients?

M. Rafiei, J. Moriguchi, M. Kittleson, J. Patel, T. Aintablian, E. Passano, R. Sharoff, J. Kwan, E. Kransdorf, D. Chang, L. Czer, J. Kobashigawa, F. Arabia.
Donation After Cardiac Death (DCD) Liver Transplantation (LT) Is Not Associated with Post-LT Renal Dysfunction.

H. Wadei, M. Mai, D. Lee, K. Croome, B. Rosser, A. Keaveny, B. Taner.
Donor Age > 50 Years and CIT Longer Than 18 Hour Are Independent Risk Factors for One Year Graft Survival in Renal Transplant Form Uncontrolled Donors After Circulatory Death (uDCD).

M. Molina, E. Gutierrez, E. Gonzalez, E. Morales, J. Cabrera, A. Andres.
Donor Body Mass Index and Utilization of Liver Biopsy: An Evaluation of National Practices and Organ Utilization.

J. Steggerda,¹ D. Marguiles,¹ D. Malinoski,² M. Bloom.¹
Donor Creatinine and Graft Outcomes in Pediatric Kidney Transplant Recipients.

N. Hayde, M. Del Rio.
Donor Families' Perspectives of the Harms of Failed Donation After Circulatory Death: A Qualitative Analysis.

L. Taylor,¹ A. Buffington,¹ S. Joseph,³ N. Fost,² M. Schwarze.¹
Donor Genetic Background Determines the Severity of Delayed Graft Function Following Kidney Transplantation in Mice.

L. Qiu, J.-J. Wang, X. Yeap, Z. Zheng, M. He, M. Abecassis, Z. Zhang.
Donor Leukocytes Are Eliminated by the Host's Immune System Shortly After Skin Transplantation in Mice.

J. Marino, B. Gonzalez-Nolasco, G. Benichou.
Donor Macrophage Depletion from CMV-Latently Infected Hearts Abrogates CMV-Accelerated Chronic Rejection.

J. Burg,¹ T. Andoh,² N. Haese,² I. Jones,² S. Orloff,¹ D. Streblow.²
Donor Smoking History Associated with Increased Risk of Death Following Lung Transplantation, but Lower Risk of Bronchiolitis Obliterans Syndrome.

S. Burger, M. Eberlein, J. Keech, E. Arshava, T. Pena, S. Larson, J. Klesney-Tait, K. Parekh.
Donor and Recipient Factors Important in Determining the Estimated GFR Difference Between Living Donor and Recipient Pairs Six Months After Transplant.

D. Keith.
Donor and Recipient Views on Their Relationship in Living Kidney Donation: Thematic Synthesis of Qualitative Studies.

A. Ralph,^1,2 P. Butow,¹ C. Hanson,^1,2 S. Chadban,^1,3 J. Chapman,¹ J. Craig,^1,2 J. Kanellis,⁴ G. Luxton,⁵ A. Tong.^1,2
Donor-Derived Cell-Free DNA Is a Dynamic Biomarker of Active Rejection in Kidney Allografts.

D. Brennan,¹ J. Bromberg,² E. Poggio,³ D. Hiller,⁴ J. Sninsky,⁴ R. Woodward,⁴ J. Yee,⁴ R. Bloom.⁵
Donor-Derived Cell-Free DNA Normal Range and Biological Variation Defined in a Reference Population.

J. Bromberg,¹ D. Brennan,² E. Poggio,³ D. Hiller,⁴ R. Woodward,⁴ J. Yee,⁴ J. Sninsky,⁴ R. Bloom.⁵
Donor-Derived Cell-Free DNA Parallels Increases in Donor Specific Antibodies in Pediatric Kidney Transplant Recipients.

D. Stoltz,¹ A. Brubaker,¹ M. Grskovic,² R. Woodward,² A. Gallo.¹
Dual Role for Caspase-3 in the Regulation of Tubular and Microvascular Damage Post-Renal Ischemia-Reperfusion Injury.

B. Yang,^1,2,3 S. Lan,^1,2,3 N. Patey,^1,3,4 J. Turgeon,^1,3 M. Dieudé,^1,3 M.-J. Hébert.^1,2,3
ECMO in Liver Transplant.

N. Goussous,^1,2 S. Hanish,¹ J. LaMattina,¹ Z. Kon,¹ D. Potosky,¹ J. Scalea,¹ W. Hutson,¹ R. Barth,¹ D. Bruno.¹
EPOR₂/ßcR₂-Independendent Effects of Low-Dose Epoetin-a in Porcine Liver Transplantation.

L. Kebschull,¹ F. Becker,¹ L. Theilmann,¹ B. Heitzplatz,² W. Uennigmann,¹ H. Spiegel,¹ D. Palmes.¹
ERK and HIF1 Play a Major Role in Hypothermic Protection Against Renal Ischemia-Reperfusion Injury.

K. Lee,¹ J. Jeong,² D. Choi,¹ K. Na,¹ H. Bae,¹ Y. Ham.¹
Early Exposure of Everolimus with and without Calcineurin Inhibitors.

C. Felipe, A. Ferreira, T. Abait, A. Bessa, P. Ruppel, L. Hiramoto, M. Ivani, H. Tedesco, J. Medina- Pestana.
Early Failure of Kidney Transplants in the Current Era.

I. Helanterä, M. Lempinen.
Early Introduction of Oral Paricalcitol in Renal Transplant Recipients. An Open-Label Randomized Study.

H. Pihlstrøm,¹ F. Gatti,² C. Hammarstrom,² I. Eide,¹ M. Kasprzycka,² J. Wang,² G. Haraldsen,² M. Svensson,³ K. Midtvedt,¹ A. Hartmann,¹ G. Mjøen,¹ D. Dahle,¹ H. Holdaas.¹
Early Outcomes of Kidney Transplantation When Comparing Waist-to-Hip Ratio vs. Body Mass Index.

R. Patankar,¹ A. Gamilla-Crudo,¹ K. Gugliuzza,² O. Salim,³ S. Shah,¹ F. Ikram,⁴ M. Mujtaba.¹
Early Rejection in the Elderly: Is It Predictable?

J. Clark, T. Sparkes, B. Masters, S. Jonchhe, A. Haririan, B. Thomas, B. Ravichandran.
Early Steroid Withdrawal and Infection in Kidney Transplant Recipients.

S. Bae, C. Durand, L. Kucirka, S. DiBrito, R. Avery, J. Garonzik Wang, D. Segev.
Early and Late High Intrapatient Variability of Tacrolimus Levels Can Predict Late Renal Allograft Rejection.

D. Goodall, M. Willicombe, D. Swerdlow, A. McLean, D. Taube.
Echinocandins in Lung Transplant Recipients (LTRs).

Y. AlJishi,¹ C. Rotstein,¹ D. Kumar,¹ A. Humar,¹ L. Singer,² S. Keshavjee,² S. Husain.¹
Eculizumab Dose Reduction Is Safe by Monitoring Eculizumab Pre-Dose Level and Functional Complement Assays.

M. Gelens,¹ T. Havenith,² J. Damoiseaux,³ M. Christiaans.¹
Eculizumab Treatment on GC3 Recurrence on Renal Graft.

G. Jeantet,¹ D. Bertrand,³ A. Lionet,² D. Anglicheau,⁴ V. Fremeaux-Bacchi,⁵ M. Le Quintrec.¹
Effect of AKI Donor Admit Creatinine on Renal Transplant Outcomes.

E. Giorgakis,¹ R. Heilman,² H. Khamash,² B. Kaplan,² A. Moss,¹ M. Smith,³ K. Reddy.¹
Effect of Blood Pressure Just Before Release of the Vascular Clamps on the Renal Function of Kidney Transplantation Recipients: A Retrospective Study.

K. Tsujimura,¹ M. Ota,¹ H. Ishida,² K. Tanabe.²
Effect of Everolimus on the Cardiac Function in Kidney Transplant Recipients.

K. Tsujimura,¹ M. Ota,¹ H. Ishida,² K. Tanabe.²
Effect of Everolimus-Based Regimen on Graft Outcomes in Kidney Transplant Recipients with Diabetes at Baseline: Post-Hoc Analysis from the ELEVATE Study.

J. de Fijter,¹ H. Holdaas,¹ J. Sanders,¹ S. Sundar,¹ F. Bemelman,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ M. van der Giet.¹
Effect of HLA-DQ Mismatch on Efficacy Outcomes and Renal Function in Kidney Transplant Recipients: Subanalysis from the ELEVATE Study.

W. Arns,¹ J. Cruzado,¹ H. Holdaas,¹ P. Lopez,² P. Bernhardt,² G. Bader,² F. Claas,¹ M. van der Giet,¹ J. de Fijter.¹
Effect of Hepatitis C (HCV) Treatment on Rejection Incidence and Severity in Post-Liver Transplant Patients.

C. Skillin, M. Mba, B. Madani, C. Frenette.
Effect of Initial Hepatic Arterial Followed by Portal Reperfusion on Outcomes After Liver Transplantation.

R. Shahbazov,¹ F. Azari,² J. Alejo,² M. Talanian,² M. Fox,² K. Kennedy,² S. Kessel,² A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹
Effect of Statins on Influenza Vaccine Antibody Concentrations in Lung Transplant Recipients.

A. Condon,¹ C. Garmoe,² M. Hayney.²
Effect of Two Anti-CD20 Abs on B Cell Depletion and Reconstitution in Non-Human Primates.

W. Sun,¹ N. O'Neill,¹ T. Zhang,¹ G. Braileanu,¹ K. Reimann,² R. Pierson,¹ A. Azimzadeh.¹
Effective Thrombolytic Therapy of Hepatic Artery Thrombosis After Liver Transplantation – A Single-Center Experience.

M. Chen,¹ X. Lin,² W. Ju,¹ D. Wang,¹ Y. Ma,¹ L. Wu,¹ X. He,¹ G. Chen.¹
Effects of Anti-HLA Antibodies on Endothelial Expression and Serum Levels of Thrombomodulin in Kidney Recipients.

S. Beland, O. Desy, P. Valin, S. De Serres.
Effects of Tofacitinib (JAK-3 Inhibitor) on De Novo HLA-A2 Antibody Production in a Mouse Model of Allo-Sensitization.

N.-N. Chai, G. Wu, I. Kim, A. Klein, S. Jordan.
Effects of the Gut-Liver Axis on Ischemia-Mediated Hepatocellular Carcinoma Recurrence in the Mouse Liver.

L. Orci,¹ S. Lacotte,¹ V. Delaune,¹ G. Oldani,¹ F. Slits,¹ C. Rossetti,² L. Rubbia-Brandt,³ P. Morel,¹ C. Toso.¹
Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.

S. Hussain, T. Taber, M. Yaqub, O. Adebiyi, D. Mishler, A. Sharfuddin.
Efficacy of Calcineurin Inhibitors Transferring to Rapamycin in Live Kidney Transplantation from Old Donors to Young Recipients.

G. Chen, C. Wang, Z. Wu, C. Wang, J. Qiu, L. Chen.
Efficacy of Trimethoprim-Sulfamethoxazole Prophylaxis for Nocardia in Solid Organ Transplant Recipients (SOTRs): Systematic Review and Meta-Analysis.

A. Alsharidi,¹ A. Gonzalez,² C. Rotstein,³ A. Humar,³ D. Kumar,³ S. Husain.³
Electronic Patient Portal Functionality Among Kidney and Liver Transplant Recipients.

A. Ruiz, K. Smith, J. Wedd, K. Little, S. Pastan, R. Patzer.
Elevated Serum Lipase Levels in Simultaneous Pancreas and Kidney Transplantation May Indicate Anti-HLA Donor Specific Antibody Response.

B. Javaid, T. Raza, P. Abrams, S. Ghasemian, J. Moore, A. Gilbert, M. Grafals, J. Verbesey, M. Cooper.
Eliminating False Positive Virtual Crossmatch Results for Lung Transplant Candidates by Using Multiple Antibody Testing Platforms.

O. Timofeeva,¹ M. Kashem,² S. Geier,¹ D. Grogan,² S. Keshavamurthy,² J. Gomez-Abraham,² Y. Toyoda,² F. Cordova.²
Endoscopic Therapy of Bile Duct Strictures After Liver Transplant.

H. Woller, P. Mantry, A. Mejia, S. Cheng, C. Fasola.
Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.

A. Cavalcanti,¹ M. Durao,^1,2 B. Santos,^1,2 E. Tonato,^1,2 M. Doher,² N. Guimaraes-Souza,^1,2 L. Moreira Valle,¹ B. Affonso,¹ F. Nasser,¹ A. Pacheco-Silva.^1,2
Engaging Clinicians and Patients Regarding Frailty Assessment in Kidney Transplant Candidates.

S. Rasmussen, J. Konel, H. Ying, C. Haugen, E. King, S. DiBrito, D. Segev, M. McAdams DeMarco.
Enhanced Hepatic Engraftment of Stem Cell Derivatives Using Magnetic Targeting into Structurally Normal Liver.

N. Liu, S. Fagg, J. Fair.
Enhanced Recovery After Surgery Pathway for Living Donor Nephrectomy Patients Decreases Length of Stay and Narcotic Utilization.

R. Forbes,¹ A. King,² T. McGrane,² D. Hale,¹ W. Sandberg,² J. Wanderer,² M. McEvoy.²
Epidemiology and Clinical Outcomes of Mycobacterium tuberculosis in Liver Transplant Recipients in an Intermediate Tuberculosis-Endemic Area.

S. Kim,¹ Y. Kim,¹ J. Choi,² S. Yoon,² J. Kim,³ I. Moon,³ Y. Yoo,³ D. Kim.³
Estrogen Receptor Alpha Mediates Female Protection from Renal Ischemia-Reperfusion Injury Through Mechanisms Extrinsic to the Kidney.

D. Aufhauser,¹ D. Murken,¹ Z. Wang,¹ G. Ge,¹ S. Concors,¹ T. Bhatti,² W. Hancock,^2,3 M. Levine.^1,4
Ethnicity and Transplant Knowledge Among Canadian ESKD Patients.

D. Wong,¹ H. Ford,¹ C. Lok,¹ G. Nesrallah,² J. Peipert,³ C. Richardson,¹ A. Waterman,³ M. Novak,¹ I. Mucsi.¹
Ethnocultural Barriers to Pre-Emptive Kidney Transplantation: A Single Centre Retrospective Cohort Study.

A. Bansal, M. Kwok, S. Cao, O. Famure, S. Kim, I. Mucsi.
Ethylene Carbodiimide Fixed Donor Splenocytes Combined with α-1 Antitrypsin Induce Indefinite Donor Specific Protection to Mice Cardiac Allografts.

G. Chen, X. Lai, L. Qiu, Y. Zhao, S. Yu, J. Zhang, L. Chen.
Evaluating Online Information on Youtube for Kidney Transplant.

P. Sheiner, S. Silver.
Evaluating Patients' Experiences Towards Their Immunosuppressive Treatment: A Way to Improve Adherence.

C. Villeneuve,^1,2 M. Grau,¹ M. Essig,^2,3 S. Hegarat,³ J. Zoughbi,³ P. Marquet,^1,2 C. Monchaud.^1,2
Evaluating T Cell Repopulation Post Alemtuzumab Induction with a Belatacept-Based Regimen.

V. Bendersky, H. Xu, A. Kirk.
Evaluation of Function and TCR signaling Profile of CD57⁺ T Cells in Allo-Specific Immunity.

H. Xu,¹ T. Brennan,¹ Q. Li,² A. Kirk.¹
Evaluation of Graft Functional Recovery After Simultaneously Pancreas and Kidney Transplantation with Donation After Cardiac Death in China (16 Cases of Report).

A. Hu, W. Liao, C. Zhang, X. Zhu, X. He.
Evaluation of Low Dose Valganciclovir for the Prevention of Cytomegalovirus in Liver Transplant Recipients.

C. Payne,¹ J. Melaragno,¹ D. Hutchinson,¹ T. Babu,² P. Prasad,^2,3 T. Dick.¹
Evaluation of Outcomes in Renal Transplantation Using Machine Perfusion for the Preservation of Kidneys from Expanded Criteria Donor.

E. Savoye, M. Macher, Kidney Working Group, C. Legeai, C. Antoine.
Evaluation of Renal Function After a Transition to Everolimus or Mycophenolate Mofetil in Liver Transplant Recipients.

C. Perez,¹ J. Fleming,¹ M. Sell,¹ B. O'brien,¹ A. Rogers,¹ I. Lee,¹ C. Mardis,¹ A. Mardis,¹ N. Patel,¹ H. Meadows,¹ N. Pilch,² K. Chavin,² D. Dubay,² R. Vinayak,² D. Taber.²
Evaluation of Vancomycin Resistant Enterococcus (VRE) Colonization and Infection Rate in Adult Liver Transplant Patients.

E. Aldag,¹ G. Fouth,¹ R. Pedersen,¹ L. Fehrenbacher,^1,2 A. Sahajpal,¹ V. Gunabushanam,¹ D. Kramer.¹
Evaluation of the Conversion from Brand Name to Generic Immunosuppression in Hospitalized Organ Transplant Recipients.

L. DeZotell,¹ K. Blunck,¹ J. Guy,¹ M. Woods,¹ M. Reffett,² J. Terrell,² A. Palermo,² K. Gosch,³ L. Cummings.⁴
Even Non-Donor-Specific HLA-Antibodies Are Associated with a Progressive Decline in Kidney Transplant Function.

T. Mueller, K. Gerritsen, R. van Breemen, B. Ruesi, S. von Moos, P. Cippa.
Everolimus Does Not Increase Risk of Delayed Graft Function or Prolong Duration of Dialysis in Renal Transplantation.

F. Shihab,¹ Y. Qazi,² S. Mulgaonkar,³ K. McCague,⁴ D. Patel,⁴ V. Peddi,⁵ D. Shaffer.⁶
Everolimus Is Associated with Less Weight Gain Than Tacrolimus Two Years Following Liver Transplantation: Results of a Randomized Multicenter Study.

M. Charlton,¹ M. Rinella,² D. Patel,³ K. McCague,³ J. Heimbach,⁴ K. Watt.⁴
Everolimus Reduces Carotid Intima-Media Thickness in Renal Transplant Recipients After One Year: Randomized Controlled Trial.

P. Garcia, H. Takase, H. Nga, M. Contti, J. Hueb, L. Morales-Buenrostro.
Evolution of CCR4highCD4+ Subpopulations in Renal Graft Blood After Steroid Withdrawal: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results.

J. Alonso-Titos,¹ P. Ruiz-Esteban,¹ E. Palma,¹ A. Caballero,² E. Sola,¹ M. Cabello,¹ T. Vazquez,¹ A. Duarte,¹ C. Jironda,¹ D. Hernandez.¹
Ex vivo Expanded Regulatory T cells Combined with Short-Term Costimulation Blockade Prevent Rejection of Vascularized Composite Allografts.

B. Oh, G. Furtmüller, M. Iglesias, M. Fryer, P. Akre, D. Cooney, W. Lee, G. Raimondi, G. Brandacher.
Ex-Vivo Mitomycin-C Exposure Reduced Immunogenicity and Prolonged Survival of Islets by Suppressing the Secretion of Multiple Chemotaxis Factors.

N. Sato,¹ T. Anazawa,² A. Kenjyo,¹ T. Kimura,¹ R. Okada,¹ T. Ishigame,¹ Y. Kofunato,¹ J. Watanabe,¹ M. Muto,¹ A. Nishimagi,¹ M. Gotoh,¹ S. Marubashi.¹
Exception Scores for Patients on the Liver Waiting List.

T. Weaver,¹ D. Schladt,¹ M. Skeans,¹ J. Pyke,¹ J. Zeglin,¹ S. Leppke,¹ A. Israni,^1,2 B. Kasiske,^1,2 W. Kim,³ J. Lake.⁴
Exceptions Points and Size Drive Gender Disparities in Liver Transplantation.

L. Nephew,¹ D. Goldberg,^1,2 J. Lewis,^1,2 P. Abt,³ M. Bryan,⁴ K. Forde.^1,2
Exosomes Containing IL35 Are Secreted by Donor-Specific Regulatory T Cells and Cause Linked-Suppression.

Y. Tomita,¹ W. Bracamonte-Baran,¹ E. Jankowska-Gan,¹ Q. Zhang,² D. Vignali,² W. Burlingham.¹
Expansion, Function and Clonotypic Analysis of Human Alloreactive Treg Stimulated with Different Dendritic Cell Populations or CD40L-Stimulated B Cells.

H. Zhang,¹ Y. Zhao,¹ Q. Tang,³ A. Thomson.^1,2
Expectations and Experiences of Follow-Up and Self-Care After Living Kidney Donation: A Focus Group Study.

K. Manera,^1,2 C. Hanson,^1,2 J. Chapman,³ J. Kanellis,^4,5 J. Gill,⁶ J. Craig,^1,2 S. Chadban,^7,8 G. Wong,^1,2,3 A. Ralph,^1,2 A. Tong.^1,2
Experimental Study of Hepatocyte Proliferation Regulated by miR26a.

J. Zhou, X. Yuan, W. Ju, X. Jiao, D. Wang, X. Zhu, X. He.
Exploring Differential Antibody Response to Bortezomib in Heart Transplantation.

K. Ghafourian, R. Hod-Dvorai, S. McCabe, N. Cool, M. Fine, M. Ackerman, J. Rich, J. Wilcox, E. Vorovich, A. Anderson, A. Tambur.
Extended Ex Vivo Kidney Perfusion Using Hemopure as an Oxygen Carrier: A Method to Preserve, Assess and Repair Discarded Organs.

F. Fontan, M. Aburawi, N. Karimian, K. Uygun, F. Delmonico, H. Yeh, J. Markmann.
Extending the Limit for Living Donor Liver Transplantation: Similar Outcomes After Left vs. Right Lobe Graft, a Propensity Score Analysis.

T. Wong, K. Ng, J. Fung, K. Chok, A. Chan, C. Lo.
Extraction Time During Liver Retrieval Impairs Survival After Transplantation.

I. Jochmans,¹ S. Fieuws,² I. Tieken,³ U. Samuel,³ J. Pirenne.¹
Factors in Association with Sepsis Differ Between Simultaneous Pancreas/Kidney and Single Kidney Transplant Recipients.

T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
False-Positive Flow Cytometric Crossmatch Results and the Utility of the Virtual Crossmatch.

N. Brown, J. Xin, J. Weidner, R. Upchurch, S. Marino.
Fate and Function of CD8+ T Cells Primed by Fetal Antigen During Pregnancy.

P. Porrett,¹ R. Xu,¹ E. Wherry.²
Felodipine Diminishes Decline in Glomerular Filtration Rate in Lung Transplanted Patients Treated with Cyclosporine: A Randomized Placebo Controlled Trial.

M. Hornum,¹ M. Iversen,² P. Oturai,³ M. Andersen,² M. Zemtsovski,⁴ P. Bredahl,⁴ N. Bjarnason,² K. Christiansen,⁵ J. Carlsen,² C. Møller,⁶ B. Feldt-Rasmussen,¹ M. Perch.²
Focal Segmental Glomerulosclerosis Recurrence in Renal Transplant Recipients Treated with Belatacept.

W. Kitchens, A. Farris, S. Pastan, T. Pearson, C. Larsen, A. Adams.
Functional Mystacial Pad Allograft Tolerance Induced and Maintained by Vascularized Bone Marrow Transplant.

C.-H. Lin,^1,2 M. Anggelia,^1,2 C.-J. Wen,¹ W.-Y. Chuang,³ H.-Y. Cheng,¹ C.-H. Lin,^1,2 G. Brandacher.⁴
Gastrointestinal Perforation After Liver Transplantation in Pediatric Patients.

M. Kirnap,¹ S. Yildirim,¹ G. Moray,¹ A. Torgay,² M. Haberal.¹
Gene Editing of Keap1/Nrf2 in Human T Cells Using CRISPR-Cas9 to Improve Outcome from Ischemia Reperfusion Injury and Other T Cell Mediated Diseases.

S. Noel,¹ S. Lee,¹ M. Sadasivam,² A. Hamad,² H. Rabb.¹
Generation of Autologous CMV and EBV-Specific T-Cell Lines from Seronegative Patients for Cell Therapy of Opportunistic Infections Following Kidney Transplantation.

C. Lamarche,¹ T. Pincez,¹ J. Orio,¹ C. Carli,¹ A. Humar,² J.-S. Delisle.¹
Generation of Potent Monocytic Myeloid-Derived Suppressor Cells from Rhesus Macaque Bone Marrow.

A. Thomson, A. Zahorchak, A. Perez-Gutierrez, M. Ezzelarab.
Geographic Differences in Secular Trends of Liver Supply and Demand.

E. Chow,¹ R. Choudhury,¹ A. Massie,¹ S. Gentry,² D. Segev.¹
Global Kidney Exchange.

M. Rees,¹ T. Dunn,² S. Rees,³ J. Rogers,⁴ A. Roth,⁵ C. Kuhr,⁶ O. Ekwenna,¹ K. Krawiec,⁷ S. Jain,¹ C. Marsh,⁸ P. Sindhwani,¹ M. Zimmerman,⁹ R. Forbes,¹⁰ M. Tan,¹¹ I. Ashlagi,⁵ R. Correa-Rotter,¹² S. Paloyo.¹³
Glucose Tolerance After Kideney Transplant Is Affected by Systemic Insulin Sensitivity Rather Than Usage of Tacrolimus.

D. Iwami,¹ A. Nakamura,² K. Hotta,¹ H. Sasaki,¹ T. Hirose,¹ H. Higuchi,¹ Y. Takada,¹ H. Miyoshi,² N. Shinohara.¹
Graft Loss from Anti-GBM Nephritis: A Rare Event in Alport Syndrome, Even with a Severe COL4A5/A4/A3 Mutation.

V. Gillion,¹ K. Dahan,² E. Goffin,¹ J.-P. Cosyns,³ M. Jadoul,¹ M. De Meyer,⁴ M. Mourad,⁴ Y. Pirson,¹ N. Kanaan.¹
Graft and Patient Survival in Liver Transplantation for Primary Sclerosing Cholangitis with Organs from DCD versus DBD Donors: Analysis of the UNOS Database.

O. Mousa,¹ J. Corral,¹ M. Pang,¹ D. Lee,² J. Nguyen,² K. Croome,² D. Harnois.²
Graft-versus-Host Disease Following Deceased Donor Liver Transplant.

K. Putchakayala, S. Skorupski, S. Farhan, M. Chaffins, S. Ilias, H. Pahari, K. Collins, S. Nagai, M. Abouljoud.
Greater Emphasis on Non-Eligible Donors as a Strategy to Decrease the Organ Shortage.

K. Croome, D. Lee, A. Keaveny, C. Taner.
HCV Eradication with DAA Therapy Should Be Attempted Prior to Liver Transplantation and Does Not Impact HCC Recurrence.

J. Emamaullee, M. Bral, G. Meeberg, A. Montano-Loza, V. Bain, D. Bigam, N. Kneteman, A. Shapiro.
HLA Alloimmunization According to the Different Immunization Events and Consequences on Access to Kidney Transplantation.

V. Pernin,¹ A. Cros,¹ I. Szwarc,¹ C. Rene,² J.-F. Eliaou,² V. Garrigue,¹ G. Mourad,¹ M. Le Quintrec-Donnette.¹
HLA Class II Molecules Partner with TLR4 to Stimulate Endothelial Cell Activation and Proliferation.

Y.-P. Jin, E. Reed.
HLA Mismatching Does Not Have an Impact on Graft or Patient Survival in Simultaneous Kidney-Pancreas Transplantation. A Single Institution Experience.

I. Moinuddin, M. Yaqub, T. Taber, D. Mishler, M. Mujtaba, J. Powelson, O. Adebiyi, J. Fridell, A. Sharfuddin.
HLA, ANA, and ANCA Negative Vasculitis in Lung Transplantation Due to Overexpression of α1 Collagen V.

E. Daoud,¹ Y. Butt,¹ F. Torres,² T. Jose.¹
HLA-DPA1 and HLA-DPB1 Frequencies in the US Populations.

Z. Du, J. Patel, C. Braun, B. Norton.
Health Literacy, Functional Status and Transplant Eligibility Among Adult Liver Transplant Candidates.

M. Serper, K. Dwinnells, M. Wolf, K. Olthoff.
Healthcare Resource Utilization for Patients with Donor-Specific Antibodies Post-Kidney Transplantation.

B. Ho,¹ H. Bhagat,² E. Lee,^2,3 K. Atiemo,¹ A. Daud,¹ R. Kang,¹ S. Montag,^1,4 L. Zhao,^1,4 J. Schwartz,² D. Ladner.¹
Heat Shock Protein 90 Inhibitor, 17DMAG Suppresses Acute Allograft Rejection and Prolongs Allograft Survival in Solid Organ Transplantation.

T. Maehana, T. Tanaka, N. Masumori.
Hepatitis C Genotypes Among Deceased Organ Donors in the United States.

D. Goldberg,¹ V. Van Deerlin,¹ M. Farooqi,¹ A. Sicilia,¹ R. Hasz,² R. Bloom,¹ E. Blumberg,¹ C. Gentile,¹ P. Abt,¹ P. Reese.¹
Heterotopic Auxiliary Liver Transplantation(ALTx) – Revisited.

V. Kirchner, E. Minja, S. Chinnakotla, R. Kandaswamy, W. Payne, T. Pruett.
High Eomesodermin Expression Correlates with Potent Human Allo-Reactive CD8⁺ Effector T Cells.

A. Perez-Gutierrez, D. Metes, Y. Ono, A. Thomson, M. Ezzelarab.
High Risk Renal Transplant Recipients on Steroid Free Immunosupression Regimen. Indiana University Experience.

O. Adebiyi, S. Hussain, D. Mishler, W. Goggins, M. Yaqub, T. Taber, A. Sharfuddin.
Histone Deacetylase Inhibition Mitigates Liver Ischemia/Reperfusion Injury in Mice.

D. Murken,¹ D. Aufhauser Jr,¹ S. Concors,¹ Z. Wang,¹ G. Ge,¹ W. Hancock,² M. Levine.¹
Histone Methyltransferase EZH2 Was Involved in the Mechanism of let-7e Inhibition of TNF-α Expression.

J. Huang,^1,2,3 Y. Zhang,^1,2,3 Q. Zhang,^1,2,3 L. Gui,^1,2,3 Y. Cai,^1,2,3 X. Deng.^1,2,3
How Potential Living Kidney Donors (LKDs) View ESRD Risk: A Multi-Center Study.

C. Thiessen,¹ G. Gannon,¹ D. Gray,² K. Kennedy,³ D. Dobosz,¹ S. Li,¹ K. Yu,¹ A. Mussell,² E. Gordon,³ P. Reese,² S. Kulkarni.¹
Human IL-10 Transfection of Porcine Lungs Significantly Increases IL-10 Levels in Vascular Perfusate During Human Blood Perfusion.

C. Laird,¹ L. Burdorf,¹ X. Cheng,¹ N. O'Neill,¹ S. Sendil,¹ D. Parsell,¹ M. Cypel,² C. Phelps,³ D. Ayares,³ A. Azimzadeh,¹ R. Pierson.¹
Human Regulatory T Cells Undergo Self-Inflicted Damage via Granzyme Pathways Upon Activation.

J. Assaker, E. Karreci, F. Dotiwala, S. Routray, A. Kurdi, A. Mihali, T. Borges, A. Chandraker, L. Riella, R. Abdi, J. Lieberman, J. Azzi.
Hurdles to Broader Implementation of the A₂/A₂BàB Deceased Donor Kidney Allocation Provision.

I. Kim,¹ A. Wilk,² A. Robinson,² P. Martins,³ V. Whitaker,⁴ E. Ward,² C. Miles.⁵
Hypogammaglobulinemia in Pediatric Heart Transplant Candidates Is Not Corrected by Transplantation.

R. Madan,¹ R. Penkert,² J. Dara,¹ J. Lamour,¹ B. Herold,¹ J. Hurwitz.²
Hypothermic Pulsatile Machine Perfusion for Human Pancreas Preservation.

J. Branchereau, K. Renaudin, D. Cantarovich.
IL-3 Contributes to Development of Basophil-Triggered Cardiac Allograft Fibrosis Development.

G. Schiechl-Brachner,¹ M. Rodriguez Gomez,¹ K. Renner,¹ S. Buchtler,¹ K. Schmidbauer,¹ D. Halbritter,¹ S. Neumayer,¹ Y. Talke,¹ H. Bruehl,² M. Mack.¹
IL-33 Enhances the Ability of Dendritic Cells to Expand Human Regulatory T Cells.

Y. Zhao,¹ H. Zhang,¹ L. Mathews,¹ H. Turnquist,^1,2 A. Thomson.^1,2
IP-10 Monoclonal Antibody Treatment Suppresses Inflammatory Components of IBMIR and Improves Pancreatic Islet Graft Function.

G. Yoshimatsu,¹ C. Chang,¹ C. Darden,¹ P. Saravanan,¹ B. Naziruddin,² M. Lawrence.¹
IVIG + Rituximab as Desensitization Agents to Reduce Donor Specific Antibodies and Improve Transplant Rates in Highly Hla Sensitized (HS) Awaiting Deceased Donor Kidney Transplantation.

R. Najjar, E. Huang, A. Vo, J. Cho, S. Louis, A. Hang, A. Peng, S. Jordan.
IdeS, an IgG Endopeptidase, Effectively Cleaves Anti-HLA Antibody (Ab), Resulting in Inhibition of Anti-HLA Ab-Mediated NK Cell Activation and Ab-Dependent Cell-Mediated Cytotoxicity (ADCC) in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts).

S. Ge, M. Chu, J. Choi, S. Louie, A. Kang, A. Vo, A. Peng, S. Jordan, M. Toyoda.
Identification of Plasma Protein Biomarkers of Acute Renal Allograft Rejection.

M. Rossetti,¹ C. Fitzpatrick,¹ N. Harre,¹ Y. Zheng,¹ N. Mercer,² G. Sunga,¹ D. Gjertson,¹ E. Reed.¹
Identification of Promising Targets for Tolerance Induction Following Heart Transplantation.

K. Klaeske, M.-T. Dieterlen, J. Fischer, J. Hahn, K. Jawad, J. Garbade, F. Mohr, S. Lehmann.
Identification of a Stable Gene Signature of Transplant Tolerance to Liver Allograft by Meta-Analysis.

G. Gu, H. Hang, Q. Xia.
Identify Clinical and Masked Hypertension and Management Strategies in Pediatric Liver Transplant Patients.

R. Hendrickson, M. Davis, A. Sherman, W. Andrews, J. Daniel, R. Fischer, D. Blowey.
Identifying Independent Risk Factors for Graft Loss After Primary Liver Transplantation: A Propensity Score Matched Analysis.

J. Gwiasda, H. Schrem, A. Kaltenborn.
Identifying Risk of Sepsis Early: A Way to Improve Outcomes for Patients with Early Allograft Dysfunction After Liver Transplantation?

D. Hoyer, T. Benko, G. Sotiropoulos, A. Paul, F. Saner.
Identifying Risks and Screening Deceased Organ Donors in the UK for Trypanosoma cruzi .

I. Ushiro-Lumb,^1,2 M. Webster,¹ A. Kitchen.¹
Imaging Cell Biology in Transplantation.

T. Ueno,¹ M. McGrath,¹ M. Yeung,¹ K. Jung,² Y. Kihara,³ O. Konno,³ Y. Nakamura,³ H. Iwamoto,³ S. Yun,² A. Chandraker.¹
Immediate vs. Delayed Kidney Implantation Is Associated with Improved Kidney Graft Survival in Combined Liver-Kidney Transplantation.

J. Halldorson, S. Rayhill.
Immune Activation and Rejection Risk in HIV-Positive Kidney Transplantation.

S. Wisel, B. Shaw, L. Lee, K. Lee, C. Leung, P. Stock, Q. Tang.
Immune Monitoring-Guided Treatment of a Pediatric Patient with Sequential GvHD, Acute Rejection and CMV Infection Following Lung Transplantation.

C. Falk,¹ S. Nicolaus,² M. Carsten,² T. Igor,³ S. Wiebke,³ D. Kerstin,¹ K. Jana,² H. Gesine,² H. Axel,³ W. Gregor.³
Immune Tolerance Monitoring in Renal Allograft Tolerance Induced by Transient Mixed Chimerism in Nonhuman Primates.

K. Hotta, T. Oura, A. Dehnadi, K. Huh, M. Matsunami, G. Benichou, J. Madsen, A. Cosimi, T. Kawai.
Immunoregulatory Roles of CD137 Signaling in Graft-versus-Host Disease.

H. Cho,^1,2 J. Kim,¹ B. Kwon,^1,3 J. Lee,^1,4 K. Park.^1,4
Immunosuppressant Costs for Medicare Part D and Kidney Transplant Recipients Since the Introduction of Generic Formulations in an Incident Kidney Transplant Population.

M. Helmuth,¹ M. Turenne,¹ J. Park,² Q. Liu,¹ M. Oguntimein,³ S. Dutcher,³ R. Balkrishnan,⁴ J. Zee,¹ A. Smith,¹ A. Leichtman.¹
Immunosuppression (IS) Withdrawal (ISW) After ATG and Rituximab in Kidney Transplant Recipients (KTR): RESTARRT Early Results (NCT01318915).

B. Burrell,¹ J. Bromberg,² C. Hartono,³ A. Posselt,⁴ A. Naji,⁵ D. Kaufman,⁶ R. Redfield III,⁶ S. Kanaparthi,¹ D. Ikle,⁷ K. Much,⁷ N. Bridges,⁸ L. Sun,¹ A. Priore,⁸ M. DesMarais,¹ K. Crisalli,⁹ S. Chandran,¹ J. Markmann.⁹
Immunosuppressive Role of Pancreas Derived Mesenchymal Stem Cells.

M. Kanak,¹ F. Kunnathodi,² M. Levy,^1,3 M. Lawrence,² B. Naziruddin.⁴
Immunosuppressive Therapy and Acute Rejection in Combined Heart and Kidney Transplantation.

M. Gallo, J. Trivedi, D. Abramov, R. Vijayakrishnan, M. Slaughter.
Impact of Antibiotic Treatment Duration for Symptomatic Lower Urinary Tract Infections in Kidney Transplant Recipients.

S. Shaikh, S. Tischer, D. Kaul, A. Naik, M. Miceli, K. Gregg, N. Leja, T. Patel.
Impact of Body Mass Index and Waist Circumference in Kidney Transplant Recipients.

J.-E. Serre, M. Huet, I. Scwarc, V. Pernin, M. Le Quintrec, G. Mourad.
Impact of Caregiver on 30 Day Readmission After Lung Transplant.

T. Coco, C. Keller, F. Alvarez, D. Erasmus, J. Mallea.
Impact of Complement Component 3 Single Nuclear Polymorphisms on Renal Transplant Recipients with Antibody-Mediated Rejection.

Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.
Impact of Culture Expansion and Inflammatory Cytokine Challenge on DNA Methylation Profiles in MSC.

S. de Witte,¹ F. Peters,¹ A. Merino,¹ S. Korevaar,¹ S. Elliman,³ P. Newsome,² J. Meurs,¹ K. Boer,¹ C. Baan,¹ M. Hoogduijn.¹
Impact of Dialysis During the Transplant Admission on Transplant and Post-Transplant Cost of Care.

J. Tao,¹ C. Horstman,¹ W. Bannister,¹ M. Schnitzler,² F. Irwin,¹ A. Bonagura,¹ B. Laihinen.¹
Impact of Donor Genotype on Recipient Tacrolimus Pharmacokinetics: The Liver Matters.

S. Tremblay,¹ T. Fukuda,² T. Mizuno,² E. Woodle,¹ B. Abu Jawdeh,¹ A. Govil,¹ U. Christians,³ J. Klawitter,³ A. Vinks,² R. Alloway.¹
Impact of Early Pancreas Graft Failure on Patient and Kidney Graft Survival After Simultaneous Pancreas and Kidney Transplantation (SPK).

A. Gruessner, M. Laftavi, V. Whittaker, Z. Acun, O. Pankowycz, R. Gruessner.
Impact of Immunosuppression Adherence on De Novo Donor-Specific Antibody Formation in Renal Transplant Recipients in Canada: A Modeling Analysis.

J. Howell,¹ R. Pollock,² J. Schwartz.³
Impact of Induction Immunosuppression on the Recurrence of Primary IgA Nephropathy.

K. Lee, C. Cho, N. Lee, K. Kim, S. Kim, J. Lee, J. Lee, H. Park, J. Park, S. Kim.
Impact of Inflammatory Bowel Disease on Survival and Risk of Retransplantation of Primary Sclerosing Cholangitis Patients Following Liver Transplantation: UNOS Data Analysis.

O. Mousa,¹ N. Patel,¹ J. Corral,¹ D. Lee,² J. Nguyen,² K. Croome,² D. Harnois.²
Impact of Intensive Dosing of Mycophenolate on Pancreas Allograft Survival.

J. Fose,¹ K. Rolling,¹ N. Menninga,¹ G. Leverson,² M. Jorgenson,¹ J. Odorico,² R. Robert.²
Impact of NODAT on Post-Transplant Survival – An Analysis of UNOS Data.

N. Sarabu, S. Deo, S. Park.
Impact of Non-Adherence in a Cohort of Kidney Transplant Recipients.

M. Merino-López,¹ C. Flores-Gama.²
Impact of Pancreas Transplant Failure in Quality of Life in Simultaneous Kidney Pancreas Transplantation.

B. Alharbi, S. Aquil, H. Sharma, O. Ali, P. Luke, A. Sener.
Impact of Pancreatic Texture Assessment on Islet Isolation and Metabolic Outcome After TPIAT.

G. Yoshimatsu,¹ M. Khadka,¹ M. Lawrence,¹ B. Appakalai,² B. Naziruddin.³
Impact of Pediatric Lung Transplant on Quality of Life Outcomes.

T. Lazor,¹ H. Grasemann,^2,3,4 M. Solomon,^2,3,4 S. Anthony.^1,4,5,6
Impact of Polymorphisms of UGT 1 A9 on the Prognosis of Renal Transplant Patients. Association with Digestive Tumors.

N. Calvo, I. Perez-Flores, A. Shabaka, M. Moreno, B. Rodriguez-Cubillo, J. Delgado, M. Calvo, A. Sanchez-Fructuoso.
Impact of Pretransplant Panel-Reactive Antibody Level on Ocular Surface Stem Cell Survival and Visual Outcome.

A. Govil,¹ A. Cheung,² E. Sarnicola,² B. Genereux,² E. Holland.²
Impact of STEEN vs Gelofusine as Perfusate During Normothermic Ex Vivo liver Perfusion on Outcome of Pig Liver Transplantation.

I. Linares, D. Kollmann, J. Echeverri, M. Kaths, R. Rosales, C. Bruguera, M. Hamar, P. Urbanellis, S. Ganesh, N. Selzner, M. Selzner.
Impact of Serum EDTA Treatment on Identification of Unacceptable Antigens for Kidney Transplant Candidates.

J. Xin, N. Brown, R. Upchurch, J. Weidner, S. Marino.
Impact of Six-Month Surveillance Biopsies and Monitoring in Pediatric Renal Transplant Recipients.

J. Lyons,^1,2,3 D. Ranch,^1,2 R. Hall,^1,2,3 P. Maxwell,^1,2,3 K. Hitchman,^1,2 Y. Hirase,³ B. Crowther.^1,2,3
Impact of Type 2 Surgical Injuries in Postmortem Donor Kidneys on the Post-Transplant Outcomes When Compared to Mate Non-Injured Kidney from the Same Donor.

M. Mujtaba,¹ A. Gamilla-Crudo,¹ K. Gugliuzza,² O. Aleter,¹ S. Shah,¹ Y. Chapman,³ J. Reese,³ S. Masood,¹ T. Taber.⁴
Impact of Type of Kidney (Living vs. Deceased) on Urinary Podocyte Excretion Rate in Renal Allografts.

A. Naik, D. Luan, D. Cibrik, M. Samaniego, K. Woodside, M. Chowdhury, S. Wang, R. Wiggins.
Impact of Visceral and Subcutaneous Adipose Tissue on Post Donation Renal Function in Living Kidney Donors.

H. Lee,¹ S. Kang,¹ Y. Yoon,¹ K. Huh,² M. Kim,² S. Kim,² Y. Kim,² W. Han.¹
Impact of a Pharmacist-Led Vaccine Recommendation Program for Pediatric Kidney Transplant Candidates.

C. Carthon,¹ R. Hall,² P. Maxwell,² B. Crowther.²
Impairment of Glucose Tolerance After Pediatric Kidney Transplant Is Associated with Worse Systemic Insulin Sensitivity Rather Than Fall in Insulin Secretion.

D. Iwami, K. Hotta, H. Sasaki, T. Hirose, H. Higuchi, Y. Takada, N. Shinohara.
Implementing a New Specialist Requester Role to the United Kingdom to Address Consent Rates.

S. Duncalf, M. Ryan.
Implementing a Successful DCD Heart Programme to the United Kingdom.

M. Ryan, S. Duncalf.
Importance of HLA-DR Expression in Pediatric Renal Transplant Biopsies.

O. Moussa, S. Self, K. Twombley.
Improved Creatinine Immediately Post-LVAD Predicts Lower AKI Risk After Heart Transplant.

A. Nanavati,¹ Y. He,³ N. Moazami,² S. Demirjian,¹ B. Stephany.¹
Improved Method to Obtain High Islet Mass from Severely Fibrotic Pancreatitis Pancreases Intended for Clinical Islet Auto-Transplantation.

A. Balamurugan, G. Loganathan, W. Tucker, M. Dhanasekaran, S. Narayanan, A. Patel, S. Mokshagundam, S. Williams, M. Hughes.
Improved Mouse Renal Transplantation Model Simulating Clinical Antibody Mediated Rejection.

D. Zhao, S. Li, T. Liao, X. Hua, F. Han, Z. Luo, X. Liu, Q. Sun.
Improved Preservation During Normothermic Ex-Vivo Liver Perfusion with Delta Opioid Agonist (D-Ala2, D-Leu5) Enkephalin (DADLE).

E. Beal,¹ J. Kim,¹ D. Hayes Jr.,² K. Washburn,¹ B. Whitson,¹ S. Black.¹
Improvement of Cyclosporine A Dosing Strategy to Enhance Medication Adherence.

M. Barten,¹ E. Harmel,¹ M. Goldmann,¹ F. Wagner,¹ H. Reichenspurner,¹ M. Rybczynski.²
Improving Clinical Decisions for Kidney Transplant Recipients Through Online Medical Simulation.

S. Gitzinger, E. Jackson, D. Blevins.
Improving Vaccination Rates for Lung Transplant Candidates.

M. Cortez,¹ R. Bag,² L. Potter.¹
In Depth Characterization of Ex Vivo Expanded Polyclonal Regulatory T Cells Used in a Phase I Clinical Trial Following Kidney Transplantation.

J. Heinrichs,¹ J. Mathew,^1,2 I. Konieczna,¹ J. He,¹ X. Haung,¹ A. LeFever,¹ J. Leventhal.¹
In Depth Characterization of the Innate Immune Response in Transplant Recipients with EBV Viremia.

V. Ferreira, J. Batist, D. Kumar, S. Husain, A. Humar.
In Mid Wait Regions Shorter Height and Female Sex Confer Lower Probability of Liver Transplant (LT) Among Patients with Hepatocellular Carcinoma (HCC).

M. Sarkar, M. Kohi, J. Dodge, J. Roberts, N. Mehta.
In the Modern Era, Cytomegalovirus Does Not Appear to Increase Intimal Thickening After Heart Transplantation.

D. Leong, B. Azarbal, J. Patel, M. Kittleson, L. Czer, T. Aintablian, D. Chang, D. Geft, J. Kobashigawa.
Incidence and Clinical Outcomes of Mycobacterium tuberculosis Infections Following Renal Transplantation in Endemic Country.

K. Jutivorakool, J. Vanichanan, G. Suwanpimolkul, Y. Avihingsanon, N. Townamchai.
Incidence and Clinical Outcomes of Active Tuberculosis in Transplant Recipients from a Low Prevalence Region.

Y. Natori, A. Humar, S. Husain, D. Kumar.
Incidence and Outcomes of Immediate Post-Operative Dialysis in Liver Transplantation.

S. Nagai, M. Safwan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud.
Incidence and Outcomes of Re-Explorations in Living Donor Liver Transplantation.

V. Varma, S. Sable, S. Kapoor, A. Chauhan, V. Kumaran.
Incidence of Acute Rejection and Donor Specific Antibodies in Low-Immunological Risk Patients Treated by Tacrolimus and Mycophenolic Acid with or without Induction Therapy.

O. Marion,¹ A. Del Bello,¹ I. Ferrandiz,¹ L. Esposito,¹ N. Congy,² A.-L. Hebral,¹ N. Kamar.¹
Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA Sensitized Patients Given Tacrolimus Once or Twice Daily During the First Two Years Post-Transplantation.

N. Kamar, V. Hajj, I. Ferrandiz, E. Younes, L. Esposito, A. Hébral, A. Del Bello.
Incidence of Fungal and Viral Infections Following Rituximab Use in Kidney Transplant Recipients.

L. Wong, M. Ison, C. Richardson, K. Cunningham, C. D'Agostino, C. Tseng, A. Shetty.
Incidence of Late-Onset Complications Related to Immunosuppressive Drugs Following Adult to Adult Living Donor Liver Transplantation, Especially Focusing on De Novo Malignancy.

S. Mizuno, Y. Iizawa, H. Kato, Y. Murata, A. Tanemura, N. Kuriyama, M. Kishiwada, M. Usui, H. Sakurai, S. Isaji.
Incidence, Recurrence and Long Term Survival Post Chemotherapy in Renal Transplant Recipients with Post Transplant Lymphoproliferative Disorder: Single Center Study.

R. Rathore, K. Tomlinson, H. Dukka, D. Farrugia, M. Lambie.
Increased Expression of Fibrillin-1 and Presence of Fibroblastic Reticular Cells in Treg-Rich Organized Lymphoid Structures (TOLS) of Accepted Kidney Allografts.

A. Ayyar, C. Yang, D. Ndishabandi, R. White, P. Russell, J. Madsen, R. Colvin, A. Alessandrini.
Increased Pro-Inflammatory and Decreased Interferon-Related Gene Expression in Older as Compared with Younger Kidney Transplant Recipients.

J. Schaenman, O. Beiard, E. Liang, T. Sidwell, V. Groysberg, M. Rosetti, B. Abdalla, E. Lum, S. Bunnapradist, T. Pham, G. Dannovitch, J. Veale, H. Gritsch, A. Karlamangla, S. Cole, E. Reed.
Increased T Cell Exhaustion in Dialysis Patients.

M. Bastiaansen, A. Uffing, L. Riella.
Increasing Living Donation by Implementing the Kidney Coach Program.

D. LaPointe Rudow, S. Geatrakas, J. Armenti, A. Tomback, R. Shapiro.
Increasing the Kidney Donor Pool by Expanding Limits on Body Mass Index and Age: A Single-Center Evaluation of Safety for Donors and Recipients.

J. Tonascia, S. Yi.
Induced Pluripotent Stem Cell (iPS) Derived Schwann Cells to Enhance Functional Recovery Following Nerve Injury and Limb Allotransplantation.

B. Kern,¹ K. Sarhane,² Z. Ibrahim,² B. Mukherjee-Clavin,³ J. Budihardjo,² C. Cashman,³ K. Krick,⁴ S. Schneeberger,¹ W. Lee,² H.-Q. Mao,⁴ G. Lee,³ G. Brandacher.²
Induction Immunotherapy in ECD and DGF Kidneys: Does ECD Equal Diminishing Induction Returns?

M. Barrett, A. Smith, K. Woodside, R. Sung.
Induction Treatment with Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplant Recipients with Planned Early Steroid Withdrawal.

S. Gabardi.
Induction in the Elderly: A Comparison of Basiliximab versus Rabbit Anti-Thymocyte Globulin After Kidney Transplantation.

J. Lee, E. Liu, M. Aull, S. Kapur.
Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Non-Human Primates.

P. Alonso-Guallart,¹ R. Duran-Struuck,¹ J. Stern,¹ S. Kofman,¹ M. Danton,¹ J. Zitsman,¹ Y. Kato,¹ E. Berglund,¹ H. Sondermeijer,¹ A. McMurchy,² M. Levings,² M. Sykes,¹ A. Griesemer.¹
Induction of Tolerance to Renal Allografts in Non Human Primates by Concomitant Donor-Matched Vascularized Osteomyocutaneous Allotransplantation.

F. Zhong,¹ G. Zhao,² Y. Wang,³ J. Jiang,³ Y. Wang,¹ S. Ye,¹ S. Tao,¹ L. Cai,¹ X. Wang,¹ Q. Ye,¹ G. Chen,² X. Zheng.¹
Infections and Outcomes in Renal Transplantation Patients Using Alemtuzumab for Induction Immunosuppression: Preliminary Results.

K. Korneffel, B. Gehring, G. Mitro, O. Aboderin, S. Makkar, W. Han, M. Rees, J. Ortiz.
Infectious Complications Following Hepatectomy for Pediatric Hepatoblastoma.

S. Commander, M. Kueht, T.-A. Ha, A. Rana, J. Goss, S. Vasudevan.
Inferior 10-Year Graft and Patient Survival After End-to-Side Reconstruction for Two Renal Arteries in Living Donor Renal Transplantation.

S. Yamanaga,^1,2,3 A. Posselt,¹ C. Freise,¹ C. Niemann,¹ A. Rosario,¹ D. Fernandez,¹ T. Kobayashi,³ A. Ahearn,⁴ M. Tavakol,¹ S.-M. Kang.¹
Inflammation, Impaired Energy Metabolism and Synthetic Failure Characterize the Liver Transcriptome of End-Stage Idiopathic Pediatric Acute Liver Failure (PALF).

M. Ningappa,¹ P. McKiernan,² R. Squires,² Q. Sun,¹ B. Higgs,¹ K. Soltys,¹ G. Bond,¹ C. Ashokkumar,¹ G. Mazariegos,¹ R. Sindhi.¹
Influence of Tacrolimus Metabolism Rate on Patients' Survival After Renal Transplantation.

G. Thölking, J. Steinke, K. Schuette-Nuetgen, H. Pavenstädt, B. Suwelack, S. Reuter.
Inhibition of Bruton Tyrosine Kinase Blocks Sensitization in Response to Allogeneic Skin Transplantation and Prolong Skin Graft Survival.

N. Datta, T. Palumbo, J. Kupiec-Weglinski, A. Zarrinpar.
Inhibition of Heat Shock Protein 90 Suppresses the Expression of MHC Class I Molecules, but Not MHC Class II Molecules, on Endothelial Cells in Allografts.

T. Tanaka, T. Maehana, N. Masumori.
Inhibition of Memory T Cell Alloresponses by TIM-1+ B Cells.

B. Gonzalez-Nolasco, H. Tector, J. Markmann, G. Benichou.
Initial Experince with Total Pancreatectomy-Islet Auto-Transplantation (TP-IAT) for Chronic Pancreatitis at the University of Louisville.

M. Hughes,¹ E. Davis,¹ S. Mokshagundam,² W. Tucker,¹ G. Logananthan,¹ S. Williams,³ B. Appakalai.¹
Insulin Therapy in Pancreas Donors as a Predictor of Subsequent Transplant Outcome.

I. Shapey,¹ H. Khambalia,² A. Summers,² T. Augustine,² M. Rutter,¹ D. van Dellen.¹
Integrated Magnetic-Electrochemical Exosome (iMEX) Technology to Detect Rejection in Kidney Transplant Recipients.

J. Assaker, J. Park, S. Routray, S. Eskandari, H. Lee, J. Azzi.
Integrative Analysis of ExomeSeq and Gene Expression Data for Identification of Novel Variants Associated with Antibody-Mediated Rejection in Kidney Transplant.

S. Pineda,^1,2 T. Sigdel,² A. Jackson,³ M. Sirota,^1,2 M. Sarwal.²
Interruption of RAAS in Hypertensive Proteinuric Kidney Donors.

O. Sanchez,¹ L. Ferrara,¹ D. Berglund,¹ A. Matas,² R. Foley,¹ H. Ibrahim.¹
Intraomental Non-Purified Islet Transplantation Isolated from DCD Donor Pancreas.

S. Wang, G. Pei, Y. Liu, Z. Wang, B. Zhang, Y. Xie, J. Wang, Z. Shen.
Intraoperative Fluid Management During Pediatric Kidney Transplantation with Less Than 15kg Body Weight Using Transesophageal Echocardiaography as Hemodynamic Parameter.

Y. Watarai,¹ S. Narumi,¹ R. Kimura,¹ K. Hatazoe,¹ M. Okada,¹ K. Futamura,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ Y. Goto.²
Is It Safe to Use Older Donor Liver Grafts for Older Recipients?

M. Safwan, K. Collins, K. Takahashi, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Is Lung Allocation Score Associated with Waitlist and Post-Transplant Survival?

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.
Is Once-Daily Extended-Release Tacrolimus Better Than Twice-Daily Standard-Release Tacrolimus? A Meta-Analysis of Randomized Controlled Trials.

G. Gu, H. Hang, Q. Xia.
Is There a Role for Electronic Health Service in of Therapeutic Drug Monitoring of Immunosuppression?

M. Barten,¹ I. Hausladen,² F. Mohr, J. Garbade.
Is There a [bdquo]Weekend Effect“ in Kidney Transplantation? – A Single Center Study.

K. Schütte-Nütgen, G. Thölking, H. Pavenstädt, B. Suwelack, S. Reuter.
Is Thymic Function Determining Rejection Onset in Heart Transplantation?

A. Sannier,^1,2 R. Dorent,^1,3 M. Le Borgne,¹ N. Stroumza,¹ J. Senemaud,¹ L. Louedec,¹ F. Andreata,¹ A. Gaston,¹ C. Deschildre,¹ P. Nataf,^1,3 A. Couvelard,² G. Caligiuri,¹ A. Nicoletti.¹
Is the Time of Appearance and Resolution of De Novo HLA-DP Donor Specific Antibodies Associated with Reduced Deleterious Effect on Lung Transplant Outcomes?

A. Zhang,¹ Y. Sun,² K. McCurry,³ M. Budev.³
Isoflurane Precondition Alleviated Murine Liver Ischemia and Reperfusion Injury by Restoring AMPK/mTOR-Mediated Autophagy.

Z. Rao,¹ H. Zhou,² X. Pan,¹ M. Gao,¹ Z. Wang,¹ J. Sun,¹ C. Liu,¹ Z. Ding.¹
Isolated Angiotensin II Receptor Type I Antibodies (AT1R) Are Not Associated with Active Antibody Mediated Rejection (ABMR) in Pediatric Renal Transplant Recipients.

J. Choi, M. Haas, X. Zhang, O. Aubert, H. Pizzo, E. Kamil, K. Irene, S. Jordan, D. Puliyanda.
It's Never too Early to Test: Frequent Anti-A₂ Titer Monitoring in Blood Group B Patients is Necessary.

S. Radomski, S. Rosen-Bronson, B. Diedrich, A. Langeberg, D. Li, M. Awwad, M. Grafals, M. Cooper, A. Gilbert.
Kidney Donation After Brain Death Followed by Circulatory Death Confers Comparable Outcomes with Kidney Donation After Brain Death.

Q. Sun,¹ Q. Sun,¹ H. Zhou,² R. Cao,³ M. Lin,⁴ X. Hua,¹ L. Hong,¹ Z. Huang,¹ N. Na,¹ R. Cai,⁴ G. Wang,² F. Meng.³
Kidney Insertion Through Vagina and Robotic Assisted Laparoscopic Kidney Transplantation: A Pilot Study.

P. Modi,¹ B. Pal,¹ S. Kumar,¹ R. Nagarajan,¹ V. Kothari,¹ M. Modi,² V. Shah,² V. Kute,³ H. Patel,³ H. Trivedi.³
Kidney Re-Transplant Rate in Simultaneous Kidney Pancreas Transplant Recipients.

M. McCormick, J. Luo, A. Hoffman.
Kidney Re-Transplantation (KRTx) from Donation After Cardiocirculatory Death (DCD)-Standard Criteria Donors (SCD).

M. Khan, B. Alradawna, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, A. Palanisamy, M. Gautreaux, W. Doares, S. Kaczmorsky, R. Stratta.
Kidney Recipients with 10 Year Belatacept-Treatment Display an Altered T Cell Subset Composition and Low Plasma Cytokine Levels Compared to Matched Patients with CNI-Based Immunosuppression.

C. Falk,¹ C. Neudörfl,¹ A. Scherf,¹ K. Daemen,¹ J. Keil,¹ J. Klempnauer,² F. Lehner,² G. Grannas.²
Kidney Size Does Not Matter: Should the Decision to Split Pediatric En Bloc Donor Kidneys Be Based on Donor Weight Rather Than Kidney Length?

A. Perry, J. Woloszyn, J. McVicar, J. Sageshima, R. Perez, C. Troppmann, C. Santhanakrishnan.
Kidney Transplantation Outcomes from Donors with Acute Kidney Injury.

S. Channapatna Suresh, M. Lubetzky, J. Graham, A. Chokechanaisakul, O. Mohammed, M. Kinkhabwala, E. Akalin, J. Rocca, P. Bedi.
Kidney Transplantation in Octogenarians: The Mayo Clinic Experience.

N. Khoury, T. Schwab, M. Prieto, H. Amer.
Kidney Waitlist Management: The Readiness Model of Predicting Transplants Under the Kidney Allocation System.

N. Elias, B. Kimball, L. Walsh, D. Wojciechowski, J. Markmann, E. Heher.
Kinetics of Liver regeneration in Donors After Living Donor Living Transplant.

S. Sable, S. Maheshwari, R. Jadhav, K. Yadav, S. Sharma, S. Kumar, A. Chouhan, S. Kapoor, V. Varma, V. Kumaran.
Knowledge of Chronic Kidney Disease Among Liver Transplant Patients.

J. Park, C. Koerschner, S. Selman, J. Mawby, S. Paknikar, C. Sonnenday, J. Wright Nunes, P. Sharma.
Lack of Xenograft Recipient Monitoring by Telemetry Lets Infection Go Unchecked and Trigger Coagulopathy.

M. Mohiuddin,¹ A. Singh,¹ J. Chan,¹ P. Corcoran,¹ B. Lewis,² M. Thomas,² D. Ayares,³ K. Horvath.¹
Lactate Level Immediate Post-Liver Transplantation Is a Predictor of Early Allograft Dysfunction.

K. Takahashi,^1,2 S. Nagai,¹ M. Safwan,¹ K. Putchakayala,¹ K. Collins,¹ M. Rizzari,¹ A. Yoshida,¹ M. Abouljoud,¹ S.-M. Jafri.³
Landscape of Multiple Donations from a Living Donor in the US.

A. Thomas,¹ A. Massie,¹ J. Garonzik-Wang,¹ K. Lentine,² M. Henderson,¹ D. Segev.¹
Life Confocal Imaging of Murine Liver Biopsies as Novel Tool to Assess Graft Viability Prior to Transplantation.

R. Oberhuber, M. Fodor, B. Cardini, M. Maglione, M. Hermann, J. Troppmaier.
Limited Impact of Pre-Existing Donor Specific HLA Antibodies on Long Term Survival After First Adult Liver Transplantation.

M. Koch,¹ M. Marget,² M. Sterneck,³ H. Thude,¹ B. Nashan.¹
Lipid Abnormalities and Cardiovascular Events After Early Conversion to Everolimus in Kidney Transplant Recipients with Pretransplant Diabetes: 24-Month Analysis from Elevate Study.

M. van der Giet,¹ J. de Fijter,¹ F. Oppenheimer,¹ G. Russ,¹ P. Lopez,² G. Bader,² J. Cruzado,¹ H. Holdaas.¹
Lipid Catabolism Provides Alternative Energy Source and Compensates for Mitochondrial Dysfunction in Reperfused Rat Kidneys After Ischaemia.

H. Huang,^1,2 L. van Dullemen,³ M. Akhtar,¹ M. Lo Faro,^1,2 A. Dona,⁴ M. Kaisar,^1,2 H. Leuvenink,³ B. Kessler,² R. Ploeg.¹
Live Donor (LDTx) HIV(+) Kidney Transplantation Improves Allograft Survival vs. Deceased Donor (CRD) Transplantation.

G. Malat, D. Lee, K. Ranganna, S. Talluri, L. Levin Mizrahi, M. Harhay, C. Culkin, S. Guy.
Liver Allograft Hepatitis and Graft Loss After Hepatitis C Clearance.

D. Bruno, S. Brown, S. Hanish, J. LaMattina, W. Hutson, S. Kottilil, W. Twadell, R. Barth.
Liver Targeted Expression of a Single Allogeneic MHC I Molecule Promotes Tolerance to Pancreatic Islet Allograft by Inducing Specific CD8+ Regulatory T Cells in Mice.

V. Le Guen,^1,2 J.-P. Judor,^1,2 V. Gauttier,^1,2 N. Ferry,³ J.-P. Soulillou,^1,2 S. Brouard,^1,2 S. Conchon.^1,2
Liver Transplant Recipients Undergoing Non-Transplant Surgeries and Everolimus Use as Primary Immunosuppressant- Busting the Myth of Wound Infection Due to mTOR Inhibitors.

S.-C. Hsu, A. Thorat, L.-B. Jeng, H.-R. Yang, P.-C. Li, C.-C. Yeh, T.-H. Chen, K.-S. Poon.
Liver Transplantation Beyond MELD 40.

J. Scalea, D. Bruno, S. Hanish, J. Lamattina, J. Alvarez-Casas, S. Malik, A. Cimeno, S. Bartlett, R. Barth.
Liver Transplantation Outcomes Using Anti-Thymocyte Globulin Induction in Patients with Autoimmune Hepatitis.

S. LeCorchick, A. Sharma, I. Yakubu, C. Bhati, T. Reichman, L. Kang, M. Levy.
Liver Transplantation Tolerance Using Outbred Mice.

M. Morita,¹ C. Miller,² J. Fung,³ L. Lu,^1,2 S. Qian.^1,2
Liver Transplantation Using Pediatric versus Adult Donor Grafts in Adult Recipients.

Z. Guo, Y. Tang, X. He, G. Chen.
Liver Transplantation for Adolescents with Biliary Atresia in the PELD/MELD Era: An Analysis of the UNOS Database.

J. Chu,^1,2 R. Annunziato,³ D. Reinoso,³ A. Ramaswami,² R. Arnon.^1,2
Liver Transplantation for Babies Weighing Less Than 10 kg.

A. Akdur,¹ G. Moray,¹ F. Ozcay,² A. Torgay,³ M. Haberal.¹
Living Donor Liver Transplantation for Alcoholic Liver Disease.

H. Braun, J. Dodge, J. Roberts, N. Ascher.
Long Term Outcomes of Adult Kidney Transplants from Small Single Pediatric Donors Are Equivalent to Standard Criteria Donors.

R. McMillan, K. Gray, T. Khader, A. Jabri, J. Kim, A. Watkins.
Long-Term Analysis of Combined Liver-Lung Transplant Outcomes at a Single-Center.

K. Freischlag,¹ B. Ezekian,² M. Mulvihill,² S. Knechtle.²
Long-Term Clinical Outcomes of Kidney Transplant Recipients with Body-Size Mismatch Between Recipient and Donor.

Y. Takada,¹ D. Iwami,¹ K. Hotta,¹ K. Kanagawa,² H. Higuchi,¹ T. Hirose,¹ H. Sasaki,¹ N. Shinohara.¹
Long-Term Follow-Up of the Safety and Effects of Bariatric Surgery on Immunosuppression in Post-Transplant Patients.

A. Keidar,¹ R. Yemini,¹ I. Carmeli,¹ E. Nesher,² J. Vinkler,² E. Mor,² M. Bendavid.¹
Long-Term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology.

E. Lorenz, B. Smith, F. Cosio, N. Shah, P. Groehler, J. Verdick, W. Park, M. Stegall.
Long-Term Malignancy Risk in Kidney Transplant Recipients Treated with Cyclophosphamide Pre-Transplant for Native Glomerular Disease.

J. Mills,¹ M. Jorgenson,¹ J. Fose,¹ B. Astor,² S. Panzer.²
Long-Term Outcomes Among Slow versus Delayed or Immediate Graft Function Kidney Transplant Recipients: A Single-Center Experience.

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Long-Term Outcomes in HIV(+) Kidney Re-Tranpslant (ReTx) Recipients vs. Primary Transplant (PrimTx) Recipients.

G. Malat, S. Guy, K. Ranganna, D. Reich, G. Xiao, S. Talluri, M. Harhay, L. Levin Mizrahi, C. Culkin.
Long-Term Outcomes of Kidney Transplant Recipients with Primary Idiopathic Focal Segmental Glomerulosclerosis (FSGS).

D. Khadzhynov, F. Halleck, L. Lehner, E. Schrezenmeier, K. Budde, O. Staeck.
Long-Term Pediatric Live-Donor Liver Transplantation Survivors: Patient and Allograft Outcomes.

N. Celik,¹ A. Ganoza,¹ G. Bond,¹ K. Soltys,¹ R. Sindhi,¹ P. McKiernan,³ A. Humar,² G. Mazariegos.¹
Long-Term Persistence of Anti-HLA Antibodies in Renal Trasplant Recipients: Risk Factors and Impact on Clinical Course.

I. Perez-Flores,¹ J. Santiago,² B. Rodriguez-Cubillo,¹ M. Moreno De La Higuera,¹ V. Lopez De La Manzanara,¹ J. Bautista-Cañas,¹ N. Calvo Romero,¹ A. Shabaka,¹ E. Urcelay,² A. Sanchez-Fructuoso.¹
Long-Term Preservation of Renal Function in Liver Transplant Recipients with Rabbit Anti-Thymocyte Globulin Induction and Delayed Initiation of Calcineurin Inhibitors.

I. Bajjoka, A. Yaldo, C. Crombez, K. Brown, M. Abouljoud.
Longer Anastomotic Time Leads to Delayed Graft Function.

M. Heer,^1,2 P. Trevillian,^1,2,3 A. Hibberd.^1,2,3
Longer Ischemic Time Is Associated with Late Graft Dysfunction in Pediatric Heart Transplant Recipients.

L. Schroeder,¹ S. Chowdhury,¹ A. Burnette,¹ H. Baker,¹ A. Savage,¹ A. Atz,¹ R. Butts.²
Loss of Bat3 Could Promote Transplant Tolerance by Regulating CD4 ⁺ T Cells Function.

G. Gu, H. Hang, Q. Xia.
Low Level Early Onset De Novo DSA's May Not Portend Early Graft Dysfunction in Kidney Transplant Recipients.

M. Abate, Y. Nigatu, B. Ryu, F. Darras, R. Jafrin, H. Suh, C. Estrada, E. Nord.
Low Level Light Laser Treatment Reduces Macrophage Retention and ROS Levels Following Tissue Injury.

A. Paredes,¹ D. Benavidez,¹ R. Patil,¹ B. Khalil,¹ M. Mitchell,¹ J. Cheng,¹ S. Mangos,² A. Bartholomew.¹
Lower Rates of Living Donation Among Transplant Centers Located in the Stroke Belt.

R. Reed, B. Shelton, P. MacLennan, M. Hanaway, V. Kumar, R. Gaston, J. Locke.
Lung Preservation Solution Exposure at Cardiac Procurement Is Associated Increased Incidence of Coronary Arterial Vasculopathy.

H. Copeland,¹ V. Garcia,² A. Sima,² D. Baran,³ A. Mankind,⁴ G. Katlaps,¹ N. Lewis,⁴ B. Dharmaj,¹ J. Copeland.⁵
Lung Transplant Recipient Travel Distance to Transplant Center Does Not Impact Survival.

W. Tsuang,¹ S. Lin,² J. Schold,² M. Valapour.¹
Lymphoid Isolation as an Adjuvant Maneuver for Belatacept-Based Immunotherapy.

M. Mulvihill,¹ K. Samy,² R. Davis,¹ F. Leopardi,¹ B. Collins,¹ A. Kirk.¹
Lymphoproliferative Disorders After Renal Transplantation Along Two Decades: A Large Longitudinal Study.

A. Franco,¹ D. Hernandez,² N. Maruri,³ A. Alonso,⁴ M. Crespo,⁵ A. Mazuecos,⁶ C. Diaz-Corte,⁷ M. Gentil.⁸
M1 Macrophage-Induced Loss of KLF15 Promotes Chronic Podocyte Injury.

S. Han,^1,2 Y. Kim,¹ S. Lee,¹ H. Lee,^1,2 R.-H. Cha,² J. Lee,^1,2 J. Lee,² D. Kim,^1,2 Y. Kim,^1,2 S. Yang.^1,2
MERTK Mediates Transplantation Tolerance via Inhibition of TBK1 Phosphorylation and IFN-a Production.

L. Zhang,¹ M. DeBerge,² X. Zhang,³ J. Wang,³ Z. Zhang,³ E. Thorp,² X. Luo.^1,2,3
MMR and Varicella Immunity After Pediatric Liver Transplant.

A. Waugh,¹ A. Opekun,^1,2 F. Munoz,² T. Miloh.²
Malignancy in Patients Undergoing Simultaneous Heart-Liver and Heart-Kidney Transplant.

A. Chin, A. Habertheuer, A. Chou, M. Acker, M. Williams, P. Atluri, C. Bermudez, P. Vallabhajosyula.
Manning the Gap: Using Technology to Reduce Barriers in Access to Renal Transplantation Waiting List Across Dialysis Facilities.

G. Ferreira,¹ K. Bastos,² E. Barbeta,² B. Pereira,² G. Souza,¹ M. de Souza,¹ V. Colares.¹
Measurement of Dissolved Oxygen by ¹⁹F MRI of Microcapsules Implanted IP in Non-Human Primates.

S. Safley,¹ M. Graham,² M. Garwood,³ K. Papas,⁵ B. Weegman,^3,4 G. Barber,¹ E. Lin,¹ J. Leisen,⁷ A. Sambanis,⁶ B. Hering,² C. Weber.¹
Mechanisms of Fibrosis in the Allograft Kidney: RNA-seq Based Analysis Using Formalin Fixed Biopsies.

G. Zeng,² L. Pan,¹ Z. Lyu,¹ Y. Huang,² P. Randhawa.²
Mechanistic Insights by RNA Profiling on Rejecting Vascularized Composite Allotransplants.

H.-Y. Cheng,¹ S.-C. Liu,² C.-F. Lin,¹ L.-Y. Shih,³ F.-C. Wei.^1,2,3
Medical Mistrust, Perceived Racism, and Experiences of Medical Discrimination Among Transplant Patients.

R. Hamoda, K. Lipford, L. McPherson, J. Gander, R. Patzer.
Medication Adherence and Medicare B Coverage Among Transplant Recipients.

S. Boghani, H. Kirkham, Z. Berry, M. Kang.
Memory T Cells Are Decreased in Transplant Recipients Deficient in miR-182.

V. Kaul, L. Wei, X. Qu, O. Martinez, S. Krams.
Metabolomics Study for Identification of Potential Biomarkers of Long-Term Survival in Kidney Transplantation Recipients.

C.-D. Kim, H.-Y. Jung, R.-H. Kim, S.-M. Park, J.-H. Park, K.-H. Lee, E.-S. Lee, K.-Y. Kim, J.-Y. Choi, J.-H. Cho, S.-H. Park, Y.-L. Kim.
MicroRNAs and Long Non-Coding RNAs as Potential Novel Biomarkers in Transplanted Patients with Candida Infection.

A. Yang,¹ C. Zhou,² D. Li,³ W. Ju,¹ Z. Guo,¹ L. Wu,¹ A. Hu,¹ Y. Ma,¹ D. Wang,¹ X. Zhu,¹ X. He.¹
Microvascular Inflammation at 4 Months Posttransplant Is Associated with Transplant Glomerulopathy at One and Two Years Independent of Rejection and Donor Specific Antibodies.

H. Khamash, G. Mour, L. Archambault, M. Buras, H. Kosiorek, M. Pando, K. Reddy, H. Chakkera, J. Huskey, S. Nair, A. Jaramillo, M. Smith, B. Kaplan, R. Heilman.
Mitochondrial Dysfunction Is a Common Feature of Injury in Donor Kidneys After Brain and Circulatory Death.

M. Lo Faro,¹ M. Akhtar,¹ H. Huang,¹ M. Kaisar,¹ R. Rebolledo,² K. Morten,¹ L. Heather,¹ A. Dona,³ H. Leuvenink,² S. Fuggle,¹ B. Kessler,¹ C. Pugh,¹ R. Ploeg.¹
Mitochondrial Permeability Can Regulate Endothelial Cell Necroptosis and Promote Cardiac Allograft Rejection.

I. Gan,^1,2 J. Jiang,¹ D. Lian,¹ A. Jevnikar,^1,3 Z.-X. Zhang.^1,2
Model to Predict Prolonged Delayed Graft Function (DGF) Following Kidney Transplantation from Deceased Donor with Acute Kidney Injury (AKI Tx).

R. Heilman,¹ B. Smith,² C. Johnson,¹ H. Khamash,¹ K. Reddy,¹ W. Kremers,² B. Kaplan.¹
Modification of Human Endothelial Cells by CRISPR/Cas9-Mediated Ablation of Class I and II Major Histocompatibility Complex Antigen Expression.

J. Merola, C. Anderson, H. Xu, T. Manes, J. Pober.
Modular Training in Organ Procurement, in the Present Era of High BMI Donors: Validation by Results.

H. Sharma, M.-T. Abraham, I. Al Hasan, B. Al-Harbi, S. Aquil, A. Sener, P. Luke, D. Quan.
Molecular Adsorbent Recirculating System (MARS) Effectively Replaces Hepatic Function in Severe Acute Liver Failure.

S. Hanish,¹ R. Barth,¹ D. Stein,² E.-O. Essien,¹ P. Thurman,² T. Scalea,² S. Bartlett.¹
Molecular Classifier of Antibody-Mediated Rejection Is a Better Predictor of Histologic Rejection Than a Corresponding Transcript Set and Is Further Improved When Combined with Classifiers of Rejection Syndromes.

K. Famulski, P. Halloran.
Molecular Significance of Peritubular Capillaritis in Early Transplant Kidney Biopsies of Donor-Specific Antibody Negative Patients.

M. Ajaimy, P. O Broin, Y. Bao, E. Akalin.
More Than Renal Function: Use of Belatacept to Improve Drug Toxicities.

E. Cohen,¹ B. Knight,³ W. Asch.²
Multi-Stakeholder Perspectives on the Importance of Outcomes for Trials in Kidney Transplantation: An International Best Worse Scaling Survey.

M. Howell,^1,2 N. Evangelidis,^1,2 B. Sautenet,² G. Wong,^1,2,3 J. Craig,^1,2 K. Howard,¹ A. Tong.^1,2
Multidisciplinary Psychosocial Liver Transplant Evaluation in Patients with Alcoholic Liver Disease – Moving Beyond the Six-Month Rule.

K. Wenzke,¹ S. Kelly,² J. Eickhoff,³ M. Lucey,¹ J. Rice.¹
Muscle Mass Is Predictive of Mortality in Obese Renal Transplant Patients.

J. Souweine,^1,3 M. Le Quintrec,¹ I. Szwarc,¹ V. Pernin,¹ G. Mourad,¹ J. Cristol,^2,3 J. Serre.¹
Myeloid HO-1 Regulates M2 Macrophage Activation in Liver Ischemia-Reperfusion Injury (IRI).

K. Nakamura,¹ M. Zhang,² S. Kageyama,¹ B. Ke,¹ R. Sosa,³ E. Reed,³ A. Zarrinpar,¹ R. Busuttil,¹ J. Araujo,² J. Kupiec-Weglinski.¹
Myocardial Improvement Six Months After Kidney Transplantation: Non-Contrast Cardiac Resonance Study.

M. Contti, L. Morales-Buenrostro, H. Nga, P. Garcia, M. Barbosa, H. Takase, M. da Silva, A. Moyses.
NAFLD in Kidney Transplant Candidates.

N. Kemmer, J. Buggs.
NFAT-Regulated Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Recipients – A Randomized Controlled Trial.

A. Webber,¹ V. Tatapudi,² C. Leung,³ F. Vincenti.^1,3
NK Cells Respond to CMV Lysate by Inducing IFNγ and CD107a Surface Expression in an Antibody-Dependent Manner: This Represents a Cytokine Flow Cytometry (CFC) Assay That Could Assess Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) as a Marker of CMV Immunity in Transplant Recipients.

S. Ge, C. Maggie, B.-H. Shin, A. Karasyov, S. Jordan, M. Toyoda.
National Trends in Utilization of Donation After Cardiac Death Donor Livers for Transplantation.

S. Kubal,¹ R. Mangus,¹ B. Ekser,¹ R. Amos,² J. Fridell.¹
National Variation in Liver Transplant Immunosuppression in the U.S..

M. Nazzal,¹ R. Ouseph,¹ M. Schnitzler,¹ Z. Zhang,¹ D. Axelrod,² D. Segev,³ A. Naik,⁴ H. Randall,¹ D. Brennan,⁵ B. Kasiske,⁶ G. Hess,⁷ T. Alhamad,⁵ K. Lentine.¹
National Variation in US Kidney Transplant Induction Therapy.

V. Dharnidharka,¹ A. Naik,² T. Alhamad,¹ D. Axelrod,³ M. Schnitzler,^4,6 Z. Zhang,⁴ S. Bae,⁵ D. Brennan,¹ D. Segev,⁵ H. Randall,⁴ M. Nazzal,⁴ R. Ouseph,⁴ B. Kasiske,⁶ K. Lentine.⁴
Neighborhood Poverty and Racial/Ethnic Disparities in Access to Live Donor Kidney Transplantation in the US.

T. Purnell, X. Luo, D. Crews, S. Bae, L. Kucirka, L. Cooper, D. Segev.
Neurogenic Orthostatic Hypotension: An Iatrogenic Complication of Successful Pancreas Transplantation?

S. Kuten,¹ E. Simpson,¹ A. Gaber,¹ D. Nguyen,¹ E. Graviss,¹ S. Patel,² R. Knight.¹
Neuropeptide PACAP Prevents Hepatocyte Damage by Promoting Yes-Associated Protein (YAP) in Mouse Liver Ischemia/Reperfusion Injury.

Y. Liu,^1,2 C. Zhang,^1,3 R. Busuttil,¹ J. Kupiec-Weglinski,¹ Q. Xia,^1,2 H. Ji.¹
Next-Generation Sequencing-Based Exosome MicroRNA Profiling for Specific Identification of Islet Damage.

P. Saravanan,¹ J. Gu,¹ X. Wang,¹ P. Nguyen,¹ G. Yoshimatsu,¹ M. Lawrence,¹ B. Naziruddin.²
No Impact of One Year of Everolimus, as Compared to MPA, in the Reversal of Left Ventricular Hypertrophy in Elderly Renal Transplant Recipients – Preliminary Data from Then Everold Study.

E. David-Neto,¹ F. Agena,¹ M. Furtado,² A. Rodriges,² J. Andrade,² F. Lemos,¹ F. Paula.¹
Non-Directed Kidney Donor Candidate Referral, Care, and Attrition in an Online Portal.

R. Hays,¹ K. Schappe,¹ D. Kaufman,¹ D. Mandelbrot.²
Non-Donor-Specific Anti-HLA Antibodies Have an Adverse Impact in Kidney Graft Outcomes.

J. Malheiro,¹ S. Tafulo,² L. Dias,¹ L. Martins,¹ I. Beirão,¹ A. Castro-Henriques.¹
Non-Human Primate Auto-Immune Responses to Col V, Kα-1Tubulin and Vimentin Are P2X7R Dependent.

J. Sullivan,¹ E. Jankowska-Gan,¹ D. Kaufman,¹ L. Denlinger,² W. Burlingham.¹
Non-Medical Factors Contributing to Racial Disparity in Kidney Transplant Wait-Listing.

Y.-H. Ng,¹ S. Pankratz,¹ K. Bornemann,² E. Croswell,² J. Pleis,² R. Shapiro,³ M. Unruh,¹ L. Myaskovsky.²
Noninvasive Renal Transplant Graft Monitoring in Single Institution Using Cell-Free DNA in Recipient Plasma via Insertion-Deletion Allele Polymorphism.

Y. Goh,¹ S. Ho,² L. Raman,¹ V. Anantharaman,³ T. Goh,³ S. Koay,² H. Tiong.¹
Normothermic Ex-Vivo Kidney Perfusion Improves Function of Extreme Marginal Renal Grafts Subjected to Prolonged Ischemia.

P. Urbanellis,¹ M. Hamar,¹ I. Linares,¹ D. Kollmann,¹ C. Cassol,² R. John,² P. Yip,¹ I. Mucsi,¹ A. Ghanekar,¹ D. Bagli,³ D. Grant,¹ L. Robinson,⁴ M. Selzner.¹
Novel Application of Localized Nanodelivery of Anti-IL6 Protects Organ Transplant from Ischemia Reperfusion Injuries.

M. Uehara,¹ Z. Solhjou,¹ B. Bahmani,¹ O. Maarouf,¹ T. Ichimura,² C. Brooks,² W. Xu,¹ V. Kasinath,¹ N. Banouni,¹ A. Elkhal,³ I. Guleria,² M. McGrath,¹ S. Tullius,³ R. Abdi.¹
Novel Biomarkers for Segregating Lung Transplant Rejection Phenotypes.

J. Yang,¹ B. Vanaudenaerde,² T. Sigdel,¹ J. Liberto,¹ S. Verlden,² M. Sarwal.¹
Novel Classification of Membranoproliferative Glomerulonephritis Pattern of Injury in Renal Allograft Based on Immunofluorescence Microscopy: Precise Diagnosis and Prognosis Analysis.

J. Wen, X. Li, M. Zhang, F. Xu, X. Ni, J. Chen, Z. Tang, Z. Liu.
Novel Insights into the Synergism of CD40 Autoantibodies and suPAR in Kidney Transplant Patients with FSGS Recurrence.

T. Sigdel, C. Wei, F. Vencenti, J. Reiser, M. Sarwal.
Nuclear Co-Repressor Complex Inhibition Reverses Benefit of HDAC2 Deletion in Renal Ischemia.

D. Aufhauser Jr,¹ D. Murken,¹ Z. Wang,¹ A. Samanta,² G. Ge,¹ T. Bhatti,³ P. Cole,⁴ J. Kalin,⁴ W. Hancock,^2,3 M. Levine.^1,5
Obese Kidney Donors: Impact of Opioid-Minimization Using Ketorolac-Based Pain Management Protocol Following Robotically Assisted, Laparoscopic Living Donor Nephrectomy.

M. Campara, B. Valdepenas, A. Virani, K. Galen, I. Tang, J. Oberholzer, E. Benedetti.
Obesity Is an Important Factor in Deceased but Not Living Donor Kidney Transplants.

A. Asderakis, A. Ilham, U. Khalid, R. Chavez.
Objective Assessment of Graft Metabolism and Function During Ex Vivo Liver Perfusion.

J. Echeverri,¹ S. Cleland,² M. Kaths,¹ I. Linares,¹ R. Roizales,¹ N. Goldaracena,¹ D. Kollmann,¹ M. Hamar,¹ P. Urbanellis,¹ S. Ganesh,¹ O. Adeyi,³ D. Grant,¹ N. Selzner,⁴ M. Wasowicz,² M. Selzner.¹
Omega 3 Attenuates Ischemia Reperfusion Renal Injury via Enhancement of Autophagy Flux.

J.-J. Kim,¹ J. Jeong,² D. Choi,³ K. Na,³ K. Lee.³
Once-Daily versus Twice-Daily Tacrolimus in Living Kidney Transplantation: A Multicenter, Parallel Group, Open-Label, 5-Year, Randomized Non-Inferiority Trial.

K. Unagami,¹ M. Okumi,² T. Hirai,² D. Toki,³ H. Shirakawa,⁴ T. Shimizu,² K. Omoto,⁵ M. Inui,³ H. Ishida,² K. Nitta,¹ K. Tanabe.²
One Year Outcomes of Low-Dose vs Very Low-Dose Extended-Release Tacrolimus/Mycophenolate mofetil in De Novo Kidney Transplantation: A Multi-Center Randomized Controlled Trial.

Y. Hidaka,¹ S. Yamanaga,¹ M. Toyoda,¹ S. Narumi,² Y. Watarai,² T. Kobayashi.³
Online Patient Resources for Deceased Donor and Live Donor Kidney Recipients: A Comparative Analysis of Readability.

E. Zhou, E. Kiwanuka, W. Cioffi, P. Morrissey.
Operational Tolerance in Intestinal Transplantation: A Proven Possibility.

B. Houlihan,¹ P. Cha,^1,2 C. Cosentino,^1,2 J. Kaiser,^1,2 A. Shukla,¹ J. Hawksworth,^1,2 C. Matsumoto,¹ T. Fishbein,¹ A. Kroemer.¹
Opioid and Opioid Substitution Therapy in Liver Transplant Candidates: A Survey of Center Policies and Practices.

J. Fleming,¹ J. Lai,³ H. Te,² A. Said,⁴ E. Spengler,⁴ S. Rogal.⁵
Optimal Induction Therapy for Kidney Transplantation in Previous Heart Transplant Recipients: Analysis of OPTN/UNOS Registry.

M. Sampaio, S. Hussain, B. Chopra, K. Sureshkumar.
Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetile Based Immunosuppression in De Novo Kidney Transplant Recipients: 2 Years Outcome.

Y. Watarai,¹ S. Narumi,¹ M. Okada,¹ R. Kimura,¹ K. Hatazoe,¹ K. Futamura,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ T. Kobayashi.²
Optimizing Support for Living Kidney Donors: Insights from a Prospective Study.

D. Dobosz,¹ C. Thiessen,¹ S. Li,¹ K. Yu,¹ J. Gannon,¹ K. Kennedy,³ D. Gray,² A. Mussell,² P. Reese,² E. Gordon,³ S. Kulkarni.¹
Optimizing Survival Outcomes for Advanced Age Patients Undergoing Liver Transplant.

J. Balogh, K. Lunsford, D. Nguyen, E. Gravis, A. Saharia, C. Mobley, S. Gordon Burroughs, O. Cercio, D. Victor, H. Monsour, A. Gaber, R. Ghobrial.
Ornithine Transcarbamylase Deficiency (OTC) in the Donor Liver, the Importance of Ascertaining the Cause of Death in the Brain Dead Donor.

M. George,¹ G. Thomas,¹ A. Shun,¹ M. Stormon.²
Outcome and Risk Factors of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation.

G. Chen, C. Wang, Z. Wu, J. Zhang, S. Yu, C. Wang, J. Qiu, L. Chen.
Outcome of Liver Transplantation in Patients with Prior Bariatric Surgery.

M. Safwan,¹ M. Abouljoud,¹ R. Salgia.²
Outcome of Systemic Monitoring of DSA and Protocol Management to Optimize Renal Allograft Outcome in a Single Transplant Center.

S. Chang,¹ I. Mallawaarachchi,² C. Yip,¹ T. Shanahan,³ A. Gundroo,¹ A. Dwivedi,² S. Patel,⁴ M. Zachariah.¹
Outcomes After Cholecystectomy in Patients with End Stage Renal Disease.

I. Olorundare, S. DiBrito, C. Holscher, J. Garonzik-Wang, D. Segev.
Outcomes After Hysterectomy in Patients with End Stage Renal Disease.

I. Olorundare, S. DiBrito, C. Haugen, J. Garonzik-Wang, D. Segev.
Outcomes After Lung Transplant: Being a Teenager Does Not Stop at Age 18.

R. Baker,¹ R. Rizwan,¹ R. Bryant III,¹ M. Schecter,² C. Towe,² J. Tweddell,¹ F. Zafar,¹ D. Morales.¹
Outcomes Following Colectomy in Liver Transplant Recipients.

S. DiBrito, Y. Alimi, C. Haugen, I. Olorundare, D. Segev, J. Garonzik-Wang.
Outcomes Following Reduction of Immunosuppression in Solid Organ Transplant Recipients with Cryptococcosis.

P. Bryant,¹ P. Pappas,¹ C. Huisingh,¹ R. Mannon,¹ J. Locke,¹ K. Wille,¹ D. Eckhoff,¹ J. Tallaj,¹ J. Baddley.^1,2
Outcomes Following Solitary Pancreas Transplantation – Do Steroids Matter?

C. Chan, I. Tang, J. Oberholzer, M. Campara.
Outcomes and Risk Factors for Graft Loss: Lessons Learned from More Than 1,056 Pediatric Kidney tx at a Single Center.

S. Chinnakotla, P. Verghese, B. Chavers, V. Kirchner, J. Najarian.
Outcomes for Plasma Cell Rich Rejection in Pediatric Kidney Transplant Patients.

O. Moussa, S. Self, K. Twombley.
Outcomes of Active Screening for Carbapenem-Resistant Enterobacteriaceae among Liver Transplant Recipients.

T. Bias,¹ G. Malat,¹ D. Lee,² S. Talluri,² K. Ranganna,² S. Epstein,² V. Patel,² S. Guy.³
Outcomes of Combined Liver/Lung Transplantation for Cystic Fibrosis Using SRTR Analysis.

J. Halldorson,¹ K. AlQahtani.²
Outcomes of Moderately to Severely Steatotic Grafts in Liver Transplantation: A Meta-Analysis.

K. Bonner,¹ C. Thongprayoon,² W. Cheungpasitporn,¹ M. Leise.¹
Outcomes of Recurrent Clostridium difficile Infection in Solid Organ Transplant Recipients.

M. Shiotsuka, Y. Natori, D. Kumar, A. Humar, C. Rotstein, S. Husain.
Outcomes of Renal Disease Related to Monoclonal Gammopathy After Kidney Transplantation: A Single Center Experience.

T. Kaur, E. Poggio, S. Nurko.
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Dosing.

D. Hesselink,¹ L. Andrews,² B. de Winter,² J. Tang,³ N. Shuker,² R. Bouamar,² R. van Schaik,⁴ B. Koch,² T. Van Gelder.¹
PPAR-γ Agonist Attenuates Hepatic Ischemia-Reperfusion Injury in a Mouse Model by Regulating Kupffer Cell Polarization.

I. Linares, K. Farrokhi, J. Echeverri, M. Kaths, D. Kollman, M. Hamar, P. Urbanellis, S. Ganesh, O. Adeyi, P. Yip, N. Selzner, M. Selzner.
Pancreas Organ Underutilization: 15-Year Analysis.

S. Siddiqi, J. Almario, K. Villaroel-Gomez, J. Yoo, C. Blackburn, R. Batra, D. DiSabato, A. Lu, S. Akkina, A. Desai, R. Garcia-Roca.
Pancreas Transplant with Duodeno-Duodenostomy and Caval Drainage Using a Diamond Patch Graft: A Single-Center Experience.

B. Choi, T. Lee, Y. Park, K. Yang, C. Chu, J. Ryu, B. Choi.
Pancreatectomy and Islet Autotransplantation After Combined Split Liver Transplantation and Pancreaticoduodenectomy: A Case Report.

R. Horneland,¹ S. Guvåg,¹ O. Korsgren,² E. Aandahl.¹
Patency of Autologous Portal Vein “Y“ Graft in Anterior Sector Outflow Reconstruction in Adult Living Donor Right Lobe Grafts.

S. Kapoor, B. Nath, V. Varma, S. Sable, A. Chauhan, V. Kumaran.
Patient Outcomes Following the Disappearance of Donor Specific Antibody in Crossmatch Positive Simultaneous Liver-Kidney Transplant Recipients.

P. Jindra,¹ G. Stacie,¹ A. Rana,² C. O'Mahony,² J. Goss,² M. Bhamidipati,² E. Whiston,³ R. Kerman.¹
Patient-Reported Barriers to the Pre-Kidney Transplant Evaluation in an At-Risk Population in the United States.

M. Lockwood,¹ W. Chon,² M. Josephson,² Y. Becker,² M. Saunders.²
Patients with Renal Failure Have a pERK-Dependent Defective TCR-Mediated Activation of CD4⁺ T Cells.

L. Huang, N. Litjens, N. Kannegieter, M. Klepper, C. Baan, M. Betjes.
Patterns and Associated Risk Factors for Early Readmissions Post Total Pancreatectomy and Islet Auto-Transplantation(TP-IAT).

V. Kirchner, A. Bagdiwala, D. Vock, M. Bellin, G. Beilman, L. Berry, S. Chinnakotla, T. Dunn, M. Freeman, D. Sutherland, T. Pruett.
Patterns of Monocyte Differentiation and Activation in a Non-Human Primate Model of Brain Death.

P. Chlebeck, J. Danobeitia, L. Zitur, T. Zens, X. Xu, S. Odorico, A. D'Alessandro, L. Fernandez.
Pediatric Liver Transplantation for Alpha-1 Antritrypsin Deficiency: A UNOS Database Analysis.

J. Jossen,¹ R. Annunziato,² J. McShane,² J. Chu,¹ R. Arnon.¹
Pediatric Recipients of Deceased Adult Donor Kidneys Have Equivalent Outcomes Compared with Pediatric Donors.

D. Mikhail,¹ H. Sharma,^3,4 J. Chen,² M. Cooper,⁴ A. Sener,^1,3 P. Luke.^1,3
Perceived Legitimacy of Using Social Support for Transplant Eligibility: Results from a National Survey of Transplant Clinicians.

K. Ladin,¹ E. Gordon,² Z. Butt,² T. Lavelle,¹ N. Daniels,³ D. Hanto.⁴
Perceived Patient Barriers for Kidney Transplant Evalution Among Transplant Center Staff.

L. McPherson, K. Lipford, R. Hamoda, J. Gander, S. Pastan, R. Patzer.
Percutaneous Direct Intrahepatic Portosystemic Shunt as a Bridge to Liver Transplantation in Pediatric Patients with Variceal Bleeding.

D. Yoeli,¹ N. Galvan,¹ D. Ashton,² K. Kumm,¹ M. Kueht,¹ E. Witte,¹ T. Miloh,³ R. Cotton,¹ A. Rana,¹ C. O'Mahony,¹ J. Goss.¹
Performance Comparison of Barcoded Oligos and Standard qPCR on Matched FFPE and RNAlater-Submerged Human Kidney Allograft Samples.

T. Sigdel, M. Nguyen, D. Dobi, J. Liberto, S.-C. Hsieh, F. Vincenti, M. Sarwal, Z. Laszik.
Persistence/Progression of Early Banff Borderline Changes (BBC) Is Associated with Chronic Renal Allograft Damage and Can Be Predicted by B Cell Cytokine Profile.

A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.
Persistent Donor Antigen Leads to Dysfunctional CD4⁺Memory T Cell Development.

M. Miller,¹ Y. Wang,¹ L. Chen,¹ Y. Lei,¹ M. Daniels,^2,3 E. Watkins,⁴ C. Mora Solano,² C. McIntosh,¹ N. Isaad,⁵ A. Chong,² M.-L. Alegre.¹
Persistent Hypophosphatemia Among Deceased-Donor Kidney Transplant Recipients Is Donor-Dependent and Associated with Superior Long-Term Allograft Outcomes.

N. Otto, T. Schachtner, P. Reinke.
Personalized Tacrolimus (TAC) Dosing Using Genetic Variants in Caucasian Kidney Transplant (Tx) Recipients.

D. Margraf,¹ R. Brundage,¹ D. Schladt,² W. Guan,³ B. Wu,³ R. Remmel,⁴ C. Dorr,^2,7 D. Berglund,¹ R. Mannon,⁵ A. Matas,⁶ W. Oetting,¹ A. Israni,^2,7 P. Jacobson,¹ For the DeKAF Genomics Investigators.
Phenotypic and Functional Assessment of T Cell Alloimmunity After Liver Transplantation.

T. Taner, M. Hansen, W. Park, M. Stegall.
Photopheresis for Recalcitrant Rejection After Heart Transplantation: Worthwhile?

J. Patel, M. Kittleson, X. Zhang, E. Klapper, T. Aintablian, K. Murayama, L. Czer, D. Geft, D. Chang, J. Kobashigawa.
Pilot Study on Acupuncture in Living Liver and Kidney Donors.

M. Jesse, M. Kulas, J. Unitis, N. Beltran, M. Abouljoud.
Placental Leukocytes Are Maternally Derived: Implications for Pregnancy-Induced Alloimmunization.

P. Porrett,¹ E. Lewis,² R. Xu,¹ A. Brown,² E. Wherry,³ M. Elovitz.²
Plasma Cell Hepatitis in Primary Sclerosing Cholangitis Patients: 15-Year Experience at a Transplant Center.

J. Putra,¹ T. Schiano,² M. Fiel.³
Platelets Stimulate Liver Sinusoidal Endothelial Cells to Secrete Interleukin-6 During the Early Phase of Liver Regeneration in Mice.

J. Meyer,^1,2 E. Perroud,² P. Fontana,^3,4 K. Sadoul,⁵ P. Morel,^1,2 C. Gonelle-Gispert,² L. Bühler.^1,2
Polycystic Liver Disease Patients May Not Be Appropriately Represented by MELD Exception Policy.

S. Chandradas,¹ J. Waalen,² C. Frenette.¹
Polypharmacy and Frailty in Kidney Transplant Recipients.

H. Ying, M. McAdams-DeMarco, D. Segev.
Population Pharmacokinetic Profiling of Tacrolimus in Renal Transplant Recipients (RTRs) Taking Diltiazem.

P. Trevillian,^1,2,3 M. Heer,^1,2 S. Ainsworth,¹ A. Hibberd.^1,2,3
Porcine Albumin Elaboration During Perfusion of Transgenic Porcine Livers with Human Blood.

A. Cimeno,¹ J. Powell,¹ B. French,¹ D. Ayares,² A. Azimzadeh,¹ R. Pierson III,¹ R. Barth,¹ J. LaMattina.
Porta Systemic Shunts Helps Us to Delay or Avoid Liver Transplantation in Patients with Portal Hypertension Post Kasai Operation for Biliary Atresia.

M. George, G. Thomas, A. Shun.
Positive Flow Crossmatch After Negative Virtual Crossmatch -A Single Center Experience.

Q. Xu, S. Leckie.
Post-Transplant Graft Function Is Associated with Major Cardiovascular Events in Kidney Transplant Recipients: A Multicenter Cohort Study.

J. Park,¹ Y. Kim,² S. Yang,³ S. Park,² S.-K. Park,⁴ D. Han,⁵ Y. Kim,² Y. Kim,⁵ J. Lee.⁶
Post-Transplant Lymphoproliferative Disorder: Risk Analysis for Pancreas Transplant Patients.

E. Minja, T. Dunn, A. Matas, T. Pruett, R. Kandaswamy, E. Finger.
Post-Transplant Sensitization: Does it Make a Difference in the Development of First-Year Intimal Thickening?

J. Patel, M. Kittleson, L. Czer, T. Aintablian, E. Stimpson, B. Azarbal, D. Geft, D. Chang, F. Esmailian, J. Kobashigawa.
Posttransplant Employment Patterns Are More Favorable in Patients with Solitary Pancreas vs. Simultaneous Pancreas/Kidney (SPK) Transplants – The Impact of Native Kidney Function.

S. Gruessner.
Potential Barriers Hindering Non-Directed (Altruistic) Living Kidney Donors from Donating Their Kidneys.

A. Maghen,¹ L. Kwan,¹ G. Vargas,¹ S. Connor,¹ S. Nassiri,¹ E. Hicks,² S. Maliski,³ J. Veale.
Potential Living Kidney Donors (LKD) Concerns About Opting Out and Preferences for an 'Alibi'.

K. Yu,¹ C. Thiessen,¹ S. Li,¹ D. Dobosz,¹ J. Gannon,¹ K. Kennedy,² D. Gray,³ A. Mussell,³ P. Reese,³ S. Kulkarni,¹ E. Gordon.²
Practice Patterns in the Treatment and Monitoring of Acute Cell-Mediated Kidney Graft Rejection in Canada.

J. Leblanc,¹ P. Subrt,² M. Paré,³ D. Hartell,⁴ L. Sénécal,⁵ T. Blydt-Hansen,⁶ H. Cardinal.¹
Pre Transplant Donor Specific Antibodies and Clinical Outcomes in Kidney Transplant Recipient on Steroid Free Maintenance Immunosupression Regimen.

O. Adebiyi,¹ A. Sharfuddin,² M. Yaqub,¹ S. Hussain,¹ D. Mishler,¹ A. Sharfuddin,¹ W. Goggins,¹ T. Taber.¹
Pre-Kidney Transplant Lower Extremity Impairment and Post-Transplant Mortality.

A. Nastasi,^1,2 M. McAdams-DeMarco,^1,2 J. Schrack,¹ H. Ying,² C. Haugen,² M. González Fernández,³ D. Segev.^1,2
Pre-OLT CKD-3 Increases Post-OLT ESRD and AKI Impacts Early Post-OLT Survival.

G. Faddoul, L. Liriano-Ward, P. Chang, Y. Azzi, K. Chauhan, G. Nadkarni, V. Nair, R. Kent, S. Lerner, S. Coca, P. Heeger, S. Florman, S. Thomas, M. Menon.
Pre-Operative Desensitization for Live Donor Liver Transplantation with Strong Donor-Specific Antibodies.

M. Fujiki,¹ K. Hashimoto,¹ A. Zhang,² F. Aucejo,¹ C. Quintini,¹ T. Diago,¹ B. Eghtesad,¹ C. Miller.¹
Pre-Transplant Non-Cytotoxic Donor Specific HLA Antibodies Do Not Increase the Risk of Graft Dysfunction in Kidney Transplant Recipients with Thymoglobulin and IVIG Induction.

A. Colovai, M. Ajaimi, N. Hayde, L. Kamal, S. Chan, C. Savchik, J. Rocca, E. Akalin.
Pre-Transplant Panel Reactive T Cells (PRT) with IL-15 as a Risk-Stratifier of Acute Rejection in Kidney Transplant Patients on Belatacept Therapy.

P. Cravedi,¹ I. Gandolfini,¹ C. Donadei,¹ R. Fairchild,² K. Newell,³ R. Mannon,⁴ P. Heeger,¹ CTOT16 Consortium.
Pre-Transplant Recipient Transcriptomic Profile May Predict Delayed Graft Function (DGF) in Kidney Transplantation.

P. Pontrelli,¹ F. Rascio,² F. Pesce,¹ M. Accetturo,¹ G. Castellano,¹ G. Zaza,³ A. Lupo,³ M. Fiorentino,¹ L. Gesualdo,¹ G. Stallone,² G. Grandaliano.²
Prediction of Evolution Toward Brain Death in Acute Neurocritical Patients Identified as Potential Organ Donors.

G. Xu, P. Xu, Z. Guo, X. He.
Prediction of Positive Cytotoxic and Flow Crossmatches for Sensitized Wait List Candidates: Comparison of Luminex MFI, C1q and FcR Binding Assays.

A. Girnita, E. Woodle.
Prediction of Renal Allograft Acute Rejection Using a Novel Non-Invasive Model Based on Acoustic Radiation Force Impulse.

C. Yang,¹ Y. Jin,² S. Wu,³ T. Zhu,¹ W. He.²
Predictive Value of Post Reperfusion TEG in Peri-Operative Outcomes During Liver Transplant.

P. Sheiner, A. Sulejamnovic, J. Salm, E. Silver, C. Rochon.
Predictive Value of Renal Poly (ADP-Ribose) Polymerase (PARP) Expression Both in Inflammation and Interstitial Fibrosis Processes in Recipients with Antibody-Mediated Rejection.

B. Ozdemir,¹ F. Ozdemir,² E. Baskin,² M. Haberal.³
Predictive Value of Renal Transplant Scintigraphy for the Duration of Delayed Graft Function.

S. Benjamens,^1,2 R. Pol,¹ A. Glaudemans,² S. Berger,³ R. Slart.²
Predictive Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy After Kidney Transplantation.

N. Maillard,¹ H. Suzuki,² H. Mohey,¹ C. Mariat,¹ J. Novak,³ B. Julian,⁴ F. Berthoux.¹
Predictors of Graft Loss in an Urban Predominantly Minority Cohort of Kidney Transplant Recipients.

N. Hayde, L. Kamal, M. Ajaimy, M. Lubetzky, P. Bedi, G. de Boccardo, E. Akalin.
Predictors of Malignancies Across Solid Organ Transplantation.

M. Bhat,¹ K. Mara,² R. Dierkhising,² K. Watt.³
Predictors of Renal Function Compensation in Live Donor Nephrectomy.

J. Choong, H. Ali, A. Ahmed.
Preformed HLA Donor-Specific Antibodies Disappearance After Kidney Transplantation: Significance and Comparison with Persistent DSA.

D. Redondo,¹ M. Pérez-Sáez,¹ M. Mir,¹ J. Gimeno,¹ C. García,² J. Hernández,² J. Yélamos,³ J. Pascual,¹ M. Crespo.¹
Pregnancy Outcomes in Female Kidney Transplant Recipients Using Assisted Fertility Methods.

L. Coscia,¹ D. Armenti,¹ S. Constantinescu,^1,2 M. Moritz.^1,3,4
Pregnandy During Kidney Trasplantation in a Low Income Population.

M. Taylor, M. Torres, D. Silvia, L. Martínez, H. Petrone.
Preoperative Pulmonary Hypertension Is Not Associated with Adverse Outcomes After Lung Transplantation.

S. Biswas Roy,¹ M. Olson,² D. Harned,¹ P. Kang,³ R. Panchanathan,³ A. Hashimi,¹ J. Huang,¹ H. Abdelrazek,¹ V. Patel,¹ A. Omar,¹ R. Bremner,¹ M. Smith,¹ R. Walia,¹ A. Kalya.⁴
Preservation Solution Affects the Immunological Milieu in Lung Transplantation and Alters the Inflammatory Balance.

R. Bellmàs Sanz,¹ M. Seyda,¹ B. Wiegmann,² C. Neudoerfl,¹ A. Haverich,^2,3 C. Falk,^1,4 G. Warnecke.^2,3
Preservation of Musculoskeletal Components in Vascularized Composite Allograft Skin Rejection.

E. Buckingham, A. Khalifeh, M. Uluer, W. Hassenein, C. Drachenberg, A. Nam, W. Twaddell, S. Bartlett, R. Barth.
Prevalence of CYP3A Genomic Variances and Impact on Tacrolimus Dosing Requirements in Kidney Transplant Recipients in Eastern North Carolina.

T. Asempa,¹ S. Hudson,² L. Rebellato,² A. Maldonado.¹
Prevalence of Cutaneous Disease in Solid Organ Transplant Recipients: A 5-Year Study from a Medical -Surgical Transplant Dermatology Center.

R. Allawh, A. Weiffenbach, K. Nadhan, M. Abdelmalek, C. Cusack, C. Chung.
Preventing Alloimmune Rejection in Heart Transplantation by Tolerogenic Dendritic Cells Induced by GDF15 Through Up-Regulation of IDO and Inhibition of the NFκB Signalling Pathway.

Y. Zhang,^1,3 G. Zhang,¹ L. Moszczynski,¹ D. Zhao,^1,3 P. Abulizi,¹ D. Quan,² T. Mele,² K. Liu,³ X. Zheng.^1,2
Prevention of Donor Specific Antibody Production After Skin Allografting by Mobilization of Endogenous Stem Cells Using a Combination of AMD3100 and Low-Dose FK506 in Rats.

A. Ahmadi,¹ L. Qi,¹ R. Wesson,¹ F. Dor,² J. Burdik,¹ B. Philosophe,¹ G. Williams,¹ A. Cameron,¹ Z. Sun.¹
Primary Graft Dysfunction Post Heart Transplantation: Is There Greater Risk for De Novo Donor-Specific Antibody Development?

J. Patel, M. Kittleson, L. Czer, T. Aintablian, T. Kao, D. Geft, D. Chang, F. Esmailian, J. Kobashigawa.
Primary Hyperoxaluria Type-1 in Chinese Population: A Case Series and Review of Literature.

D. Du,^1,2 Q. Li,^1,2 H. Shi,^1,2 S. Chen,^1,2 B. Liu,^1,2 Z. Lin,^1,2 G. Chen,^1,2 F. Zeng,^1,2 W. Zhang,^1,2 Z. Chen.^1,2
Primary Urtero- Ureterostomy in Renal Transplant, an Old Forgotten but Promising Technique.

H. Shokouh-Amiri, G. Zibari, S. Ahmadzadeh, R. Poudel, D. Aultman, H. Samant, N. Singh.
Prioritization for Kidney Transplant Due to Medical Urgency: Clinical Characteristics and Outcomes After Transplantation.

J. Oliveira,¹ T. Sandes-Freitas,^1,2 M. Oliveira,¹ L. Mesquita,² G. Dantas,² E. Daher,² R. Esmeraldo.¹
Pro Inflammatory Transitional B (TrB) Cells Characterize Renal Allograft Recipients with DSA and T Cell Mediated Rejection (TCMR).

A. Sharma, A. Cherukuri, D. Rothstein.
Prognostic Histopathologic Characteristics in Recurrent IgA Nephropathy: The Clinical Significance of Vascular Change.

S. Park, H. Cho, M.-Y. Yu, Y. Kim, K. Moon, Y. Kim, H. Lee.
Prolonged Cold Ischemia Time as a Risk for Low Regeneration at the Early Phase After Living Donor Liver Transplantation.

K. Takahashi,^1,2 S. Nagai,¹ M. Safwan,¹ K. Putchakayala,¹ M. Rizzari,¹ K. Collins,¹ A. Yoshida,¹ G. Schnickel,¹ M. Abouljoud.¹
Prolonged Liver Ischemia Triggers Necrotic Depletion of TIM4+ Kupffer Cells to Facilitate Tissue Inflammatory Immune Activation in Liver Ischemia-Reperfusion Injury.

H. Wang,¹ S. Yue,¹ M. Ni,¹ R. Busittil,¹ J. Kupiec-Weglinski,¹ L. Lu,² Y. Zhai.¹
Propensity-Matched Comparison of Diabetic Patients and Non-Diabetic Patients in Living Donor Kidney Transplantation.

C. Baek,¹ H. Kim,¹ W. Yang,¹ D. Han,² S.-K. Park.¹
Propensity-Score Matched Comparison of Lung Transplant Recipients of Age <70 and ≥70 Years.

A. Kashem,¹ S. Keshavamurthy,¹ J. Gomez-Abraham,¹ T. Yoshizumi,¹ H. Zhao,² F. Cordova,³ G. Criner,³ Y. Toyoda.¹
Prophylactic Therapy Against Multidrug-Resistant Acinetobacter baumannii Contamination of Preservation Solution in Renal Transplantation: A Single Center Experience.

R. Wang, J. Zhou, J. Wu.
Proposal for HCC Exception Points to Match Drop Out Risk.

H. Yeh,³ M. Akan,¹ N.-H. Leung,² J. Markmann,³ S. Tayur.¹
Prospective DSA Monitoring and Significance of De Novo DSA in Adult Liver Transplantation.

S. Kubal,¹ R. Mangus,¹ J. Fridell,¹ B. Ekser,¹ R. Saxena,² N. Rush,² N. Higgins,⁴ M. Ghabril,³ M. Lacerda,³ A. Lobashevsky.⁴
Prospective Monitoring of 25-Hydroxyvitamin Vitamin D Levels After Kidney Transplantation and Its Associations with Clinical Outcomes.

P. Bedi, N. Hayde, L. Kamal, M. Ajaimy, M. Lubetzky, G. de Boccardo, E. Akalin.
Prospective Monitoring of De Novo Donor-Specific Antibodies: Incidence, Clinical Outcomes and Dynamic Changes Over 5 Years After Kidney Transplantation.

M. Ajaimy, A. Colovai, N. Hayde, J. Graham, M. Lubetzky, L. Kamal, G. De Bocardo, E. Akalin.
Prospective Randomized Study to Evaluate the Efficacy and Safety of Rabbit Antithymocyte Globulin (rATG) 3mg/kg vs. 6mg/kg in Kidney Transplant Patients Under Steroid-Free and CNI Minimization Maintenance Immunosuppressive Regimen.

T. Sandes-Freitas, J. Junqueira, Jr, C. Girão, M. Oliveira, R. Esmeraldo.
Proteasome Modulation an Effective Strategy to Ameliorate Steatotic Liver Grafts Viability After Preservation.

M. Zaouali,¹ A. Panisello Roselló,¹ T. Carbonell,² A. Garcia-Gil,³ A. Lopez,⁴ R. Adam,⁴ J. Rosello-Catafau.¹
Protective Effect of New Delivery System of Nitric Oxide Releasing Nanofiber in Rat Model of Renal Ischemia-Reperfusion Injury.

J. Kim,¹ H. Ahn,² D. Kim,¹ S. Jung,¹ E. Park,¹ T. Lee,¹ C. Ihm,¹ S. Lee,¹ J. Moon,¹ Y. Kim,¹ K. Jeong.¹
Proteins in Preservation Fluid Predict Delayed Graft Function of Kidneys from Donors After Circulatory Death.

B. van Balkom,¹ H. Gremmels,¹ L. Ooms,⁴ R. Toorop,² F. Dor,⁵ O. de Jong,¹ L. Michielsen,¹ G. de Borst,² W. de Jager,³ A. van Zuilen,¹ M. Verhaar.¹
Protocol of the KTFT-TALK Study to Reduce Racial Disparities in Kidney Transplant Evaluation and Living Donor Kidney Transplantation.

K. Bornemann,¹ E. Croswell,¹ M. Abaye,¹ C. Bryce,¹ J. Chang,^1,2 D. Good,³ C. Freehling Heiles,³ M. Dew,¹ L. Boulware,⁴ A. Tevar,^1,3 L. Myaskovsky.^1,2
Psychosocial Distress in Chronic Kidney Disease: Benefits of Kidney Transplantation.

C. Richardson,¹ D. Belenko,¹ E. Mucsi,¹ N. Edwards,¹ D. Wong,¹ M. Novak,² M. Li,³ I. Mucsi.¹
Pulse Pressure After Renal Transplantation – Influence on Outcome: Results from the Collaborative Transplant Study.

B. Krüger,¹ B. Döhler,² B. Krämer,¹ C. Süsal.²
Quantity and Functions of CD4^–CD8^– Double Negative (DN) αβ T Cells in Kidney Is MHC Dependent.

M. Sadasivam, S. Noel, S. Lee, A. Hamad, H. Rabb.
RAS Inhibition Attenuates Urine Angiotensin II-Regulated Proteins Associated with Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.

Z. Mohammed-Ali,¹ S. Reid,³ P. Yip,¹ H. Cardinal,² M.-J. Hébert,² Y. Li,⁴ S. Kim,^1,3,4 A. Konvalinka.^1,3
Rabbit Anti-Human Thymocyte Immunoglobulin (rATG) for Rescue Treatment of Chronic Antibody-Mediated Rejection (cAMR) After Pediatric Kidney Transplantation.

L. Pape, T. Ahlenstiel-Grunow, J. Drube, M. Kreuzer, C. Lerch, N. Kanzelmeyer, S. Wente, I. Hennies, Y. Cihan.
Race, Admissions, and Renal Transplant Waitlisting.

R. Lynch, R. Zhang, R. Patzer, C. Larsen, A. Adams.
Racial Differences in Liver Cirrhosis-Related Mortality Among Patients with Model for End-Stage Liver Disease Sodium Score (MELDNa) ≤ 15.

K. Atiemo,¹ H. Maddur,¹ L. Zhao,¹ A. Skaro,² S. Montag,¹ L. VanWagner,¹ S. Goel,¹ A. Kho,¹ R. Kang,¹ J. Holl,¹ M. Abecassis,¹ J. Levitsky,¹ L. Kulik,¹ D. Ladner.¹
Racial Disparities in Self-Care Among Liver Transplant Candidates.

J. Wedd, J. Gander, K. Smith, S. Mujtaba, R. Subramanian, R. Parker, C. Reilly, R. Patzer.
Racial and Ethnic Disparities in Renal Replacement Therapy in Pediatric and Young Adult Population with End Stage Renal Disease (2005-2015).

R. George,¹ M. Basu,² L. Greenbaum,¹ A. Kirk,^2,3 N. Kutner,⁴ R. Patzer.^2,5
Raising Awareness of the Importance of Exercise Training in Solid Organ Transplant: A Description of a Canadian Knowledge Dissemination Project.

T. Janaudis-Ferreira,¹ S. Mathur,² T. Blydt-Hansen.³
Rapamycin Maintenance Therapy in Pediatric Liver Transplant Recipients Associated with Trend Toward Decreasing Th2 Cytokine Levels Compared to Tacrolimus Therapy.

R. Fischer,¹ A. Seng,² L. Gardner,² L. Steele,² L. Harvey,¹ H. Wasserkrug,¹ W. Andrews,¹ R. Hendrickson,¹ J. Daniel,¹ T. Yankee.²
Rapid Deterioration of Pre-Transplant Kidney Function Requiring Dialysis Is a Prognostic Factor in Liver Transplant Alone.

S. Nagai,¹ M. Safwan,¹ K. Collins,¹ M. Rizzari,¹ D. Moonka,² A. Patel,³ K. Brown,² A. Yoshida,¹ M. Abouljoud.¹
Rapid Regression of Xanthomata After Orthotopic Liver Tranplantation for Alagille Syndrome.

N. Galvan,¹ P. Nguyen,¹ S. Koohmaraie,² R. Cotton,¹ A. Rana,¹ C. O'Mahony,¹ J. Goss.¹
Rates of Lost to Follow-Up Among Pediatric Heart, Kidney, and Liver Transplant Recipients.

W. Cherikh,¹ S. Bartosh,² R. Urban,¹ W. Mahle,³ G. Mazariegos,⁴ E. Brewer.⁵
Readmission and Reoperation After Living Donor Hepatectomy.

S. Kapoor, B. Nath, V. Varma, S. Sable, A. Chauhan, V. Kumaran.
Readmissions After Liver Transplantation–They May Be Predictable, but Are They Inevitable?

B. O'Brien, C. Mardis, A. Mardis, J. Fleming, H. Meadows, N. Patel, N. Pilch, C. Perez, M. Sell, A. Rogers, I. Lee, J. McGillicuddy, K. Chavin, D. DuBay, D. Taber.
Reasons for Racial Disparities in Living Donor Liver Transplants (LDLT).

M. McCauley,¹ D. Goldberg,¹ L. Nephew,¹ R. Kalman,¹ K. Forde.¹
Recipient iNOS Deficiency Reduces Spontaneous Kidney Allograft Acceptance by Accelerating Allograft Loss.

I. Aljabban, B. Jiang, C. Yang, D. Ndishabandi, R. White, P. Russell, J. Madsen, R. Colvin, A. Alessandrini.
Recognition of Islet Xenografts In Vivo by Non-Obese Diabetic (NOD) Insulin-Specific CD4 T Cells.

R. Gill, W. Dale, M. Crawford.
Recovery from Hypophosphatemia as a Predictor of Post-Operative Morbidity in Live Donor Hepatectomy.

O. Serrano,¹ D. Berglund,¹ V. Goduguchinta,¹ A. Reddy,¹ J. Menk,² D. Vock,³ V. Kirchner,¹ R. Kandaswamy,¹ A. Matas,¹ T. Pruett,¹ S. Chinnakotla.¹
Recurrence of IgA Nephropathy After Kidney Transplantation in Maintenance Steroids versus Steroid Avoidance Regimens: A UNOS/OPTN Analysis.

N. Leeaphorn, N. Garg, E. Khankin, F. Cardarelli, M. Pavlakis.
Recurrent Lupus Nephritis in a Multi-Ethnic Kidney Transplant Population.

I. Tang,¹ A. Koganti,¹ S. Setty,² S. Akkina.³
Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes Following Lung Transplantation.

L. Michielsen,¹ K. Budding,² D. Drop,² E. van de Graaf,³ T. Kardol-Hoefnagel,² M. Verhaar,¹ A. van Zuilen,¹ H. Otten.²
Reduced Racial Disparity in Outcomes of Kidney Transplant Recipients.

E. Iranpour, A. Tavabi, R. Garakani, R. Gohh, P. Morrissey, R. Saidi, R. Saidi.
Reduced Rituximab with Prophylactic Antibiotic Treatment Improves the Infectious Complications in Patients Undergoing ABO-Incompatible Living Donor Liver Transplantation.

S.-C. Hsu, A. Thorat, L.-B. Jeng, H.-R. Yang, P.-C. Li, C.-C. Yeh, T.-H. Chen, K.-S. Poon.
Reducing the Early Readmission Rates in Kidney Transplantation.

M. Tavares, M. Cristelli, L. Viana, I. Malbouisson, M. Paula, H. Silva Junior, J. Pestana.
Refinement of an Old Faithful: A Standardized Flow Cytometry Approach to Measure Donor-Recipient Alloreactivity (a Pilot Study).

A. Halpin,¹ M. Sosniuk,¹ S. Urschel,¹ P. Campbell,² I. Larsen,¹ L. West.¹
Regional Variation in Liver Donor Utilization Across the U.S.

A. Friedman,¹ P. Bagavan,² S. Florman,³ H. Irving,¹ B. Samstein,⁴ B. Schleich.¹
Rejection of Human Kidney Allografts According to BANFF Classification Is Associated with a Chemokine-Enriched Protein Microenvironment in Biopsy Tssue.

C. Falk,¹ K. Daemen,¹ J. Keil,¹ F. Lehner,² H. Haller,³ J. Schmitz,⁴ J.-H. Bräsen,⁴ C. Blume.⁵
Relationship of Liver Extraction Times to Early Allograft Dysfunction and Post-Transplant Kidney Injury.

D. Simpson, M. Gupta, C. McAllister, P. Porrett, D. Goldberg, M. Levine, K. Olthoff, A. Shaked, P. Abt.
Renal Function Outcomes by HLA Mismatch in De Novo Kidney Transplant Recipients Receiving Everolimus PlusReduced-Dose Cyclosporine versus Mycophenolate Plus Standard-Dose Cyclosporine: 24-Month Subanalysis of A1202 Study.

K. Yoshida,¹ Y. Watarai,² K. Nakagawa,³ O. Kamisawa.⁴
Renal Function Variability Is a Significant and Independent Risk Factor for Graft Loss and Death in Kidney Transplantation.

D. Taber,¹ Z. Su,¹ A. Posadas,¹ D. Dubay,¹ C. Bratton,¹ J. McGillicuddy,¹ K. Chavin,¹ T. Srinivas,² S. Nadig,¹ V. Rohan,¹ P. Baliga.¹
Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

N. Lam,¹ M. Tonelli,² K. Lentine,³ B. Hemmelgarn,² F. Ye,¹ A. Bello,¹ S. Klarenbach.¹
Renal Function, Albuminuria, and the Risk of Death and Graft Loss After Kidney Transplantation.

N. Lam,¹ M. Tonelli,² K. Lentine,³ B. Hemmelgarn,² F. Ye,¹ K. Wen,¹ S. Klarenbach.¹
Renal Secretion of Organic Anionic Drugs Is Compromised in Renal Transplant Patients.

H. Kalluri,¹ P. Sood,² P. Randhawa,^2,3 S. Hariharan,² A. Tevar,² A. Humar,² R. Venkataramanan.^1,2,3
Renal Transplant Outcomes in Primary FSGS Compared with Other Recipients: A National Review of the Irish Transplant Registry.

S. Cormican,¹ C. Kennedy,^1,2 P. O'Kelly,¹ B. Doyle,³ A. Dorman,³ P. Conlon.^1,2
Renal Transplant Patient Outcomes Following Plasmapheresis, Thymoglobulin, and Rituximab Induction for High Risk DSA Positive Recipients.

E. Lessmann,¹ M. Moaddab,¹ M. Manson,¹ A. Ram,² R. Kerman,² P. Jindra.²
Renal Transplant Recipients with Indication for Antiplatelet Therapy: Increased Risk for the Allograft?

T. Benko, M. Gottmann, S. Radunz, J. Treckmann, F. Saner, A. Paul, D. Hoyer.
Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg Can Be Performed Safely.

K. Hata,¹ M. Okumi,¹ K. Ishizuka,² K. Unagami,³ T. Hirai,¹ T. Shimizu,¹ K. Omoto,¹ H. Ishida,¹ M. Hattori,² K. Tanabe.¹
Renoprotective Effects of Carbon Monoxide–Releasing Molecule 3 in Ischemia Reperfusion Injury and Cisplatin-Induced Toxicity.

Y. Yoon,¹ H. Lee,¹ K. Huh,² M. Kim,² S. Kim,² Y. Kim,² W. Han.¹
Restrictive Approach to Simultaneous Liver Kidney Transplantation.

S. Sultan, S. Fitzpatrick, T. Kozlowski, S. Malik, S. Hanish, D. Bruno, M. Weir, W. Hutson, R. Barth, J. LaMattina.
Retroperitoneoscopic Living Donor Nephrectomy Safely Secures Excellent Graft Function.

T. Hirose, K. Hotta, D. Iwami, H. Sasaki, H. Higuchi, Y. Takada, N. Shinohara.
Retrospective Analysis of Kidney Transplant Recipients with Antibody-Mediated Rejection.

G. Piñeiro,¹ E. Desousa,¹ J. Villarreal,¹ M. Lozano,² J. Cid,² M. Sole,³ F. Oppenheimer,¹ F. Diekmann.¹
Retrospective Review of Early versus Late Initiation of Oral Sildenafil for Right Ventricular Dysfunction in Post-Cardiac Transplant Surgery Patients.

P. Brown, B. Hamandi, M. McDonald, H. Ahmed, R. Whitty, D. Lowe.
Review of UK-Wide Practice of Pancreas Transplantation: Donor Selection, Back-Bench Preparation & Implantation Technique.

H. Sharma,¹ S. Bhutani,³ D. Vandellen,² T. Campbell,² R. Pararajasingham,² B. Forgacs,² A. Tavakoli,² P. Friend,⁴ T. Augustine,² R. Dhanda.²
Risk Analysis of Patients with Proven Coronary Artery Disease Undergoing Liver Transplant.

J. Balogh, K. Lunsford, D. Nguyen, E. Gravis, O. Cercio, C. Mobley, A. Saharia, S. Gordon Burroughs, A. Gaber, R. Ghobrial.
Risk Factors and Outcomes of Intracardiac Thrombosis During Orthotopic Liver Transplantation.

W. Al-Darzi, M. El-Atrache, F. Georgie, O. Sadiq, S. Singla, C. Fernandez, R. Pompa, D. Galusca, A. Yoshida, S.-M. Jafri.
Risk Factors for Cryptococcal Disease in Transplant as Compared with Non-Transplant Patients: A Single Center Study.

O. Beaird,¹ O. Garner,² R. Humphries,² J. Schaenman.¹
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Trasplant.

B. Rodriguez Cubillo, M. Calvo, V. Lopez De La Manzanara, J. Bautista-Cañas, I. Perez-Flores, M. Moreno De La Higuera, N. Calvo Romero, A. Sanchez-Fructuoso.
Risk Prediction Models for Living Donor Kidney Transplantation to Predict Donor and Recipient Mortality and Graft Loss.

M. Haller,¹ G. Mjøen,² H. Holdaas,³ G. Heinze,⁴ R. Oberbauer.⁵
Risk and Prognosis of Developing Procedural Complications in Renal Allograft Biopsy, Including AVF and DVT.

H. Ide, K. Iwadoh, I. Nakajima, S. Fuchinoue.
Risk of Amiodarone and Permanent Pacemaker Placement After Heart Transplantation.

E. Kransdorf, M. Kittleson, J. Patel, T. Aintablian, R. Levine, B. Kearney, N. Musto, A. Hage, D. Geft, L. Czer, F. Esmailian, A. Trento, J. Kobashigawa.
Risk of Kidney Rejection Following Simultaneous Liver Kidney Transplantation.

S. Shah,¹ A. Suddle,¹ V. Aluvihare,¹ O. Shaw,³ C. Shaw,¹ N. Mamode,² C. Callaghan,² G. Koffman,² N. Heaton.¹
Risk of Major Bleeding in Solid Organ Transplant Recipients Taking Calcineurin Inhibitors Concomitantly with Direct Oral Anticoagulants Compared to Warfarin.

J. Hazelcorn, R. Yau, N. Sabagha, M. Moaddab, M. Manson.
Risk of Venous Thromboembolism After Lung Transplant.

R. Felkner,¹ A. Condon,² K. Rolling,³ M. Hayney.³
Risks Associated with Recombinant IL2 Therapy in Renal Transplantation.

M. McGrath, S. Tripathi, A. Chandraker.
Role of HMG CoA Reductase Inhibitors on Time to Development of Chronic Lung Allograft Dysfunction Post-Lung Transplant.

A. Szczepanik, A. Hulbert, H. Lee, C. Benedetti, L. Snyder, J. Byrns.
Role of Induction Therapy in Low Immune Risk Kidney Transplant Recipients: A Mate Kidney Analysis.

M. Sampaio, K. Sureshkumar.
Routine Surveillance of Heart Transplant Recipients with Gene Expression Profiling: Lack of an Impact of Race on Outcomes.

J. Teuteberg,¹ M. Shullo,¹ D. Rinde-Hoffman,² M. Wigger,³ Y. Wang,⁴ T. Wolf,⁴ P. Arnold,⁴ J. Sninsky,⁴ P. Berman.²
SIRPα⁺ DCs and the Time-Dependent CD4⁺CD8⁺ Double Positive T Cell Infiltration in Accepted Renal Allografts.

T. Ashry,^1,2 C. Yang,² B. Jiang,² D. Ndishabandi,² P. Russel,^1,2 R. Colvin,^1,2 J. Madsen,^1,2 A. Alessandrini.^1,2
Safety and Decreased Inflammation of Early Double Cytokine Blockade (IL-1β and TNF-α) Facilitates Engraftment in Islet Allotransplantation.

N. Onaca,¹ M. Takita,² M. Levy,³ B. Naziruddin.¹
Safety of Liver Donation from Living Donors with Sickle Cell Trait.

H. Elsiesy,^1,2 M. Sturdevant,¹ W. Al-Hamoudi,¹ H. Elbeshbeshy,¹ M. Al Sebayel,¹ A. Jaafari,¹ F. Abaalkhail.^1,2
Safety of Percutaneous Pancreas Allograft Biopsy in Enteric Drained Pancreas Transplants.

Y. Kassis, E. Poggio, Z. Zaky.
Safety of Statin Therapy After Liver Transplantation.

M. Glynn, A. Jantz, B. Summers, R. Salgia, N. Sulejmani.
Scoring of Distinct Tubular Injury Features and Assessment of Cellular Proliferation and of Non-Apoptotic Cell Death by the Novel Marker FACL4 Allow to Determine the Long-Term Prognosis of Renal Grafts.

A. Bohlmann,¹ J. Schmitz,¹ A. Melk,¹ R. Schmitt,¹ I. Scheffner,¹ V. Broeker,² H. Haller,¹ J. Metzger,³ J. Braesen,¹ W. Gwinner.¹
Screening and Referral of High Risk Liver Transplant Recipients to a Transitional Care Coordination (TCC) Program to Reduce Hospital Readmissions.

A. Masoumi,¹ J. Krzyzewski,¹ T. Stern,¹ N. Schluterman,² D. Bruno,² J. Bromberg,² R. Barth,² S. Hanish.²
Seasonality of Mortality and Graft Failure Among Kidney Transplant Recipients in the US.

B. Astor,¹ M. Melamed,² D. Mandelbrot,¹ A. Djamali.¹
Second-Line Therapy After Standard of Care in Antibody-Mediated Rejection: A Prospective Study.

D. Viglietti, A. Loupy, O. Aubert, E. Pillebout, C. Legendre, D. Glotz, C. Lefaucheur.
Semi-Automated Pre-Donation Computed Topography (CT) Cortical Renal Volume to Predict Kidney Function in Live Kidney Donors 2 Years Following Donation.

L.-X. Chen,¹ G. Fananapazir,² R. Benzl,² M. Corwin,² S. Stewart,³ C. Troppmann.⁴
Send Diabetes on a Long Trip: The Pancreas Travels Well.

J. Graham, M. Lubetzky, A. Chokechanachaisakul, M. Kinkhabwala, J. Rocca.
Senescence and Uremia Effects in Circulating T Cells Diverge in TREG Population and Cause T Cell Shift to a Memory Profile.

G. Freitas,¹ M. Fernandes,¹ F. Agena,¹ O. Jabuul,² V. Coelho,³ F. Lemos,¹ F. Ramos,¹ A. Triboni,¹ E. David-Neto,¹ N. Galante.¹
Sensitized KPD Pairs Take Longer to Find Matches.

C. Holscher,¹ E. Chow,¹ C. Purcell,² M. Ronin,² J. Garonzik-Wang,¹ A. Massie,¹ S. Gentry,³ D. Segev.¹
Sequential Liver-Kidney Transplantation Is Equivalent to Simultaneous Liver–Kidney Transplantation in Candidates Requiring Dialysis Pre-Transplant.

M. Mulvihill, B. Yerokun, R. Davis, K. Anderson, M. Hartwig, A. Barbas.
Sequential Surgical Strategy for Heart-Kidney Transplantation.

D. Mital,¹ M. Petruccione,¹ J. Brown,¹ S. Vasquez,¹ S. Wheaton,¹ W. Johnson,¹ C. Desai,¹ D. Chhabra,¹ G. Kinzler,¹ H. Sankary,¹ T. Lawrecki,^1,2 P. Pappas,² A. Tatooles,² M. Bresticker,² W. Cotts,² G. Bhat.²
Serum Alkaline Phosphatase Predicts Graft Failure and Mortality in Kidney Transplant Recipients.

Y. Kim,¹ S. Park,¹ S. Yang,² H. Lee,¹ Y. Kim,³ S.-K. Park,⁴ D. Han,³ I. Jung,⁵ J. Ha,⁶ C. Lim,⁷ Y. Kim,¹ J. Lee.⁷
Serum Phosphorus and Cardiovascular Disease Outcomes, Graft Failure, or Total Mortality in Chronic Kidney Transplant Recipients.

B. Merhi,¹ T. Shireman,² M. Carpenter,³ J. Kusek,⁴ P. Jacques,⁵ M. Pfeffer,⁶ A. Levey,⁷ M. Rao,⁷ J. Kim,⁸ J. Ix,⁹ A. Bostom.¹
Serva NB1 versus Vitacyte Collagenase: Comparable Human Islet Isolation Outcomes Using DCD Donor Pancreas in China.

Y. Liu, P. Sun, J. Zou, G. Wang, T. Liu, L. Wang, S. Wang.
Severe Tricuspid Regurgitation After Heart Transplantation: Does It Require Surgical Repair?

J. Patel, M. Kittleson, L. Czer, T. Aintablian, R. Sharoff, R. Levine, A. Velleca, D. Ramzy, F. Esmailian, J. Kobashigawa.
Sexual Dysfunction Among Living Kidney Donors.

S. Halpern,¹ A. Thomas,¹ C. Holscher,¹ A. Massie,¹ M. Henderson,¹ S. Anjum,¹ J. Locke,² D. Segev.¹
Shared Decision Aid to Decipher Long-Term Treatment Risks for End Stage Renal Disease Patients.

J. Gander, A. Manatunga, K. Jacob Arriola, S. Pastan, R. Patzer.
Short Term Renal Allograft Outcomes Following Treatment of Early Subclinical Borderline Changes on Surveillance Biopsies.

C. James, K. Woodside, J. Park, A. Naik, E. Farkash, R. Sung, M. Samaniego, Y. Huang.
Significance of Atypical Cytology in the Evaluation of Patients with End Stage Renal Disease for Transplantation.

J. Law, O. Ali, H. Brar, P. Luke, A. Sener.
Significance of Thrombotic Microangiopathy in Renal Allografts.

B. Ozdemir,¹ A. Ok Atilgan,¹ M. Haberal.²
Simultaneous Heart and Kidney Transplant vs Heart Transplant: Single Center Review of Candidate Selection and List Management.

N. Fonseka,¹ H. Mangrolia,¹ S. Karhadkar,² S. Rao,² L. Punnoose.¹
Simultaneous Liver-Kidney Transplants Using Donation After Cardiac Death Donors Long Term Outcomes Not Inferior to Brain Dead Donors.

J. Alvarez-Casas, S. Sultan, J. Scalea, K. McClure, J. LaMattina, D. Bruno, S. Hanish, R. Barth.
Simultaneous Pancreas and Kidney Transplant (SPK) – The New Standard of Care for Uremic Patients with Type 2 Diabetes Mellitus (T2DM).

A. Gruessner, M. Laftavi, V. Whittaker, Z. Acun, O. Pankowycz, R. Gruessner.
Simultaneous Pancreas-Kidney Transplantation Can Be Safely Done on Dabigatran Therapy.

W. Lisik,¹ A. Jozwik,¹ J. Czerwinski,² L. Gorski,¹ M. Kosieradzki.¹
Simultaneous Pancreas-Kidney Transplantation and Center Volume: Bigger Is Not Necessarily Better.

T. Alhamad,¹ A. Malone,¹ D. Brennan,¹ R. Stratta,³ J. Wellen,¹ K. Lentine.²
Simultaneous Pancreas/Kidney Transplant Recipients Are Predisposed to Symptomatic CMV-Infection and Concomitant Infectious Complications.

T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
Single Kidney Transplantation from Pediatric Donors Younger Than 3 Years to Adult Recipients.

L. Zhu, B. Liu, S. Chang, D. Du, N. Gong, J. Jiang, Z. Chen, G. Chen.
Single-Center, Prospective, Open Label Pilot Study to Investigate the Effectiveness of Everolimus Associated with Mycophenolic Acid and Prednisone in Adult Patients Submitted to an Allograft Renal Transplant with Calcineurin Inhibitor Withdrawl on Week 16th.

L. Giordano,^1,2 M. Lasmar,^1,2 H. Vianna,^1,2 E. Lasmar.^1,2
Small Pediatric Donor Kidney Transplantation in Pediatric Recipients.

H. Yaffe,^1,2 P. Friedmann,² L. Kayler.³
Soluble Fibrinogen-Like Protein 2 Regulates Differentiation and Enhances Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Allograft Immunity.

C. Yang, B. Peng, M. Xu, T. Zhu.
Soluble Human Leukocyte Antigen-G Levels and Prolonged Allograft Survival: A Demographic Analysis.

C. Callaway,¹ A. Ajith,² V. Portik-Dobos,² P. Best,³ C. Zayas,³ R. Kapoor,³ A. Horuzsko,² L. Mulloy.³
Spiritual and Religious Faith of Actual and Potential Non-Directed (Altruistic) Living Kidney Donors.

A. Maghen,¹ G. Vargas,¹ S. Connor,¹ S. Nassiri,¹ E. Hicks,² L. Kwan,¹ S. Maliski,³ J. Veale.¹
Split Liver Ex-situ Oxygenated Machine Perfusion: A Novel Approach to Organ Preservation and Treatment.

N. Karimian,¹ V. Huang,¹ S. Geerts,¹ S. Mert,¹ I. Beijert,² F. Fontan,¹ M. Aburawi,¹ R. Porte,² K. Uygun,¹ J. Markmann,¹ H. Yeh.¹
Spousal Transmission of Hepatitis B from a Hepatitis B Core Antibody Positive Liver Transplant Recipient – A Case Report.

J. Gripshover, K. Hidalgo, B. Ravichandran.
State Law Restrictions on HIV Positive-to-Positive Transplantation.

S. Rasmussen,¹ A. Glazier,² A. Cash,¹ M. Henderson,¹ B. Boyarsky,¹ K. Miller,³ S. Schoettes,⁴ D. Segev,¹ C. Durand.¹
Statins in Liver Transplant Recipients: Rates of Use, Mortality and Rejection.

R. Selim,¹ A. Abdulhamid,¹ A. Shyamraj,² A. Watson,² J. Tang,² S.-M. Jafri.²
Status 1 Liver Transplantation: Changes in Characteristics and Outcome Over Time.

H. Truong, L. Lacar, L. Wong.
Steroid Free Maintenance Immunosupression in Kidney Transplantation: Indiana University Experience.

S. Hussain, T. Taber, A. Sharfuddin, M. Yaqub, W. Goggins, D. Mishler, O. Adebiyi.
Steroid Withdrawal Using Everolimus in Maintenance Kidney Transplant Recipients with Post-Transplant Diabetes Mellitus.

K. Nanmoku, A. Kurosawa, T. Kubo, T. Shinzato, T. Shimizu, T. Kimura, T. Yagisawa.
Steroid-Free Immunosuppression After Liver Transplant for Autoimmune Disease Does Not Result in Increased Disease Recurrence.

A. Hooper,¹ C. Frenette.²
Strategies to Economize Dialysis and Transplantation in Low Resource Settings.

S. Rizvi, M. Zafar, T. Aziz, A. Hasan, R. Mohsin, A. Hashmi, Z. Hussain, F. Akhtar, E. Ahmed, A. Naqvi.
Strategies to Promote Pediatric Kidney Transplant Program in China – A Coming Opportunity with Development of Pediatric Deceased Donation.

L. Liu,¹ H. Wang,² J. Ding,³ B. Shi,⁴ X. Zhong,³ W. Jiang,² L. Chen,⁴ H. Zhang,¹ C. Wang.¹
Streamlining Discharge Pathways in Kidney Transplant Recipients with Delayed Graft Function.

E. Chan, J. Kim.
Strongyloides Infection in Solid Organ Transplant Recipients: A Single Center Experience and Review of the Literature.

H. El Haddad,¹ V. Hemmige,¹ A. Sofjan,² T. Lasco,³ A. Restrepo.¹
Subclinical Histologic Findings Are Observed in 25% of Stable Adult Liver Transplant Recipients (ALTRs) Screened for Immunosuppression Withdrawal (ISW): OPTIMAL (NCT02533180).

S. Chandran,¹ M. Abecassis,² J. Levitsky,² S. Feng,³ A. Humar,⁴ J. Emond,⁵ G. Klintmalm,⁶ A. Demetris,⁴ K. Much,⁷ L. Sun,¹ A. Priore,⁸ D. Ikle,⁷ N. Bridges,⁸ M. DesMarais,¹ B. Burrell,⁹ J. Markmann.¹⁰
Subpopulations of Peripheral Blood Monocytes in Kidney Allograft Recipients.

I. Striz,¹ V. Svachova,¹ A. Sekerkova,¹ J. Slatinska,² K. Kopecka,¹ M. Fialova,¹ O. Viklicky.²
Substance Use Among Potential Kidney Transplant Candidates and Its Impact on Access to Kidney Transplantation; a Canadian Cohort Study.

E. Tang,¹ A. Bansal,¹ M. Kwok,¹ O. Famure,¹ S. Kim,¹ D. Buchman,² M. Novak,³ I. Mucsi.¹
Successful Implementation of a Pneumococcal Vaccination Program for Pediatric Kidney Transplant Recipients.

K. Sprott, S. Nadig, K. Twombley.
Superior Long-Term Hypertension Management in Pediatric Kidney Transplant Recipients with Bilateral Native Nephrectomies.

D. Stoltz,¹ A. Brubaker,¹ A. Chaudhuri,² P. Grimm,² W. Concepcion,¹ A. Gallo.¹
Suppression of T Cell Proliferation by CpG-Activated B Cells Depends on Granzyme-B and Cell-Cell Contact, but Not on IL-10.

L. Kojima,¹ S. Kimura,^1,2 K. Lee,¹ C. Schuetz,¹ L. Washburn,¹ K. Deng,¹ H. Tector,¹ B. Amundsen,^1,2 D. Ndishabandi,^1,2 A. Markmann,¹ M. Markmann-Porch,¹ T. Oura,¹ A. Alessandrini,^1,2 J. Kim,¹ H. Yeh,^1,2 J. Markmann.^1,2
Surgical Outcomes of Pair-Watch Suturing Technique (PWST) for Duct-To-Duct Biliary Anastomosis in an Attempt to Reduce the Biliary Complications in Living Donor Liver Transplantation.

A. Tanemura, Y. Iizawa, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Surgical Techniques for Pancreas Transplantation Graft without Vascular Reconstruction (Report of 8 Cases).

A. Hu, W. Liao, C. Zhang, X. Zhu, X. He.
Survival Benefit of Kidney and/or Pancreas Transplantation for Patients with Type 1 Diabetes in the United States.

R. Gruessner,¹ M. Laftavi,¹ O. Pankowycz,² V. Whittaker,¹ Z. Acun,¹ V. Aggarwal,² N. Ozden,² A. Gruessner.¹
Survival Benefit of Liver Transplantation for Patients with MELD Spike.

X. Luo, A. Massie, D. Segev.
Systemic Immunosuppression in the Setting of Ocular Surface Stem Cell Transplantation.

A. Govil,¹ A. Cheung,² E. Sarnicola,² E. Holland.²
Systemic Meta-Analysis: Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients?

K. Jayant,¹ I. Reccia,² J. Walton,¹ A. Sharma,³ A. Halawa.¹
T-Cell Aging Parameters in the Lymph Node and Peripheral Blood Are Strongly Associated but Terminally Differentiated T Cells Are Mainly Located within the Circulation.

B. Dedeoglu,¹ A. de Weerd,¹ L. Huang,¹ A. Langerak,² M. Klepper,¹ W. Verschoor,¹ D. Reijerkerk,¹ C. Baan,¹ N. Litjens,¹ M. Betjes.¹
TB Chemoprophylaxis Post Transplantation in West London.

Y. Al-Mula Abed,¹ R. Charif,² O. Kon,³ D. Taube.²
TGF-β1 Induces Transplant Kidney Interstitial Fibrosis Through Endothelial-to-Mesenchymal Transition via TGF-β/Smad and Akt/mTOR/p70S6K Pathways.

Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.
TIMP-3 Plays a Key Regulatory Role in the Cleavage of E-Cadherin and Has an Essential Protective Function in Hepatic IRI.

T. Fujii, S. Duarte, R. Busuttil, A. Coito.
TNF[part]-I After Kidney Transplantation.

B. Muth, B. Astor, D. Mandelbrot.
Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients.

L. Qu, Z. Xie, H. Huang, H. Jiang, J. Chen, H. Jiang, H. Jiang, J. Chen, J. Chen, J. Chen.
Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients.

S. Seibert,¹ D. Schladt,² B. Wu,³ W. Guan,³ C. Dorr,^2,7 D. Berglund,¹ R. Remmel,⁴ A. Matas,⁵ R. Mannon,⁶ A. Israni,^2,7 W. Oetting,¹ P. Jacobson,¹ For the DeKAF Genomics Investigators.
Tacrolimus Pharmacogenomics: Association of Genetic Variants with Clinical Factors Including Tacrolimus Requirement, Clearance, Intraindividual Variability, and Coefficient Variation.

S.-Y. Kim,¹ J. Oh,² S. Yun,² I.-J. Jang,² S.-I. Min,¹ W. Cho,¹ S. Cho,¹ S. Ahn,¹ S.-K. Min,¹ J. Ha.¹
Tacrolimus and Mycophenolate Exposure and Subclinical Tubulo-Interstitial Inflammation in Low Immunological Risk Renal Transplants.

I. Torres,¹ A. Reisaeter,² F. Moreso,¹ A. Asberg,² M. Perello,¹ C. Dörje,² J. Sellares,¹ K. Midtved,² H. Holdaas,² D. Seron.¹
Tangible Benefits in Caregiving Burden Among Spouses/Partners of Transplant Patients: Adding “Donor Benefit” to Live Donor Risk Assessment.

S. Rasmussen, L. Duquette, M. Henderson, D. Segev.
Technical Characteristics, Optimization and Outcomes of Ultrasound-Guided Biopsy Performed on Kidney Transplant Patients.

J. Juega, M. Perez, L. Cañas, M. Troya, I. Bancu, J. Bonet, R. Lauzurica.
Technically Successful Miniaturization of Blood Hemofilters for an Artificial Kidney via Bioengineering Techniques.

R. Forbes,¹ C. Kensinger,¹ S. Karp,¹ J. Groszek,¹ A. Buck,² D. Colvin,² S. Roy,³ W. Fissell.¹
Technique and Result of Anastomosing Right Hepatic Vein to Inferior Vena Cava with a Separate Cavotomy Inferior to Right Hepatic Vein Orfice.

R. Rai, E. Trivedi, I. Shaikh, S. Nagral, N. Doctor.
Telemedicine Utilization After Kidney Transplantation Was Not Associated with Decreased Early Hospital Readmission Rate.

N. Elfadawy, E. Sanchez, K. Woodside, J. Augustine, D. Hricik, N. Sarabu.
Tenofovir Use Is Not Associated with Reduced Bone Density or Fractures in Liver Transplant Recipients.

N. Lim, C. Engler, J. Lake.
The 'W' Technique: A Safe and Reproducible Technique for Hepatic Arterial Reconstruction in Living Donor Liver Transplantation.

V. Kumaran, V. Varma, S. Kapoor, B. Nath, A. Chauhan, S. Sable, K. Yadav, S. Kumar, S. Sharma.
The Adoption of Generic Immunosuppressant Medications Among Kidney and Liver Transplant Recipients Using the Colorado All Payer Claims Database.

Q. Liu,¹ A. Smith,¹ J. Park,² M. Oguntimein,³ S. Dutcher,³ G. Bello,¹ M. Helmuth,¹ M. Turenne,¹ R. Balkrishnan,⁴ M. Fava,¹ P. Sharma,² C. Beil,¹ A. Leichtman,¹ J. Zee.¹
The Association of Donor Vasoactive Drugs with Pancreas Transplant Graft Survival.

I. Shapey,¹ P. Yianoullou,² A. Summers,² T. Augustine,² M. Rutter,¹ D. van Dellen.²
The Associations Between Immunosuppression Use, Loss of Medicare and Kidney Allograft Outcomes.

A. Hart,^1,2 S. Gustafson,² A. Wey,² N. Hadley,² A. Israni.²
The Beneficial Effects of mTOR Inhibitors on Liver Resident Natural Killer Cells.

J. Saparbay, Y. Tanaka, T. Yano, H. Ohdan.
The Clinical Significance of Red Cell Distribution Width (RDW) in Kidney Transplant Recipients.

S. Park,¹ J. Ha,¹ Y. Kim,¹ H. Lee,¹ Y. Kim,¹ C. Lim,¹ I. Jung,¹ D.-J. Han,² S.-K. Park,² Y. Kim,² J. Lee.¹
The Effect of BMI on Renal Transplant Outcomes.

E. Giorgakis,¹ K. Reddy,¹ A. Singer,¹ H. Khamash,² R. Heilman.²
The Effect of Histological Isolated Endarteritis and Solid Endoarteritis Combined with CD20 Positive B Cell Infiltration Appeared in Acute Cellular Rejection on Kidney Allograft Survival.

R. Wang, Y. Jiang, J. Wu, W. Peng, H. Huang, J. Chen.
The Effect of Low-Dose IL-2 in Clinical Facial Transplantation: Molecular and Immunological Response.

N. Murakami,¹ T. Win,¹ T. Borges,¹ C. Lian,¹ G. Murphy,¹ E. Bueno,¹ R. Clark,¹ T. Strom,² B. Pomahac,¹ L. Riella.¹
The Effect of Semimature Dendritic Cell on Transplantation Tolerance of Hepatocytes Differentiated from Mouse Embryonic Stem Cells.

A. Hu, C. Zhang, W. Liao, X. Zhu, X. He.
The Effect of Transplant Center Volume on Survival Outcomes for Patients Listed for Simultaneous Liver and Kidney Transplantation.

R. Modi,¹ D. Tumin,² E. Beal,^3,4 D. Hayes Jr.,^4,5 J. Hanje,^4,6 A. Michaels,^4,6 K. Washburn,^3,4 L. Conteh,^4,6 S. Black,^3,4 K. Mumtaz.^4,6
The Effects of Aspirin on Major Adverse Cardiac Events and Kidney Allograft Outcomes: A Meta-Analysis.

W. Cheungpasitporn, C. Thongprayoon, D. Mitema, M. Mao, W. Kittanamongkolchai, M. Gonzalez-Suarez, S. Erickson.
The Efficacy and Safety of Plaquenil in Kidney Transplants Patients with Lupus.

S. Rhazouani,^1,4 S. Anwar,² D. Brennan,¹ K. Lentine,³ K. Venkatachalam,¹ A. Malone,¹ T. Alhamad.¹
The Effiency and Safety of Chemotherapy for Urothelial Carcinoma in Post-Kidney Transplanted Patients.

Y. Zhu, J. Lin.
The Forgotten Element of KAS: A2 to B Transplantation Reduces Waiting Time for Blood Group B Patients by 20%.

A. Gilbert, S. Radomski, A. Langeberg, B. Diedrich, S. Rosen-Bronson, D. Li, M. Awwad, M. Grafals, J. Moore, J. Verbesey, P. Abrams, S. Ghasemian, M. Cooper.
The IL6/Th17 Pathway May Play Different Roles in Cell-Mediated and Antibody-Mediated Alloimmune Injury in Renal Allografts.

D. Dobi,¹ Q. Tang,² S. Chandran,³ F. Vincenti,³ Z. Laszik.¹
The Immunophenotype of Peritubular Capillaritis in Renal Transplant Biopsies.

T. Chen,¹ L. Rasch,¹ T. Al Johani,² H. McPhail,¹ M. Willicombe,³ A. McLean,³ J. Galliford,³ T. Cook,¹ C. Roufosse.¹
The Impact of De Novo Post-Transplant Diabetes on Hepatic Steatosis and Liver Transplant Outcomes.

C. Reuter,¹ R.-A. Lee,¹ R. Watkins,³ S. Lieber,² K. Szempruch,¹ D. Gerber,⁴ G. DeCherney,² A. Barritt IV.²
The Impact of Early Clinical and Subclinical T Cell Rejection After Kidney Transplantation.

W. Hoffman, P. Sood, R. Mehta, A. Cherukuri, C. Wu, C. Puttarajappa, N. Shah, P. Randhawa, A. Tevar, S. Hariharan.
The Impact of Induction Therapy on Delayed Graft Function Following Kidney Transplantation in Mated Kidneys.

T. Butler, N. Hayde.
The Impact of Insurance Status on Waiting List and Post-Lung Transplant Survival in Patients with Cystic Fibrosis.

C. Lehr,¹ M. Skeans,² E. Dasenbrook,¹ M. Valapour.^1,2
The Impact of Scleroderma Diagnosis on Lung Transplant Outcomes: A Single Center's Experience.

H. Memon, A. Frost, E. Graviss, D. Nguyen, A. Goodarzi, N. Sinha.
The Impact of Tacrolimus and MPA Derivative Immunosuppression on Acheived GFR in Recipients without Rejection: A Comparison of GFR of Living Donor Recipient Pairs at Six Months Post-Transplant.

D. Keith.
The Impact of Tracheal Epithelial Cells Apoptosis on the Biological Behavior of Bone Marrow Mesenchymal Stem Cells (BMSCs) in OB.

X. Zhang,¹ T. Xia,² C. Wang,² K. Jiang,² J. Wang,² J. Nie.²
The Impact of the New Kidney Allocation System on Living Donor Kidney Transplantation(LDTX) Among Patients in the Lowest Quintile of Expected Post-Transplant Survival (EPTS).

C. Rose, J. Gill, J. Lesage, Y. Joffres, J. Gill.
The Implication of the Dominant Side Split Renal Function by Diethylenetriamine Penta-Acetic Acid (DTPA) in Live Kidney Donor.

H. Lee,¹ Y. Yoon,¹ S. Kang,¹ K. Huh,² M. Kim,² S. Kim,² Y. Kim,² W. Han.¹
The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation.

R. Klasek,¹ S. Kuten,¹ S. Patel,^1,3 D. Nguyen,¹ E. Graviss,¹ A. Gaber,¹ R. Knight.¹
The Incremental of Cost of Incompatible Living Donor Kidney Transplant: A National Cohort Analysis.

D. Axelrod,¹ K. Lentine,² M. Schnitzler,² H. Xiao,² X. Lou,³ B. Orandi,³ J. Garonzik Wang,³ A. Massie,³ D. Segev.³
The Inhibitory Effect of Plasma on T Cell Activation: Possible Role of Plasma Exchange in Anti Rejection Therapy.

A. Assounga,^1,2 S. Omarjee.¹
The Intragraft Vascularized Bone Marrow Component and Recipient T Regulatory Cells Facilitate Tolerance Induction After Post Transplant High Dose Cyclophosphamide Treatment in VCA.

G. Furtmüller, B. Oh, M. Fryer, S. Ganguly, V. Malek, X. Zhou, J. Dodd-o, G. Raimondi, D. Cooney, C. Brayton, W. Lee, L. Luznik, G. Brandacher.
The New Kidney Allocation System: The Effect on Elderly Transplantation in the US. Review of UNOS Database.

V. Whittaker, M. Laftavi, Z. Acun, R. Gruessner, A. Gruessner.
The Novel Establishment of Neuroma in Continuity Animal Model Based on Buccal Nerve in Rats.

Y.-H. Hsieh,^1,2 C.-J. Wen,^1,3 C.-H. Lin,^1,2,3,4 F.-C. Wei,^1,2,3 Y.-C. Pei.^3,5
The Outcome of 0 Mismatch Kidney in Pediatric Population with High Immunologic. The Impact of Induction Therapy. An Analysis of UNOS Database.

V. Whittaker, M. Laftavi, Z. Acun, R. Gruessner, A. Gruessner.
The Outcome of Kidney Grafts from Living Donors with Pyelo-Ureteric Junction Dysfunction.

C. Gledhill-Flynn, H. Ali, A. Ahmed.
The Paradox in Pancreas After Kidney Transplantation (PAK): Better Results but Fewer Transplants Despite an Increase in High-Risk Patients.

O. Pankewycz,¹ A. Gruessner,² M. Laftavi,² V. Whittaker,² V. Aggarwal,¹ R. Gruessner.²
The Performance of Four Tools for the Prediction of Potential for Organ Donation After Cardiac Death in Neurocritical Patients: A Prospective, Multicenter, Observational Study.

Z. Guo,¹ G. Xu,¹ P. Schroder,² M. Manyalich,³ X. He,¹ G. Chen.¹
The Polymer Pro-Drug APP-103 Mitigates I/R Injury and Improves Graft Function in a Pre-Clinical Renal Transplant Model.

K. Minami,^1,3 H. Uehara,¹ A. Elkhal,¹ S. Bae,³ J. Reder,² B. Houser,² P. Kang,³ S. Tullius.¹
The Role of Anti-Neu5Gc IgM in Xenograft Antibody Mediated Rejection.

W. Hassanein,¹ G. Braileanu,¹ L. Burdorf,¹ W. Sun,¹ B. French,¹ C. Laird,¹ S. Sendil,¹ C. Ahn,³ D. Ayares,² R. Pierson III,¹ A. Azimzadeh.¹
The Transcription Factor Batf and IRF1 Controls IL-10/IL-27 Expression in Dendritic Cells and Transplant Tolerance Induction.

G. Gu, H. Hang, Q. Xia.
The Treatment of the Graft and the Recipient with α-Lipoic Acid Improves the Delay Graft Function Severity in the Human Kidney Transplant.

G. Weber,¹ N. Ambrosi,² F. Caro,² S. Beltramino,¹ A. Fernández,¹ I. Cabrera,¹ G. Hilchenbach,¹ D. Fernandez,¹ C. Incardona,³ E. Chuluyan,² D. Casadei.¹
The Treg/Th17 Axis: A Dynamic Balance Regulated by Stromal Laminins.

T. Simon, J. Bromberg.
The Value of Protocol Biopsy at Third Month After Kidney Transplant: A Single-Center Cohort Analysis.

R. Rosado-Canto, C. Barrientos-Aguilar, I. Parra-Avila, L. Marino, M. Arvizu-Hernandez, N. Uribe-Uribe, L. Morales-Buenrostro.
Third Liver Transplantation, Outcomes, and the Impact of Previous Graft Survival.

M. Barry,¹ M. Gupta,² D. Goldberg,³ M. Levine,² D. Simpson,² K. Olthoff,² A. Shaked,² P. Abt.²
This is Why We Can't Have Nice Things- Real World Experience with Everolimus in Livers.

C. Perez,¹ J. Fleming,¹ M. Sell,¹ B. O'Brien,¹ A. Rogers,¹ I. Lee,¹ C. Mardis,¹ A. Mardis,¹ N. Patel,¹ H. Meadows,¹ N. Pilch,² K. Chavin,² D. Dubay,² D. Taber.²
Three Induction Therapies on Patients with Delayed Graft Function After Kidney Transplantation, a Three-Year Outcome Analysis.

A. Umber, M. Killackey, A. Paramesh, B. Alper, F. Teran, A. Baudy, Y. Liu, J. Buell, R. Zhang.
Thrombalexin and Mirococept Synergistically Reduce IBMIR in a Porcine to Rhesus Xenoislet Model.

M. Manook,^1,2 J. Kwun,¹ J. Yoon,¹ K. Samy,¹ A. MacDonald,¹ H. Xu,¹ R. Smith,³ A. Dorling,³ A. Kirk,¹ N. Mamode,² S. Knechtle.¹
Time to First Therapeutic Tacrolimus Level: What Impact Does It Have After Heart Transplantation?

O. Witkowsky, J. Teuteberg, C. Sciortino, M. Shullo.
Timing of HLA Testing as a Means of Reducing Cost and Increasing Efficiency of Living Kidney Donation.

E. Venniro, J. Taylor.
Timing, Frequency, and Precipitating Factors of Early Readmission After Heart Transplant.

J. Van Liew, L. Potter, N. Uriel, L. Lourenco.
Titers of Blood Group B Patients Using Non-A1 Reagent/Donor Cells for the Purpose of ABO Incompatible Kidney Transplantation.

D. King, M. Aguilucho, M. Marchioni, B. Figueiredo, I. Okere, P. Rao.
Tocilizmab (Anti-IL-6R) Treatment (TCZ-Rx) Reduced Total IgG Levels Including Anti-HLA IgG: Analysis of IgG Subclasses (IgG1-IgG4) and Anti-HLA IgG Subclasses Show Similar Reductions in All Subclasses from Patients with DSA+ Chronic Antibody-Mediated Rejection (CABMR).

B.-H. Shin,¹ M. Everly,² J. Choi,¹ S. Ge,¹ A. Petrosyan,¹ A. Vo,¹ S. Jordan,¹ M. Toyoda.¹
Tofacitinib-Loaded Solid Lipid Nanoparticles Inhibits Dendritic Cell Antigen Presenting Functions and Achieve Selective In Vivo Targeting.

G. Raimondi,¹ X. Calderon-Colon,² J. Budihardjo,¹ A. Mirdad,¹ M. Iglesias-Lozano,¹ J. Walch,¹ W. Lee,¹ G. Brandacher,¹ J. Patrone.²
Tolerogenic Potential, Migratory Pathways, Engraftment and Long-Term Survival of Human Hematopoietic Chimeric Cells – A Novel Strategy to Induce Tolerance in Transplantation.

M. Siemionow, E. Bryndza Tfaily, E. Szilagyi, J. Cwykiel, S. Uygur, M. Czerwinski.
Toll-Like Receptor 4-Dependent CCAAT-Enhancer-Binding Protein Homologous Protein Activation Induces Hepatocellular Cell Death in Liver Ischemia and Reperfusion Injury.

H. Zhou,¹ Z. Rao,² H. Wang,¹ X. Wang,¹ L. Lu.¹
Total Pancreatectomy and Islet Autotransplantation into the Liver of a Patient with Previous Hepatitis C Infection.

A. Rajab,¹ J. Buss,¹ P. Hart,² D. Conwell,² S. Black,¹ K. Washburn.¹
Total Pancreatectomy with Islet Autotransplantation Improves Quality of Life Allowing for the Resolution of the Intractable Pain with Good Glucose Control in Properly Selected Patients with Chronic Pancreatitis.

A. Kotukhov,¹ J. Solomina,¹ E. Konsur,¹ K. Cieply,¹ L. Basto,¹ L.-J. Wang,¹ K. Golab,¹ M. Tibudan,¹ A. Gelrud,² C. Thomas,² J. Matthews,¹ P. Witkowski.¹
Trafficking of Donor Leukocytes and Recipient Cells Cross-Dressed with Donor MHC Molecules After Transplantation of Cardiac Allografts in Monkeys.

J. Marino, K. Robinson, J. Paster, I. Hanekamp, J. Madsen, G. Benichou.
Transcatheter Relief of Symptomatic Hepatic Venous Outflow Obstruction Following Pediatric Liver Transplantation.

B. Goldstein, G. Tiao, M. Alonso, N. Johnson, J. Heubi, K. Averin, J. Bucuvalas.
Transcript Changes Associated with Graft Rejection Are Not Specific for Rejection Because They Are Shared with Tissue Responses to Wounding.

P. Halloran, K. Famulski, INTERCOMEX Study Group.
Transcriptome Analysis of CD4-Lymphocyte Specifically Deleted of IKKbeta or NEMO in an Experimental Model of Rapid Progressive Glomerulonephritis (RPGN).

F. Thaiss,¹ J. Huang,² M. Chen,¹ H. Paust,¹ G. Zahner,¹ M. Alawi,² R. Geffers,³ L. Guo.¹
Transient High Dose Tacrolimus Allows Tolerance of a Vascularized Composite Allograft Tolerance Across a Full MHC Mismatch.

A. Leto Barone, H. Wang, E. Swanson, K. Kolegraff, J. Lopez, G. Furtmüller, B. Oh, S. Alfadil, S. Mermulla, J. Sacks, S. Bonawitz, G. Raimondi, J. Shores, D. Cooney, W. Lee, G. Brandacher.
Transplant Center Knowledge and Planned Practice of HIV Positive-to-Positive Transplants.

S. Rasmussen, M. Bowring, A. Shaffer, C. Durand, D. Segev.
Transplant Professionals' Attitudes and Approaches to the Living Kidney Donor-Recipient Relationship: Interview Study.

A. Ralph,^1,2,3 P. Butow,^3,4,5 J. Craig,^1,2 J. Chapman,⁸ J. Gill,⁶ J. Kanellis,⁷ A. Tong.^1,2
Transplant without Borders – A New Project for Decentralization of Transplant Centers in Brazil.

M. Perosa, J. Branez, L. Mota, B. Zeballos, H. Noujaim, M. Paredes, T. Miranda, G. Martinho, T. Genzini.
Transplantation of Hepatitis C Kidneys to Hepatitis C Recipients Confers Significantly Shorter Waiting Times in the Era of the New Kidney Allocation System.

B. Concepcion, A. Langone, B. Edmundson, J. Johnson, A. Rajput, T. Johnson, D. Rybacki, D. Hale, R. Forbes.
Treating Refractory Liver Allograft Rejection with Photopheresis.

I. Lopez Plaza,¹ A. Eisenbrey,¹ M. Raoufi,¹ A. Yoshida,² D. Moonka.²
Treatment of Post-Transplant Nephrotic Syndrome with Adrenocorticotropic (ACTH) Gel.

A. Khalil,² A. Karabala,¹ A. Sharfuddin,² M. Grafals.¹
Trends in Infection Among Kidney Transplant Recipients, 1999-2013.

S. Bae, C. Durand, L. Kucirka, S. DiBrito, R. Avery, J. Garonzik Wang, D. Segev.
Trends in Liver Transplantation Among Older Adults with ESLD.

C. Haugen,¹ Q. Huang,² M. Pozo,¹ M. McAdams-DeMarco,² D. Segev.^1,2
Trends in Long-Term Outcomes of Kidney Transplantation in Australia and New Zealand.

W. Lim,¹ W.-C. Yeung,² S. Campbell,³ S. Chadban,⁴ P. Clayton,⁵ C. Hawley,³ D. Johnson,³ S. McDonald,⁵ E. Pascoe,⁶ G. Wong,⁷ S. Badve.²
Triptolide Alleviating Acute Antibody Mediated Rejection by Inhibition of B Cell Activation in Presensitized Recipients.

D. Zhao,¹ S. Li,¹ T. Liao,¹ Y. Wei,² X. Hua,¹ F. Han,¹ Z. Luo,¹ X. Liu,¹ Q. Sun.
Two Months Delayed Induction of Mixed Chimerism After Heart and Kidney Cotransplantation in Nonhuman Primates.

K. Huh,¹ W. Sommer,¹ K. Robinson,¹ X. Wu,¹ J. Paster,¹ I. Hanekamp,¹ A. Dehnadi,¹ T. Kawai,^1,2 R. Smith,³ R. Colvin,^1,3 G. Benichou,¹ J. Madsen.^1,4
Two Promoter Polymorphisms in the Genes Encoding for Complement Regulating Proteins CD46 and CD59 in Kidney Donors Are Associated with Biopsy Proven Acute Rejection.

L. Michielsen,¹ A. van Zuilen,¹ T. Kardol-Hoefnagel,² M. Verhaar,¹ H. Otten.²
Type of Surgical Procedures and Clinical Significance of Calcineurin Inhibitor Temporary Discontinuation Regarding LT Recipients Undergoing Major Elective Surgery.

C. Cho, J. Lee, K. Kim, S. Kim, J. Lee, K. Lee, J.-M. Kim, G.-S. Choi, C. Kwon, J.-W. Joh.
Type-1 Interferon Impairs the Immunoregulatory Activity of IL-10: A Mechanism in the Abrogation of Transplant Tolerance.

M. Iglesias, A. Arun, B. Lam, W. Lee, G. Raimondi, G. Brandacher.
Understanding the Role of Induction Agents in Older versus Younger Kidney Transplant Recipients.

Q. Huang, F. Ammary, M. McAdams-DeMarco, D. Segev.
Urinary Concentration Ability in Kidney Transplant Patients as Predictor for CKD.

P. Garcia-Garcia,¹ A. Jarque,¹ A. Rivero,¹ A. Rodriguez,¹ J. Gonzalez Posadas,¹ M. Macia,¹ V. Garcia Nieto,² J. Navarro.¹
Urinary Proteomics to Diagnose Chronic-Antibody-Mediated Rejection in Pediatric Kidney Transplantation.

N. Kanzelmeyer, P. Zürbig, H. Mischack, K. Heindl Ruszai, T. Seemann, M. Hansen, M. Henn, A. Fichtner, B. Toenshoff, A. Melk, L. Pape.
Urinary Type III Procollagen (PIIINP) Is Associated with Chronic Allograft Dysfunction and Predicts Graft Survival.

R. Yilmaz,¹ T. Yildirim,¹ D. Baydar,² B. Altun,¹ Y. Erdem.¹
Urine Biomarkers (UBio) Correlate Poorly with Pre-Liver Transplant (LT) Kidney Biopsy Findings and Post-LT Kidney Function.

H. Wadei,¹ J. Belcher,² C. Parikh,² T. Gonwa,¹ M. Mai,¹ J. Lieske.³
Uromodulin and Toll-Like Receptor 4 Levels Predict Susceptibility to Bacterial Urinary Tract Infection After Renal Transplantation.

K. Stahl,¹ H. Lührs,¹ J. Schmitz,² I. Scheffner,¹ W. Gwinner,¹ J. Bräsen,² H. Haller,¹ M. Schiffer.¹
Use of Biodegradable Stents for the Treatment of Anastomotic Biliary Strictures in Pediatric Liver Transplant Patients.

J. Quintero,¹ J. Juamperez,¹ V. Cabello,¹ M. Perez,³ I. Bilbao,² J. Molino,¹ R. Charco.²
Use of Forensic DNA Testing to Trace Unethical Organ Procurement and Organ Trafficking Practices.

M. He,^1,2 A. Corson,² Z. Wang,³ J. Russo,² T. Trey.²
Use of Hepatitis C Infected Organs for Kidney Transplantation: A Cost-Effective Analysis.

B. Kiberd,¹ K. Doucette,² K. Tennankore.¹
Use of Modified Geriatric Assessment in Evaluation of Older Adults for Kidney Transplant Suitability.

K. Campbell,¹ F. Enger, E. Patrick,² M. Saunders,³ M. Josephson,¹ Y. Becker.²
Use of Pulsatile Perfusion Modifies the Effect of Delayed Graft Function on Graft Failure.

A. Thomas, A. Shaffer, A. Massie, D. Segev.
Usefulness of Multi-Detector Computed Tomography (MDCT) Scanning as a Replacement for Diethylenetriamine Pentaacetic Acid (DTPA).

H. Lee,¹ W. Han,¹ K. Huh,² M. Kim,² S. Kim,² Y. Kim,² Y. Yoon.¹
Using Basiliximab Does Not Increase De Novo DSA Incidence but Reduces Cytomegalovirus Infections and Neoplastic Complications in Non-Sensitized Kidney Transplant Patients.

M. Marron-Wojewodzki,¹ I. Szwarc,¹ C. Rene,² J.-F. Eliaou,² G. Mourad,¹ M. Le Quintrec.^1,3
Using Buccal Swabs for Deceased Organ Donor HLA Typing.

C. Muse,² S. Longobardi,¹ I. Gimferrer,¹ J. Orlowski.²
Utility of Concomitant Biopsy in Simultaneous Pancreas Kidney Transplant Recipients in the Identification of Rejection of Pancreas and Kidney.

C. Johnson, K. Johnson, B. Kaplan, M. Temkit, R. Heilman, S. Sukumaran Nair, H. Khamash, J. Huskey, G. Mour, H. Chakkera.
Utility of Electron Microscopy in Kidney Transplant Biopsies.

J. Grodsky,¹ R. Craver,^1,2 I. Ashoor.²
Utility of a 10-Minute Functional Test as a Predictor of Kidney Transplant (KTP) Listing.

M. Swee,^1,2 J. Hornickel,² R. Kalil.^1,2
Vancomycin Prophylaxis for Prevention of Clostridium difficile Recurrence in Renal Transplant Patients.

L. Spliner,¹ J. Fose,¹ G. Leverson,² J. Smith,³ C. Saddler,³ M. Jorgenson.¹
Variability in Tacrolimus Concentrations Across Pediatric Solid Organ Transplants.

S. Min,¹ T. Daljevic,¹ O. Lee,¹ M.-E. Alary,⁶ F. Murdoch,⁵ R. Parekh,¹ V. Ng,¹ D. Hebert,¹ L. Hamiwka,² T. Blydt-Hansen,³ V. Phan,⁴ P. Birk,³ U. Allen,¹ S. Urschel,⁵ CNTRP POSITIVE Research Group, B. Foster,⁶ S. Mital.¹
Variables Associated with Liver Graft Utilization and 30-Day Failure: A Liver Graft Quality Index.

J. Tang,¹ M. Esfandiari,¹ A. Zarrinpar.²
Vascularized Bone Marrow Mechanisms of Immunomodulation.

A. Khalifeh, E. Buckingham, M. Uluer, W. Hassanein, W. Twaddell, C. Drachenberg, A. Nam, S. Bartlett, R. Barth.
Very Long Term Graft Survival. Forecasts Factors.

S. Jimenez Alvaro, R. Marcen Letosa, A. Fernandez Rodriguez, S. Elias Treviño, C. Galeano Alvarez, F. Liaño Garcia.
Vimentin Regulates ß-Catenin Translocation During Epithelial to Mesenchymal Transition in Renal Fibrosis.

R. Lopez-Soler, Z. Wang, A. Divanyan.
WHO Group II Pulmonary Hypertension Is Associated with Decreased Survival in Patients Awaiting Liver Transplantation.

H. Memon, J.-A. Guerra, B. Trachtenberg, J. Estep, A. Bhimaraj, I. Hussain, M. Park, H. Monsour, M. Ghobrial, A. Guha.
Waitlist Outcomes of Patients Re-Listed Following Failed Donation After Cardiac Death (DCD) Liver Transplant.

K. Croome, D. Lee, A. Keaveny, C. Taner.
Waitlist and Post-Lung Transplant Mortality Vary by Diagnosis for a Given Lung Allocation Score.

H. Maredia, M. Bowring, A. Massie, S. Oyetunji, C. Merlo, R. Higgins, D. Segev, E. Bush.
Warm Ischemic Time as an Additive Predictor of Graft Survival in KDPI/KDRI Era of Kidneys from Donors After Cardiac Death: A Single-Center Experience Over Three Decades.

M. Kusaka,¹ Y. Kubota,¹ H. Takahashi,² H. Sasaki,¹ M. Takenaka,¹ N. Fukami,¹ T. Kenmochi,³ R. Shiroki,¹ K. Hoshinaga.¹
Weekend Discharge and Early Hospital Readmission After Kidney Transplant: A Multi-Center Analysis.

M. Harhay,¹ Y. Jia,² H. Thiessen Philbrook,² B. Besharatian,³ R. Gumber,³ F. Weng,⁴ I. Hall,⁵ M. Doshi,⁶ B. Schroeppel,⁷ C. Parikh,² P. Reese.³
What Are “Normal” CSF Findings in the Non-Infected Brain Dead Organ Donor?

R. Steiner,^1,2 C. Wainaina,² J. Tragaser,² L. Stocks.²
Which Tr1 Is Better for Transplant Tolerance Induction: Comparing the Tr1 Generated by IL-27 or TGF-βplus IL-27.

G. Gu, H. Hang, Q. Xia.
Willingness of Canadian ESRD Patients to Consider Transplant Tourism.

J. Gill, G. Gill, Y. Joffres, C. Rose, J. Gill, L. Russell, A. Levin, C. Richardson.
Worsening Rather Than Severe Acute Kidney Injury Affects Kidney Transplantation Outcomes.

M.-Y. Yu,¹ B. Yu,² Y. Kim,¹ S. Mi,³ J. Ha,³ J. Yang,³ Y. Kim,¹ H. Lee.¹
Xenogeneic Lung Transplantation: Identifying Transgenes and Supportive Drug Treatments to Achieve Long-Term Survival.

L. Burdorf,¹ C. Laird,¹ N. O'Neill,¹ T. Zhang,¹ D. Parsell,¹ I. Tatarov,¹ A. Cimeno,² S. Sendil,¹ K. Thomas,¹ C. Phelps,² D. Ayares,² A. Azimzadeh,¹ R. Pierson III.¹
eHealth Literacy and Patient Portal Utilization Among Transplant Recipients.

K. Smith, A. Ruiz, J. Wedd, S. Pastan, R. Parker, R. Patzer.
mTOR Inhibitor and Low-Dose Tacrolimus in Pediatric Kidney Transplant (PKT): 9-Years Data of a Bi-Therapy Treatment.

R. Vilalta, E. Lara, A. Madrid, M. Muñoz, S. Chocron, G. Ariceta.
mTORC1 and 2 Regulate Dendritic Cell (DC) Metabolism and Allostimulatory Function of Donor DCs in Skin Transplantation.

A. Watson,^1,2 H. Dai,^1,3 A. Menk,^4,5 G. Delgoffe,^4,5 A. Thomson.^1,2,3
Tissue Transcriptional Profile of Portal Inflammation with Interface Activity in Pediatric Liver Transplant (LT) Recipients with Normal Liver Tests Closely Resembles T Cell Mediated Rejection (TCMR).

A. Sanchez-Fueyo, S. Feng, A. Demetris, J. Bucuvalas, J. Lozano, J. Magee, K. Spain, S. Kanaparthi, iWITH Investigators.
Costimulation Independent Acute Rejection Requires CD127 Signaling.

D. Mathews, Y. Dong, S. Kim, C. Breeden, A. Adams.
Community Health, Center Proximity, and Liver Transplant Waitlist Mortality.

R. Lynch,¹ K. Ross,¹ D. Goldberg,² R. Patzer.¹
Improving Communication of SRTR Transplant Program Outcomes Evaluations Using a 5-Tier System.

J. Snyder, A. Wey, N. Salkowski, A. Israni, B. Kasiske.
Outcomes from a Multinational Randomised Controlled Trial Comparing Normothermic Machine Perfusion with Static Cold Storage in Human Liver Transplantation.

D. Nasralla,¹ Consortium for Organ Preservation in Europe Liver Research Group,¹ R. Ploeg,¹ C. Coussios,² P. Friend.¹
Transplanting Hepatitis C Kidneys into Negative KidnEy Recipients [THINKER] Trial.

D. Goldberg, E. Blumberg, R. Reddy, S. Nazarian, V. Van Deerlin, J. Trofe-Clarke, M. Levine, D. Sawinski, R. Bloom, P. Abt, P. Reese.
EXPANDER-1: Exploring Renal Transplants Using Hepatitis-C Infected Donors for HCV-Negative Recipients.

C. Durand, D. Brown, R. Wesson, N. Bhair, F. Naqvi, D. Ostrander, M. Bowring, A. Massie, S. Rasmussen, J. Sugarman, D. Segev, M. Sulkowski, N. Desai.
Etiology and Timing of ESRD After Kidney Donation.

A. Matas, D. Berglund, B. Sengupta, H. Ibrahim.
Is the Current Heart Allocation System Just and Fair for Blood Type O Recipients? – A Propensity-Matched Analysis of 34353 Patients in the UNOS Registry.

M. Ando, K. Takeda, P. Kurlansky, M. Wright, C. Lee, J. Han, A. Garan, V. Topkara, M. Yuzefpolskaya, P. Colombo, M. Farr, Y. Naka, H. Takayama.
Vital Role of the CoREST Complex as a Master Regulator of Foxp3+ T-Regulatory Cell Gene Expression and Suppressive Function.

L. Wang,¹ A. Samanta,¹ M. Levine,¹ U. Beier,¹ R. Han,¹ J. Kalin,² E. Holson,³ P. Cole,² W. Hancock.¹
A Multidimensional Prognostic Score and Nomogram to Predict Kidney Transplant Survival: The Integrative Box (iBox) System.

A. Loupy,¹ O. Aubert,¹ B. Orandi,² A. Jackson,² M. Naesens,³ N. Kamar,¹ O. Thaunat,¹ E. Morelon,¹ M. Delahousse,¹ D. Viglietti,¹ D. Glotz,¹ C. Legendre,¹ X. Jouven,¹ R. Montgomery,² M. Stegall,⁴ D. Segev,² C. Lefaucheur.¹
Emerging Application of Active Immune Targeted Delivery in Transplantation.

M. Uehara,¹ J. Azzi,¹ B. Bahmani,^1,2 J. Cheng,³ Q. Yin,³ L. Tang,³ K. Cai,³ Q. Sun,³ M. Kwon,³ Q. Xu,² G. Brandacher,⁴ R. Abdi.¹
MHC Class II-Peptide Complexes Displayed on Activated T Cells Guide Treg Suppression.

M. Fryer, S. Junius, S. Germana, L. Turka, C. LeGuern.
Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Solid Organ Transplant Recipients: A Phase 2 Study.

M. Pereira,¹ F. Silveira,² G. Papanicolaou,³ A. Langston,⁴ R. Avery,⁵ A. Wijatyk,⁶ J. Wu,⁶ M. Boeckh,⁷ F. Marty,⁸ S. Villano.⁹
Donor SIRPa Polymorphism Modulates the Innate Immune Response to Allogeneic Grafts.

H. Dai,¹ A. Friday,¹ K. Abou-Daya,¹ A. Williams,¹ M. Oberbarnscheidt,¹ J. Danska,² F. Lakkis.¹
HCC and Liver Transplantation Following the Recent Allocation Policy Change.

T. Ishaque, A. Massie, M. Bowring, J. Ruck, A. Cameron, B. Philosophe, D. Segev.
Uptake of Extracellular Mitochondria Activates Human Endothelial Cells That Stimulate Alloreactive Effector T Cell Responses.

T. Brennan,¹ F. Feng,¹ L. Lin,¹ M. Song,¹ Q.-J. Li,² A. Kirk,^1,2 H. Xu.¹
Dysregulated Innate Immune Response Is a Robust Predictor of Allograft Injury and Survival Across All Transplanted Organs.

T. Azad,¹ M. Donato,¹ L. Heylen,² S. Shen-Orr,³ T. Sweeney,¹ M. Naesens,² P. Khatri.¹
Inflammasome, Unfolded Protein Response, and T Cell Immunity in DAIH.

A. Arterbery,¹ M. Martinez,³ S. Lobritto,³ Y. Avitzur,² U. Ekong.¹

« View all sessions from the 2017 American Transplant Congress